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A B S T R A C T 
N U C L E O S I D E AND N U C L E O T I D E A N A L O G U E S C O N T A I N I N G 
F L U O R I N E 
hv Nigel Christonher Parkinson 
The work contained in this thesis is divided into four sections detailing the 
formation of (diethoxyphosphinyl)difluoromethylene substituted cycloalkanes and 
alkenes and their chemistry, as well as the syntheses of purine and pyrimidine substituted 
polyfluoroethers: 
(i) The methodology for the introduction of the (diethoxyphosphinyl)difluoromethylene 
group was studied and extended, with specific reference to cyclic systems. The group 
was successfully introduced into cyclic alkenes with (diethoxyphosphinyl)difluoro-
methylene zinc bromide and saturated systems with (diethoxyphosphinyl)difluoromethyl 
lithium. The organolithium reagent was also shown to be capable of ring opening 
epoxides to yield alcohols; 
(ii) The (diethoxyphosphinyl)difluoromethylene substituted cyclohexene derivative was 
further functionalised in a four step process to a new class of adenine and guanine based 
nucleotide analogues. Model studies were carried out on the (diethoxyphosphinyl)-
difluoromethylene substituted cyclohexene derivative with a variety of reagents to 
introduce functionality at the double bond; 
(i i i ) The radical addition of (diethoxyphosphinyl)bromodifluoromethane and 
(diethoxyphosphinyl)difluoroiodomethane to cycloalkenes using ultraviolet photolysis 
and gamma-ray initiation were successfully carried out, thus opening up a new route into 
(diethoxyphosphinyl)difluoromethylene substituted cycloalkanes; 
(iv) The synthesis of purine and pyrimidine nucleoside analogues is described via the 
coupling of 2-amino-6-chloropurine, 6-chloropurine, silylated 5-fluorouracil and silylated 
uracil to various a-haloethers. The a-haloethers having previously been synthesised by 
radical chlorination of both cyclic and acycUc polyfluoroethers. 
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C H A P T E R ONE 
F L U O R I N A T E D N U C L E O S I D E S AND N U C L E O T I D E ANALOGUES 
L A General Introduction 
As the thirteenth most abundant element in the Earth's crust,^ surprisingly, 
fluorine is found in very few natural products, e.g. potassium monofluoroacetate present 
in the South African Gifblaar plant {Dichapetalam cymosum) and more than thirty other 
tropical plants in South America, Africa and Australia,^ co-fluorooleic acid-^  and co-
fluoropalmitic acid'^ found in the shrub ratsbane (Dichapetalam toxicarium), and 
nucleocidin,^ an antibiotic isolated from Streptomyces calvus. Most organofluorine 
compounds are therefore 'unnatural', i.e. man made moieties, and the introduction of 
fluorine into organic molecules has spawned a large number of compounds with a wide 
and varied application.^"^ 
Fluorinated compounds can be generally divided into highly fluorinated 
derivatives, i.e. where all or most of the carbon to hydrogen bonds are replaced by 
fluorine, or lightly fluorinated compounds. These two broad groups generally find quite 
different application. 
Highly fluorinated saturated compounds are used as c o o l a n t s , f i r e 
extinguishers,^^ anaesthetics,^ ^ polymers^ '^^ "^ and blood substitutes,^ ^-^^ the prerequisite 
in their applications being the chemical inertness of the compounds. Inertness of such 
compounds can be attributed mostiy to the strength of the carbon to fluorine bond; which 
at 485kJmol-^ is the strongest single covalent bond to carbon. 
Lightly fluorinated compounds have become extremely important to the 
pharmaceutical industry, where a certain similarity must exist between the biologically 
active substrate and the modified derivative. To this end lightiy fluorinated materials have 
found uses as antitumour,^^ antifungaP^ and antiviral agents-^° as well as biological tools 
for probing-^^ and NMR imaging.'^ '^ '^ "' 
It is these lightiy fluorinated compounds which will be discussed in this thesis 
with specific reference to nucleoside and nucleotide analogues. 
LB Fluorine in Biological Systems 
The chemical alteration of biologically active compounds, for use as potential 
antimetabolites, is very well established.•^ •^•^ ^ Modification, by the introduction of 
halogen atoms is of particular interest, in that, enhancement of biological activity is often 
observed, e.g. the highly potent pesticide decamethrin (1),^ ^ based on the natural 
occurring pyrethroid pesticides isolated from chrysanthemums, or the important class of 
compounds, the fluorosteriods, e.g. 6-a-fluoroprogesterone (2),^ ^ which is ten times 
more reactive than the natural hormone progesterone. 
CH3 .^°<^"3 
Br' ^ ° ° a " ~ " | r ^ ' ' 
(1 R, 3fl, a S ) 
F 
(1) (2) 
As new reagents, and improved techniques, for the selective introduction of 
fluorine and polyfluoroalkyl/alkenyl groups become available,^^'^^ fluorine containing 
pharmaceuticals and agrochemicals have achieved an increased prominence in modern 
bioorganic chemistry, due to their unique physiological effects and properties, these are 
outlined below. 
L B . l Fluorine as a Hydrogen Suhstitute 
The most sterically similar monovalent element to hydrogen is the fluorine atom 
(the Van Der Waals' radius of fluorine: 1.35A; of hydrogen: l.lA).^^ Thus, in most 
instances, the substitution of hydrogen by fluorine in an organic substrate causes littie or 
no perturbation of the geometry; and generally a fluorinated analogue will bind at an 
enzymic site with comparable affinity. Once bound the substrate can: 
i) be turned over by the biological system, to give an unnatural product containing 
fluorine, i.e. mimic the natural substrate; e.g. the hydrolysis of the prochiral ester diethyl-
2-fluoro-2-methylmalonate by Lipase-MY from the yeast Candida cylindracea in 91% 
enantiomeric excess. 
0 0 0 0 
JL Esterase Lipase-MY ^ JL JL 
Eio^ yC yC 
p C H - , p CH3 
(S)-isomer 
or 
ii) inhibit the enzyme, stopping key biological processes e.g. the use of 
monofluoroacetate by the Gifblaar plant as a defensive mechanism, where 
monofluoroacetate blocks the Krebs cycle and inhibits citrate transport;^-' or compound 
(3) which inhibits acetyl-cholinesterase, a neurotransmitter.^"* These are termed 'lethal 
syntheses' because the modified substrate binds irreversibly to the enzyme active site 
precipitating the death of the cell and ultimately the organism. 
The mode of action of the enzyme on the substrate depends on whether the 
mimicking fluorine atoms are directly involved in electrostatic interactions or chemical 
processes at the active site. Given that either or both the afore mentioned facts are the 
case, inhibition may occur due to the dramatic differences in the strength and electronic 
properties associated with the carbon-fluorine and carbon-hydrogen bonds. 
Fluorine Hydrogen 
Average bond strength to carbon^^ 
(kJmol-1) 
485 413 
Electronegativity on Pauling scale^ ^ 
(carbon: 2.55) 
3.98 2.20 
I.B.2 Flupring a$ a" Qxyggn Mimiy 
The high electronegativity of fluorine means it can be used to mimic oxygen in many 
biological systems^ -^^ ^ due to : 
i) The polar effect of a fluorine atom being similar to that of a hydroxyl group; 
ii) three lone pairs available on a fluorine atom mean it can act as a Lewis base in 
hydrogen bonding, though not a donor cf. the hydroxyl group; 
iii) the difluoromethylene group can be considered to be isosteric with the oxygen 
moiety. The bond angle C-CF2-P in l,l-difluoro-2-aminoethylphosphonic acid (4) is 
very similar to that of the corresponding phosphate C-O-P angle , at 116.5° for the 
former and 118.7° in the latter, compared to 112.1° for C-CH2-P in 2-
aminoethylphosphonate.^^ Other evidence for the isosteric nature of the 
difluoromethylene unit is that the (dihydroxyphosphinyl)difluoromethylene group is 
capable of being metabolised in enzymic systems e.g. NADH linked glycerol-3-
phosphate dehydrogenase;^^ 
118.7^ 
H^N 
O 
II 
P - 0 -
OH 
116.5° 
(4) 
H.N 
O 
II 
P - 0 -
6H 
H H 
112.1° 
iv) the effect on charge distribution of the two groups is similar, which can be 
judged by the second acid dissociation constants of the substituted phosphate anions 
(figure 
pKa2 
figure 1.1 
O 
7.08 
I.B.3 FluQring in Transport Mgghani§m$ 
The introduction of fluorine or a small perfluoroalkyl/aUcenyl group, Rp, into an 
organic molecule is highly desirable in connection with biological studies. This is due to 
the high lipophilic nature of the Rp group,-^^ which can favour increased in vivo 
transport, and absorption rate of a drug across a lipid membrane. This is used to greatest 
effect in the agrochemical industry, with the almost routine introduction of a 
trifluoromethyl group. 
I .C Fluorine Containing Nucleosides 
I . C . I Intrp^uctiQn 
Fluoronucleosides constitute a group of synthetic compounds useful as potential 
antiviral agents'*^ i.e. they can directly inhibit virally encoded enzymes without a major 
effect on cellular metabolism; to this end fluorine has been selectively substituted into a 
number of sites in naturally occurring nucleosides (figure!.2) with the hope of preventing 
viral nucleic acid replication in vivo. 
CxHyFz 
CxHyFz 
CxHyFz 
figure 1.2 
To gain an insight into the physiological mode of action of the nucleoside 
analogues it is important to understand the cellular cycle for DNA or RNA synthesis from 
the nucleoside pool; scheme 1.1 illustrates the biosynthesis of deoxythymidine 
triphosphate by repeated phosphorylation, which can then be incorporated into DNA by 
the enzyme DNA polymerase. It is at the last step that most antiviral agents discussed in 
this section are targeted. 
T 
HO 
Thymidine 
Kinase 
OH 
. i Cellular Enzymes 
y 
DNA 
DNA 
Polymerase HO 
0 0 0 
II II II 
^ 0 ^ 1 
HO HO HO 
scheme 1.1 
I.C.2 Base Modified Derivatives 
The advent of the potent antitumour drug 5-fluorouracil'^^ in the 1950s for the treatment 
of bowel cancer, leukaemia and Hodgkin's disease demonstrated the potential of 
introducing fluorine into a nucleic acid base. From this starting point selective 
fluorination of bases attached to nucleosides began. 
I,C.2.a Pyrimiclingg 
I.C.2.a.(i) Modification at C5 in the Ring 
In 1959 iododeoxyuridine (5)'^^ and later 5-trifluoromethyldeoxyuridine (6),'^ '^  
originally synthesised as potential antitumour agents, were found, in the form of their 
triphosphates, to inhibit viral DNA polymerase. They were non-specific in their action, 
with a problem therefore of high toxicity, however, despite this they were used clinically 
against herpes infections.'^^ 
HO HO 
The fluoronucleoside (6) was synthesised from the acetyl protected derivative of 
(5), however, the difluoro- and monofluoro-methyl analogues were prepared via halogen 
exchange on the thymidine methyl group"^ ^ (scheme 1.2); these analogues of (6) showed 
falling activity, the monofluoromethyl derivative possessing negligible antiviral activity, 
o o o 
NH N ^ ^ N H Y ^ ^ N H 
A . — N^A^  HO-. N^A, 
(i) 
AcO V O . ^ N 
OAc OH 
(6) 
(i) Ac20, pyridine; (ii) Cu, DMF, CF3I; (iii) H3O+. 
O 
FoHC 
BuPhoSO 
(i) 'BuPh2SiCl, pyridine; (ii) 2Br2, CCI4, hv; (iii) AgF, MeCN; (iv) "BU4NF, THF. 
scheme 1.2 
A significant discovery followed when it was observed that replacement of the 
thymidine methyl group with a larger carbon chain led to greater efficacy against herpes 
simplex virus 1 (HSVl).^! The increase in activity came from a greater substrate 
specificity of the analogues towards virally encoded thymidine kinase (TK),^2 in so 
doing the mono- and diphosphate concentration of the antiviral agent increased over that 
of the natural nucleotides in infected cells. 
1970 saw the synthesis of the (£')-5-bromovinyl analogue BVDU (S)'*^  the most 
active of the C5 substituted thymidines. Fluorinated side chains have also been 
investigated, however, their efficacy was shown to be much lower (table 1.1). 
A 
Compound R 1 HSV-1 activity | HSV-2 activity 
6 CF3 vv 
7 CHF2 vvv 
8 (£:)-CH=CHBr 
9 CH2F Inactive Inactive 
10a (£:)-CH=CHF 
10b (Z)-CH=CHF Inactive Inactive 
11 (£:)-CH=CHCF3 W W vv 
12 CF=CFCF3 Inactive Inactive 
13 
v % 
Inactive Inactive 
14 Inactive Inactive 
15 CF2CF3 V 
V = indicates relative measure of potency 
table 1.1 
Compounds (12)-(14) were synthesised by Coe et al.'^^ by the reaction of (5) 
with butyllithium, followed by subsequent electrophilic attack of a polyfluoroolefin, 
(scheme 1.3); 
R2 Ri 
OSiMea OSiMeg OH 
(12)-(14) 
(i) (Me3SiN)2H, (NH4)2S04, A; (ii) '^BuLi; (iii) Fluoroalkene; (iv) H3O+. 
Rl = F, CF3; R2 = R3 = F, H, -(CF2)3-, -(CF2)4-
scheme 1.3 
while the methodology for the attachment of fluoroalkyl substituents at C5, e.g. 
compound (15), was achieved by the use of fluoroalkyl mercury reagents'*^ 
(schemel.4). 
(i) 2,2'-azobisisobutyromtrile; (ii) (C2F5)2Hg 
scheme 1.4 
8 
It can be seen from table 1.1 that activity is dependant on a number of factors,^° 
although, these are not clearly understood. However, the number of vinylic hydrogens is 
important; activity drops in the polyfluoroalkenyl series with increased halogen 
substitution. Similarly, geometric isomers of the same group also show wide variation in 
inhibiting DNA polymerase; (Z)-isomers showing little or no action.^^ The crystal 
structure^^ of (£')-BVDU (8) indicates a structure (figure 1.3) with the bromovinylic 
hydrogen bonding to the 4-oxygen, which may allow the nucleoside to fit ideally within 
the catalytic site of the viral TK. This hydrogen bond would be absent in the (Z)-isomers 
and higher halogenated moieties. 
OH 
(8) 
figure 1.3 
LC.2.a.(ii) MQ^lifipatign at Q4 PQ i^tiQn 
German workers^^ have successfully modified the C4 keto group of thymidine 
and uracil derivatives by its conversion into a difluoromethylene ether. The themiolysis 
of bis(trifluoromethyl) mercury yields difluorocarbene which with suitable protection and 
activation of the nucleosides yields a range of difluoromethylene ethers (scheme 1.5). 
The mode of action of these compounds in vivo is as yet uncertain, though some of the 
analogues show significant inhibition of DNA polymerase. 
AcO 
OSiMe. OCF2SiMe3 OCFoH 
A A O AcO 
(i) 
OAc OAc 
(i) Nal, Hg(CF3)2, THF; (ii) H2O; (iii) HCl, EtOH, 0°C. 
scheme 1.5 
9 
I.C.2.a.(iii) Modification at N3 in the Ring 
The detiberate substitution of the N3 nitrogen in cytidine led M^Namara and 
Cook^ "^  to a potent anticancer agent (scheme 1.6). 
1 NHo 1 
X 
1 1 \ 1 1 / H " H 
HO 
(iv),(v),(vi) 
OH OH 
(16) 
(i) NH3; (ii) NaOH; (iii) N2H4, EtOH, A; (iv) (Me3SiN)2H; (NH4)2S04; (v) SnC^, 1-chloro-tri-O-benzyl-
ftiranose; (vi) NaOCH3, MeOH. 
scheme 1.6 
The 3-fluoropyridone nucleoside (16) was synthesised by nucleophilic aromatic 
substitution on pentafluoropyridine in an overall yield of 12% and, although, the 
cytostatic properties and efficacy of the nucleoside were found to be excellent, again a 
definitive reason for activity is unclear, and may be due to the CF bond acting as an 
isostere and isopolar group for nitrogen. 
I.C.2.b Purines 
I.C.2.b.(i) MQ^ificatipn at C2 in th^ ring 
Modification at the C2 position of purine derivatives with fluorine containing 
moieties came to the fore when Montgomery and co-workers^^ found that 2-
fluoroadenosine (17) and its sugar modified congeners were cytostatic, with resistance 
towards deamination by the catabolic enzyme adenosine deaminase and thus potential 
anticancer agents. This enzyme is responsible for conversion of the nucleic acid residue 
adenine to inosine in vivo; consequentiy depleting the bioavailability of any adenine based 
antiviral agent. To this end a number of routes to introduce fluorine containing moieties 
at C2 have arisen. 
Robins and Uznanski^^ developed a high yielding route into 2-fluoroadenosine 
derivatives by non-aqueous diazotisation (scheme 1.7), overcoming hydrolysis of the 
glycosidic linkage found in previous routes^ -^^ ^ utilising diazotisation in strongly acidic 
media. 
10 
H o N - ^ M ^ ^ N 
HO OH 
(vi) 
AcO OAc AcO OAc 
(v) AcO 
AcO OAc AcO OAc HO OH 
(17) 
(i) Ac20, pyridine, DMF; (ii) POCI3, PhNMe2, Et4NCl. MeCN; (iii) K F , MesN, DMF; (iv) tBuN02, HF, 
pyridine; (v) NH3, (CH20CH3)2; (vi) EtOH, NH3. 
scheme 1.7 
Transglycolization^^ has also been used to convert more easily accessible 
pyrimidine nucleosides into the C2 fluoropurine equivalents, Matthes et al.^^ coupling 1-
(5'-0-acetyl-2',3'-dideoxy-3'-fluoro-j8-D-ribofuranosyl) thymine with 2-fluoroadenine 
to give compound (18). This compound together with other 3'-fluorosugars cited 
showed negligible cytotoxicity and high efficacy in inhibiting the enzyme reverse 
transcriptase (RT). 
(18) 
Organometallic reagents have also been used to introduce the trifluoroniethyl 
group into 2',3'-dideoxyadenosine (19) at the C2 position to give compound (20), Nair 
and Buenger^^ synthesising a series of 2-substituted analogues from 2-iodoadenosine 
(21). 
11 
OH OH 
NH, 
F3C 
HO' \ ^ ° N (ii), (ill) ^ buMesSiO' 
OH OH 
(vl—BuMeaSiO 
1' 
(iii).(iv) buM&^SiO 
(20) 
(i) CF3ZnBr, CuBr, DMF, HMPA; (ii) 'BuMe2SiCl, 4-(dimethylamino)pyridine, Et3N, DMF, CH2CI2; (iii) 1,1'-
thiocarbonyldiimidazole, DMF; (iv) "BusSnH, AIBN, PhMe, A; (v) Et4NF, MeCN. 
scheme 1.8 
These derivatives were totally resistant to hydrolytic deamination by mammalian 
adenosine deaminase, and were inherently more stable with respect to glycosidic bond 
cleavage than their parent compounds. 
I.C.2.b.(ii) Modification at C6 in the ring 
Substitution of fluorine into the C6 position of purine analogues is easily 
accomplished by aromatic nucleophilic substitution. 6-Chloropurine derivatives of 
nucleosides, e.g. (22), undergo facile halogen exchange with silver fluoride in toluene or 
xylene to give the corresponding 6-fluoroderivative.^^ 
AqF/ toluene/A 
Alternatively 6-trimethylammoniopurines, although having a tendency to undergo 
alkyl migration,^2 ^ re amenable to nucleophilic substitution a process which has only 
begun to be explored. The ease of production of 6-fluoropurines by the reaction of the 
12 
quaternized product with KHF2 or KF in ethanol^^ or DMF^-^^ is evidence for the great 
potential of this method; seen previously in scheme 1.7. 
Biological activity of such analogues is of little importance, due to the highly 
reactive and hence, unstable nature of the subsequent 6-fluoronucleosides e.g. rapid 
hydrolysis. Therefore, there use is one of key intermediate,^^ were the fluoro group can 
be nucleophilically displaced to give more stable and hopefully more active analogues. 
I.C.2.b.(iii) Modification at C8 in the ring 
Little work has been carried on the substitution of the fluoro group in the C8 
position of purine derivatives due, unfortunately, to variable results. However, Robins 
et al.^^ successfully obtained halogen displacement of a chloro-group utilising caesium 
fluoride and 18-crown-6 as a phase transfer agent to give (23). 
P NH, 
NH, 
AcO OAc F OH 
(23) (24) 
A Japanese group^^ have synthesised a range of 8-fluoroadenosine derivatives as 
anutumour agents e.g. (24). Although the effective mode of action for these C8 
substituted compounds is unclear. 
I.C.3 ^Sugar MQdifig^l DgrivativgS 
The field of fluorinated sugar nucleosides is vast, with numerous methods 
described in the literature for introducing the fluorine moiety. Reviews and treatise on 
these subjects are readily available,^^'^^ so only a few examples will be covered in this 
section to give a flavour of the area. 
Base modification of nucleosides has led to a number of antiviral compounds now 
used clinically, however, these have tended to be pyrimidine derived analogues rather 
than purines. With the purine series, greater success was to be achieved when the 
modification has been made on the sugar ring. 
I.C.3.a C2' FluQrQn»clmi<igS 
The lead compound for this group of antiviral agents was a naturally occurring 
pyrimidine nucleoside analogue l-j3-D-arabinofuranosylthymine ARA-T (25), which 
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was isolated from the sponge Cryptoethya crypta?^ In ARA-T the C2' position is no 
longer deoxy, but has a hydroxyl group with the epimeric configuration to that of a 
ribonucleoside. This compounds displays excellent activity against HSVl and HSV2 as 
well as low cytotoxicity. The nucleoside is only activated by virally encoded TK, and 
shows no efficacy against TK mutants. Compound (25) represents one of the few 
naturally occurring antiviral agents, but was rapidly superseded by more potent synthetic 
analogues. 
OH in 
(25) (26) 
Replacement of the thymidine base by adenine gave ARA-A (26),^ ^ the first 
potent adenine derived antiviral agent. It was found to have broad spectrum antiviral 
properties, inhibiting not only HSV DNA polymerase, as the triphosphate, but also other 
viral and cellular processes; including activity against some RNA viruses; the higher 
cytotoxicity of ARA-A over (25) may be due to this diversity of action. 
ARA-A was itself superseded in 1979 by the introduction of fluorine in the C2' 
position; fluorine presumably acting as a hydroxyl mimic. The 2'-fluoroarabinose sugar 
derivatives are some of the most potent and selective inhibitors of HSV-1 and HSV-2, 
with l-(2'-fluoro-5-iodo-j8-D-arabinofuranosyl)cytosine FIAC (27)"^ ^ and l-(2'-fluoro-
5-methyl-j3-D-arabino-furanosyl)uracil FMAU (28)'^ emerging as the most potent of the 
series. These compounds have been prepared in 11 and 12 steps respectively (scheme 
1.9). 
0 \ y ^ J M i i j H O . ^ (iii). (V) _ B z O 
O C O H 
N.(vii) 
BzO, 
OAc 
I 
OH OH 
OAc OAc 
(27) (xiii).|(xiv), (xii) 
T HO 
(28) 
(i) K F , acetamide, 210°C; (ii) TsOH, MeOH; (iii) PhCOCl, pyridine; (iv) amberlite IR-120 (H+); (v) KIO4, 
H2O; (vi) NaOMe, MeOH; (vii) Ac20, pyridine; (viii) CH2CI2, HBr; (ix) disilyl-4N-acetyl-cytosine; (x) 
NH3, MeOH; (xi) AcOH, HIO3,12, CCI4, H2O, 40°C; (xii) Amberlite IR-120 (H+); (xiii) disilyl-4N-acetyl-
5-methyl-cytosine (xiv) 80% AcOH, A. 
scheme 1.9 
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Fox and co-workers reported that the 2'-hydrogen, 2'-hydroxy or even the 2'-
deoxy-2'-fluororibosugar conferred poorer anfiherpes activity than the 2'-
fluoroarabinosugar derivatives, highlighting the importance of the C2' position in 
determining antiviral and cytotoxic activity.^^ 
FIAC (27) highlights an important principle which recurrs in antiviral 
chemotherapy, in that it combines the potency of a C5 substituted base with that of an 
arabinose sugar derivative, and therefore gains activity lost due to the hydrolysis of the 
modified C5 congeners such as BVDU (8). Scheme 1.10 illustrates the stabilisation 
conferred to acid hydrolysis in vivo by the electron withdrawing 2'-fluoro substituent.^ '^  
HoN 
HO' 
HjN 
HO 
scheme 1.10 
FMAU (28) demonstrated a lower cytotoxicity than (26) and (27), however, 
more recenfly it has been demonstrated that l-(2'-fluoro-5-ethyl-/3-D-arabino-
furanosyl)uracil (29) is a less toxic congener with similar efficacy.^^ 
O 
NH 
C2H5 
A 
HO 
(29) 
HO 
(30) 
One strategy for enhancing the pharmacokinetics of the FIAC and FMAU was 
exploited by Biggadike et al.^^ who synthesised the C6' carbocyclic analogues (31) and 
(32), which is the active metaboUte of FIAC l-(2'-fluoro-5-iodo-j8-D-
arabinofuranosyl)uracil (30) (scheme 1.11). 
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HO 
NH-DNP 
(iii) 
HO OH 
O 
0) . ( i i )_ O 
NH-DNP 
\ ^ O OH 
SiPr'2 SiPr", 
° (viii) HO 
NHo.HGI 
• DNP 
(vi) HO 
HO HO 
(32) (31) 
(i) DNP-F, DMF, Na2C03; (ii) 0('Pr2SiCl)2, DMF, imidazole; (iii) DAST, CH2CI2, -30°C; (iv) nBu4NF, THF; 
(v) Amberlite IR400 (OH"), H2O, MeOH; (vi) EtOCH:C(Me)CONCO, DBU, DMF,-20°C, tiien 2M HCI; (vii) 
EtOCH:CHCONCO, DBU, DMF,-20°C, then 2M HCl; (viii) I2, HNO3, CHCI3. 
scheme 1.11 
The carbocyclic derivative of FMAU (31) showed a large reduction in antiviral activity 
i.e. a drop of two orders of magnitude, while (32) displayed negligible activity. 
However, the synthesis of the carbocyclic derivative of 2'-fluoroaraguanosine, itself 
inactive, opened the way to a new highly potent anti-herpatic agent (33), scheme 1.12,^ ^ 
demonstrating for the first time carbocycUc derivatives were active in their own right and 
not merely stable forms of the furanose derivative. 
H O ^ ' ^ ' ^ ^ ^ ^ V (i), ( i i ) ^ 
OCHoPh OCHaPh 
MeOCHaO 
OTs 
MeOCHaO MeOCHjO 
" ° \ 2 y ^ " " ' " ' ' ^ 
HO 
(33) 
(i) tBu02H, PhMe, VO(acac)2; (ii) NaH, THF, N2, then PhCH2Br, nBu4NI; (iii) KHF2, (CH20H)2, ISO-ieO'C; 
(iv) MeOCH2Cl, iPr2NEt, CH2CI2, then Pd-C, H2, EtOAc, H3O+, then TsCl, Et3N, 4-(dimethylamino)pyridine; 
(v) K2CO3, DMSG, 2-amino-6-chloropurine, 80°C; (vi) IM HCl, A. 
scheme 1.12 
In 1989 McCarthysynthesised a range of novel mono- and di-halomethyhdene 
nucleosides via dihalomethylidene yUdes and aryl sulphonylhalomethylidene derivatives, 
which allowed conversion to the 2'-halomethylidene nucleosides (34) (scheme 1.13). 
Base 
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Base 
H 
Base 
HO 
PhSC^CFH2-
O 
/ 
SiPr'2 
\ 
O 
\ -
SIPr'2 
. 0 
(ii) PhS02CFHP(0)(OEt)2-
SiP 
\ 
o 
\ (!) p-SOzPh 
SiPr'; 
(ill) 
X = CH2orO 
Base = Cytosine.Uracil, 
Guanine.Thymine 
Base 
(iv) 
H O ' - ' N ^ / ^ 
Base 
HO OH 
S02Ph 
(34) 
(i) 0('Pr2SiCl)2, DMF, imidazole; (ii) (Et0)2P(0)Cl, LDA, THF, -78°C; (iii) nBu4NF, THF; (iv) Al/Hg, A. 
scheme 1.13 
M'^Carthy et al. claimed that these compounds exhibit broad spectrum activity not only 
against HSVl and HSV2 but also retroviruses i.e. a single stranded RNA virus in which 
the RNA is its own messenger and activates an RNA-directed DNA polymerase, a 
reversal of the normal DNA-RNA protein sequence. 
Greater success against retroviruses, especially Human Immunodeficiency Virus 
(HIV), came when it was found that dideoxysugars, a group of nucleoside analogues 
lacking the 3'-hydroxyl group of the 2'-deoxyribosugar, showed high activity against 
reverse transcriptase (RT). They acted in the form of their triphosphates as DNA chain 
terminators; indeed the differences within the group of compounds (19), and (35)-(38) 
seem to be tied into their relative ability to be phosphorylated in vivo to the triphosphate. 
Base 
Base = A (19) 
= C (35) 
= 1 (36) vJ 
R=N3; X=H (37) 
R=H;X=H (38) 
R=N3; X=F (39) 
R 
The RT inhibitory activity of AZT (37) was shown in the early 1970s, and it 
therefore came to the fore for the control of the HIV virus.^^ Since HIV does not specify 
its own TK to convert nucleosides to the monophosphates cellular enzymes must perform 
this task. Compound (37) shows specificity as the triphosphate by inhibiting HIV RT 
one hundred fold better than cellular DNA polymerase.^^ The success of (37) spawned a 
large number of congeners, Blackburn et al. synthesising l-(3'-azido-2',3'-dideoxy-2'-
fluoro-j3-D-arabinofuranosyl)thymine (39),^ ^ Fox and coworkers^^ making l-(3'-azido-
2',3'-dideoxy-2'-fluoro-y3-D-ribofuranosyI)thymine (40), both inactive against H I V l 
(scheme 1.14). 
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HO 
HO OH 
j ( i ) . ( i i ) ^ TroA^^vJ (iii) ^ TroA^^°\j (iv). TrO 
MsO OMs 
HO 
(V) . (VI) 
TrO 
N3 F 
(40) 
(i) Ph3CCl, pyridine, 50°C; (ii) CH3SO2CI; (iii) EtOH, IN NaOH, then 80% AcOH; (iv) LiN3, EtOH, A; (v) 
DAST, PhH, -5°C; (vi) 80% AcOH, A. 
scheme 1.14 
The dideoxy nucleoside analogue (19) and its biological composite (36), figure 
1.4, are potent inhibitors of HIV but suffer from extreme acid instability. 
ADP 
\ 
Succinyl 
AMP 
adenosine inosine xanthosine guanosine 
adenine hypo-
xanthine thine 
guanine 
Cellular interconversion of adenine derivatives to guanine derivatives via inosine. 
figure 1.4 
It was seen previously that the introduction of an electron withdrawing group obviates 
this process, thus 2'-fluoro arabinose derivatives of (19) and (36) were synthesised 
(scheme 1.16).^ ^ 
]—%>Bz \—^ 
HO ' A ^ ^ N j j M ^ M e ^ S i O 
OBz OBz 
(42) 
'BuMe 
, (vii) 
(41) 
OH OH 
(V) 
2 S i O " \ , 0 . i ^ ^ i B u M e 2 S i O - \ ^ 0 ^ 
Ph(S)CO 
(i) HBr, HOAc, CH2CI2; (ii) N9-trimethylsilyl-6-chloropurine; (iii) NH3, MeOH, 100°C; (iv) 'BuMe2SiCl, 
imidazole; (v) PhCSCl, 4-(dimethylamino)pyridine; (vi) "Bu3SnH, AIBN, PhMe, A; (vii) "BU4NF, THF; (viii) 
H3O+, NaN02. 
scheme 1.16 
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Both (41), (42) and the a-fluorosubstituted derivative of (41) all showed increased 
acid stability, but for biological activity the fluorine atom had to be in the /J- position, the 
analogues (41) and (42) showing potent efficacy against the HIV virus equal to that of 
the clinically used non-fluorinated analogues (19),(35),(36) and AZT (37). 
I.C.3.b C3' Fluoronucleosides 
The importance of the 3' position in nucleosides has already been seen in the 
dideoxy class of compounds which lack a 3'-hydroxy group paramount for the 
biosynthesis of DNA or RNA, which are built up from phosphate linked nucleosides 
bound at the 5' and 3' position. Etzold and co-workers, therefore, synthesised the 
fluorinated congener of (38), viz. 2',3'-dideoxy-3'-fluorothymidine (43), utilising 
hydrogen fluoride in the presence of a Lewis acid.^^ Later Fox and et al^^ came up with 
a more efficient synthesis of (43) (scheme 1.18) as well as the AZT analogue 2'-azido-
2',3'-dideoxy-3'-fluorothymidine (44). 
O 
(i). (ii) _ L ^ (iii), (iv) H0'''^\^^\ 
(43) 
(i) MeS02Cl, pyridine; (ii) H2O, pH<5; (iii) HF, AIF3; (iv) OH", EtOH. 
scheme 1.18 
Compound (43) showed good activity against HIV-1 and increased stability of 
the glycosidic link, cf. CT substitution, over the thymidine derivative, while (44) 
showed no significant antiviral properties. Two groups reporied the stereospecific 
synthesis of the carbocyclic analogue of (43),^ " '^^ ^ one utilising a chemicoenzymic 
approach '^* starting with the enzymic transformation of (±)-e«rf(9-5-norbomen-2-ol to 
give (l/?,3/?,4^)-4-hydroxy-cyclopentane-l,3-dimethanol and the corresponding (S)-
enantiomer (scheme 1.19), but as yet no biological data is available 
-^ w~"" "°^ w°^ ' °^'V^ ' 
MsO 
,R = H 
(i) PhCH2Cl, CH2CI2 , pyridine; (ii) DAST, CH2CI2, -70°C; (iii) pyridinium chlorochromate; (iv) 
Ph2P(0)N3. 
scheme 1.19 
Other 3'-deoxy-3'-fluoronucleobases, e.g. (45)^^ and (46),^^ have been 
synthesised which show inhibition of RT, the uracil derivative (46) prepared by a similar 
route to scheme 1.19; however, only 31% of the desired isomer was produced and 47% 
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of the 2'-fluoroisomer (47) via rearrangement of 2,3'-anhydro-l-(^-D-xylofuranosyl)-
uracil to the 2,2'-anhydro intermediate.^^ 
H O ' - N ^ * HO^^0 H 0 - ^ \ ^ 
F N3 F OH F OH OH F 
(44) (45) (46) (47) 
Seela and Rosemeyer^^ rationalised that given the potency of (45); and its poor 
stability to adenosine deaminase, that the 3'-fluorotubercidin derivative (48) would be a 
better RT inhibitor (scheme 1.20); and indeed the 7-deazaadenine group showed no sign 
of degradation by cellular enzymes. 
'BuPhgSiO 'BuPhgSiO 
(vi) 'BuPhgSiO ,(iv).(v) , BuPh2SiO 
(i) fBuPh2SiCl, DMF, imidazole; (ii) C r O s , pyridine. Ac20, CH2CI2; (iii)NaBH4, E t O H , 0°C; (iv) DAST, 
PhMe; (V) nBu4NF, THF; (vi) NH3, MeOH, A. 
scheme 1.20 
More recently Coe et alP modified the 3' position by using mono- and difluoro-
methylene as a hydroxyl mimic, thus introducing the extra dimension of hydrogen 
donation. Scheme 1.21 demonstrates the reaction pathway starting f rom the 3'-C-(4,5-
dihydro-5-methyl-l,3,5-dithiazin-2-yl analogue (49), utilising diethylaminosulphur 
trifluoride (DAST), none of the C3' fluorosubstituted methyl derivatives shared any 
activity. 
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•BuPhjSiO \ / 0 > J 
eOTHP) 
'BuPhjSiO 
(ii) 
07MeOTHP) 
'N 
I 
CH3 
(49) 
I 
CH3 
CHO 
•BuPhoSiO 
(iv), (V) 
CF2H 
Y d/MeOTHP) 
(i) 4-methoxy-5,6-dihydro-2H-pyran (MeOTHP), TsOH, dioxane; (ii) HgO, HgCl2, H2O, THF; (iii) DAST, 
CH2CI2; (iv) 'BU4NF, THF; (v) O.OIM HCl, 1,4-dioxane, then O.OIM NaOH. 
scheme 1.21 
This lack of activity was prescribed to the fluoronucleosides adopting the C3'-endo sugar 
conformation. Recent studies suggest a C3'-exo conformation is necessary for anti-HIV 
activity^° (figure 1.5). 
B a s e 
H O 
2 ' ^ ^ B a s e 
C3' endo 
T.r .3 .c C 4 ' Fliinrnniicleosides 
3' 
C3' exo 
figure 1.5 
Nucleocidin (50)^ is one of the few naturally occurring compounds to contain 
fluorine and despite its inherent antibiotic properties, very littie work was done on the 
synthesis of other C4' fluoronucleosides. 
H,N — S — O 
II 
O 
(50) 
OH OH 
Verheyden and co-workers in 1973 successfully synthesised nucleocidin via an 
addition reaction to a 4',5'-unsaturated nucleoside.^! Extending this methodology, they 
went on to synthesis the uracil derivative (Sl)^^ ^nd the monophosphate (52) (scheme 
1.22). 
21 
34° 
(V) 
H2N—s —o t 
OH O H 
(51) 
(vi), (vii) 
O 
( H O j j P O C H j 
HOCH2 o, 
;viii), (ix),(x) 
O H O H 
(52) 
(i) I2, CH2CI2, AgF; (11) LiN3, DMF, lOS'C; (lii) NOBF4, MeCN; (iv) Na2HP04(aq); (v) CF3COOH, THF, H2O; 
(vi) H 2 N S O 2 C I , dioxane; (vii) 9 0 % HCOOH; (viii) ( C I 3 C H 2 0 ) 2 P ( 0 ) ( O E t ) , 2,4,6-tri-
isopropylbenzenesuiphonyl chloride, pyridine, then H2O; (ix) Zn, DMF, AcOH, H2O, AgOAc, (x) Dowex 50 
(NH4+), Ba(0Ac)2. 
scheme 1.22 
Biologically it was found that in vitro the C4' substituted derivatives (51) and 
(52) exhibited decreased stability tq hydrolysis in both acid and alkali conditions, this led 
Danenburg to synthesis the fluoronucleoside 5'-deoxy-4',5-difluorouridine (53) as a 
new prodrug for 5-fluorouracil (scheme 1.23).^^ 
TrO 
5FU 
MsO 
5FU 
(i),(ii) & (iii) 
HO O H PhCHgO OCHgPh 
(iv) 
5FU 
P h C H j O O C H j P h 
5FU 
HO O H 
(53) 
(vi) 
(V) 
5FU 
O. 
PhGH20 O C H j P h 
(i) PhCH2Cl; (ii) H C O O H ; (iii) CH3SO2CI; (iv) ' B U O K ; (V) C6H5N+(HF)xF-, - 5 0 ° C ; (vi) H2. Pd(0H)2 
scheme 1.23 
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A number of carbocyclic 4'-fluoro derivatives have also been prepared, e.g. of 
the potent carbocyclic anuherpes drug 2'-fluoro-araguanosine (32), using DAST to 
introduce fluorine at C4' effectively in the last step of the reaction (scheme 1.24).^'' 
OMe 
TrHN TrHN TrHN 
OMe OMe 
(ix) 
TrHN TrHN 
isomer 
TrO 
(54) 
(i) NaOMe, MeOH, 50°C; (ii) tBuMe2SiCl, imidazole, DMF; (iii) PhsCCl, molecular seize, CH2CI2, A; (iv) 
"BU4NF, THF; (v) (PhO)3PMeI, THF, -65 to 0°C; (vi) DBN, pyridine, 60°C; (vii) OSO4, pyridine; (viii) DAST, 
CH2CI2, 0°C; (ix) AcOH, 80°C, ihen 2M HCl, 80°C. 
scheme 1.24 
The 4'-a-fluoro derivative (54) displayed potent activity against H S V l and 2, animal 
tests showing a thirty fold increase in efficacy over acyclovir (55) against HSV2 in mice. 
I .C .3 .d C 5 ' Fluoronucleosides 
Fluorination or polyfluoroalkylation at the C5' position of nucleosides is 
relatively simple, e.g. displacement of sulphonates using tetrabutylammonium fluoride 
w i l l introduce 5'-fluorogroups. The removal of the hydroxyl group does though 
introduce the problem that phosphorylation can no longer take place in the 5' position to 
yield nucleotides; a consequence exploited in designing prodrugs for 5-fluorouracil.^-^ 
This, however, has not disqualified substituted C5' nucleosides, as potential antiviral 
agents, as the activity of such analogues is expressed through different cellular pathways. 
The enzyme 5-adenosyl-L-homocysteine (SAH) hydrolyase is responsible for the 
hydrolytic cleavage of SAH (56) to adenosine and L-homocysteine in vivo^^ (scheme 
1.25). This important process indirectiy, via a feedback mechanism, regulates biological 
methylation and is required by many viruses for 5' capping of mRNA. 
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COp-
*H,N 
•Ov. I NAD* 
/.-HOMO-
CYSTEINE 
HO OH 
H ^ 
NADH 
HO 
HO OH 
scheme 1.25 
Robins and Wnuk^^ synthesised a series o f 5 ' - 5 - a r y l ( a l k y l ) t h i o - 5 ' -
fluoronucleosides e.g. (57) (scheme 1.26) to act as S A H inhibitors, as did M'^Carthy et 
al.^^ who synthesised some novel fluoroalkenyl derivatives (58a) and (58b). A l l of 
these compounds exhibited both inhibition of the enzyme SAH and anriretroviral activity 
in vitro, (58a) exhibiting the greatest potency.^^ 
(i), (ii) 
HO OH 
J ^ h S ^ X ^ (iii), (iv) 
O 
II 
HO OH AcO OAc 
PhS 
(vi) 
PhS 
HO OH AcO OAc 
(57) 
(i) S0C12, pyridine, MeCN, then NH3, MeOH, H2O; (ii) PhSH, NaH, DMF; (iii) Ac20, pyridine; (iv) 3-
chloroperoxybenzoic acid, CH2CI2, -40°C; (v) DAST, SbCl3, CH2CI2; (vi) NH3, MeOH. 
scheme 1.26 
HO OH 
R l = F , R 2 = H (58a), R l = H , R 2 = F (58b) 
Another similar class of compounds to those of Robins and Wnuk were prepared 
as inhibitors of 5'-deoxy-5'-(methylthio)adenosine ( M T A ) phosphorylase, used in the 
biosynthesis of polyamines^^ e.g. spermine. The acetal of adenosine was treatment with 
thionyl chloride to yield the 5'-chloronucleoside (59), which was nucleophilically 
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displaced by 2-thioethanol, subsequendy treated with DAST and deprotected to give 5'-
deoxy-5'-[(2-monofluoroethyl)]thioadenosine (60)^^ (scheme 1.27). 
HO OH 
(60) 
(i) S0C12, HMPA; (ii) NaOH, HOCH2CH2SH; (iii) DAST, CH2CI2; (W) HCOOH. 
scheme 1.27 
The fluoroderivative (60) proved to be both the most hydrolytically stable of a 
range of M T A derivatives synthesised, with no degradation after five days in 
physiological conditions, and a good inhibitory effect on cell growth in vitro. 
I . C J . e r 6 ' Fluoroniicleosides 
A 
HO HO 
HO OH 
(63) 
HO OH HO OH 
(61) (62) 
Replacement of the furanose ring oxygen by carbon is of particular interest since 
the resulting carbocyclic nucleosides possess greater metabolic stability to phosphorylase 
e n z y m e s , w h i c h cleave the glycosidic linkage of nucleosides, e.g. the deactivation of 
B V D U (8). Carbocyclic nucleosides are not new, aristeromycin^^^ (61) and its 
cyclopentenyl derivative neoplanocin A (62),^°^"^°^ are both natural products. From the 
latter class of compounds the cytosine derivative cyclopentenyl cytosine (63) was 
synthesised, ^ '^ •^^ '^ ^ which exhibits both antitumour properties and antiviral properties in 
vivoj'^ particularly against H S V l in T K mutants to which acyclovir (55) shows no 
efficacy. However, its toxicity perhaps outweighs this benefit. 
Fluorine was introduced in the C6' position to act as an effective mimic for 
oxygen, especially i f the furanose oxygen was required for some polar interaction at the 
active site. Both the monofluoromethylene^°^ and difluoromethylene*^° group have 
therefore been used as a replacement for 06' . 
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Most work in this f ie ld has been carried out by a team including Biggadike and 
Roberts, who devised a short efficient route to both a-d- and /5-6'-fluoroderivatives via 
the key chiral epoxide (64)''6'"! (scheme 1.28). 
„ ^ Base 
base = G,U or 
5-iodouracil 
64a R=H 
64bR=Bn 
BnO 
(vii), (viii) 
OBn (vi) 
OBn OBn 
(i) Na, THF, -5°C. then PhCH20CH2Cl, 4 5 ° C (ii) (-) Di-isopinocampheylborane, -60°C, then H2O2, NaOH; 
(iii) 'BUO2H, V02(acac)2; (iv) PhCH2Br, NaH; (v) NaN3; (vi) TfCl; (vii) "BU4NF; (viii) H2, Lindlar catalyst; 
(ix) DAST. 
scheme 1.28 
They found for both the carbocycles of the pyrimidine series e.g. the carbocycle of 5-
iododeoxyuridine,^^and the purine series e.g. carbocyclic 2'-fluoroaraguanosine 
(33),!!! that the antiviral activity was retained in the o;-6'-fluoro derivative (65) but 
abolished in the /?-6'-fluoroisomer. This indicates that the configuration at C6' is of 
significant importance to biological activity, the stereochemistry of the fluorogroup 
causing a conformational or steric difference adversely affecting antiviral activity. 
A n alternative approach to 6'-a-fluoro derivatives was therefore developed, 
relying upon an enzymically controlled Baeyer Villager reaction.!!2 Scheme 1.29 
demonstrates how the 6'-a-fluoroAZT derivative (66) was synthesised by this method; 
biological activity of this analogue was significantiy lower than A Z T (37), because of 
conformational differences.!!^ 
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(i).(ii) & (iii) 
"BuPhgSiO 
(viii),(ix),(x) 
+ byproduct 
byproduct 
(i) Cl2CHc6c i , 'Et3N; (ii) Zn, AcOH; (iii) Br2; (iv) (Me3SiN)2Na; (v) Et3N.3HF; (vi) Acinetobacter NCIB 
9871; (vii) 3-chloroperoxybenzoic acid; (viii) NH3; (ix) 'BuPh2SiCl; (x) PhI(OCOCF3)2. 
scheme 1.29 
The 6-a-f luoro carbocyclic variant of 3'-fluorodideoxythymine (43) was also 
synthesised by Roberts et al.^^^ f r o m cyclopentadiene, however, 6-a-fluoro-3'-
fluorodideoxythymine was inactive against HSV1. 
L C . 4 Acyclic Flnnroniicleosides 
Wellcome set out to find an inhibitor of adenosine deaminase to co-administer 
wi th such drugs as A R A - A (26), thus increasing their efficacy. As part of this work, 
they looked at derivatives of adenosine in which the sugar was replaced by an acyclic 
moiety representing a partial sugar structure. Of the compounds synthesised, 9-(2-
hydroxyethoxymethyl)adenine was found to be a substrate for the enzyme. The fact this 
was recognised by an enzyme suggested that other enzymes may recognise this acyclic 
side chain. This proved to be the case and in 1978 the revolutionary antiherpes agent 
acyclovir (55),^''^ where adenine was replaced by guanine, and the more potent drug 
DHPG (67) were synthesised. 
HO. 
(55) 
Acyclovir (55) exhibits antiviral activity by acting as a selective irreversible 
inhibitor of HSV-1 and HSV-2 D N A polymerase. To get to the active triphosphate 
(55) must first be monophosphorylated by virally encoded TK. Compound (55) is in 
fact a very poor substrate for cellular TK,^°^ but i t is further phosphorylated by cellular 
enzymes to give the active substrate. 
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Fluorinated acyclic derivatives are neither as potent nor common, loss of activity 
being associated with fluorine insertion at any site in (67). ' ' ! Abushanab and 
coworkers!!^ reported recentiy a synthesis of a (68) and (69) nucleosides incorporating 
similar structural features to (28) (scheme 1.30). 
X OBn 0" 
VII , IX) 
VIM), (IX) 
pen 
PBn 
(i) " B u 4 N F , PhH, A; (ii) NaH, PhCH2Br; (iii) Amberlite IR 120, H2O. EtOH, HCl; (iv) di-
isopropyldiazodicarboxylate, PPhs, PhH; (v) NaOH, PhCH20H; (vi) (C02H)n, HCl, CH2CI2, 0°C; (vii) 2,4-
disilylthymine (viii) 2-amino-6-(benzyloxy)-9H-purine, LiH, DMF, (ix) Pd(0H)2/C, cyclohexene, EtOH. 
scheme 1.30 
The compounds were found to be inactive against H I V l in vitro even when introduced in 
the monophosphate form. Viani et al.^^^ outlined a synthesis of a class of optically pure 
nucleosides of the general structure (70), where the base is adenine or thymine. 
However, no biological test data is yet available. 
H O 
Base 
C H 2 F 
(70) 
I .D. Fluorine Containing Nucleotides 
I . D . I Introduction 
Nucleotides!!^ are synthesised in vivo by phosphorylation of nucleosides, it 
therefore would seem feasible to alter the physiological properties of nucleotides by 
modifying not only the nucleic acid residue but also the phosphate groups themselves, 
figure 1.6. 
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HoC 
C x H y F z 
O I o \ 0\ 
Ho-W-H-^^^VN 
HO^ Y HO p HO a \ / M/ 
A 
OH 
figure 1.6 
L D . 2 FluQrQphQSphate? 
Generally known for their high toxicity, fluorophosphate analogues have been 
primarily synthesised for enzymic studies. Their synthesis was accomplished by 
Wittmann^2° in 1963, who devised a synthesis of nucleoside monofluorophosphates by 
aromatic nucleophilic substitution (scheme 1.31). This method is generally applicable. 
o 
II 
N E , O P ^ 
I o 
ONH4 
HO OH 
0 , N 
H.N-^-0 
HO O H 
O 
NH4OP 
HO OH 
(i) 2,4-dinitrofluorobenzene, EtN3 
scheme 1.31 
However Sund and Chattopadhyaya^^^ found that O-aryl-O ,S-
dialkylphosphorothioates of various nucleosides could easily be converted upon treatment 
with tetrabutylammonium fluoride to the monofluorophosphate, reaction products being 
dependant on the fluoride ion concentration (table 1.2). 
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A 
AcO OAc 
NBz O 
AcO OAc 
I II 
- W • H 
AcO OAc AcO OAc 
(71) (72) (73) 
TBAF.3H20 THF.pyr.H2O Products 
(eq) (v/v/v) (71) (72) (73) 
1.3 8:1:1 55 - 45 
5.0 8:1:1 70 10 20 
10.0 8:1:1 60 30 10 
5.0 9:1 58 42 -
table 1.2 
A key study involving fluorophosphates was carried out to determine whether a 
mono- or di-ionic form of the nucleotide was required for enzymic activity. Vogel et 
al.^^^ determined the effect of terminal fluorine substitution on adenosine mono-, di- and 
tri-phosphate respectively (74a-c) to give (75a-c). He found that the inclusion of a 
fluorine atom decreased metal binding, the compounds having a propensity to exist only 
as the monoanions of (75a) and (75b); however (75c) gave inconclusive results, still 
having a significantly lower binding affini ty for magnesium (II) ions than ATP (74c). 
This was easily explained by the enhanced stability of the fluorophosphate moiety, 
weakening binding to metal cations. 
H O - / 
HO 
• 0 -
O 
II 
-P . 
HO 
•o O. 
O 
II 
. p . / 
HO OH 
(74a) n=0, (74b) n = l , (74c) n=2 
HO 
HO OH 
(75a) n=0, (75b) n = l , (75c) n=2 
30 
Indeed adenosine 5'-fluorophosphate (75a) is incapable of activating glycogen 
phosphorylase b, yet inhibits the activation of this enzyme by (74a), shown to be 
indicative of the phosphate dianion being the only acceptable substrate. 
I .D .3 F l u o r o a l k v l D h o s n h o n a f e . s 
L D . 3 . a g - . Q g . a - F l u o r o m e t h v l D h o s D h o n a t e s 
Reagents are readily available fo r the incorporation of a- and a,a-
fluoromethylphosphonates into nucleosides.^^'^^'* This is highly desirable given that the 
phosphate linkage is hydrolytically labile, unlike the alkylfluorophosphonate derivative, 
allowing drugs to be administered orally in a potentially activated form, i.e. obviating the 
need for thymidine kinase phosphorylation. The o;,a-fluoromethylphosphonate group 
representing the closest non-chiral analogue to the phosphate group in both physiological 
pKa (figure 1.1) and steric bulk. 
Acycl ic nucleoside derivatives such as DHPG (67) show powerful viral 
inhibition and negligible cytotoxicity, the acyclic sugar moiety inhibiting the enzyme 
adenosine deaminase, therfore, Casara and coworkers'-^^ set out to synthesis the a,a-
difluorophosphonate derivative of (67). Scheme 1.32 shows the methodology adopted 
to yield the a,a-difluoromethylphosphonate (76) which was then cyclised to (77). 
Compound (76) and its congeners were found to have lower activity to the inhibition of 
HSV-1 and -2 in vitro than the parent nucleoside. 
9 O H 9 OCH^Cl 9 
B r J J ^ O ^ ^ C F A o E t ) 2 - ^ ^ ^ v ^ A ^ C F j ! ' ( O E t ) , i i v L ^ B z O , ^ ^ l ^ C F ^ O E t : 
(V), (vi) 
^ o" o ^ 
C F ^ Y ^ < ( H O ) , P ( 0 ) C F , - ^ ^ 0 ^ ^ ^ i ^ ) ( E t O ) 2 P ( 0 ) C F 2 ^ ^ 0 v l 
HO' O ^ O H " ^ O B Z 
(77) (76) 
(i) (EtO)2P(0)CF2Li, -78°C; (li) 3-chloroperbenzoic acid, CH2CI2; (iii) NaH, THF, PhCH20H, A; (iv) 
(C02H)[i , HCl, CH2CI2; (v) EtN3, 2-amino-6-chloropurine, DMF; (vi) 50% HCOOH; (vii) Pd(0H)2/C, 
cyclohexene, EiOH; (viii) trimethylsilylbromide, then H2O; (ix) pyridine, dicyclohexylcarbodiimide. 
scheme 1.32 
A modelling study of a,a-difluoromethylphosphonate as a phosphate mimic in 
the (phosphonomethoxy)alkylpurine and pyrimidine class of compounds, given 
[(phosphonomethoxy)ethyl]guanine (78) and adenine (79) were potent and broad 
spectrum antiviral phosphonate nucleotide analogues, was undertaken in 1990 by K i m et 
a/.,^^ who showed that (80) (scheme 1.33) was a poor mimic, exhibiting no activity 
against H I V l and 2, as well as possessing a significantiy lower pKa2 (table 1.3). 
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Compound R pKa2 
78 
0 
\ ^ ^ ' ^ 0 ^ ^ P(OH) 2 
6.52 
80 
\ ' ' ' ^ ^ ^ ^ ' ^ ^ P ( 0 H ) 2 
5.52 
8 1 
0 
^ - ^ ^ ' ' ' ' \ ^ ' ^ P ( 0 H ) 2 
7.08 
82 
0 
\ ' ' ^ ' ^ S ^ ^ P ( O H ) 2 
6.59 
This was probably due to the inability of cellular or virally induced kinases to catalyse the 
conversion of (80) to the diphosphate form. 
.0(CH2)3l 0 . ^ 0 ( C H 2 ) 3 C F 2 P ( 0 ) ( O E t ) 2 (ii, (iii)^  (iv) ,CF2P(0)(OEt); 
(V) 
(H0)2P(0)CF2 (vi) 
(80) 
|^^, . ,v^^CF2P (0 ) (OEt)2 
(i) (EtO)2P(0)CF2Li, THF, HMPA, -78°C; (ii) 3N HCl; (iii) CH3SO2CI, EtN3; (iv) Nal; (v) 2-amino-6-
(benzyloxy)purine, NaH; (vi) trimethylsilylbromide, DMF. 
scheme 1.33 
It has ah-eady been demonstrated how dideoxyadenosine (19) is a potent inhibitor 
of H I V RT (section I.C.3.a). Thus, it occurred to Halazy and Wolff-Kugel to synthesis 
the carbocyclic phosphonate derivative of this c o m p o u n d , h o p i n g to simultaneously 
improve in vivo stability of the glycosidic link and bypass the degradation of (19) and 
(36) by introducing the agent as the non-labile a,a-difluoromethylphosphonate. 
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H O ( E t O j g P C F g 
(i). (ii) (iii). (iv) 
O 
( E t O ) 2 P C F 2 — 
( H O )2PCF2 
' S e P h 
(i) (TfO)20, pyrindine; (ii) (EtO)2P(0)CF2Li, -78°C; (iii) PhSeCl, CH2CI2; (iv) 6-chloropurine, CH3NO2,. 
AgBF4, CaC03; (v) "Bu3SnH, AIBN, PhMe, 70°C; (vi) irimethylsilylbromide, MeCN; (vii) NH3, MeOH. 
scheme 1.34 
Their strategy involved ring opening of a seleniranium salt by the nucleic acid moiety and 
yielded (83) in under 9%. 
I.D.3.b a.p: ^.7-Fluoropho.sDhonates 
Phosphonate derivatives of nucleotides in which the oxygen of a P-O-P link is 
replaced by a methylene group, have great potential as analogues of many biological 
phosphates, to probe enzymic pathways. However, i t has been found the electron 
distribution of the phosphonates deviate f rom the naturally occurring phosphate. 
Blackburn set out to find a more effective mimic of the phosphate group for probing both 
enzymic cleavage and binding sites in phosphate systems.!^' 
In a simple experiment, similar to Vogel and coworkers,!-^'^ Blackburn et al. 
synthesised a series of substituted phosphates of the structure (84a-d), and studied these 
with respect to pKa and divalent metal binding.-^^ 
0 
o-
O 
II 
•o-
o 
II 
- p . 
o o o 
HO OH 
X = C H 2 (84a), X=CHF (84b), X=CF2 (84c), X=C=C (84d) 
It was found that (84c) was the most effective isopolar and isosteric mimic to ATP (74c) 
in binding experiments. 
On this premise, work was carried out on the enzymic hydrolysis of dinucleotide 
tetraphosphates, which exist in cells, but with a yet uncertain role.'^! In higher organisms 
tetraphosphate nucleotides are degraded by asymmetric PaOP^ fission to give the 
nucleotide monophosphate and nucleotide triphosphate, however, eukaryotes possess an 
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enzyme which produces two equivalents of nucleotide diphosphate by symmetric P^gOPyj' 
fission. The phosphonates (85a-c) and (86a-c) were synthesised (table 1.4) and 
introduced as substrates into the two systems. 
HO OH 
O 
•Y-
O 
II 
- P -
O 0 
HO OH 
Substituent Precursor Condensing agent 
85a X=CH2, Y = 0 84a Morph-p-Ado 
85b X=CHF, Y = 0 84b Morph-p-Ado 
85c X-CF2, Y = 0 84c Morph-p-Ado 
86a X = 0 , Y-CH2 pCH2pAdo DCC 
86b X = 0 , Y=CHF pCFHpAdo DCC 
86c X = 0 , Y=CF2 pCF2pAdo DCC 
For the asymmetric enzyme, it was found previously using labelled water, that 
attack occurs at Pa,^ '^ ^ therefore substitution of oxygen in the P^gOP^g-bridge for a 
methylene substituted moiety should give products still sensitive to hydrolysis (85a-c). 
This was observed, the rate of hydrolysis of the substrate being dependant on the number 
of hydrogens replaced by more electron withdrawing fluorine, due to the resulting ability 
o f the phosphate leaving group increasing CF2 > CFH > CH2; the natural product was 
still the most effective substrate. 
In the replacement of the P^OP^ bridges by methylene groups (86a-c) the 
product should be resistant to hydrolysis by the asymmetric enzyme, this was found to a 
limited extent, both (86a) and (86b) giving some breakdown products showing a 
possible Pp attack i f in line polar interactions are not unfavourable, this is the case in 
(86c). 
In the symmetric cleavage, which can occur only at Pp or Pp- with cleavage of the 
PjgOP^' the analogues (85a) and (85b) were found to be inert, while (85c) gave a very 
small amount of product. 
This information allowed Blackburn to model the binding site of bis(5'-
nucleosidyl)tetraphosphate pyrophosphohydrolayse, the asymmetric fission enzyme 
(figure 1.7)P0 
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H O O H 
(a) 
O Q- O G O G O G 
H O O H 
H O O H 
(c) 
0 \ ^ . 
P / ^ P / 
/ / \ / / \ / / \ / / \ 
O G O G O G O G 
figure 1.7 
Blackburn has carried out similar work on the bisadenosyl triphosphates (87),!3! 
t r i - and tetra-(thiophosphonates).!^^"!-^'* 
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HO OH 
O 
II 
O 
II 
. P -
o 
II 
.p-
o 
X=CH2, CFH, CF2 Y=0, CH2 
(87) 
De Clercq and co-workers synthesised by a similar method to Blackburn the 
P^P^difluoromethylene analogue of AZT (37) as a potential antiviral agent, given that 
AZT (37) is phosphorylated entirely by cellular enzymes and is active as an inhibitor of 
RT only as the triphosphate. However, the difluoromethylenephosphonate analogue 
showed a thirty fold reduction in activity.^-^^ 
I.D.4 Fluoroalkvlphosphates 
The introduction of a fluoroalkyi group as a hydroxyl mimic has foundation in the 
similar polarity and hydrogen bonding characterisdcs of such a group compared to the 
hydroxyl group. The synthesis of these moiedes has been accomplished by a number of 
procedures, using a modified Yoshikawa process difluoromethylphosphonate esters can 
be prepared (scheme 1.35) in 2 steps, the mixture of products (88), (89) and (90) being 
easily separated by chromatography 
0-
(i)&(ii) 
o 
II 
-Ps 
/ 
CHF 
/ o I HO 
(88) 
C H F 2 
(89) (90) 
(i) (C1)2P(0)CF2H, (MeO)3P(0); (ii) DEAE-Sephadex chromatography. 
scheme 1.35 
Alternatively Casara et (3/.i25,i37.i38 synthesised a range of similar compounds 
by a facile condensadon reaction (scheme 1.36) of the appropriate protected base, the 
fluorophosphonic acid and dicylohexylcarbodiimide. Of the analogues prepared the 
trifluoromethylphosphonate of (37) showed the greatest activity against RT in vitro. 
Work is currently underway to ascertain the mode of action of these non 
trisphosphorylated active inhibitors. 
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O 
II 
(i) & (ii) 
CHs-nFn — P —0 
w HO 
(i) (HO)2P(0)CH3.nFn, pyridine, evaporation; (ii) dicyclohexylcarbodiimide. 
scheme 1.36 
I . E . FluQrin? Cpntaining QMgQpuclgQti^ lgs 
I . E . I Intrp^lugtiQn 
It has been postulated that oligonucleotides (15-20 nucleotides) complementary to 
well defined portions of the HIV genome may form a triple helical structure with the 
proviral DNA, thus preventing transcription of proviral DNA into mRNA, transcription 
arrest. Alternatively the antisense oligonucleotide may also bind to viral mRNA forming 
a RNA/DNA hybrid and preventing translation of the viral mRNA, translational arrest. 
To accomplish this the oligonucleotides must be able to permeate cell membranes and 
resist premature degradation, this has been achieved by the replacement of the labile 
phosphate linkage with methyl phosphates and phosphothioates. 
I.E.2 Polv(2'-Fluoronucleotides) 
- I n 1_ 
(91) (92) 
Poly(2'-deoxy-2'-fluoroadenylic acid) (91) has been tested in vitro as mRNA in 
protein synthesising systems. It was found that the modified compound exhibited activity 
as a messenger and lead to incorporation of radiolabelled lysine into polypeptides, at rate 
greater than natural poIy(riboadenylic acid). Oligonucleotide (91) also exhibited greater 
resistance to breakdown, i.e. was longer-lived.^-^^ 
Poly(2'-deoxy-2'-fluoroinosinic acid) (92), synthesised by polymerisation of 2'-
deoxy-2'-fluoroinosine 5'-diphosphate catalysed by a polynucleotide phosphorylase,'-^^ 
is an effective template for RT unlike poly(inosinic acid). It is apparent that 
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conformational differences induced by the inclusion of the electronegative fluorine atom at 
C2', affect the polymer structure and hence binding properties which in turn affect 
biological activity. 
I .E.3 FluQrpalkylphQSphQnatg Pimgrg 
Bergstrom and Shum^^*" carried out NMR studies utilising l ^p NMR, to 
determine the structure of difluoroalkylphosphonate dimers, obtaining detailed 
information on the configuration of F-deoxy-/'-(difluoromethyl)thymidylyl(3'-
5')thymidine (scheme 1.38). 
DMTrO 
(i) 
BTO 
DMTrO 
DMTrO 
DMTrO 
where BTO = 
(i) (BTO)2P(0)CF2H, pyridine; (ii) 5'-0-(4,4'-di-methoxytrityl)-3'-0-levulinylthymidine, pyridine. 
scheme 1.38 
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C H A P T E R TT 
T H E r P I E T H O X Y P H O S P H I N Y D D I F U J O R O M E T H Y L E N E GROUP 
I L A Introduction 
The ability of the difluoromethylene unit to mimic an oxygen (section I.B.2), 
especially in phosphate chemistry,^^'^^ has spawned a wide range of 
(dihydroxyphosphinyl)difluoromethylene containing compounds. Indeed, the 
pharmaceutical industry has used the group as a non-labile phosphate group in the area of 
antiviral chemotherapy.^^^• '^^ ^ Consequently, routes into (dihydroxyphosphinyl)-
difluoromethylene substituted compounds are of significant importance and at present 
accomplished via three processes: 
(i) nucleophilic alkylation reactions utilising organometallic reagents e.g. the 
(dialkoxyphosphinyl)difluoromethylene organometallic reagents or via perfluorinated 
Grignard reagents; 
(ii) by electrophilic fluorination; 
(iii) a single electron transfer process, e.g. palladium (0) mediated coupling. 
In this section the development and utility of the first two routes will be 
discussed, with particular attention to the (dialkoxyphosphinyl)difluoromethylene 
organometalhc reagents. 
I I . A . l Organometallic Reagents 
n.A.La (DiethoxvDhosDhinvndifluoromethvlene Reagents 
This subject area has recentiy been reviewed,^° so only a brief synopsis of these 
reagents is given. 
In 1981 Burton et al.^^'^ developed the cadmium reagent (93) the first 
(diethoxyphosphinyl)difluoromethylene organometallic reagent from (diethoxy-
phosphinyl)bromodifluoromethane (94). "^^^ This was later followed by the zinc reagent 
(95)'"^ which had the advantage of greater hydrolytic stability. Both (93) and (95) were 
capable of nucleophilic displacement reactions (table 2.1) but only at activated carbon 
sites such as allylic, benzyUc, and carbonyl centres. 
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(EtO)2P(0)CF2CdBr 
(93) 
(EtO)2P(0)CF2ZnBr 
(95) 
E X / A ^ (EtO)2P(0)CF2E + CdBrX 
EX / r.t. 
Cu(I)Br 
(EtO)2P(0)CF2E + ZnBrX 
Reagent EX Product Yield 
(93) h (EtO)2P(0)CF2l 57% 
(93) SO2 (EtO)2P(0)CF2S03H 90% 145,146 
(93) H2O (EtO)2P(0)CF2H 100% 
(95) CH2=CHCH2Br (EtO)2P(0)CF2CH2CH=CH2 47% 147 
(95) 0 
0 
0 
| f ^ [ ^ N ^ C F 2 P ( 0 ) ( O E t ) 2 
0 
54%37 
(95) ClC(0)NEt2 (EtO)2P(0)CF2C(0)NEt2 38%3° 
Reactions of (diethoxyphosphinyl)difluoromethylene metal bromides 
table 2.1 
However, the problem of introducing the (diethoxyphosphinyl)difluoromethylene 
moiety at unsaturated sites was overcome with the advent of the organolithium reagent 
(96). The lithium reagent is the most reactive, i.e. nucleophilic, of the 
(diethoxyphosphinyl)difluoromethylene metal reagents. The anion generated is reactive 
enough to allow substitution in high yields at primary carbon centres (table 2.2). 
However, the yields obtained for activated carbonyl and allylic sites are not high, and the 
corresponding zinc reagent (95) is both preferable and more stable in such systems. 
(EtO)2P(0)CF2" Li^ 
EX 
-78°C 
(EtO)2P(0)CF2E + LiX 
EX Product Yieldi48 
(CH3)3SiCl (EtO)2P(0)CF2Si(CH3)3 87% 
C2H5Br (EtO)2P(0)CF2C2H5 82% 
n-(C4H9)3SnCl (EtO)2P(0)CF2Sn(C4H9)3 77% 
(EtO)2P(0)Cl (EtO)2P(0)CF2P(0)(EtO)2 74% 
C6Hi3Br (EtO)2P(0)CF2C6Hi3 66% 
C6H5COCI (EtO)2P(0)CF2COC6H5 25% 
CH2=CHCH2Br (EtO)2P(0)CF2CH2CH=CH2 23% 
table 2.2 
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I I .A . l .b Reaction of Perfluoroalkvl Grignard Reagents with Diethvl 
Chloronhosnhate 
Cen and Shen^ '*^  found that perfluoroalkyl Grignard reagents generated in situ by 
the reaction of perfluoroalkyl iodides and phenylmagnesium bromide could react with 
diethyl chlorophosphate, at low temperature leading to the formation of the -CF2-P bond 
and affording (diethoxyphosphinyl)perfluoroalkane derivatives (table 2.3). 
R,, PhMflBr ^ R^^gB^ CIP(0)(OEt). ^ RpP(0)(OEt), 
R F Yield 
n -QFn 56% 
C1(CF2)8 45% 
C1(CF2)6 58% 
C1(CF2)4 36% 
F02S(CF2)20(CF2)4 31% 
Reaction of perfluoroalkyl Grignard reagents 
table 2.3 
n.A.2 ElectroDhilic Fluorinating Agents 
n.A.2.a PgrQhlqryl Flupriclg 
Perchloryl fluoride^^ was one of the first electrophilic fluorinating agents 
developed, however, fluorination with perchloryl fluoride only proceeds in the presence 
of anionic substrates; the primary production of a carbanion with a sufficiently strong 
base is thus a necessary precondition, consequentiy problems are associated with this 
method of fluorination i.e. it tend to be non-selective.^^ M^Kenna and Shen^^°'^^^ used 
perchloryl fluoride to prepare bis(dihydroxyphosphinyl)fluoromethane (97) and 
bis(dihydroxyphosphinyl)difluoro-methane (98), the latter an important antitumour 
a g e n t , i n 33% and 52% respectively (scheme 2.1). 
[(EtO)2P(0)]2CH2F [(HO)2P(0)]2CH2F(97) 
[ ( E t O ) 2 P ( 0 ) ] 2 C H 2 - ^ - ^ + - ^ ^ ^ + 
[(EtO)2P(0)]2CF2 [(HO)2P(0)]2CF2 (98) 
(i) 'BuOK, FCIO3, PhCHj, 22°C; (ii) TMSBr, HjO. 
scheme 2.1 
Similarly, Blackburn used perchloryl fluoride in an alternative synthesis of 
(diethoxyphosphinyl)fluoromethane.^^^ 
n.A.2.b A^-FluorobenzenesulDhonamide (99) 
Differding and coworkers^^'* extended this methodology by using A'-
fluorobenzenesulphonamide (99); one of the next generation electrophilic fluorinating 
agents, the A^-fluoro derivatives, which are both cleaner and more selective m dieir mode 
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of action than perchloryl fluoride. Differding et al. went on to synthesise a range of 
mono- and di-fluorinated diethoxyphosphinyl derivatives (table 2.4) utilising this reagent. 
o 
II 
,P(0Et)2 
(i).(ii) 
O 
II 
P(OEt)2 
(i). Oi) 
F F 
O 
II 
P(0Et)2 
Product Yield 
(EtO)2P(0)CFH2 11% 
(EtO)2P(0)CFHCH3 45% 
(EtO)2P(0)CF2CH3 66% 
(EtO)2P(0)CFHCH2CH2CH2CH3 48% 
(EtO)2P(0)CF2CH2CH2CH2CH3 70% 
Reactions with A'-fluorobenzenesuIphonamide 
table 2.4 
II .B The Chemi.strv of (Diethoxvphosnhinvnrtifliinrnmethvlene Zing 
Brgmi^lg (95) 
I I . B . l R^aCtiQn qf Benzyl Brgmi^lg With (95) 
The reaction of activated allylic sites with (95) is well documented,unlike the 
reaction with benzylic sites and although Chambers et al.^^^ synthesised benzylic 
(diethoxyphosphinyl)difluoromethylene analogues via the organocadmium reagent (93), 
the literature gives no analogous reaction for the organozinc reagent (95). The reaction 
between benzyl bromide and (95) was therefore undertaken. 
When a freshly prepared solution of (95) in monoglyme was added dropwise to a 
solution of benzyl bromide in the presence of a catalytic quantity of copper (I) bromide, 
the product of the reaction was not 2-(diethoxyphosphinyl)-2,2-difluoroethylbenzene, but 
rather the coupled product bibenzyl (100), verified by ' H NMR and melting point 
comparison with commercially available material, and the carbene addition products (£)-
and (Z)-l,2-bis(diethoxyphosphinyl)-l,2-difluoroethene (lOla-b), together with 
(diethoxyphosphinyl)difluoromethane (102). 
Attempts to repeat the coupling process of benzyl bromide without (95) but in the 
presence of copper (I) bromide, a method effective for coupling benzyl bromides,'^^ or 
with only (95), resulted in no formation of bibenzyl, both (95) and the copper (I) salt 
being necessary. 
It was shown that (E)- and (Z)-l,2-bis(diethoxyphosphinyl)-l,2-difluoroethene 
(lOla-b) could be synthesised by heating (95) in the presence of copper (I) bromide in 
high yield i f no electrophile is ava i l ab le .The conclusion one must draw, therefore, is 
that the organozinc reagent is not a strong enough nucleophile to react with benzyl 
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bromide, or the rate of nucleophilic attack is slower than that of the carbene dissociation 
process. The bibenzyl could be generated by a bromophilic or radical abstraction process 
involving the (diedioxyphosphinyl)fluorometiiylene carbene intermediate (scheme 2.2). 
(EtO)2P{0)CF2ZnBr • ( E t O s P W F g C u ' Z n B r a 
(EtO)2P(0)CF2Cu'ZnBr2 
^ ^ P h 
2PhCH2 
(EtO)2P(0)CF2Cu"Br 
2(EtO)2P(0)CF: 
(EtO)2P(0)CF2Cu Br + ZnBrj 
+ 
PhCHg 
PhCH2CH2Ph 
(100) 
(EtO)2P(0)CF; + CuFBr 
scheme 2.2 
n.B.2 Reactions of Allvlic Bromides With (95) 
n.B.2.a Preparation of 3-Bromocvcloalkenes 
(EtO)2P(0)CF:CFP(0)(OEt)2 
( l O l a - b ) 
It has previously been demonstrated by Bunon et al.^'^^ that the organozinc 
reagent (95) reacts with allylic bromides e.g. allyl bromide to yield the corresponding 
allylic (diethoxyphosphinyl)difluoromethylene derivative. It was decided therefore to 
extend this methodology, to synthesise a range of cyclic alkenyl 
(diethoxyphosphinyl)difluoromethylene compounds. To facilitate this process it was first 
necessary to prepare the cycloalkenyl bromides. 
The bromination of allylic protons by the use of A'-bromosuccinimide is a 
standard laboratory reaction and following the work of Hatch and Bachmann^^^ 3-bromo 
derivatives of cyclopentene (103), cyclohexene (104) and cycloheptene (105) were 
prepared (table 2.5). 
H 
NBS/CCl}/AIBN/A 
•(CH2)n 
Br 
Compound n Yield 
(103) 2 35% 
(104) 3 52% 
(105) 4 41% 
-(CH2)fr 
(103)-(105) 
Yields of cyclic 3-bromoalkenes 
table 2.5 
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The reaction was not as simple as indicated in the literature due to the instability of 
the 3-bromocycloalkenes, which decompose at room temperature. Indeed this fact was 
reflected in the yields; isolation of the compounds required a distillation in vacuo at 
elevated temperature resulting in significant decomposition. The 3-bromocycloalkenes 
were all colourless oils which were subsequently stored below -10°C. 
II.B.2.b JH R m t i p n Qf PrQinpcyglQalkgngS With (95) 
From the 3-bromocycloalkenes we accomplished the syntheses of the 
(diethoxyphosphinyl)difluoromethylene derivatives by the dropwise addition of the 
organozinc reagent (95) in monoglyme to the 3-bromoalkenes (103)-(105) in the 
presence of a copper (I) bromide catalyst. Various conditions were attempted to optimise 
yields, a clear pattern emerging between the stability of the 3-bromoalkene and the yield 
of the desired products (table 2.6). 
Br 
•(CH2)n-
(103)-(105) 
(EtO)2P(0)CF^nBr/monoglyme 
Cu(i)Br 
^(CH2)n 
CF2P(0)(0Et)2 
(106)-(108) 
Compound n Temperature (°C) Yield 
(106) 2 20 0% 
(106) 2 -10 to 20 5% 
(106) 2 -78 to 20 9% 
(107) 3 -78 to 20 51% 
(107) 3 -78 to 86 65% 
(108) 4 -78 to 20 30% 
(108) 4 -78 to 86 51% 
Effect of temperature on the yield of 3-[(diethoxyphosphinyI)difluoromethyl]cycloalkenes 
table 2.6 
The reaction of 3-bromocyclopentene with (95), to give 3-
[(diethoxyphosphinyl)difluoromethyl]cyclopentene (106), was hampered by the extreme 
instability of the bromoalkene, to such an extent that no product could be detected when 
the reaction was carried out at room temperature. This could have been due to the 
extremely exothermic nature of the reaction, gas evolution and a rapid darkening in colour 
accompanied the reaction at room temperature. Thus, the temperature rise could have 
caused auto-decomposition of 3-bromocyclopentene (103), via elimination of hydrogen 
bromide. Indeed, ease of elimination would be expected to follow the trend; (103) > 
(105) > (104) (assuming an equatorial disposition for bromine). The rigid almost planar 
conformation in the strained five-membered ring leaving bromine well set up for coplanar 
fl/zri-elimination of hydrogen bromide, and the cycloheptenyl ring with a greater degree of 
flexibility in the ring would be expected to be less stable than the six membered ring. 
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The degree of instability in (103) could be contrasted with the results found in the 
reactions of the bromides (104) and (105). The effect of temperature became less 
important in these systems, indeed 3-bromocycloheptene give an increased yield upon 
heating to reflux temperature. Once again this phenomenon could be explained in terms 
of the stability of the bromides, both 3-bromocyclohexene and 3-bromocycloheptene 
were quite stable at room temperature for a number of days, the conformational 
geometries of the molecules moving away from the ideal fixed anri-regiochemistry for 
elimination held in the cyclopentenyl ring. 
The 3-[(diethoxyphosphinyl)difluoromethyl]cycloalkenes (106)-(108) could be 
readily identified by the presence of the heavily coupled ring proton geminal to the 
(diethoxyphosphinyl)difluoromethylene moiety, which, occurred in all cases at 
=2.97ppm^'*'' and a characteristic ^^p NMR shift from the precursor bromide (94) (table 
2.7). However, the stereochemical assignment of the products proved to be a more 
difficult task (section ILB.2.d). 
Compound Shift (ppm) Coupling Constant (Hz) 
(EtO)2P(0)CF2Br 
(94) 
-60.63 2JFP =93.1 
^ ^ ' ^ ^ C F 2 P ( 0 ) ( O E t ) 2 
(106) 
-115.345 2 J F F = 301.3 
2JFP =113.2 
3 J H F = 17.4 
^ C F 2 P ( 0 ) ( O E t ) 2 
(107) 
-114.419 2 J F F = 300,0 
2JFP =108.6 
3 J H F = 18.6 
(^^^^^^)—CF2P(0)(OEt)2 
~ ~ (108) 
-109.280 2 J H F = 298.4 
2 J F P = 111.8 
3 J H F = 21.4 
19F N M R shifts and coupling for 3-[(diethoxyphosphinyl)dinuoromethyl]cycloalkenes 
Table 2.7 
II.B.2.C Reaction Mechanism of Allvlic and Propargvlic Halides With (95) 
SN2 ' mechanism 
(EtO)2P(0)CF2—2cBr 
H C = C - ^ C H 2 C I 
(Et0)2P(0)CF2CH = C=CHj 
major product 
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S N 2 mechanism 
(EtO)2P(0)CF2—2oBr 
Br 
• (EtO)2P(0)CF2 
only product 
scheme 2.3 
The mechanism for the reaction appears to be predominantly via a SN2' /SN2 type 
process (scheme 2.3) dependant upon which allylic site is least sterically hindtred}'^^-^^^ 
though evidence that a competing single electron transfer (SET) process is also operating 
can not be ruled out. Indeed, evidence for the SET process comes from the presence of 
carbene addition side products, such as the vinylic species l,2-bis(diethoxyphosphinyl)-
1,2-difluoroethene (101), derived from (diethoxyphosphinyl)fluoromethylenecarbenei^^ 
(109) dimerisation or a (diethoxyphosphinyl)difluoromethylene copper carbenoid. 
The role of the copper (I) halides as a means of activation for the nucleophilic 
attack of (95) on 3-bromoalkenes has precedent, a copper (HI) allyl complex intermediate 
(110) proposed for a number of copper mediated reactions. However, Sprague later 
dismissed this intermediate in the reaction of (95) with allylic bromides,rather 
ac t iva t ion came f r o m the fo rma t ion of a very reactive 
(diethoxyphosphinyl)difluoromethylene copper species (111), which could be isolated in 
DMF.160 
(EtO)2P(0)CF2^^"2^^ 
C u - C H (EtO)2P(0)CF2CuZnBr2 
(110) (111) 
ILB.2.d Stereochemistry for the Reaction of Allvlic Halides With (95) 
The stereochemical course of the reaction of (95) with 3-bromocycloalkenes was 
determined by ^H NMR studies, utilising both conventional one dimensional spectra, 
decoupling experiments as well as two dimensional homonuclear correlation specQ-oscopy 
(COSY). 
The narrow band decoupling of the cyclopentene derivative (106) allowed 
unambiguous assignments of which protons were coupled to each other, and their relative 
positions around the cylopentene ring (figure 2.1). 
However, the unambiguous assignment of the position of the 
(diethoxyphosphinyl)difluoromethylene group could not be made due to the lack of 
axial/equatorial positions in such systems. 
The conformation adopted in cyclohexene systems has been shown 
experimentally!^! and by calculation to be a twist chair, with the methylene groups 
adjacent the double bond termed as pseudoaxial or pseudoequatorial. For the 
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cyclohexenyl derivative (107) a combination of decoupling and two dimensional ^H 
COSY allowed the assignment of the relative positions of the protons around the ring 
(figure 2.2). 
The COSY spectrum shows that: 
(i) Hi is coupled strongly to H 3 and H 5 or H6; 
(ii) H 2 is coupled strongly to H 4 ; 
(iii) H 3 is coupled strongly to Hi and H 5 or H6. 
y-CF2P(0)(OEt)2 
Hd He 
i! 
decoupled H ^ 
decoupled H, 
decoupled H 
A 
CH2O 
decoupled H^ 
Hd H , 
- T 
5 
PPM 
figure 2.1 
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\ y ^ C F 2 P ( 0 ) ( O E t ) 2 
He H5 H , H. 
r\j ru ru 
m CD 
• I • ~ • I 
figure 2.2 
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Subsequent narrow band decoupling of the proton geminal to the 
(diethoxyphosphinyl)difluoromethylene group ( H 7 ) showed that H7 coupled to H 9 and 
H 2 (figure 2.3). 
6 . 0 5 . S 
HsHs 
1-5 4 . 0 3 . 5 3 . 0 2 . 0 1 . 5 
figure 2.3 
Assignment of the relative positions of the protons around die cyclohexenyl ring 
could now be made. Axial protons generally resonate at higher field than equatorial 
protons, therefore, it can be assumed H i and H 2 are axial and must adopt the positions 
Hf, Hd or Hb in figure 2.4. However, H i and H 2 do not show a characteristically large 
axial-axial coupling constant and H 2 is coupled to H 7 , therefore, H2 must be Hb and Hi 
is Hf. Since H 2 couples strongly only to H4 it can be deduced that H4 is the geminal 
proton He. Given that H3 resonates at a higher field than eiUier H5 or He then it can be 
assigned to H j . However, this leaves H 5 and Hg which can not be unambiguously 
assigned due to significant overlap, they must be either He or Hg. 
CF2P(0)(OEt)2 
- H e 
Hb 
figure 2.4 
The elucidation of the stereochemical position of the (diethoxyphosphinyl)-
difluoromethlyene group could then be determined from the coupUng constants of the ^ H 
NMR spectrum of (107) (figure 2.5). 
" ' ' J F H = 18.8Hz 
= 12.4Hz 
6.4Hz 
J H H = 3.2Hz 
1—1—]—r -1—\—r 1—r 
3 . 1 3 . 0 2 . 9 
figure 2.5 
2 . 8 
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The ^JHaHb coupling constant would be expected to be of the order of 6-14Hz for an 
axial-axial interaction, cf. 12.4Hz, the axial-equatorial relationship between Ha and He 
should give a coupling in the order of 0-5Hz, ^ J H H H C = 6.4Hz and the vicinal coupling to 
the alkenyl proton at ^JnaH = 3.2Hz compares favourably with literature values of 
between 4-lOHz.i^^ Thus the relative position of the (diethoxyphosphinyl)difluoro-
methylene group is pseudoequatorial, this conformer minimising unfavourable 1,3-diaxial 
interactions between the axial hydrogen and the bulky (diethoxyphosphinyl)-
difluoromethylene group. 
No attempt was made to define the stereochemistry of the 
(diethoxyphosphinyl)difluoromethylene group for (108). 
II.B.3 Attempted Palladium (0) Catalysed Reactions of (95) with Allvlic 
A ^ a t g ? anq Phenyl Allyl Ethgrg 
Trost and coworkers^^^ have shown that allylic alcohols, allyl phenyl ethers, and 
allyl carboxylates can be efficiently, and with a high degree of chemoselectivity, 
converted by a palladium (0) catalysed allylic substitution reaction to give compounds 
derived from soft nucleophiles, e.g. malonate, or bis(benzenesulphonyl)methane (scheme 
2.4). 
a c t i v a t i o n , s u b s t i t u t i o n ^ 
OAc M H 
scheme 2.4 
This methodology, based on carboxylates and phenyl allyl ethers, has advantages 
over conventional alkylation reactions, in that: 
(i) The carboxylates are more readily available in stereodefined form, necessary for 
asymmetric synthesis; 
(ii) The carboxylates and ethers are more stable in comparison to the equivalent allylic 
halides. 
Given these advantages, and the fact elimination reactions frequendy compete 
with substitution reactions, particularly when cyclic allylic halides are used (section 
I I . B . l ) , the palladium (0) catalysed route should provide a greater degree of 
chemoselective control, especially for the problematic cyclopentenyl systems. 
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ILB.3.a The Attempted Palladium (0) Catalysed Reaction of r95) with 
Ct.v-Acetoxv-5-carbomethoxv-l-cvcIohexene (112) 
Before any attempt to react (95) with allylic acetates in the presence of a 
palladium (0) catalyst, c/5-acetoxy-5-carbomethoxy-l-cyclohexene (112) had to be 
synthesised. This was achieved via a five step synthesis (scheme 2.5).^ -^^ "^ ^^  
.COOH 
COOH 
i l l l 
Q 
-0 
( i i i ) 
Q 
OMe 
Q Q 
.OAc OMe 
( iv ) 
-O 
^ ^ 
(112) (113) 
(i) 160°C, 0.5hr; (ii) KI, NaHCOj, I j , H2O; (iii) AgOAc, DMSO, I S C C ; (iv) MeONa, MeOH; 
(v) AcOCl, pyridine, CH2CI2. 
scheme 2.5 
Dehydroiodination was achieved most successfully by the use of silver acetate, 
in yields up to 84%, the silver being easily removed as the insoluble chloride and the 
reduced metal by filtration. Initially l,5-diazabicyclo[5.4.0]undecane-5 (DBU) a very 
hindered base, was used to dehydroiodinate the iodolactone but the presence of iodine 
reduced yields, the maximum yield obtained being only 25%. The low yield was due to 
the reaction of the DBU with iodine to form the iodide salt, which was insoluble in 
benzene, effectively removing the DBU from the reaction. 
The ring opening of 6-oxabicyclo[3.2.1]octen-5-one (113) with a catalytic 
amount of sodium methoxide in methanol yielded 3-hydroxy-5-carbomethoxy-
cyclohexene in a predominantiy c«-conformation in a yield of 65% (figure 2.6). 
COgMe COjMe 
HO 4 
i 
Me02C 
4 "OH 
figure 2.6 
Analysis of the product by g.c. showed contamination with 4.5% of the rra/25'-isomer, 
arising from ester epimerisation during methanolysis. The final step to (112) was 
accomplished in a 53% yield by acetylation of the alcohol by acetyl chloride in the 
presence of pyridine, to remove the hydrogen chloride generated. 
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The purified allyl acetate (112) was taken and stirred in anhydrous oxolane, 
THF, with a catalytic amount of the palladium (0) complex, tetrakis(triphenylphosphine) 
palladium, for one hour to generate the symmetrical ;r-allyl complex, the symmetry of the 
species removing problems arising from differentiation of both stereo- and regio-isomers. 
Into this solution an excess of (95) in monoglyme was then added, and the 
mixture heated to reflux for one day. The reaction was monitored by both high field ^^F 
NMR and thin layer chromatography, TLC, each showing no reaction had taken place. 
Prolonged heating for a further two days, again, showed no sign of reaction. 
ILB.3.b The Attempted Palladium (0) Catalysed Reaction of (95) with 3-
PhgnQxymlQPgntgng (114) 
3-Phenoxycyclopentene (114) is capable of undergoing nucleophilic alkylation 
reactions in the presence of a palladium(O) catalyst. It was thought that this system 
could be used as a route to a five-membered (diethoxyphosphinyl)difluoromethylene 
derivative. 
The thermally stable compound (114), cf. 3-bromocycIopentene, was 
synthesised, by a route shown in scheme 2.6. 
(i) ^ < ^ ( i i ) ^ - m ^ < ^ ^ o ? ^ 
(114) 
(i) 160°C; (ii) HCl(g), -69°C; (iii) PhOH. NaOH, DMF, H2O 
scheme 2.6 
The cracking of dicyclopentadiene provided cyclopentadiene which was used 
immediately in the next stage of the reaction, due to its tendency to polymerise at room 
temperature. The diene was collected in a solid carbon dioxide-acetone cooled receiver 
flask, in which the next step of the synthesis could be carried out. 
The conversion of the diene to 3-chlorocyclopentene*^' was accomplished by the 
bubbling of a rapid stream of dry hydrogen chloride into the cooled flask with vigorous 
stirring, the temperature never being allowed to rise above 0°C. Polyaddition did not 
occur and the 3-chlorocyclopentene was used without further purification. 
The phenyl allyl ether was then generated by an SN2 or 8^2' displacement of the 
chloro group by the phenoxide ion aided by the use of the polar solvent media, NJ^-
dimethylformamide-water. The yield obtained was low at 11%, but acceptable given the 
literature yield of 10%. 
The purified phenyl allyl ether (114) was stirred with the palladium (0) catalyst in 
THF for one hour, under nitrogen, a colour change being observed from pale green to 
dark red. An excess of (95), in monoglyme, was then added and the mixture refluxed 
for one day. 
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19 f NMR and TLC showed no generation of the expected product 3-
[(diethoxyphosphinyl)difluoromethyl]cyclopentene (106). 
II.B.3.C The Attempted Palladium (0) Catalysed Reaction of (95) with 6-
Oxabicvclor3.2.nocten-5.one (U^) 
It has been reported by Trost et al.^^^ that the lactone (113) proves to be an 
excellent substrate for palladium (0) catalysed alkylation reactions, and provides a 
synthetically simpler target than c/5-3-acetoxy-5-carbomethoxycyclohexene (112). 
Thus, lactone (113) was stirred in THF with a catalytic amount of 
tetrakis(triphenylphosphine) palladium for one hour, under nitrogen. An excess of the 
organozinc reagent (95) was then added, and the reaction mixture heated to reflux. 
19f NMR and TLC showed no conversion to product. 
II.B.3.d Conclusion 
It can be concluded that from the three systems tried i.e. d5-3-acetoxy-5-
carbomethoxycyclohexene, 3-phenoxycyclopentene, and 6-oxabicyclo[3.2.1]octen-5-one 
are all inert towards alkylation by the (diethoxyphosphinyl)difluoromethylene group 
under the normal conditions viz. oxolane heated to reflux. This is not without precedent, 
in some systems boiling dimethylsulphoxide having to be used as the solvent e.g. (115) 
gives a mixture of (116) and (117) in 50% yield.^^^ 
.OAc 
(115) 
COgMe 
^COoMe 
NaCHCCOgCHa); 
D M S 0 , 1 2 0 ° C 
(116) 
COgMe 
COgMf 
(117) 
Burton et al.^^^ also encountered d i f f icu l ty in introducing a 
(diethoxyphosphinyl)difluoromethylene group into internal alkenes using palladium (0) 
catalysis with (diethoxyphosphinyl)difluoroiodomethane (118). 
II.B.4 General Conclusion 
The (diethoxyphosphinyl)difluoromethylene zinc bromide reagent gives high 
yields with allylic systems, and is the reagent of choice for substitution of allylic 
bromides, the yields only being dependant on the stability of the allyl halides. 
The mechanism of the substitution reaction is unclear, evidence pointing at a SN2 
or SN2' type mechanism, but side products are indicative of a carbene or carbenoid 
intermediate. It is however known that it does not progress via an addition/substitution 
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mechanism. The actual mechanism probably lies in between the two extremes 
mentioned. 
I I . C The Chemistry of (Diethoxvphosphinvndifluoromethvlene Lithium 
1961 
As indicated previously Obayashi et al.^'^^-'^'^^ carried out significant research into 
the uses of the organolithium reagent (96). A study was undertaken to first, evaluate the 
reagent, and then extend its synthetic utility. 
II.C.1 Ggngratign pf thg Lithium Salt (96) 
The (diethoxyphosphinyl)difluoromethylene anion is generated at temperatures 
below -78°C (scheme 2.7) due to its extreme instability via dissociation. '^^  
Eto^P -CF ,H ' ^ f ^ ' - ^ ^ ' ^ . E tO- f -CF, -L i^ 
EtO (Pr)2NH EtO 
(96) 
scheme 2.7 
Thus, the anion (96) was generated, under a standard set of conditions, and 
quenched with deuterium oxide to generate (diethoxyphosphinyl)difluorodeuteromeihane 
(119) to determine the maximum conversion to the anion (96). The ratio of (119) to 
(diethoxyphosphinyl)difluoromethane (102) could then be found by measurement of 
peak areas in the NMR spectrum (figure 2.7). The integration of the peak areas 
showed that the ratio of (119) to (102) was 2:1 indicative of a 66% conversion to the 
anion (96). 
(EtO)2P(0)CF2H 
(EtO)2P(0)CF2D 
figure 2.7 
The fluorine atoms in (diethoxyphosphinyl)difluoromethane (102) were split by 
phosphorus (2jpp=96.03Hz) and the hydrogen atom (2jpH=46.60Hz), nuclei with a 
nuclear spin (I) of 1/2 hence a doublet of doublets centred at 134.433ppm was observed, 
while (diethoxyphosphinyl)difluorodeuteromethane with a deuterium atom, which has a 
nuclear spin of 1, gave a doublet from phosphorus (2Jfp=80.(X)Hz), of triplets from 
deuterium (2jpD=6.59Hz) centred at 135.141ppm. However, the deuterium coupling is 
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only =0.152 that of hydrogen coupting and further expansion was needed to resolve the 
triplets. 
II .C.2 The Reaction of (96) with Halides 
Almost all previous work utilising the lithium reagent involves halide 
displacement on a suitable substrate.-^ *^^ ^^  Experiments were therefore carried out with 
primary, secondary and benzylic halides. 
ILC.2.a Saturated Halides 
Burton had shown that the organozinc reagent (95) could not effect the 
displacement of halide from saturated alkyl halides with the exception of the most reactive 
to S N 2 substitution, methyl iodide,-^° this contrasts with our findings for the lithium 
reagent. 
(EtO)2P(=0)CF2"Lr (EtO)2P(=0)CF2E + LiX 
EX Product Yield 
C H 3 I (EtO)2P(0)CF2CH3 80% 
C 2 H 5 I (EtO)2P(0)CF2C2H5 47% 
p-N02C6H4CH2CH2Br ;7-N02C6H4CH2CH2Br 0% 
(CH3)2CHBr (CH3)2CHBr 0% 
0 - " 
<VB. 2%t 
table 2.7 
The reactivity of (diethoxyphosphinyl)difluoromethylene lithium (96) at saturated 
carbon centres was: 
substitution of primary halides > secondary halides. 
This is consistent with a typical SN2 process were branching at either the a or (5 
carbon decreases the rate of the SN2 mechanism, due almost certainly to steric factors.'''^ 
The anomalous result for the primary halide ;j-nitrobromoethylbenzene was 
perhaps due to the lability of the hydrogen atom at the benzylic site, which the lithium salt 
(96) may have abstracted in preference to the bromine atom, i.e. the elimination process 
competing against the nucleophilic substitution of bromine. 
t Yield determined by l ^ F NMR 
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II.C.2.b Bgnzylig and Allylig Halid^S 
The methodology used for the following reactions is identical to that described in 
the previous section (section II .C. l) . 
(EtO)2P{=0)CF2"Lr ^Qo(^ (EtO)2P(=0)CF2E + LiX 
EX Product Yield 
C6H5CHBrCH3 (EtO)2P(0)CF2CH(CH3)C6H5 (120) 30% 
CH2=CHCH2Br (EtO)2P(0)CF2CH2CH=CH2 (121) 66% 
XT' (EtO)2P(0)CF2P(0)(OEt)2 (122) 18% 
^ y-CF2P(0)(Oa)2 
(107) 51% 
Reaction of (96) with benzylic and allylic halides 
table 2.8 
Products were isolated in moderate yields by displacement of the bromo group at 
the benzylic site of a-bromoethylbenzene to give (120), and at the allylic site of allyl 
bromide and 3-bromocyclohexene (104) giving (121) and (107) respectively. 
However, the reaction of the organolithium reagent with 3-bromocyclopentene 
(103), did not yield the expected substituted cycloalkene (106) but 
bis(diethoxyphosphinyl)difluoromethane (122); a mechanism to rationalise this 
unexpected product is shown in scheme 2.8. 
O 
E t O — P - r C F 2 Li 
O B 
OEt— 
O 
P-
OEt 
:CF, 
O 
EtO— Br-
OEt 
O 
+ E t O - P — B r 
OEt 
EtO-
O 
OEt 
O 0 
E t O — P — C F p — P — OEt 
OEt OEt 
scheme 2.8 
(122) 
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Evidence to support this mechanism comes from two sources: 
(i) quenching of the anion of (diethoxyphosphinyl)difluoromethane by bromine, which 
gave not only (diethoxyphosphinyl)bromodifluoromethane (94), but also 
bis(diethoxyphosphinyl)difluoromethane (122), the major product; 
(ii) Burton has shown that (diethoxyphosphinyl)bromodifluoromethane reacts with 
sodium di(tert-hutyV)phosphite to give a mixture of symmetrical and unsymmetrical 
difluoromethylbisphosphonates,'^^ a consequence of difluorocarbene scrambling via the 
unstable intermediate (diethoxyphosphinyl)difluoromethylene sodium. 
Hence a bromophilic reaction must have occurred to give (122), it should be noted, 
however, our attempts to trap the carbene with cyclohexene proved unsuccessful. 
II.C.3 Displacement of Other Leaving Groups by (96) 
Diacetone-D-glucose (123) is an ideal model system for a sugar and allows some 
interesting chemistry to be done, in the form of the direct introduction of the 
(diethoxyphosphinyl)difluoromethylene unit. 
(123) 
Initially the hydroxyl group was converted into the tosylate, or triflate, since the 
hydroxyl group is incompatible with the organolithium reagent (scheme 2.9). 
.0. 
(124) \ 
87% 
79% 
s " ' 0 \ . 
) \ " ' (125  
(i) pyridine, tosyl chloride TsCl, 0°C; (ii) pyridine, friflic anhydride (TfO)20, 0°C. 
scheme 2.9 
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The tosylate (124)^ "^ "^  and triflate (125)'^^ of diacetone-D-glucose, obtained in 
high yield, were subsequendy reacted under standard conditions with the lithium reagent 
(96). However, in both cases no reaction was apparent by ^^F NMR. 
Tosylate and triflate are often considered as very good leaving groups in organic 
chemistry, yet no reaction was observed. This must be due to steric crowding at the site 
for substitution, the (diethoxyphosphinyl)difluoromethylene anion being hindered by the 
steric bulk of the adjacent ketal group. The hard tosylate and triflate groups have been 
successfully displaced at primary carbon centres by Wolff-Kugel et a/.^ "*^  in the synthesis 
of (83). 
O O 
II II 
T f O — I ^ (EtO)2PCF2—^ (HO)2PCF2 
(i) ^ 
(83) 
(ii) (EtO)2P(0)CF2Li, -78°C 
Thus it appears the lithium salt (96) is a poor nucleophile at secondary alkyl 
centres due most probably to steric hindrance. 
II.C.4 Reaction of (96) with Oxirane 
The reaction of organolithium reagents on epoxide rings has been well studied, 
the reagents open an epoxide ring as shown in scheme 2.10. 
scheme 2.10 
(Diethoxyphosphinyl)difluoromethylene lithium (96) was reacted with oxirane, 
the simplest of the epoxides, in an attempt to synthesise l-(diethoxyphosphinyl)-l,l-
difluoropropan-3-ol (126). 
The l^F NMR spectrum showed that a new (diethoxyphosphinyl)difluoro-
methylene substituted product had been formed (figure 2.8), the product easily 
differentiated from (diethoxyphosphinyl)difluoromethane (102) by a change in the 
chemical shift of the two fluorine atoms down field; (diethoxyphosphinyl)difluoro-
methylene groups appendant on carbon chains occur in the region between -110 and -
125ppm, differing greatly from (diethoxyphosphinyl)difluoromethane (102) in which the 
fluorine atoms resonate at -136ppm. Attempts to isolate the product by silica gel 
chromatography ended in failure with only starting material being recovered, however 
based on the NMR evidence this product is tentatively assigned as 1-
(diethoxyphosphinyl)-l,l-difluoropropan-3-ol (126). 
(EtO)2P(0)CF2H 
[(EtO)2P(0)CF2CH2CH20H] 
l^F NMR of the reaction between oxirane and (96) 
figure 2.8 
II .C.5 General Conclusion 
The organolithium reagent is suitable for replacement at primary halide sites and 
for the ring opening of epoxides. However, the reagent does fall down at more crowded 
sites such as secondary halides and tosylates unless activation is present, i.e. substitution 
at benzylic or allylic carbon centres. 
The effect of solvent on the generation of the anion has not yet been studied 
though Kim et al?^ report the use of hexamethylphosphoramide increases the yield of a 
substitution reaction involving (diethoxyphosphinyl)difluoromethylene lithium from 0% 
to 23%. 
II .D Reactions of 3-r(Diethoxvphosphinvl)difluoromethyncvclohexene 
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The synthesis of nucleotide derivatives as potential antiviral agents is of obvious 
benefit. However, to accomplish this for carbocyclic systems based on the 3-
[(diethoxyphosphinyl)difluoromethyl]cyclohexene skeleton it becomes necessary to 
functionalise the molecule by conversion of the double bond to such groups as the 
dihydroxy species, the epoxide, fluoride or even azide. 
I L D . l Th^ Preparation Qf l-f(Digth9xyph9<yphinyl)tlifluQr9mgthyl]-2,3-
epoxycvclohexene (127) 
The simplest approach to epoxidise a double bond is via the action of a 
peracid,^^^ however, initial studies carried out on (107) with magnesium 
monoperoxyphthalate in acetonitrile proved discouraging. Thus, an alternative procedure 
to epoxide (127) was affected via the chlorohydrin (scheme 2.11). The cycloalkene 
(107) was stirred for two days with an excess of calcium oxychloride in acetonitrile, 
producing the epoxide (127) in moderate yield, 52%. 
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5- 5+ 
/HO—CI 
rl 
( V-CF2P(0)(OEt)2 
H O " ^ CI 
( )—C¥2PmOEt)2 
HO CI 
•HOI 
^ ^CF2P(0)(OEt)2 
O 
^^^^CF2P(0) (OEt )2 
(127) 
scheme 2.11 
However, with the peracid 3-chloroperoxybenzoic acid the epoxide could be 
isolated in yields of upto 90%, after silica gel flash column chromatography. 
0 
CF2P(0)(OEt)2 
(107) 
(i) CF2P(0)(OEt)2 
(127) 
(i) 3-chloroperbenzoic acid, CH2CI2, 12h. 
I I . D . l . a The Stereochemistry of l-r(DiethoxvDho.SDhinvDdifluoro-
methvll-2.3-eDoxvcvclohexene(127) 
Epoxidation of a cyclohexenyl ring witii an allylic substituent can give rise to two 
possible products (figure 2.9): 
(i) The ann-product (127a), which would be expected i f the substituent is bulky, the 
peracid attacking from the least hindered face; 
(ii) The ^yn-product (127b), obtained where hydrogen bonding exists between the 
incoming peracid and the substituent, seen in allylic alcohols.^'^ 
C^4CI 
antt ^S^^y^T^ CF2P(0)(OEt)2 
(127a) 
+ CIC6H4COOH 
CF2P(0)(OEt)2 
CF2P(0)(OEt)2 
C6H4CI 
•o 
(127b) 
figure 2.9 
The IH and 13C NMR spectra for the epoxide (127) indicate predominatiy one 
product (figure 2.10) the ratio of the epoxides being 5:1. However, the structure could 
not be unequivocally assigned by elucidation of coupling constants, because, unlike 
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the cyclohexenyl systems assigned previously (section II.B.2.d) the energy barrier 
between the conformers of the epoxide is relatively low, molecular modelling 
(COSMIC) indicating at least three low energy conformations which could be adopted. 
Thus, the NMR is likely to be an equilibrium distribution of conformers. 
"1—I—I I I I I I I I I I I I I I I I I i — | — 1 — I - I I I I I I i [ r- i — [ I I I I I I I I I i I I I 
125 124 123 122 121 120 119 118 ppm 
a section of the NMR spectrum of (127) showing presence of the other isomer 
figure 2.10 
However, given the steric bulk of the (diethoxyphosphinyl)difluoromethylene 
group and the possibility of lone pair repulsion between the difluoromethylene group and 
the incoming peracid the stereochemistry of the groups can be tentatively assigned as the 
fl«r/-product (127b). 
I L D . l . b Thg Attemptetl EpQxi^lg CIgavagg Qf (127) with DAgT 
Diethylaminosulphur trifluoride (DAST) reacts with epoxides to form vicinal 
difluorides and bis(2-fluoroalkyl)ethers, the relative ratios of each being dependant upon 
the reaction temperature. Since fluorine in the C2' and C3' position of nucleosides is 
advantageous for increased efficacy^^ the epoxide (127) was reacted with DAST to 
isolate i f possible l-[(diethoxyphosphinyl)difluoromethyl]-2,3-cw-difluorocyclohexane 
(128)(scheme 2.12). 
NEt2 
S ^ F 
NEt, 
CF2P(0)(0Et) CF2P(0)(OEt)2 
EtN2S(0)F 
^ ^ ^ ^ ^ C F 2 P ( 0 ) ( O E t ) 2 
(128) 
scheme 2.12 
The epoxide (127) was added dropwise to neat DAST at 55°C, the reaction 
mixture rapidly darkened and was monitored by ^^F NMR. The broad DAST peak at -
46.5ppm was seen to slowly disappear and a peak at -54.0ppm appear, due to the 
diethylaminosulphinyl fluoride. On quenching the reaction and extraction a ^^F NMR 
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spectrum indicated a large number of fluorine environments, none of which correspotKlcd 
to the expected c/.s-difluoride. However, it was apparent that fluorination had occurred ;ii 
the phosphorus centre, a doublet centred at -66.24ppm and a coupling of =95011 z, 
characteristic of a i jpp c o u p l i n g , t h e materials were therefore destroyed in 
concentrated sodium hydroxide solution. 
II.D.2 The Attempted Preparation of l-r(DiethoxvDhosnhinvndifluoro-
methvll-2.3-C/.9-dihvdroxvcvclohexane (128) 
A number of routes exist to add two hydroxy groups to an alkene in a syn 
addit ion.Potassium permanganate in alkaline solution has been used,^^° but rarely 
gives yields in excess of 50% due to the facile oxidation of the diols to diketones and then 
subsequent cleavage. Therefore, two alternative methods to 5y«-dihydroxyIation were 
tried. 
H.D.2.a Via a Catalytic Osmium Tetroxide/A^-Methvl-Morpholine-A^-Oxide 
System 
Osmium tetroxide can be used to dihydroxylate alkenes both stoichiometrically^^' 
and catalytically.^^^'^^^ However, due to the extreme toxicity of the reagent and high 
cost a catalytic method is preferred. O'Hagan^^"* indicated that the allylic 
(diethoxyphosphinyl)difluorometiiylene compound (121) could be hydroxylated with A'-
methyl-morpholine-A^-oxide as the co-oxidant in a modest yield of 48% (scheme 2.13), 
thus similar conditions were tried for (107). 
( E t O ) 2 P ( 0 ) C F 2 v ^ ^5s^ Os04_ 
2^ V ^ 2 \ ^ ^ 1 ^ (EtO)2P(0)CF2 
(121) 
H20 
OSO4 + (EtO)2P(=0)CF5\^A^O^ 
scheme 2.13 
Unfortunately after 7 days no addition across the double bond could be observed 
by 1 H NMR. It can be surmised given the reactivity of (121) under these conditions that 
the difluorinated substituent is not responsible for the inactivity but rather the internal 
double bond of (107), literature reporting poor yields and sluggish reaction times for 
substituted alkenes. 
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ILD.2.b Via the Woodward Method 
Woodward^^^ found that when an alkene was treated with iodine and silver 
acetate in a 1:1 molar ratio in aqueous acetic acid that ^yrt-hydroxylation results. Scheme 
2.14 indicates possible intermediates, proceeding initially with the formation of the {5-
haloester; the addition is anti and a nucleophilic replacement of iodine occurs. The 
monoacetate is now syn and hydrolyses to give a diol with overall syn addition. 
CH3C(0)0,^ J 
• • • i C F 2 P ( 0 ) ( O E t ) 2 
VCH3C02Ag 
• i C F 2 P ( 0 ) ( O E t ) 2 
(i) 
HO,^  CH3C(0)Q, 
. C F 2 P ( 0 ) ( O E t ) 2 
H 2 O 
i . C F 2 P ( 0 ) ( O E t ) 2 
(129) (i) I2, AgOAc, HOAc, HjO. 
scheme 2.14 
Again the ^yn-dihydroxy compound (129) could not be prepared, with the 
attempted reaction under Woodward's conditions resulted in only the starting material 
being isolated. 
n.D.3 CQnglusign 
The alkenyl group in 3-[(diethoxyphosphinyl)difluoromethyl]cyclohexenyl 
systems is not easily converted to the highly desirable fluoro or hydroxy groups, 
probably due to three factors: 
(i) the (diethoxyphosphinyl)difluoromethylene group is an electron withdrawing group 
and thus disfavours the electrophilic substitution characteristic of alkenes; 
(ii) it contains a phosphorus centre which can be susceptible to nucleophilic attack; 
(iii) and the (diethoxyphosphinyl)difluoromethylene group is bulky hindering the attack 
of the double bond. 
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C H A P T E R I I I 
T H E S Y N T H E S I S O F 3 - W 9 - A D E N Y L ) - 6 - r m T H Y D R O X Y P H O S P H -
I N Y D D I F L U O R Q M E T I f Y L I C Y C L Q H E T C E N E (139) AND 3-(A^9-
GIJANYD-r t - rrnTHYDROXYPHOSPHTNYDDTFLIJOROMETHYLl -
C Y C L O H E X E N E n40) 
I I L A Intrp^uctipn 
Carbocyclic nucleoside derivatives have become increasingly important, with the 
discovery that the removal of oxygen from the sugar component of a nucleoside increases 
in vivo stability of the analogue to cleavage by phosphorylases.'^' The routes employed 
to synthesise this class of compounds has recently been reviewed by Borthwick and 
Biggadike,^°^ so only two features of the class will be discussed, the effect of ring size 
and introduction of unsaturation, on metabolic activity. 
H L B Effect of Ring Size in Carbocvcles 
o o 
HO — 
(130) (131) 
A number of carbocyclic nucleoside analogues have been synthesised with 
varying ring sizes, ranging from the three carbon cyclopropane ring to six carbon 
cyclohexane ring, e.g. (130),'^^ (131),'^'' (132)1^^ and ( 1 3 3 ) . I t should be noted, 
however, that not all showed antiviral p roper t ies , the class showing the greatest 
potential, excluding the cyclopentane derivatives (section I.C.3.e), being those based on 
oxetanocin. 
Japanese workers^^° in 1986 isolated a naturally occurring oxetane nucleoside, 
oxetanocin (134), from a strain of bacterium Bacillus megeterium. Oxetanocin is the 
only known example of a four membered ring nucleoside in nature, and showed not only 
antibiotic properties but activity against HIV. 
HO-
(134) 
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Further modification of (134) gave, in 1986, the carbocyclic analogue (131) utilising not 
adenine as the base but guanine. Indeed, compound (131) exhibits the greatest activity 
of all the oxetanocin analogues synthesised at present,^ ^^ and is extremely potent against 
HSVl and HSV2 infections, i.e. one order of magnitude more effective than the current 
reference acyclovir (55).^ '^^  
I I L C Effect of Unsaturation 
Unsaturated nucleosides are of obvious benefit as intermediates and have been 
reviewed to this purpose by Zemlicka et a/.^ ^^  However, much interest is now being 
expressed in the area, stemming from the isolation of the fermentation product neplanocin 
A (62),'^ a naturally occurring carbocyclic nucleoside, which possesses unsaturation 
between the C4' and C6' position, and exhibits a limited antitumour activity. Ohno^°^ 
found the close analogue (63) was even more potent in its ability to selectively inhibit 
tumour cell growth and displayed antiviral properties,thus giving rise to a range of 
nucleoside derivatives containing unsaturation. 
HO OH HO OH 
(62) (63) 
In 1990 Biggadike and Borthwick described a synthesis of the 4',6'-unsaturated 
derivative of 2'-ara-fluoro carbocyclic guanosine (32).^ "* In order to increase antiviral 
activity of the unsaturated carbocyclic derivatives and simultaneously reduce the 
cytotoxicity, the new cyclopentenyl nucleoside (135) included the important T-ara-
fluoro substituent, known to confer antiviral activity (section l.C.3.a). The nucleoside 
analogue (135) was found to be equipotent to acyclovir in vitro. 
Unsaturation is not only confined to the C4'/C6' position, with the synthesis of 
the non-carbocyclic 2',3'-dehydro analogues (136) and (137),^ '^^  both of which 
exhibited potent activity in the inhibition of RT,^^^ necessary for the integration of the 
HIV virus' genetic information into the host cell genome in the form of DNA, comparable 
to that of AZT (37) and have been used in the clinic. 
H 0 - - \ . N ^ N ^ N H , . " N - ' ^ O 2 HO 
(136) (137) (138) 
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Carbocyclic 2',3'-unsaturated variants have also been prepared, however, the 
most hopeful 2',3'-dideoxy-2',3'-didehydroguanosine (138) is only as effective an 
inhibitor of HIV RT as AZT (37), though of reduced toxicity. 
The mode of action of the unsaturated congeners is not fully understood, but in 
the case of the 2',3'-unsaturated nucleosides the absence of the C2' and C3' hydroxy 
functionaUty does, as previously discussed (section I.C.3.a), chain terminate DNA or 
RNA synthesis by negating the possibility of 3' to 5' phosphate linkages. However, it is 
necessary to invoke further explanation for 4',6'-unsaturated nucleosides because 
although the saturated analogue of (62)^ ^^ expresses antitumour activity in vivo via the 
same pathway as the unsaturated analogue, it is two orders of magnitude less potent, 
indicating (62) is a more effective substrate for cytidine triphosphate synthetase; the 
enzyme responsible for de novo pyrimidine biosynthesis, catalysing the synthesis of 
cytidine triphosphate from uridine triphosphate.'^-' 
I I I .D Synthesis of 3-(A^9-Adenyn-6-r(dihvdroxvphosphinvndifluoro-
methyllcvclohexene (139) and 3-(A^9-Guanyn-6-r(dihvdroxvDhosphinvl)-
^liflUQrQm^thYllcYglghgxgn^ (140) 
Given the interest in carbocyclic nucleosides, we therefore embarked upon the 
synthesis of the unsaturated cyclohexenyl derivatives (139) and (140). The 
methodologies for coupting nucleoside bases to sugar analogues are well defined, three 
basic strategies commonly being deployed; the Mitsonobu reaction,'^^ ring opening of an 
epoxide'^^ and halogen displacement.'^^° In devising a synthetic route to the carbocyclic 
nucleotides 3-(A'9-adenyl)-6-[(dihydroxyphosphinyl)difluoromethyI]cyclohexene (139) 
and 3-(A'9-guanyl)-6-[(dihydroxyphosphinyl)difluoromethyl]cyclohexene (140) two of 
these approaches were attempted (scheme 3.1); method A proceeding via a Mitsonobu 
reaction with the allylic alcohol (141),^°' while method B proceeds via halogen 
displacement at the activated allylic position.-^^^ 
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CF2P(0)(OEt)2 
NBS/CCIVA SeCydioxane^ 
AC2 9 
HO { ) CF2P(0)(OEt)2 
(141)a 
Diethyl azodicarboxylate/j 
01 
N 
\ / P P f V T H F 
> 
\^ y—CF2P (0 ) (OEt )2 
NH3T 
NH2 
1 ir 
MeOH/A 
1 ^ ^ ^ C F 2 P ( 0 ) ( O E t ) 2 
i) TMSBr 
II) 1MHa(aq) 
NH, 
1^ y — C F 2 P ( 0 ) ( O H ) ; 
(139) 
Method A 
(142) 
CF2P(0)(OEt)2 
a 
K2C03/DMf/ jT''^ '^  
1MHCI(aq) 
GF2P(0)(OEt)2 
HpN 
^ ^ — C F 2 P ( 0 ) (OEt ) 2 
O 
HjN 
(i) TN4SBr 
(ii) IMHa(aq) 
1 
1^ ^ — C F 2 P ( 0 ) ( 0 H ) ; 
(140) 
Method B 
scheme 3.1 
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I I I . D . l MgthQ l^ A; Via A'lYliC 0?ci(latiQn Qf 3-r(DiethQyYPQ§phinYl)-
difluoromethvllcvclohexene ri07) 
Treatment of double bond compounds with selenium dioxide introduces a 
hydroxy functionality into the allylic position.-^^^ The mechanism for this reaction is not 
radical but involves two pericyclic steps, an ene-type reaction and a [2,3] sigmatropic 
shift (scheme 3.2)204 
H O - / 
HO 
HO. 
Se(OH); 
\ 
14,0 HOSe J 
scheme 3.2 
It was found that the literature method for allylic oxidation, by use of selenium 
dioxide in dioxane-acetic acid, yielded only a small quantity, 16%, of the desired alcohol 
(141), after hydrolysis, even after prolonged heating. Indeed, the yields of alcohols 
from sterically hindered or highly substituted alkenes are generally low, and in a sterically 
analogous substituted cyclohexenyl system 3-methyIcycIohexene Trachtenberg and 
Carver^o^ cited a yield of less than 15% for the isomeric mixture of (Z)- and (£')-6-
methylcyclohexen-3-ol. It can be postulated that the yield is further reduced by virtue of 
the fact that the initial step of the reaction involves nucleophilic attack by the double bond, 
via an 'ene'-type step, thus the decreased electron density due to the presence of the 
electron withdrawing (diethoxyphosphinyl)difluoromethylene moiety would be expected 
to retard attack of the hydrated selenium dioxide reducing the rate and correspondingly 
the yield of the allylic alcohol. 
/ \ 
CF2P(0)(OCH2CH3)2 
(141) 
NMR studies clearly showed that no 3,3-disubstituted cyclohexenyl product was 
produced in the reaction, the remainder of the material recovered being starting material. 
Given the poor yield of effectively the first step of the reaction it was decided to follow 
method B. 
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III.D.2 Method B: Via Allvlic Bromination of 3-f(DiethoxvposphinvD-
difliioromethvllcvclohexene (101) 
The halogenation of alkenes in the allylic position by A'-halosuccinimdes is well 
documented,^°^ first being reported by Wohl in 1919.^^' The reaction is a special case 
of alicyl halogenation proceeding via a free radical process to give excellent yields of the 
allylic substituted haloalkene (scheme 33)}^^ 
K H Br H 
Bro + 
HBr 
Br 
HBr + N—Br + Bro 
O O 
scheme 3.3 
As can be seen from the scheme 3.3, bromine in low concentration is the actual 
halogenating agent. The double bond is not halogenated by bromine, either radically or 
ionically (figure 3.2) because, after initial bromination, only one atom of an attacking 
bromine moiety becomes attached to the substrate, to give an unstable intermediate. 
V • , Y . - \ - ^ ' 
_ ^ - Br-- Br<^ + Brg • + 2Br A Br—Br Br-
Br 
A Br-
Br. 
Br-
-Br 
Br 
figure 3.2 
This must subsequently react with a second bromine containing molecule, however, there 
is a low probability that the desired species will be in the vicinity, thus the intermediate 
disproportionates back to starting materials. This hypothesis was verified by M'^ Garth 
and Tedder,^^^ whom carried allylic bromination using bromine in very low 
concentration, removing any hydrogen bromide generated. 
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CF2P(0)(OEt)2 CCC/A^ ^ *• B r — ( )—CF2P(0)(OEt)2 
(107) "T142) 
scheme 3.4 
The reaction of the substituted alkene (107) with A^-bromosuccinimide was 
therefore undertaken utilising the standard conditions of a-azo-wobutyronitrile, initiator, 
in carbon tetrachloride (scheme 3.4). The crude product so obtained was purified by 
flash column chromatography (eluent hexane-acetone; 3:2) to give in 78% yield (142) as 
a clear colourless oil. The stereochemical outcome of the reaction was determined by 
NMR experiments. It has been shown previously that the (diethoxyphosphinyl)difluoro-
methylene group adopted a pseudoequatorial conformation (section II.B.2.d), thus, since 
the allylic bromination reaction occurs at a remote centre via a free radical addition 
process, no alteration of the stereochemical assignment of the 
(diethoxyphosphinyl)difluoromethylene group would be expected. Indeed, the indication 
in the NMR that (142) was a mixture of two isomers must be due to bromine 
disposed in a pseudoequatorial conformation (142a) and in (142b) in a pseudoaxial 
conformation. This was not unexpected given the limited stereochemical control in free 
radical reactions, i.e. allylic bromination, the ratio of the two isomers being 
approximately 1:1. 
^ ^ ' ^ ~ ^ = ^ ^ ^ C F 2 P ( 0 ) ( O E t ) 2 " ^ ' - ^ ^ = ^ ^ C F 2 P ( 0 ) ( O E t ) 2 
(142a) (142b) 
No attempt was made to separate the isomers, at this stage, due to the relative 
instability of cyclic 3-bromoalkenes previously synthesised, i.e. (103), (104) and 
(105). NMR also demonstrated that no 3,3- or 3,4-disubstituted derivatives were 
present. 
The absence of the 3,3-disubstituted product can be rationalised by two factors: 
steric, the bulky (diethoxyphosphinyl)difluoromethylene group hinders attack of 
bromine; and electronic, Pearson and Martin^^^ showed the effect of electron donating 
and withdrawing substituents on hydrogen abstraction by bromine radicals on para-
substituted toluenes. The overriding factor dictating rates was the polar transition state in 
the generation of the radical centre (figure 3.3). 
= \ j :F2P(0 ) (OEt )2 
Br 
figure 3.3 
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Thus the developing positive charge on the site adjacent the electron withdrawing group 
is destabilized, raising the energy of the system, i.e. the electrophilic bromine radical 
shuns the site due to its low electron density. 
A 3,4-disubstituted product could arise due the possibility of an allylic shift in the 
intermediate unsymmetrical allylic radical generated (figure 3.4).-'' However, a COSY 
spectrum of (142) indicated no coupling between the CHBr proton and the CHCF2 
proton (figure 3.5). 
(EtO)2P(0)CF; (EtO)2P(0)CF, 
figure 3.4 
CHBr 
l l 
CHCF2 
- J . - , 
CHBr 
CHCF2 
figure 3.5 
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" I J ^ - ^ a RgactiQn of 3-Bromo-6-rrdiethoxvnhn.phinvnd.fl.mrnmPthyl]-
cvclohexene n42) w.fh /^-Chlorom.HnP (}AA) 
It was determined at an early stage that the easiest method to couple the nucleoside 
base would be under the conditions developed by Schaeffer and co-workers for 2-
bromocyclohexene.2'2 N/^-Dimethylformamide, a strongly polar aprotic solvent, was 
used to facilitate the SN2 displacement reaction, effectively lowering A G ^ by 
destabilising (raising) the ground-state energy level of the nucleophile, i.e. the nucleoside 
base. Potassium carbonate was present to act as a base, scavenging hydrogen bromide 
liberated during the reaction, which could attack the double bond to give the undesired 
bromide (143) {N.B. the competing electrophilic addition process would also be 
promoted by the polar solvent). 
CF2P(0)(OEt)2 
CF2P(0)(OEt)2 HBr or 
CF2P(0)(OEt)2 
Br' H 
(143) 
On completion of the reaction of the allylic bromide (142) with the 6-
chloropurine (144) the desired coupled product 3-[A^9-(6-chloropurinyl)]-6-
[(diethoxyphosphinyl)difluoromethyl]cyclohexene (145) was isolated in 46% yield 
(based on recovered starting material), after flash chromatography (eluent ethyl acetate). 
Two isomers were then separated by further chromatography (eluent ethyl acetate-hexane; 
3:2). The stereochemical course of the reaction was deduced as illustrated below. 
I"-D.2.b Geometry of the Isomers of 3-rA^9.(6-Chloronurinvni .6 . 
Kdiethoxvnhosnhinvndifluoromethvllcvclnhexene OA'^) 
The course of substitution to give (145) is not as simple as first envisaged 
(scheme 3.5). 
Nuc-
CF2P(0)(OEt)2 Nuc 
scheme 3.5 
The variables in the reaction which need to be considered are: 
CF2P(0)(OEt)2 
(i) the substitution mechanism S N I or SN2/SN2'; 
(ii) the possibility of allylic shifts; 
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(iii) the purine (144) can react as a nucleophile at two sites, N7 or N9. 
all these factors can be addressed by interpretation of spectral data. 
It follows from the Jt-electron excessive character of the imidazole ring^^-' that 
either of the nitrogen atoms is potentially available for electrophilic substitution. The 
electron density map of (144) (COSMIC, Liverpool charge method) indicates that N9 is 
the most nucleophilic centre (figure 3.5), and these results are borne out 
experimentally.^'^ 
0-143 CI 0 . 0 6 3 ^ . 0 . 1 5 7 
0 . 1 4 7 — N ^ ^ ^ S A ^ X 
" \ > - ^ 0 . 0 3 5 
9 / 0 . 0 6 8 - ^ % 
/ 
•0 .155 
(144) 
figure 3.5 
9 
^ - 0 . 2 6 6 
0.095 
Thus, the reaction should proceed to give predominantiy the desired N9 substituted 
product. The N7 product can be easily differentiated from the desired N9 substimted 
compound by observing the ultraviolet absorption spectra, N9 substituted products show 
characteristic absorption at 266nm while N7 substituted analogues absorb at 270nm,-^°^ 
the ultraviolet absorption at 265nm confirming N9 substitution in compound (145). 
Nucleophilic attack at an allylic site can proceed either via a S N I or as previously 
discussed an SN2/SN2' process. The NMR spectrum of (145) was indicative of a 3,6-
disubstitution pattern, rather than the possible 3,4-disubstitution pattern in die ring of 
(146), a product which would be common for both a S N I or SN2' process. In a S N I 
process allylic shifts are extremely facile,^ ^"* because of the subsequent generation of a 
delocalised allylic cation, hence, a mixture of 3,6- and 3,4- disubstituted products would 
be expected, the 3,4-product is not observed. The SN2' mechanism will be slightiy 
disfavoured by the steric inhibition of the (diethoxyphosphinyl)difluoromethylene group 
to the approach of the bulky nucleophile (144) (scheme 3.6). Thus it can be concluded 
that an SN2 process is the most likely mechanism in operation. 
CF2P(0)(OEt)2 • ^ )—CF2P(0)(0Et) 
N u c ) Nuc 
(146) 
scheme 3.6 
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Two distinct sets of ^H, ^^C and l^p NMR resonances were observed for the 
allylic bromide (142), this can be reconcilled by considering that with two chiral centres, 
four stereoisomeric compounds would be formed, of these two are merely enantiomers of 
the others i.e. RR/SS (142a) and SR/RS (142b), thus only two possible 
diastereoisomers can be distinguished by NMR. Therefore, we would expect the attack 
of the base (144) to give the corresponding isomers RS/SR (145a) and SS/RR il45h) 
respectively under a SN2 mechanism (scheme 3.7). 
. SN2 ^ ^ ^ ' ^ "=^-\rcF2P(0)(OEt)2 
^^•Nuc^ ^ NUC ^ 
(1424 (1454 
^ ^ ^ r — = ^ c F 2 P ( 0 ) ( O E t ) 2 N u c ^ : : ^ , ^ ^ 
(142^ 
CF2P(0)(OEt)2 
Hi' 
(145^ 
scheme 3.7 
Indeed this was the case for compound (145); two isomers were observed in the 
relative ratios 1:1, determined by comparison of the integration heights of the ^H NMR 
resonances in the alkenyl region, representing the two sets of diastereoisomers. 
The preferred conformation of the cyclohexene ring is a twist chair,'^' verified by 
modelling of the 6-chloropurine derivative (145) on the Sybyl package (version 5.4). 
Therefore, it was thought the absolute configuration of each disastereoisomeric pair could 
be elucidated i.e. which of the isolated isomers of (145) was the RR/SS diastereomeric 
pair and which was RS/SR diastereomeric pair. 
Two dimensional NMR studies were used, therefore, to assign unambiguously 
the structure of the two isolated isomers of (145), notably heteronuclear correlation 
(HETCOR). The HETCOR technique is a plot of coupling between l^c and ^H nuclei, 
in the case shown in figure 3.5 the coupling was optimised over three bonds. The 
Karplus equation states that i f a 0° or 180° relationship (or close to these ideal maxima) 
exists for the dihedral angle between a proton and a carbon atom three bonds removed, 
then a large coupling between the atoms will be observed. However, i f the relationship 
between them tends to 90° then litde or no coupling will be observed.-^ '^  
J c H coupl ing 
CF2P(0)(0Et) 
Ol Ul C . I I I I I I I I I . I I I r I I I I I r I ! I - I 
4-
CP, 
13c 
NMR 
figure 3.5 
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For the system under study the key feature is the coupling between the isolated 
proton geminal to the (diethoxyphosphinyl)difluoromethylene moiety in the cyclohexene 
ring (Ha') and the carbon atom marked. If the proton Ha' is pseudoaxial then no coupling 
will be observed i.e. the dihedral angle between Ha' and the carbon marked tends to 90°, 
while i f the proton is predisposed in a psuedoequatorial position coupling will be 
observed (figure 3.6). 
-180° =90° 
the dihedral angle between Ha' and the carbon atom indicated 
figure 3.6 
As can be seen from figure 3.5 coupling is evident between Ha' (seen at 3.04ppm) 
and the vicinal carbon (seen at 17.1ppm), hence the proton geminal to the 
(dietiioxyphosphinyl)difluoromediylene moiety in isomer A is equatorial. The HETCOR 
spectrum for isomer B showed no coupUng so it can be assumed that the geminal proton 
in isomer B is psuedoaxial. 
The position of the purine functionaUty can be assigned from the one dimensional 
^H NMR (figure 3.7); the alkenyl protons in isomer A show one half of the AB splitting 
pattern to be heavily coupled. This wil l be due to ^JuH coupling between the 
pseudoequatorial proton Ha' and the vicinal alkenyl proton. I f the proton geminal to the 
purinyl functionality is also equatorial then it would follow that a similar ^ J^u couphng 
would be seen on the other half of the AB spUtting pattern. This is clearly not observed; 
thus, in isomer A since the (diethoxyphosphinyl)difluoromethylene group is psuedoaxial 
then the purinyl base must be pseudoequatorial, i.e. a m-structure (145a)iSR/RS). For 
isomer B only structure (145b) is feasible, with no fine coupting on either half of the AB 
splitting pattern, indicative of two pseudoequatorial groups (SS/RR). 
- T - I I ; I I I I I 1 1 I I I I I I I I I I I I I I I I 
6 . 4 6 . 3 6 . 2 6 . 1 6 .0 5. 
I ' I I I I I I I I I I I I J I i I I I I I I I I I I I 
6 .6 6 .5 6 .4 6 .3 6 .2 6. 
isomer B figure 3.7 
isomer A 
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The 2D NMR spectrum also indicates that the 6-chloropurinyl group is 
energetically favoured in a pseudoequatorial position, cf. rm-butyl, thus to maintain a c/.v-
configuration flipping of the cyclohexenyl ring in the case of (145a) must have occurred 
i.e. going frorn the a'e' to an e'a' conformation. 
III.D.2.C Synthesis of (± ) -3 - (A^9-Adenvn-6 - f (d ie thoxvnhosnhinvn-
difliroromethyllcyclohexene (147) 
In the synthesis of compound (147) problems were encountered in the 
conversion of the 6-chloropurine derivative (145) into compound (147), various 
methodologies proving unsatisfactory. 
Literature methods for the nucleophilic aromatic substitution of the 6-chloro group 
in purine derivatives are numerous. The most common procedure, amination using 
saturated methanolic ammonia at high temperature,^ '^ ''-^^^ did not yield in sufficient 
quantity the desired product. TLC indicated total consumption of the starting material, 
confirmed by the appearance of two new spots of greater polarity than the starting 
material (145). However, attempts to then isolate these two products by flash 
chromatography yielded only the faster moving component, confirmed as the desired 
product (147), in only 1.1% yield (eluent chloroform-methanol; 9:1), while the slower 
moving, major, component remained on the column even after ramping of solvent 
mixture to 100% methanol. 
To obviate the poor yield of compound (147) a variety of means were tried (table 
3.1), including the effect of temperature to increase the ratio of the desired faster moving 
component (147) over that of the baseline material, this method proved unsatisfactory 
due to, in some instances, incomplete consumption of the starting material. French 
workers-^^^ described a high yielding route to amines via azide reduction, again the 
method failed to give any of the adenine derivative (147). Given the increased proclivity 
of fluorine to undergo nucleophilic aromatic substitution'^'^ the conversion of the 6-
chloro group to the 6-fluoro moiety was attempted, to obviate the sluggish substitution of 
the chloro group, using both silver (I) fluoride^' and silver (II) fluoride.-^'^ Silver (1) 
fluoride had no affect on compound (145), only starting material being isolated, while 
the use of silver (II) fluoride resulted in fragmentation and decomposition of (145). 
t The stereochemical assignment of the (diethoxyphosphinyl)difluoromethyl group is stated last in all 
cases. 
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CF2P (0)(OEt )2 
(145) 
(i) to (vi) 
Number Conditions Results 
(i)^^^ (a) NaN3/DMF 
(b) PPhsmiF 
(c) H3O+ 
Decomposition of (145) 
(ii)220 NaNH2/DMF No reaction 
(iii)221 NH3(l)/2h No reaction 
(iv)141 NH3/MeOH/100°C l%of (147) and 
decomposition of (145) 
(V)61 AgF/PhCH3/A No reaction 
(Vi)219 AgF2/CHCl3 decomposition of (145) 
Attempted nucleophilic displacement reactions at the 6-position of 6-chloropurine 
table 3.1 
The product was finally isolated in good yield by the use of aqueous dioxane-
ammonia solution giving (147) in 66% yield, after purification by flash silica gel 
chromatography (eluent 5:1 chloroform-methanol). The choice of solvent system was 
based on earlier work carried out in our laboratory in relation to nucleophilic substitution, 
were dioxane was found to be an excellent solvent. 
III.D.2.d Deprotection of (±)-3-(A^9-Adenvl)-6-r(diethoxvphosphinvl)-
difluoromethvllcvclohexene (145) 
The final deprotection of the diethoxyphosphinyl residue to yield the free acid was 
accomplished by the standard literature method,222 via hydrolysis of the trimethylsilyl 
ester. The ester was synthesised by stirring compound (147) in twenty equivalents of 
trimethylsilyl bromide (no solvent is necessary), failure to use a vast excess of the silyl 
reagent resulted in a mixture of mono- and di-silyl esters, easily seen by T L C on cellulose 
plates (eluent methanol). The reaction was followed by the consumption of the starting 
material, which upon silylation became soluble in the reaction mixture. The solution was 
then hydrolysed by dilute mineral acid, the intermediate silyl ester never being isolated. 
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0 : > 
' O 
(i) 20 eqs. TMSBr ^ ^ ^ m ' V I I ^ O H 
(147) (139) 
Purification of the crude nucleotide was then accomplished by evaporation to 
dryness of the reaction mixture, thus removing any volatile silyl components, and 
repeated washing with methanol, to remove traces of water and hydrogen bromide. The 
nucleotide (139) was then purified by reverse phase chromatography (eluent water) to 
yie ld (13 9 ) in 73%, a total overall yield of 17% from 3-
[(diethoxyphosphinyl)difluoromethyl]cyclohexene (107). 
IILD .2 .e Reaction of 3-Bromo-6-rrdiethoxynhosnhinyndifluoromethyn-
cvclohexene (142) with 2-Amino-6-chloroDurine (148) 
The coupling of 2-amino-6-chloropurine (148) to the allylic bromide (142) was 
performed under the same conditions as those outiined for the 6-chloropurine derivative 
(144)(scheme 3.8). 
CF2P(0)(OEt)2 
\ l 2-amino-6-chloropurine H2N 
/ K2CO3/DMF 
CF2P(0)(OEt)2 
(142) (149) 
scheme 3.8 
However, the yield of the desired product 3-[A'9-(2-amino-6-chloropurinyl)]-6-
[(diethoxyphosphinyl)difluoromethyl]cyclohexene (149), isolated in 31% (based on 
recovered starting material), was far lower than that for the corresponding 6-chloropurine 
compound. This can easily be explained by the effect on electron density of the purine 
ring on addition of the amino group, this raises the conjugate pKa value of (148), thus 2-
amino-6-chloropurine is both a weaker base and poorer nucleophile than 6-chloropurine 
(144). 
The product (149) was obtained as a mixture of isomers, as in the case of the 
coupling of 6-chloropurine with the bromide (142), the relative ratio of the e'e' and e'a' 
isomers being 2:3, however, unlike compound (145) these could not be separated by 
flash column chromatography, even by the variation of the solvent system. 
The substitution at N9 was again confirmed by UV spectroscopy, showing no N7 
substitution, only characteristic absorptions at 247 and 306nm being apparent for N9 
substitution."^ However (148) has a higher proclivity to form N7 substituted 
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derivatives than (144), figure 3.8 showing that N7 is actually the most nucleophilic 
nitrogen site. However, as mentioned earlier, steric hindrance by the 6-chloro group 
disfavours attack at the N7 position. 
0.065 
-0 
0.183 
-0.047 
0.146s^CI 0.065 
-0.143 ' 
/ 0.095 
•0.154 
-0.135 
0.104 
(148) 
figure 3.8 
III.D.2.f Synthesis of (+).3-W9-Guanvh-6-r(diethoxvphosphinvn-
difluoromethvllcvclohexene (150) 
The conversion of the 2-amino-6-chloropurinyl residue to the guanyl residue is a 
facile process accomplished by acid hydrolysis, thus the reaction of (149) with I M 
hydrochloric acid was followed by TLC, and terminated after consumption of the starting 
material. Upon purification by reverse phase chromatography (eluent water) the white 
solid obtained was not the expected product (150) but rather the monoalkylated ester 
(151); confirmed by mass spectrometry M+ 353 (not the expected mass ion peak at M"*" 
386), and a broad deuterium oxide exchangeable peak at 4.441ppm on the ^H NMR 
spectrum. 
(149) 
,OEt 
h^N N 
(151) 
The hydrolysis of one of the ethoxy groups was not unexpected in the acidic 
conditions utilised, scheme 3.9 showing a possible mechanism for the hydrolysis, 3-
(A'9-Guanyl)-6-[(ethoxyhydroxyphosphinyl)difluoromethyl]cyclohexene being obtained 
in a 83% yield. 
The alkoxy group is not a good leaving group, so the ester must be converted to 
the conjugate acid before it can be hydrolysed. This is a facile process for the diester but 
subsequent hydrolysis of the monoalkoxy ester to the free acid does not occur due to the 
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difficulty in the protonation step, the equilibrium constant for such a step being very low 
in the conditions used. Prolonged heating at reflux or a greater acid concentration may 
have yielded the diacid, however, guanine compounds are acid sensitive undergoing 
glycoside cleavage.-^ ^^ 
o OH 
" I ...xOEt ^ ^ ...xOEt ^ 
RCF. 
2 OEt 4 ; 6 — H :6H2 
H 
1^ 
OH 
I ...vOH OH O 
.H+ RCFg—P-^^nw ^ 2 H 2 0 I J3H ^ H"- II 
o 
II 
,p<^  
+ H p + EtOH +H30'- + H p + EtOH 
scheme 3.9 
IILD.2,g Deprotection of (+)-3-(A^9-Cruanyl)-6-r(diethoxyDhosDhinyl)-
qiflUQrQmethYlkYglQhexene (151) 
The removal of the final ethoxy group was accomplished in an analogous manner 
to that used for the synthesis of (139) except (151) was the starting material to give the 
fully deprotected nucleotide (140) in a 88% yield, a total overall yield of 18% from 3-
[(diethoxyphosphinyl)difluoromethyl]cyclohexene (107). 
o 
j ^ J ^ I ^ ^ ^ ^ N ^ v / ^ p f " " (0 go q^s. TMSBr 
.OH 
1/ \ ? ^ o E t (ii)IMHCI " 2 ^ 
II . O H 
(140) 
I I I . E Biological Test Data on 3 -W9-Adenv l ) -6 -r (d ihydroxyDhosDhiny l1 -
difluoromethyDcyclohexene (139) and 3-(A^9-Guanyn-6-r(dihvdroxy-
phosphinylldifluoromethyDcyclohexene (140) 
The compounds (139) and (140) are currently under test at SmithKline Beecham 
Laboratories (Great Burgh) for any in vitro antiviral activity. 
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C H A P T E R IV 
F R E E R A D I C A L REACTIONS OF rPTETHOXYPHOSPHINYD-
D I F L U O R O M E T H Y L E N F H A L i n F S 
IV.A Introduction 
The introduction of fluorinated substituents via anionic polyfluoroalkylating 
agents such as Grignard reagents, analogous to those commonly used as alkylating 
reagents, are generally unsuccessful due to their instability and tendency to decompose. 
However, this problem has gradually been overcome and can be accomplished utilising 
metals such as zinc, as discussed in chapters 11 and m . 142,159,171 Another alternative for 
the inclusion of a fluorinated moiety is to add it via a radical pathway, i.e. by a free 
radical addition or single electron transfer (SET) pathway, since the generation of 
polyfluoroalkyl radicals is relatively easy. 
Novel routes into the synthesis of (diethoxyphosphinyl)difluoromethylene 
substituted compounds were explored utilising literature procedures exploiting these two 
methods. 
IV.B Frg^ Radical Addition FrQyggggg 
The use of a free radical process has many advantages over a route involving 
nucleophilic displacement with organometallic reagents in that, effectively, hydrogen 
atoms can be substituted directly by the fluoroalkyl or fluorine containing species. 
The free radical addition of perfluoroalkyl halides to alkenes has been a 
particularly well researched area, because of the wide applications in the synthesis of 
telomers.224-226 jj^g initiation processes for the perfluoroalkylation reaction achieved by 
the utilisation of UV photo-irradiation,22'' thermolysis,228.229 organic peroxides 2^° and 
gamma-ray irradiation. 
Thus, the free radical addition of (diethoxyphosphinyl)bromodifluoromethane 
(94) and the corresponding iodo derivative (diethoxyphosphinyl)difluoroiodomethane 
(118) to various cyclic alkenes, utilising gamma-ray and UV photo-irradiation, was 
attempted. 
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I V . B . l Utilising Gamma-ray Irradiation 
I V . B . l . a The Reaction of Cyclohexene and (DiethoxyphosphinyD-
bromodifluoromethane (94) 
The carbon-bromine bond has a bond strength of only 287.4 ± 6.3kJmol"^ (C2F5-
B r ) ^ ' and can be easily cleaved by high energy ^^Co gamma-ray irradiation to give in the 
case of (94) a (diethoxyphosphinyl)difluoromethyl radical (152) which could then, in 
principle, react with an alkene (scheme 4.1). 
( E t O ) 2 P ( 0 ) C ^ B r q a m m a - r a y s / r t ^ (EtO)2P(0)CF2 + Br" 
( 9 4 ) ^ (152) 
E t O b P p C F s 
CF2P(0)(OEt)2 
Br 
< ; ^ ^ ^ C F 2 P ( 0 ) ( 0 E t ) ^ ^ ^ ^ ^ ^ (EtO)2P(0)CF2-
scheme 4.1 
Indeed, it has been previously shown that (dialkyl)phosphites react in high yield 
to give dialkylphosphonate derivatives^-^ (scheme 4.2). Therefore, factors such as steric 
hindrance or homolysis of any other constituent bond in (diethoxyphosphinyl)-
bromodifluoromethane (94) or the iodo-derivative (118) should not influence the radical 
reaction. 
, „ 0 , P , 0 , H . C H . = C P . ' • B " ° ' / 1 3 0 - C / S . . < - , . P < 0 , O H , C . . H 
(EtO)2P(0)CH2CF2CH2CF2H 3% 
scheme 4.2 
When the irradiation of (94) in the presence of cyclohexene was attempted it was 
found that a free radical addition reaction (scheme 4.3) had been induced by gamma-ray 
mitiation, although only a 25% conversion was realised. 
(EtQ)2P(0)CF2Br g ^ ^ ^ i ^ ^ s y s ^ ^ ^—CF2P(0)(OEt)2 + (EtO)2P(0)CF2H 
(25%) 41% 44% 
(153) (102) 
scheme 4.3 
The ^^F NMR spectrum of the crude reaction mixture showed not only 1-bromo-
2-[(diethoxyphosphinyl)difluoromethyl]cyclohexane (153) but also (diethoxyphos-
phinyl)difluoromethane (102). The fact (102) was the major product of the reaction via 
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hydrogen abstraction raised the question of which route had the hydrogen atom been 
abstracted. 
The (diethoxyphosphinyl)difluoromethyl radical (152) could have abstracted a 
hydrogen from only two sources to form (102): 
(i) from cyclohexene; 
(ii) from the starting material (94). 
The latter would seem more probable due to heteroatom stabilisation of the radical 
developed upon abstraction of a hydrogen atom from one of the ethoxy groups (scheme 
4.4), in an analogous manner to radical stabilisation in ethers.-^ ^^  It was decided to 
prepare the free acid of (94) to deter the formation of the hydrogen abstracted product. 
(EtO)2P(0)CF2-^ ( ,_>^^J,P(0)CF2Br 
H . • 
V^sC OJ I H \ 
(EtO)2P(0)CF2H 
(102) 
P(0)CF2Br 
scheme 4.4 
I V . B . l . b The Synthesis of (DihvdroxvDhosDhinvnbromodifluoromethane 
(154) and Reaction with Cvclohexene 
The starting material (dihydroxyphosphinyl)bromodifluoromethane (154) was 
synthesised from (94) in a two step process (scheme 4.5). 
(EtO)2P(0)CF2Br ^TMSBr/ r t ^ (Me3SiO)2P(0)CF2Br 54% 
(155) 
(Me3SiO)2P(0)CF2Br ^ • (HO)2P(0)CF2Br 87% 
(155) (154) 
scheme 4.5 
Compound (94) was treated with two equivalents of trimethylsilyl bromide (TMSBr)^^^ 
under a nitrogen atmosphere, to afford the silyl ester [bis(trimethylsiloxy)-
phosphinyljbromodifluoromethane (155). This was isolated before subsequent 
hydrolysis, to ensure no contamination of the product by the less volatile monosilylated 
derivative. The NMR spectrum showed only 1 peak at 0.002ppm due to the 6 
equivalent methyl protons. Hydrolysis yielded the free acid (154), a viscous 
hygroscopic liquid. 
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The acid was immiscible in cyclohexene, and 1,1,1-trifluoroethanol was used as a 
solvent. After irradiation and subsequent work-up the ^^F NMR spectrum indicated the 
presence of [(dihydroxyphosphinyl)difluoromethyl]cyclohexane (156) and, again, the 
hydrogen atom abstracted product (dihydroxyphosphinyl)difluoromethane (157) (scheme 
4.6). Although the ratio of the two products had now swung in favour of the radical 
addition product (156). 
Br 
(H0)3P(0)CF,Br C F s C H ^ O H ^ m a - r a y s ^ ^ ; ^^^CF,P ( 0 ) ( 0 H ) 3 . (HO).P(0)CF,H 
(156) (157) 
(20%) 48% 39% 
scheme 4.6 
It can be concluded, therefore, that the conversion of the ethoxy groups present in 
(94) to hydroxyl groups did reverse the relative ratio of the radical addition product to 
cyclohexene over that of the radical abstracted product. However, a significant amount of 
the hydrogen abstracted product, i.e. (102) or (157), was still present. The majority of 
the abstracted hydrogen atoms must have come from cyclohexene or possibly 1,1,1-
trifluoroethanol. However, experiments conducted by Walling-^ '^^  and independently by 
Chambers^^ demonstrated a decrease in the relative rate of hydrogen abstraction for tert-
butoxy radicals with an increased number of electron withdrawing substituents, therefore, 
it seems unlikely hydrogen atoms had been abstracted from 1,1,1-trifluoroethanol. 
Indeed the results of Walling showed cyclohexene readily loses a hydrogen atom to 
generate an allylic stabilised radical.^ ^^^ Furthermore, 1,1,1-trifluoroethanol is widely 
used in our laboratory for radical reactions as a solvent, implying a low reactivity to 
radical processes. Hence scheme 4.7 reflects the most probable mechanism for hydrogen 
abstraction. 
(EtO)2P(0)CF2-
] 
^ 1 I + (EtO)2P(0)CF2H 
scheme 4.7 
IV .B . l . c The StereochemLstrv of the Addition of (DiethoxvphosphinvD-
hromodifluoromethane (94) to Cvclohexene 
The radical addition to cyclohexene must proceed via the intermediate radical 
(158). The e.s.r. spectra of a variety of cyclohexyl radicals are consistent with rapidly 
interconverting chair conformers with a planar radical centre.^^^ Therefore, the 
possibility exists for the radical centre to abstract a halogen atom which may go on either 
face of the cyclohexene ring, the trigonal radical centre destroying any possibility of 
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stereochemical control.^^ However, results have shown that the abstraction of the hahde 
atom to regenerate the (diethoxyphosphinyl)difluoromethyl radical (152) tends to favour 
an equatorial approach to yield the trans-isomer (153a) over the c/\y-isomer (153b) (ratio 
3:2 respectively). This outcome is probably due to the reduction in steric crowding on the 
formation of the trans-isomer as opposed to the cw-isomer, given diequatorial substitution 
represents the more thermodynamically stable product (scheme 4.8). 
H 
1^ 
\ 
/ - ""--.^CF2P(0)(OEt)2 
(158) H 
^Y^CF2P(0)(OEt)2 
H trans 
Br 
(153a) 
/^ -^ -^ C^^ ZcF2P(0)(0Et), 
CIS 
(153b) 
scheme 4.8 
This selectivity is revealed in the ' ^ f NMR spectra of the compounds (153a) and 
(153b), thus table 4.1 shows the different couplings for the two isomers which compare 
well with the literature values for the iodo derivative synthesised by Burton et al.^^ 
Isomer 2JFF (HZ) 2JFP (HZ) 3JFH (HZ) 
cis 302.2 110.7 26.4 
302.0 110.7 21.6 
trans 300.0 110.0 19.8 
304.1 110.1 21.6 
Coupling Constants for cis- and trans- l-Bromo-2-[(cliethoxyphosphinyl)difluoromethyl]cyclohexane 
table 4.1 
IV.B.2 Utilising Ultraviolet Irradiation 
The fission of chemical bonds using UV radiation is a direct method of producing 
free radicals. The radicals are generally produced as highly excited entities with excess 
kinetic energy, in a greater quantity than via gamma-ray irradiation due to the limited 
interaction of gamma-rays with matter. Since carbon-halogen (bromine or iodine) bond 
strengths are relatively weak i.e. less than 300kJmol-l these tend to cleave first. 
However, the actual production of radicals from photoexcited molecules is a multi-step 
process. Absorption of energy results in the initial excitation of CJ, n, or tc electrons to 
the excited a* or n* state in which electrons are paired. This excited state normally 
contains an excess of vibrational energy which is rapidly dissipated and thereafter one of 
the following takes place:^^ 
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(i) radiation is emitted (fluorescence) and the molecule returns to the ground state; 
(ii) energy is lost by collision with the solvent; 
(iii) the excited singlet state may undergo intersystem crossing to an excited triplet state, 
provided there exists a triplet state of the appropriate energy and then phosphoresce; 
(iv) homolysis can occur, giving a radical pair in which the electron spins are anti-
parallel. The triplet state may undergo homolysis, in which case radicals with unpaired 
spins would be produced. 
To aid absorption of UV radiation a photo-sensitiser was used in all cases. These 
compounds contain a chromophore, e.g. the carbonyl functionality which absorbs UV 
radiation strongly and undergo a facile n to K* transition. The energy of the excited 
photo-sensitiser (D) can then be transferred to an acceptor molecule (A) promoting this to 
the excited state (figure 4.1). 
D* + A • A* + D 
figure 4.1 
In most cases acetone was used as both the solvent and photo-
sensitizer,^'^^ however, comparative studies were made with benzophenone, a very 
efficient photo-sensitizer.^^ 
IV.B.2.a The Reaction of Cvclohexene and (DiethoxvphosphinvD-
bromodifluoromethane (94) 
Given the higher energy of free radicals generated by UV photolysis it seemed 
reasonable to react cyclohexene with (94), to afford a higher yield of the desired product 
(153). The reaction was set up in an analogous manner for gamma-ray irradiation. 
However, the tube was irradiated for 72 hours, with a medium pressure IkW mercury 
vapour lamp. It was noted that during the experiment heating of the contents was 
unavoidable and at extremes reached upto 50°C, so temperature effects may also have 
enhanced reaction rates. 
A NMR spectrum of the crude mixture showed an increase in the conversion 
of the bromide (94) to the desired product (153) as well as the ubiquitous hydrogen 
abstraction product (102)(scheme 4.9), compared to the analogous gamma-ray initiated 
reaction. 
(EtO)2P(0)CF2Br hv /agone ^ ^ ^CF2P(0)(OEt)2 + (EtO)2P(0)CF2H 
(61%) ' 36% 9% 
(153) (102) 
scheme 4.9 
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Unlike gamma-ray initiated reaction the ratio of l-bromo-2-
[(diethoxyphosphinyl)difluoromethyl]cyclohexane (153) to that of (102) was 4:1, 
indicative of the more energetic (diethoxyphosphinyl)difluoromethyl radicals (152) 
undergoing radical addition to cyclohexene at a faster rate than the hydrogen abstraction 
process. Note the increase in the proportion of (153) could also be due to some 
excitation of the alkenyl 7i-electrons. The isomeric ratio for (153), i.e. trans to cis, was 
3:2 respectively, the trans-isomer again dominant. 
A repeat of the above experiment with benzophenone as the photo-sensitiser, and 
no solvent, resulted in both a lower conversion to products (27%) and ratio of the 
addition product (153) to (102) (2:1 respectively)(data accrued from comparison of ^^ F 
NMR spectra). 
The utilisation of UV photolysis appears, therefore, to give a higher conversion 
for a similar time period than i f the same reactants were exposed to gamma-ray 
irradiation. This is due to the combination of: 
(i) a greater radical flux as a result of exposure to UV irradiation; 
(ii) the excess of kinetic energy these 'hot' radicals posses; 
(iii) the unavoidable temperature rise associated with UV irradiation (a rise in temperature 
of 10°C approximately increases the rate of a reaction two-fold; Arrhenius equation^ ^). 
IV.B.2.b The Reaction of Cvcloalkenes and ( D i e t h o x v p h o s p h i n v D -
tliflUQrQiQqQmgthan^ (118) 
Given the weaker carbon-iodine bond, i.e. 214.2 ± 4.2kJmol"l (C2F5-I),^ '*-^ 
compared to the carbon-bromine bond it seemed appropriate to repeat the reaction of 
cyclohexene with the iodide (118). It was first necessary, however, to synthesise this 
compound. Burton has described a facile procedure for the synthesis of (118) from 
(94), the literature procedure "^*^ (scheme 4.10) was followed to afford the clear pale 
yellow liquid (118). 
(EtO)2P(0)CF2CdBr 
(EtO)2P(0)CF2Br + Cd ^ ^ ^ / ^ » + 
[(EtO)2P(0)CF2]2Cd 
(EtO)2P(0)CF2CdBr + [(EtO)2P(0)CF2]2Cd 'g/OMF/rt ^ (EtO)2P(0)CF2l 43% 
(118) 
scheme 4.10 
The iodide (118) was then reacted with cyclohexene under identical conditions to 
that used for the bromide (94)(scheme 4.11). 
(EtO)2P(0)CF2l hv /acetone 
o 
(93%) 
88 
CF2P(0)(OEt)2 
53% 
(159) 
scheme 4.11 
(EtO)2P(0)CF2H 
20% 
(102) 
The radical reaction of the iodide (118) gave l-[(diethoxyphosphinyl)-
difluoromethyl]-2-iodocyclohexane (159) and the hydrogen abstracted material (102). 
The conversion of the iodide (118) had risen from the 61% obtained with the bromide 
(94) under identical conditions. This is probably due to the weaker carbon-halogen bond 
strength. However, the ratio of (159) to (102) was not as favourable, probably due to 
the more energetic and hence less selective nature of the 
(diethoxyphosphinyl)difluoromethylene radicals generated from the iodide (118). The 
ratio of the cis- to trans- products was approximately 3:2 in favour of the rra/w-product 
comparable to the previous experiments with the bromide (94). 
Given the success of the iodide (118) with cyclohexene other cycloalkenes were 
tried (table 4.2). 
(EtO)2P(0)CF2l + 
(118) 
acetone/hv 
(CH2)n 
CF2P(0)(OEt)2 
(CH2)?r 
(160)-(161) 
n Product Conversion (%) Yield (%) 
2 (160) 70 34 
4 (161) 86 67 
tabl e4.2 
The assignment of the relative dispositions of the iodo and 
(diethoxyphosphinyl)difluoromethylene groups in the cyclopentene ring could not be 
ascertained from the ^H NMR spectrum of (160) due to the almost planar nature of the 
ring leading to coupling constants for both the cis - and the trans -isomers of between 0-
7Hz, more typically in the region of 4-5Hz.^^^ The ^^F NMR spectrum on the other 
hand showed only one set of resonances due to the difluoromethylene group, unlike the 
cyclohexane derivative (159). Figure 4.2 shows the fluorine coupling constants for the 
cyclopentene derivative. 
108.3 
A , 
300.2 '^^ •^ 
coupling constants for (160)(Hz) 
figure 4.2 
For the cycloheptane substituted compound (161) once again only one isomer 
was evident for which the coupling constants could be assigned from the '^F NMR 
spectrum (figure 4.3). 
107.8 19.3 
A 
EtO—P 
306.2 
coupling constants for (161)(Hz) 
figure 4.3 
IV.B.2 .C The Reaction of Furanvl Systems with (DlethoxvphosphinvD-
difluoroiodomethane (118) 
The possibility of inserting a (diethoxyphosphinyl)difluoromethyl moiety directly 
into a heterocycle is of interest. Therefore, a study was undertaken to investigate the 
reaction of various furan derivatives with (118). 
The experimental procedure followed for the furan derivatives was the same as 
that described for the cycloalkanes and the furans used are indicated in the table 4.3. 
(EtO)2P(0)CF2l hv/acetone substrate 
(162)-(164) 
Entry Reactant Conversion (%)"!" ratio of product to (102) 
(162) 0 -
(163) 0 4 1:1 
(164) 0 2 1:1 
table 4.3 
+ Conversion based on'^F NMR data 
90 
The table shows that although a reaction occurred between 2,5-dihydrofuran, or 
furan itself, with the iodide (118) no reaction was observed with 2,3-dihydrofuran. The 
resulting crude reaction mixtures after exposure to UV initiation were very discoloured 
and the conversion of the iodide (118) to the coupled product was less than 5% in the 
two furanyl systems which did react. No products could be isolated by distillation from 
the mixtures, thus, all data had to be interpreted from .^^ F NMR spectra. 
The furan derivatives should have been more reactive towards radical addition of 
(118) given the possibility of stabilisation of the intermediate radical centre generated by 
the lone pairs available on the oxygen atom. However, this is clearly not the case, given 
that 2,3-dihydrofuran did not afford any addition product with (118). Low conversion 
and discolouration could be due the liberation of iodine or more likely the polymerisation 
of the furan derivatives, which undergo a number of photochemical rearrangements, as 
well as, dissociation and polymerisation. This results in a wide product distribution.-^^ 
i v . c s . E . T . nw^ms 
i v . c . i PaUaginni (0) Catalyses! CQUpiing 
It has been known for some time that iododifluoroacetates undergo an addition-
reduction process to provide a,a-difluoroesters in the presence of a copper catalyst,^ "*^ 
Bunon and Yang thus proposed that (diethoxyphosphinyl)difluoroiodomethane (118) 
would undergo an analogous addition-reduction process to yield a,a-
(diethoxyphosphinyl)difluoromethylene derivatives. Indeed, this was the case for 
various terminal alkenes, which could include such functionalities as epoxy, carbonyl and 
hydroxy. These substrates reacted with the iodide (118) in yields upto 91% in the 
presence of a palladium (0) catalyst e.g. teti-akis(diphenylphosphine)palladium (scheme 
4.12). 
ICF2P(0)(OEt)2 + CH 2=CHR ^^^^^^^^^^^ RCHICH 2CF2P(0)(OEt)2 R=SiMe3 88% 
(118) 
RCHICH 2CF2P(0)(OEt)2 + Zn NiCl2.6tH20^ RCH2CH2CF2P(0)(OEt)2 R=SiMe3 84% 
I Mr, r.t. 
scheme 4.12 
However, the catalyst system used could not introduce (118) into cyclic alkenes. 
I V . C . 2 Copper Catalysed Coiiniin^ of miethoxvnhosphin vD-
difluorohalides to Cvcloalkenes 
Burton et al?^^ recentiy established that copper metal could effect the addition to 
cyclic alkenes of (118), thus Burton facihtated the addition of (118) to cyclohexene in 
91 
69% yield both with and without solvent, the hydrogen abstracted product (102) formed 
as a by-product (scheme 4.13). 
(EtO)2P(0)CF2l C ^ - C ^ ^ | ^ ~ ~ ^ C F 2 P ( 0 ) ( O E t ) 2 ^ (EtO)2P(0)CF2H 
(118) (159) (102) 
scheme 4.13 
We had previously attempted the addition of (94) to cyclohexene (scheme 4.14) 
but found the reaction to be unsuccessful. 
Br 
(EtO)2P(0)CF2Br . Cu/DMF/80^ y ^ < ^ ^ ^ C F 2 P ( 0 ) ( O E t ) 2 
(94) 
scheme 4.14 
The lack of reactivity for the bromide (94) can only be ascribed to the stronger 
carbon-bromine bond, the carbon-iodine bond having an energy of only 214.2 ± 
4.2kJmol-l, since the steric differences between (94) and (118) are minimal. 
IV.C .3 Samarium Diiodide Catalysed Coupling of (Diethoxvphosphinvn-
difluorohalides to Cvcloalkenes 
IV.C . 3 .a Attempted Reaction of (Diethoxvphosphinyhhromodifiuoro-
methane (94) with Cyclohexene 
Samarium diiodide was found to be an effective initiator in the addition of 
fluoroalkyl iodides to both alkenes-^ "^ ^ and alkynes-^ "^ ^ (scheme 4.15). 
CF2(CF2)3CI 36% 
SmU/THF/r t 
CI(CF2)3CF2l • 
scheme 4.15 
A study was undertaken to explore the above method as a route to add 
(diethoxyphosphinyl)bromodifluoromethane (94) across the double bond of cyclohexene 
via a SET mechanism (scheme 4.16). 
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(EtO)2P(0)CF2Br 
[(EtO)2P(0)CF2]--
S m l o / T H F 
[(EtO)2P(0)CF2]-
(165) 
(EtO)2P(0)CF2- + Br-
(EtO)2P(0)CF2 • 
^ ^ C F 2 P ( 0 ) ( O E t ) 2 
.Br 
<g -^CF,P(0)(OEt). i ^ ^ h m B r ^ ^ ^ C F , P ( 0 ) ( O E . ) , 
scheme 4.16 
The addition of a catalytic amount of samarium diiodide in oxolane to a solution 
of bromide (94) and cyclohexene resulted in a striking colour change, due to the 
oxidation of samarium diiodide. However, the ^ ^F NMR spectrum indicated no reaction 
(scheme 4.17). The next step, therefore, was to attempt the reaction with the iodide 
(118). 
Br 
(EtO)2P(0)CF2Br + 
S m l 2 / T H F / r t 
scheme 4.17 
CF2P(0)(OEt)2 
IV.C .3 .b Attempted Reaction of miethoxynhosphinyndifluoroiodo-
methane (118) with Cyclohexene 
To a solution of the iodide (118), synthesised as previously described, and 
cyclohexene in THE was injected a catalytic quantity of samarium diiodide solution 
(THE). Again a colour change was observed from blue to colourless, characteristic of 
the oxidation of the samarium diiodide to the triiodide. It was evident from the ^ ^F NMR 
spectrum, however, that no reaction had taken place between (118) and cyclohexene 
(scheme 4.18). 
(EtO)2P(0)CF2l + 
Sml2 /THF/ r t 
scheme 4.18 
/ ^ C F 2 P ( 0 ) ( O E t ) 2 
\ / 
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IV.C.3 .C Conglusipn 
Although samarium diiodide has proved an excellent means for the coupling of 
polyfluoroalkyl iodides to alkenes i t proved ineffective at coupling 
(diethoxyphosphinyl)difluorohalides to cyclohexene. This could be due to the electrode 
potential of the transformation illustrated^'*^ in figure 4.4 being insufficient to generate 
the radicaf anion (165). • 
Sm^^ • Sm "^*" + 1e' E°> 0.9V 
figure 4.4 
Steric reasons for the inhibition of the reaction can not be ruled out, however, it 
should be noted that both the reactions involving irradiation, as a means of generating the 
radical (152) and the SET copper catalysed addition of the iodide (118) to cyclohexene 
requiring the input of high energies either by elevated temperature or irradiation to yield 
products unlike the samarium diiodide route. 
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C H A P T E R V 
T H E gYlVTHEglg OF PURINF AND PYRIMIDINE F p L Y F L U O R Q -
N U C L E O S I D E S 
V.A Introduction 
5-Fluorouracil (166) was synthesised and developed as an antimetabolite by 
Danenberg et al.^'^ (scheme 5.1), in 1957, on the premise that tumour cells showed 
increased utilisation of uracil, needed for the production in vivo of thymine. They 
expected (166) to be incorporated into RNA but not DNA, and also to inhibit DNA 
biosynthesis, because the firmly bonded fluorine atom at C5 prevents attachment of Uie 
one carbon unit to the C5 position that becomes the methyl group of thymine. 
F2/HOAC 
HOAc 
scheme 5.1 
The action of 5-fluorouracil in vivo is via two pathways: 
(i) conversion to the 5-fluoro-deoxyuridine monophosphate (167) a potent 'suicide 
inhibitor' of the enzyme thymidylate synthetase; 
(ii) conversion to 5-fluorouridine monophosphate (168), which is further incorporated 
into RNA, this leads ultimately to transcription errors in later cellular processes.' 
0 0 0 0 
HN HN 
^ . . ^ . . A . J J ^ . 
(H0)2P(0)0' (H0)2P(0)0-
18 
HO HO OH HO OH 
(167) (168) (169) (170) 
5-Fluorouracil and its anabolic metabolites (167) and (168) have, thus, been 
used clinically for cancer treatment but have the disadvantage of both high toxicity and 
requirement for high dosage. This fact has led to the synthesis of a variety of prodrugs 
for (166) obviating these toxicological problems, of which 5'-deoxy-5-fluorouridine 
(j^9-)248 5-fluoro-l-(teQ-ahydro-2-furyl)uracil (170) show the most promise. 
V.B 5'-Deoxvniicleoside Derivatives of 5-Fluorouracil 
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Russian workers effected the synthesis of (170) in 1969,-^ '^ ^ and more recently 
Earl et al.^^^ devised a new route to (170) and the pyranyl derivative (171) via 
fluorination of the corresponding uracil derivatives with trifluoromethyl hypofluorite 
(scheme 5.2). The 5'-deoxynucleosides (169) and (170) demonstrated superior activity 
over (166), apparently because of greater specific toxicity for the tumour compared to 
potentially susceptible host cells and the inability of the nucleoside analogues to be 
phosphorylated to nucleotides.-^^ 
O 
°^y-CI (i) > (M) 
(CH2)n (CH2)n (CH2)n 
n=2(170);n=3(171) 
(i) bis(trimethylsilyl)uracil. CH2CI2, -78°C; (ii) C F 3 O F , CH2CI2,- 2 0 T 
scheme 5.2 
The mode of action of these derivatives is that of hydrolytic cleavage in vivo of 
the glycosidic Unkage by thymidine phosphorylase,^^ thus yielding 5-fluorouracil which 
can be metabolised by the methods described earlier (section V.A). 
Further alterations are possible, Danenberg et alP introducing a fluoro group in 
the C4' position of the sugar moiety to give the 5-fluorouracil prodrug (53) (section 
I.C.3 .C). Modification at the C4' position in the sugar ring decreases hydrolytic stability 
in acidic conditions due to the presence of the electron withdrawing fluoro group, thus 
Danenberg rationalised, that i f the action of uridine phosphorylase involves an acid 
catalysed step to release 5-fluorouracil from such prodrugs as (53) or (170), then 5-
fluorouracil would be cleaved at an accelerated rate from (53). Indeed, this proved to be 
the case. 
HO OH 
(53) 
It therefore appeared to be an ideal opportunity to develop C5' substituted 
analogues of (170) containing a lipophilic polyfluoroalkyl substituent known to increase 
transport of drugs across lipid membranes.^ ^ 
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V.C Free Radical Formation of Polvfluoroalkvl Ethers 
The first step in the synthesis of new 5-fluorouracil prodrugs involved the 
attachment of a polyfluoroalkyl group to the sugar skeleton via a free radical process. 
This field of work, essentially the radical addition of ethers to polyfluoroalkenes has been 
extensively covered by Chambers et a/. 235,252-254 utilises the carbon-hydrogen bond 
in ethers as a functional group. 
In the free radical reaction of fluoroalkenes with an ether (scheme 5.3) the 
initiation step, i.e. the homolytic cleavage of a carbon-hydrogen bond to form two 
radicals, was induced by ^^Co gamma-ray irradiation without exception (reactions occur 
at room temperature, produce little or no side products, and the products are readily 
isolated); sources of initiation used previously in the free radical reaction of ethers and 
fluoroalkenes have included peroxides^ -^^ -'^ '^* and UV photolysis.-^ '^^ -'^ ^ 
R . ^ O , ^ ^ R • + H' (initiation) 
H 
" \ / 0 ^ R • F3C-. .CF2 . 0 ^ . R 
CF2=CFCF3 
R ^ O ^ . R 
CF (propagation) 
R 
(172) 
^ F 3 C ^ ^ ^ . C F 2 ^ 0 ^ ^ R ^ R > ^ O . ^ R 
FocL. ^CFo ^ O ^ ^ R Z^'i^y^' 2 
r 
H R 
C F ^ Y 
R 
R 
2 ^— H U 
R (lerminaiion) 
R . ^ O ^ 
R ^ ^ O ^ ^ R + H- • 
H 
scheme 5.3 
In the propagation steps of the reaction it can be seen that two processes occur; 
(i) attack of a nucleophilic radical on the electron deficient fluoroalkene double bond to 
give (172); 
(ii) proton abstraction by (172) at the carbon-hydrogen bond alpha to oxygen. 
These two steps can be rationalised. 
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V . C . I Factors Affecting Regiochemistrv and Stereochemistry of Free 
Radical Addition 
The dominant force for the regiochemical direction of the free radical addition of 
fluoroalkenes to ethers can be attributed to two factors, the stabilisation of the radical 
centres generated and stereoelectronic effects. 
In the generation of the radical (172) attack occurs at the difluoromethylene site of 
the alkene; NMR experiments indicate no evidence of attack at the internal vinylic fluorine 
site. This fact can be explained by a combination of: 
(i) steric hindrance of the attacking nucleophilic radical, minimised by attack at the least 
hindered site of the alkene i.e. the difluoromethylene group. Reinforced by the electronic 
effect, the difluoromethylene site constituting the most electron deficient vinylic site; 
(ii) stabilisation of the new radical centre, remote and near stabilisation of the radical 
centre is maximised by generation of the radical at the internal vinylic fluorine centre, 
demonstrated theoretically^^^ and experimentally.-^^^ 
The fluoroalkyl ether radical (172), could in theory react with another molecule of 
fluoroalkene but hexafluoropropene does not homopolymerise, rather the radical attacks 
the ether at the site alpha to oxygen generating a heteroatom stabiUsed radical centre.'^ ^^ 
Indeed, molecular orbital calculations by Hudson et alP'^ have shown a high degree of 
stabiUsation of the singly occupied molecular orbital by the oxygen lone pair represented 
diagramatically in figure 5.1. 
-'6-CH -P-&1 
Energy 
C H 
figure 5.1 
When the generation of a radical centre takes place at a chiral or prochiral carbon, 
loss of stereochemical control is almost always observed, because free radicals do not 
retain their configuration except under certain circumstances e.g. cyclopropyl substrates 
which show both retention-^^^ and inversion^^^ and via neighbouring group 
participation.-^^^ 
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Thus in the formation of the mono-adducts between fluoroalkenes and ethers the 
fluoromethinyl position and, i f the ether is cyclic, at the newly generated chiral centre 
adjacent oxygen, would be predicted to be a mixture of stereoisomers (approximately 
5 0 : 5 0 ) . However, some stereoselecrivity is observed e.g. in the reaction of 
hexafluoropropene with oxolane, discussed later in this chapter (section V.C.3.b). 
V.C.2 Acyclic Fluorinated Ethers 
Dimethyl ether has previously been reacted with hexafluoropropene to give 
exclusively the monoadduct, by ^^Co gamma-ray irradiation.'^^^ This work was 
repeated, together with some other fluoroolefins, to build up a series of short chain 
acyclic polyfluoroethers to ultimately yield nucleosides with a similarity to acyclovir (55), 
bearing a fluoroalkyl rather than a hydroxy substituent. 
.N 
H2N' 
(55) RF = CF3CFHCF2; CF3CH2CF2 
The yield of the hexafluoropropene adduct (173), 79%, was comparable to that 
obtained previously,-^-'^  and identification by N M R spectrometry confirmed the structural 
assignment of a monoadduct with a difluoromethylene group beta to oxygen, the alpha 
hydrogens showing coupling characteristic of an adjacent difluoromethylene group 
(figure 5.2). 
OCH. 
F X X CF, 
(17 3) 
1 1 . 4 
22.8 
.CHFCF.. 
coupling constants for (173)(Hz) 
figure 5.2 
1,1,3,3,3-Pentafluoropropene, however, gave methoxy-1,1,3,3,3-
pentafluorobutane (174)(figure 5.3) in a 5 8 % yield, a significant drop in reactivity, 
almost half of the 1,1,3,3,3-pentafluoropropene being recovered. The large difference in 
reactivity was not expected given the only difference between the two fluoroalkenes is the 
presence of a vinylic hydrogen in 1,1,3,3,3-pentafluoropropene. 
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OCHg 
FgC^ X F 2 O' 
(17 4) 
12.4 
12.4 
CHoCF 
12.4 
coupling constants for (174)(Hz) 
figure 5.3 
The i H NMR spectrum for (174) contrasted dramatically with that for the adduct 
(173), in (174) both the methylene protons and the two difluoromethylene fluorine 
atoms were equivalent. Thus, a triplet was observed (^JpH = 12.4Hz) for the coupling of 
the difluoromethylene group to the methylene group. However, Methoxy-2,2,3,4,4,4-
hexafluorobutane (173) gave a complex splitting pattern (ABddd) due to the 
inequivalence of the methylene protons and the difluoromethylene fluorine atoms. This 
can be rationalised by the presence of the extra fluorine atom at the 2-position which 
would prefer to be eclipsed relative to the two difluoromethylene fluorine atoms (lone pair 
repulsion) which gives rise to a preferred low energy conformadon. 
When 3,3,3-trifluoropropene was reacted with dimethyl ether, an even more 
anomalous result was observed. No fluoroalkene was recovered and the only product 
was a very viscous liquid (175). This liquid proved to be of a high molecular weight 
MR>500 (by FAB mass spectrometry) indicative of telomerisation. This has been 
previously reported for 3,3,3-trifluoropropene in the radical addition to oxolane, by 
Bergstrom,^^^ the telomerisation initiated by peroxides present in the ether. Indeed, 
stringent conditions had to be adopted by Bergstrom to obtain the mono-adduct in 
isolation. However, gamma-ray initiation even with a vast deficiency of the alkene still 
yielded polymeric products, presumably due to a similar runaway telomerisation process 
(scheme 5.4); the [1,5]-hydrogen shift proceeding via a chair transition state (Figure 5.4). 
CP 
CW^O-^^^^-^ C F 3 
figure 5.4 
'O • C F 3 
100 
o 
1,5-H shifu 
1,5-H shift. 
. C F 3 CF3 
etc. 
eto. 
scheme 5.4 
V.C.2.a Competition Studies of Hexafluoronronene. Pentafluoropropene, 
and TriHuoronropene with Dimethyl Ether 
To obtain a clearer picture of the anomalous results obtained, a series of 
competition reactions between the three fluoroalkenes and a deficiency of dimethyl ether 
were carried out (table 5.1). 
Reactant Mole Ratio Product 
CF3CH=CH2 4.5 (175) 
CF3CF=CF2 4.5 
C H 3 O C H 3 1.0 
CF3CH=CF2 5.0 (173) 
CF3CF=CF2 5.0 
C H 3 O C H 3 1.0 
C F 3 C H = C H 2 4.1 (175) 
CF3CH=CF2 4.1 
C H 3 O C H 3 1.0 
table 5.1 
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The table clearly shows an order of reactivity thus: 
3,3,3-trifluoropropene> hexafluoropropene > 1,1,3,3,3-pentafluoropropene 
Explanations as to why the reactivity is so are put forward: 
i) Steric - 3,3,3-Trifluoropropene is sterically less hindered at the carbon site 
under attack than either hexafluoropropene or 1,1,3.3,3-pentafluoropropene; 
ii) Electronic - It is well known that a radical centre is stabilised by fluorine 
atoms,^^^ thus greater stabilisation of the radical centre on the C2 carbon occurs in 
hexafluoropropene, where there is one fluorine atom compared to 1,1,3.3,3-
pentafluoropropene and 3,3,3-trifluoropropene which have only hydrogen at C2. The 
trifluoromethyl group is common to all three fluoroalkenes, therefore, the effect of this 
group can be neglected; 
iii) Deactivation due to fluorine - Mono-adducts show low reactivity towards 
fluorinated alkenes, because of the electron withdrawing effect of the polyfluoroalkyl 
group reducing the ability of the oxygen lone pairs to stabilise the radical centre.^ ^-' 
However, energetically hydrogen abstraction to generate a primary radical centre is 
greater than to generate a secondary radical centre. Thus, in the adduct between 3,3,3-
trifluoropropene and dimethyl ether (figure 5.5) where one trifluoromethyl group is 
present and three secondary sites are generated, the methylene group adjacent to oxygen 
is far enough away from the deactivating trifluoromethyl group that it seems conceivable 
(175) is as reactive or more reactive than dimethyl ether, which has only primary 
hydrogens, hence telomerisation. For the other mono-adducts (173) and (174) the 
proximity of the difluoromethylene group must deactivate the oxygen to a much greater 
extent, hence no telomerisation or di-adduct formation. 
Energy 
RR 
x ^ ^ ^ / ^ ^ X / ' ^ ' ^ s + InH 
Abstraction of secondary hydrogen R=F 
RR 
^ ° \ / ^ ^ \ / * " ^ 3 + InH 
Abstraction of primary hydrogen R=H,F 
RR 
, 0 . ^ . C F , InH 
Abstraction of secondary hydrogen R=H 
figure 5.5 
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An overall combining of all the points would suggest that (i) and (iii) are the 
dictating factors, and give the overall reactivity series shown earlier. 
V.C.3 Cyclic Fluorinated Ethers 
Oxolane, a cyclic ether system, was also studied, due to its similarity to the 
skeleton of the five membered carbohydrate ring in many nucleosides. The ether was 
once again reacted with various fluoroalkenes with a view to further functionalisation. 
V.C.3.a The Synthesis of Cyclic Fluorinated Ethers 
A deficiency of hexafluoropropene is known to react with oxolane under gamma-
ray initiation to produce predominantly the mono-adduct,'^ '^* this reaction was extended to 
include the adducts formed using 1,1,3,3,3-pentafluoropropene and 
chlorotrifluoroethene^^^'^^^ to give (176), (177) and (178) respectively in yields of 
81%, 75% and 41%, some polysubstitution also occurring. 
F s C y ^ C F ^ F s C y ^ C F g ^ O y ^ C l y ^ C F g ^ O s ^ 
^(176) (177) ^ (178) 
In contrast to dimethyl ether, di-adducts between oxolane and polyfluorinated 
alkenes are well documented and can be formed under gamma-ray initiation, however, an 
excess of the fluoroalkene is required to favour polysubstitution. In such a process a 
capto-dative effect could be envisaged from the inductively electron withdrawing 
fluoroalkyl group and the donating oxygen atom favouring a radical centre of the type 
(179 ) .2" 
F R R F R R T R R 
(179) R=CH3 (180) 
Chambers et al^^ demonstrated that the capto-dative effect did not operate, and 
rather than enhancing reactivity, the polyfluoroalkyl group deactivates the sites next to 
oxygen. If disubstitution does occur the di-adduct is formed via an intramolecular [1,5]-
hydrogen extraction mechanism (scheme 5.5) to give a 2,5-disubstitution pattern in 
oxolane (181) and in diethyl ether d/5-(2,2,3,4,4,4-hexafluoro-l-methylbutyl)ether 
(182) not ethyl-4-(l,l,l,2,3,3,5,5,6,7,7,7-dodecafluoro-4-methylheptyl) ether (180). 
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F. F F. F 
C . F , 
F. F 
3'-6 F , C O F , 
C F j — C P H 
R R F R R P ^ P P 
R=-(CH2)2- (181);R=CH3 (182) 
scheme 5.5 
Examination of the ^^F NMR spectrum of the mono-adduct (177) from the 
reaction of 1,1,3,3,3-pentafluoropropene with oxolane showed not only resonances for 
(177), but also for a di-adduct (183). The di-adduct was not isolated because the ratio 
of (177) to (183) was approximately 60:1, and was only observable by gas 
chromatography and NMR spectra (figure 5.6). 
C F 3 region C F 2 region 
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figure 5.6 
However, by comparison of the ^^p NMR resonances and splitting patterns (table 
5.2) for the di-adduct of hexafluoropropene (HFP) and oxolane (181) with that of (183) 
it was clear that a further molecule of 1,1,3,3,3-pentafluoropropene (PFP) had not added 
to the 5-position of oxolane. 
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C F3 C F2 
HFPt PFP HFPt PFP 
mono-adduct -74.19 -74.96 -120.10 -118.13 
-124.26 -121.88 
di-adduct -74.27 -61.784 -119.74 -108.25 
-124.64 -115.00 
Comparison of pentafluoropropyl and hexafluoropropyl mono- and di-adducts 
table 5.2 
Further substitution of 2-monosubstituted oxolanes, e.g. (176), to the 2,5-
disubstituted adducts, e.g. (181), gives rise to only a minor perturbation in the 
trifluoromethyl and difluoromethylene fluorine resonances, due to the element of 
symmetry possessed by the molecule. The di-adduct of 1,1,3,3,3-pentafluoropropene 
and oxolane (183) shows a large deviation from the mono-adduct trifluoromethyl and 
difluoromethylene fluorine resonances. Indeed, the trifluoromethylene region of the ^^ F 
NMR spectrum showed two non-equivalent trifluoromethyl units, and one 
trifluoromethyl group possessed a splitting pattern indicative of coupling to just one 
adjacent proton rather than two. This leads to the assignment of a structure where the 
other pentafluoropropyl unit is at the 2-position of the fluoroalkene (scheme 5.6) i.e. 2-
[l,l,3,3,5,5,5-heptafluoro-2-(trifluoromethyl)pentyl]oxolane (183). 
F. r 
=^HCF3 
F F 
CF3 CF2=CHCF3 
scheme 5.6 
F F 
(183) 
The orientation of the free radical addition in (176)-(178) is due to the 
combination of steric, electronic and stabilisation effects described earlier, thus the 
difluoromethylene group is attached to the carbon alpha to oxygen. 1,1,3,3,3-
Pentafluoropropene lacks a fluorine atom at the 2 position which results in a reduction in 
stabilisation for the radical centre generated, as compared to the other fluoroolefins, 
therefore, some homopolymerisation can occur cf. 1,1,1-trifluoropropene.-^ '^^  The low 
yield of (183) can be explained by steric and electronic constraints, the presence of the 
t The 3,3,3,2,1,1-hexafluoropropyl adducts are diastereomeric, hence data is quoted for the major 
diastereoisomer only. 
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first polyfluoroalkyl group reducing the nucleophilicity of the newly generated radical 
centre. 
V.C.a.b stereochemistry of Cyclic Fluorinated Ethers 
For compounds 2-(l,l,2,3,3,3-hexafIuoropropane)oxoIane (176) and 2-(2-
chloro-l,l,2-trifluoroethyl)oxolane (178) two chiral centres exist in the molecule, thus 
more than one diastereoisomer is observed in the ^H, and ^^C NMR spectra, indeed, 
Cortieu et al?^^ have recently assigned the ^H and ^^F spectra of adduct (176) using the 
intemuclear double resonance NMR experiment (INDOR) and decoupling techniques, 
indicating the diastereomeric configuration at the two chiral centres. Thus, it was thought 
that the structure and assignment of the diastereoisomers of (178) could be expedited 
experimentally given the only difference between (176) and (178) is the replacement of 
the trifluoromethyl group by the chloro group, simplifying spectral analysis. 
It would be expected given the presence of two chiral centres, that four 
stereoisomeric products would be formed (figure 5.7), of these two are merely 
enantiomers of the others i.e. (178a) with (178d) and (178b) with (178c), thus only 
two possible diastereoisomers can be distinguished by NMR. Table 5.3 indicates the 
assignment of shifts and coupling constants for the two diastereoisomers based on data 
from Cortieu^^^ and Joel^ ^^ for the structurally similar molecule (176). 
CFCIH 
F ^ C l 
-2-CF2 (178a) 
C l ^ F 
figure 5.7 
^ 1 , ^ . H 
^ ^ 2 \ l 
P ci (1780 
(I78d) 
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C C l F H a - C F a F b - C H b — C H 2 — C H 2 — C H 2 — O 
Ha Fa Fb Hb 5 
F SS/RR 48.9 14.1 14.1 - -160.697 
SR/RS 47.4 9.8' 15.1 3.0 -152.787 
Ha SS/RR _ 12.8 12.8 3.6 6.335 
SR/RS - 14.4 . 14.4 1.6 6.383 
Fa S S / R R - - 255.5 19.6 -128.202 
SR/RS - - 264.2 22.2 -127.458 
Fb S S / R R - - - 12.4 -126.072 
SR/RS - - - 3.4 -126.399 
Hb S S / R R - - - - 4.368 
SR/RS - - - 4.331 
^ ^ F , N M R assignments for the diastereoisomers of (178) 
table 5.3 
The ratio of the diastereoisomers in (178) is 55:45 (RS/SR:RR/SS), cf. 53:47 
iRS/SR:RR/SS) in (176).^^'' The ratio is not 50:50 by virtue of a neighbouring group 
interaction induced by the first chiral centre generated in the furanyl ring, hydrogen atom 
abstraction by the polyfluoroalkyl group occurring with a slight preference on the planar 
face most remote from the ring. 
The adduct (177) exists as two indistinguishable enantiomers, therefore no 
stereochemical assignment could be determined based on the NMR data, due to the use of 
a non-chiral solvent. 
V.D Haiogenation of Fluorinated Ethers 
V.D.I IntrQdUgtiQn 
To carry out further reactions on the fluorinated ethers it becomes necessary to 
functionalise them by direct halogenation using bromine or chlorine to give an a-
haloether.^^^ These reactive intermediates can be readily reacted with various 
nucleophiles e.g. the use of 2-methoxyethoxymethyl chloride as an alcohol protection 
group.•^^^ 
The mechanism for halogenation is via a free radical process (scheme 5.7); which 
results in an a-haloether due to the oxygen heteroatom, which stabilises an adjacent 
radical site via the mesomeric effect.'^ -^ -^'^ ^^  However, the regiospecificity of substitution 
must be controlled. 
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CL ^ 2C1-
0 1 — C I ^ R P - - N ^ / ^ C I 
o ' ' O' 
scheme 5.7 
V.D.2 Regioselectivity of Halogenation 
The favourable stabiUsation of a radical centre by oxygen dictates that the halogen 
atom initially abstracts a proton adjacent to oxygen, however, two such positions exist. 
The Hammond Postulate states that for a single reaction step the geometry of the 
transition state for that step resembles the side to which it is closer to in free energy. 
Thus two extreme transitions states could be envisaged for proton abstraction by a 
halogen(figure 5.8): 
-c-H + Hal-
figure 5.8 
transition state (i) - The early transition step would be favoured by an initial state 
of relatively high energy and a final state of low energy i.e. a relatively energetic or 
unstable halogen radical in the initial state, and a relatively strong H-halide bond in the 
final state; 
transition state (ii) - The late transition state would be favoured by a final state of 
relatively higher energy that the initial state i.e. a lower energy halogen radical in the 
initial state, and a relatively weak H-haUde bond in the final state. 
However, these are not the only two effects, the repulsion between the initial 
radical Hal- and reactant and the newly generated carbon radical and H-Hal must also be 
considered. 
Thus for chlorination, following the Hammond Postulate, the reactive nature of a 
chlorine radical means the initial state is of high energy and the hydrogen chlorine bond is 
quite strong (432kJmol"l) which lowers the energy of the final state, pointing to an early 
transition state (i). In transition state (i) the repulsion between the chlorine atom (no 
dipole) and the reactant will be negligible in the initial state, however, for the final state 
hydrogen chloride has a high dipole so any electron withdrawing or donating groups on 
the carbon radical will have a marked effect, thus, leaving chlorination dominated by 
polar effects. 
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Contrast bromination, a relatively less reactive radical and weaker bond 
dissociation energy for hydrogen bromide (366kJmol-^ ) indicate a late transition state (ii). 
The dipole moment of hydrogen bromide is relatively small so polar effects are 
negligible, therefore, the stability of the developing radical would be the most important 
factor in influencing the regioselectivity, with hydrogen atom abstraction at what would 
become the most stabilised carbon centre. 
This was home out experimentally. Chambers et al?^^ found that when methoxy-
2,2,3,4,4,4-hexafluorobutane ( 1 7 3 ) was treated widi bromine in carbon disulphide the 
predominant product was methoxy-l-bromo-2,2,3,4,4,4-hexafluorobutane ( 1 8 4 ) , 
together with a small quantity of dehydrodimers (scheme 5.8), i.e. bromination gave the 
product favoured by a late transition state, the radical formed at the more stable secondary 
site rather than the primary carbon site. 
C F g C F H C F g ^ 
( 1 7 3 ) 
sunl ight. 
Br 
C F a C F H C F j " ^ ' 
( 1 8 4 ) 81% 
scheme 5.8 
O ^ - t C F o C F H C F , ' 
^ dehydro-
r +dimers 
9% 
Chlorination was more solvent dependant; polyhalogenation predominated if no 
solvent was present, and the major products were as a result of halogenation on the 
methyl group on the opposite side of the ether oxygen. 
However, the yield of the mono-adduct l-chloromethoxy-2,2,3,4,4,4-
hexafluorobutane ( 1 8 5 ) was optimised by the use of carbon disulphide as a solvent, 
perhaps due to solvent interaction with the chlorine radical inducing selectivity and thus 
less polychlorinated by-products.^ ^^ Thus, chlorination gave predominantly 1-
chloromethyl-2,2,3,4,4,4-hexafluorobutane ( 1 8 5 ) due to attack at the least electrophilic 
site, i.e. the terminal methyl group, a polar effect and a consequence of an early transition 
state. 
Chlorination of the polyfluoroalkylethers gave the coirect regiochemistry to make 
analogues of ( 5 5 ) , thus a series of chlorinations were carried out (table 5.4). 
R2 
Reactant R F Product Yield(%) 
( 1 7 3 ) C F 3 C F H C F 2 R l = H ; R 2 = H ( 1 8 5 ) 47 
( 1 7 6 ) CF3CFHCF2 R1=R2= -(CH2)2- ( 1 8 6 ) 84t 
( 1 7 7 ) CF3CH2CF2 R1=R2= -(CH2)2- ( 1 8 7 ) 52t 
( 1 7 8 ) CFCIHCF2 R1=R2= -(CH2)2- ( 1 8 8 ) 63t 
table 5.4 
t Yields are based on NMR spectra 
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The a-haloether (185) was the only polyhalogenated ether which could be 
purified, since the a-haloethers (186)-(188) were, without exception, thermally and 
hydrolytically unstable entities. The oxolanes (186)-(188) readily lost hydrogen 
chloride, via a/iri-elimination, in the presence of base e.g. powdered sodium hydroxide. 
Both stereoisomers could undergo elimination (scheme 5.9), an equatorial chloro group 
undergoing inversion of the oxygen centre allowing the chloro group to 'flip' into the 
axial position, the dihedral angle with the adjacent hydrogen atom tending to 180° ideal 
for anri-elimination, to yield the dihydrofuran derivatives. The dihydrofuran derivative 
was isolated in the case of (186) as a clear colourless oil (189). 
^ " NaOH ^ { V R F 
R R . -HCl / 
a ' C f y ^ o ^ R.= cP3CPHc,(i89) 
H 
scheme 5.9 
The acyclic a-haloether (185) lacked an alpha methylene group, which excluded 
the possibility of elimination and could be isolated by preparative gas chromatography in 
a 47% yield. 
The yields were unaffected by the nature of the polyfluoroalkyl group, due to the 
remote position of the polyfluoroalkyl group ft-om the site of chlorine attack. However, 
the bulky groups may have had an effect in the stereospecificity of the chlorine atom 
abstraction. This factor could only be ascertained from NMR studies. 
V.D.3 Snectrometric Assignment of Polyfluorinated g-Haloethers 
The assignment of the NMR shifts for the products of halogenation, (186) to 
(188), was greatly complicated by the introduction of a further chiral centre into the 
molecules. Indeed (186) and (188) have eight possible stereoisomers, essentially giving 
four sets of ^H ring resonances, each heavily coupled to each other, while for (187) with 
only four stereoisomers two sets of peaks are obtained, thus all have multiple AB 
systems overlapping in a narrow range. Therefore, only a limited assignment of the 
chemical shifts could be obtained relating to the stereo- and regio-selectivity of 
chlorination. 
Some evidence exists for a certain amount of stereochemical control in the free 
radical addition process.'^ ^^ This has been observed by Joel^ '^^  who invoked a steric 
argument for the approach of an electrophilic radical trans- to that of a bulky 
polyfluoroalkyl group. This process would be expected, therefore, to yield an inversion 
of the chirality of the new chiral centre with respect to the old one. This is in fact 
observed in the ^H NMR spectrum of the a-haloethers (figure 5.9) with resonances for 
the geminal proton to the chloro group coming at both 6.35ppm (trans-) and 6.23ppm 
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(cis-) in (186). A non-selective radical process should in theory give a mixture of the 
cis- and fra/j^-isomers (approximately 1:1). However, figure 5.9 shows the ratio 
between the isomers was greatiy in favour of the trans-isomcr (71:29). Indeed, some 
form of neighbouring group participation must be taking place, the bulky polyfluoroalkyl 
group favouring approach of the chlorine molecule fi"om the opposite face. 
trans-
I I I I I I I I I I I I ' I I I I ' ' ' ' I ' ' ' ' I 
6 5 4 
I , 1 , 1 — , — I . - I 
2 5 . 5 0 . 0 1.4 5 6 . 9 
figure 5.9 
The i H NMR spectra also indicated that the 5 position was not fully chlorinated, 
however, it could not be determined whether this was due to the formation of 2-chloro-2-
polyflUoroalkyloxolanes or merely starting material. 
V . E The Coupling of Nucleoside Bases to Polvfluorinated «-Haloethers 
V . E . I Introduction 
Previously (Chapter III) the coupling of purine bases by nucleophilic attack at an 
activated halogenated allylic site was described. However, the displacement of a halogen 
substituent adjacent to oxygen has been extensively studied, particularly for the 
inti-oduction of pyrimidine bases. 
V.E.2 MgthQ l^s 9f CQltpliqg Pyrimi<|ing BflggS 
Initially, methods to couple pyrimidine bases to chloro- or acetoxy- furanose 
systems employed heavy metal derivatives,^^^ e.g. silver and mercury salts, however, 
this was undesirable in biological systems, due to contamination of the nucleosides by 
these toxic metals and their derivatives. The problem was negated with the advent of the 
Hilbert-Johnson method. 
The original Hilbert-Johnson method^^^ required the use of 2,4-
dialkoxypyrimidines, and proceeded via the formation of a quaternary ammonium salt, 
followed by subsequent deprotection to liberate the nucleoside. With the advent of the 
2,4-substituted silyl derivatives of heterocyclic bases the nucleosides could be obtained 
directly.^^"* Funher, addition of a Lewis acid catalyst e.g. tin (IV) chloride^^^ or more 
recently trimethylsilyl triflate,'^^^ had been shown to significantiy increase the yield of the 
I l l 
nucleoside product. Thus, the latter methodology was adopted to couple the pyrimidine 
bases uracil and 5-fluorouracil to the polyfluorinated a-haloethers (185)-(188). 
V.E .2 .a SilYlatipn gf Uracil an<i 5-Flu9r9»racn 
Silylation of both uracil and 5-fluorouracil are a prerequisite of the modified 
Hilbert-Johnson method. This facile process was carried out in accordance to the 
literature method,^ ^"* i.e. excess hexamethyldisilizane (HMDS) in the presence of 
ammonium sulphate catalyst (scheme 5.8). 
0 
[(CH3)3Si]2NH/(NH4),804 
160°C/16hirs 
OSiMe, 
N 
' OSiMeg 
R=H (190); R=F (191) 
scheme 5.8 
The silylated bases 1,3-disilyloxypyrimidine (190) and 5-fluoro-l,3-disilyloxy-
pyrimidine (191), were isolated as oily residues after distillation, in vacuo, to remove 
excess HMDS, and used without further purification or analysis due to their hydrolytic 
instability. 
V.E .2 .b Coupling of Silylated Uracil (190) and 5-Fiuorouracil (191) to 
Polyfluorinated nr-Haloethers 
Following literature procedures the silylated bases (190) and (191) were coupled 
to the a-haloethers (185)-(188), utilising a Lewis acid catalyst, either trimethylsilyl 
triflate'^^^'^^^ or tin (IV) chloride.-^^ '^'^ ^^ The products isolated, in all cases, were 
anomeric mixtures (by ^H NMR) of the desired pyrimidine substituted polyfluoroethers 
(scheme 5.9). 
OSiMe^ 
NtejSiSOjCFj/fcHjC N/-3 0"C 
V Y 
cis (p) trans (a) 
R = H; R F = CF2CFCIH (192), CF2CH2CF3 (194), CF2CFHCF3 (196) 
R = F; R F = CF2CFCIH (193), CF2CH2CF3 (195), CF2CFHCF3 (197) 
scheme 5.9 
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The results are summarised in table 5.6, which illustrate: 
(i) the choice of Lewis acid catalysis does not have a significant effect on either the yield 
or the anomeric ratio of the products. In the synthesis of (196) the anomeric ratio was 
1:1 via tin (IV) chloride catalysis, cf. 5:7 for trimethylsilyl triflate catalysis; 
(ii) the yields of the 5-fluorouracil derivatives were in general much lower than that of the 
uracil analogues, due to the reduction of electron density at the N l position. 
o 
cpsiMej 
N ' R f q R f 
1 R Y N H 
MejSiO 
(190)-(191) 
R' R' 
(185)-(188) a92)-(199) 
Base a -Haloether Product Yield (%) Anomeric Ratio 
R=H (190) R F = C F 2 C C 1 F H ^gg^ 
R'=R '=-(CH2)2-
(192) 47 2:3 
R = F (191) R F = C F 2 C C 1 F H ^jgg^ 
R'=R '=-(CH2)2-
(193) 45 1:1 
R=H (190) R F = C F 2 C H 2 C F 2 (187) 
R = R ' = - ( C H 2 ) 2 -
(194) 52 5:7 
R = F (191) R F = C F 2 C H 2 C F 2 
R'=R '=-(CH2)2-
(195) 49 2:3 
R=H (190) R F = C F 2 C F H C F 2 (18^) 
R'=R '=-(CH2)2-
(196) 72 5:7 
R=H (190) R F = C F 2 C F H C F 2 (ig^) 
R'=R '=-(CH2)2-
(196) 68 
R = F (191) R F = C F 2 C F H C F 2 (136) 
R'=R '=- (CH2)2-
(197) 63 2:3 
R=H (190) R F = C F 2 C F H C F 2 (185) 
R ' = R ' = H 
(198) 33 -
R = F (191) R F = C F 2 C F H C F 2 (185) 
R ' = R ' = H 
(199) 25 -
yield and the ratio of the anomcric products (192)-(199) 
table 5.6 
V.E.2 .C Stereochemistry of the Pvrimidine Substituted Polvfluorinated a-
Haloethers 
The assignment of the stereochemical outcome of the coupling reactions was 
determined by interpretation of ' H NMR spectra, particularly the region from 5.5ppm to 
7.0ppm where the H I ' resonance can be found. The H I ' chemical shift giving an 
a Tin (IV) chloride was used as the Lewis acid catalyst 
113 
indication of whether the substituted pyrimidine ring is cis- or trans- to the 
polyfluoroalkyl group. 
The acyclic pyrimidine substituted derivatives (198) and (199) have no chiral 
centre, thus ^H NMR showed only one product, which could be assigned as 
uradylmethoxy-2,2,3,4,4,4-hexafluorobutane and 5-fluorouradylmethoxy-2,2,3,4,4,4-
hexafluorobutane respectively. 
Howeyer, in the cyclic oxolane systems a number of stereoisomers are possible 
by the very nature of the substitution mechanism (scheme 5.10). Indeed, the mechanism 
indicates that although the a-haloethers (186), (187) and (188) were a mixture of c/5-
and trans- isomers, ultimately, no isomeric separation was required, as racemisation of 
the chloromethinyl position occurred via generation of an intermediate carbocation. 
V ^ CI 
Me,SiSO,CF, 
+ CF3SO3" + MegSiCI 
— St 
OSiMft 
C F 3 S O 3 
0SiMe3 
MesSiSOjCFa 
R = H or F; R F = CF2CFCIH, CF2CH2CF3, CF2CFHCF3 
scheme 5.10 
The highly unstable intermediate carbocation could be subsequendy attacked from 
either face of the molecule, hence cis- and trans- isomers are possible, i.e. /3- and a-
anomers respectively. Thus, with the addition of the chiral centre in the polyfluoroalkyl 
group of (192),(193),(196) and (197) four diastereoisomers exist, all of which are 
observed by NMR (figure 5.10). 
to 10 10 to (D (D 
H5 
I I I I I I ' I I I I ' I M I I I I I I I I I I I I I I I I I I I I I I I I I I ' I I I 
6.4 6.2 6.0 5.8 
the four diastereoisomeric resonances for Ihe HI' atom in 2-(3,3.3,2,l,l-hexafluoropropyl)-5-uradylonoUne(196). 
figure 5.10 
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The resonances for the cis- and rran^-isomers and, subsequentiy, the anomeric 
ratios quoted in table 5.6 were assigned empirically based on the NMR data of closely 
related compounds,'^^°"^^^ thus Pedersen^^^ obtained the structurely similar nucleoside 
2',3'-dideoxy-6-/V,A^-dimethyladenosine as the a-isomer (200b) with a resonance for 
the C2' hydrogens at 2.53ppm, and a C I ' hydrogen resonance at 6.32ppm compared to 
the /5-isomer (200a) which had chemical shifts of 2.75ppm for C2' and 6.03ppm for the 
hydrogen at CI ' in li-chloroform, this can be compared directiy to the ^H NMR spectrum 
of 2-(3,3,3,l,l-pentafluoropropyl)-5-uradyloxolane (194) where resonances occur at 
2.13ppm, 2.58ppm and 6.14ppm, assigned as the jS-isomer and at 2.01ppm, 2.42ppm 
and 6.30ppm, the a-isomer. Finally, the anomeric ratios were calculated by comparison 
of the integration of the ^H resonances of the hydrogen at CI ' (figure 5.10). 
NMe, 
(200a) 
HO 
NMej 
(200b) 
Although distinguishable by NMR techniques the diastereoisomers could not be 
separated by thin layer or medium pressure chromatography on silica, thus pure samples 
of the anomers could not be obtained. However, separation was observed by analytical 
high pressure liquid chromatography, running on a normal phase silica column (figure 
5.11). 
c: u-ian i n 
^ i 1 \ 
C I 
R e t e n t i o n 
R e s u l t T i m e 
( ) (m i n ) 
0 . 1478 2 . 0 9 3 
0 . 0 6 6 3 2 . 2 7 5 
^ » 0 
. 0 7 8 6 2 . 3 8 1 
. 2 7 2 2 2 . 5 0 5 
4 0 . 0 7 1 8 9 636 0 0 . 0934 2 760 
0 . 1 1 0 7 o 861 
0 0611 3 052 
0 2438 3 228 
0 2310 • 3 231 
0 2493 3 564 
18 3628 3 750 
4 7029 3 893 
6 1581 3 925 
19 7779 3 946 
27 1505 4 830 
18 5405 5 268 
0 0308 8 . 168 
0 0679 1 0 . 609 
3 . 3637 1 2 . 765 
0 . 0384 15 . 787 
0 . 0981 1 6 . 641 
0 . 0326 1 7 . 583 
1 0 0 . 0000 
figure 5.11 
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Full assignment of the remaining ring hydrogens was made by use of COSY 
spectra, thus from figure 5.12, the COSY spectrum of 2-(l-chloro-1,2,2-
trifluoroethyl)-5-uradyloxolane (192) it can be seen: 
(i) Hr(a-isomer) at 6.30ppm is coupled to two hydrogen atoms at shifts of 
2.04ppm and 2.45ppm, these must be H2'(a-isomer), one of which is cis- to Hr(a -
isomer); 
(ii) the hydrogen atom at 2.04ppm i.e. H2'(a-isomer) is coupled td a large 
multiplet at 2.35ppm which must be the resonance of the two H3'(a-isomer); 
(iii) they in turn are strongly coupled to a resonance at 4.52ppm, which by a 
process of elimination must be H4'(a-isomer); 
(iv) a similar treatment for the remaining resonances gives the Hr(/J-isomer) at 
6.15ppm, coupled to H2'(y3-isomer) 2.14ppm, which is in turn coupled to the other 
H2'()3-isomer) 2.60ppm and two hydrogen atoms resonating at 2.39ppm H3'()8-isomer) 
and finally at 4.80ppm H4'()5-isomer) 
JHlH2fci) 
•felH2(cii 
(a) (b) 
figure 5.13 
The fact the COSY spectrum shows the coupling of HI' in one instance to 
both H2' atoms, while for the other case only one coupling to the lower field H2' atom 
can easily be explained in terms of the Karplus equation. Thus, in figure 5.13 for 
structure (a) the Karplus equation would lead us to expect an approximately equal 
coupling to both the H2' atoms from HI', while in (b) there will be a large coupling 
between HI' and H2'(c/j) and no coupling to Hl'itrans). However, this information 
does not give any indication whether the resonances correspond to an a- or j3-anomer, 
because only the relative disposition of one side of the molecule has been deduced. The 
COSY spectrum reveals no detailed coupling between H3' and H4', which would have 
enabled a similar analysis of the stereochemistry of the polyfluoroalkyl group. 
The 2D COSY spectra also showed that no N3 substitution had taken place in the 
nucleosides (192)-(199). N3 substitution manifesting itself in a ^JNHCH coupling of 
approximately 7Hz,^'^ however, no coupling between the Nl hydrogen atom and the 
vicinal C6 hydrogen atom could be observed (figure 5.12). 
The anomeric ratio for the pyrimidine nucleosides varied in all the systems, 
however, the substitution did not favour the sterically less demanding, 'unnatural' trans -
isomers. 
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2D 1H COSY N M R spectrum 
H V> 2 3 
(192) 
figure 5.12 
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V . F The Synthesis of 2-(5-Fluorouradvn-5-(1.1.1.3.3-Dentafluoro-
nronvDoxolane (195) hv Direct Fluorination 
The synthesis of 5-fluorouracil and its derivatives via direct fluorination is well 
documented, and therefore it was decided to attempt the fluorination of the uracil 
derivative (194) to yield 2-(5-fluorouradyl)-5-(l,l,l,3,3-pentafluoropropyl)oxolane 
(195) (scheme 5.11). 
F2/CF3COOH 
(194) (195) 
scheme 5.11 
The initial experimental procedure used to fluorinate (194), was to bubble a 10% 
mixture of fluorine in nitrogen into a stirred solution of 2-uradyl-5-(l,l,l,3,3-
pentafluoropropyl)oxolane (194) in trifluoroacetic acid. Trifluoroacetic acid was used 
rather than water or acetic acid to effect the transformation to (195) because of three 
factors: 
(i) work by Rozen-^ '^^ -'^ ^^  and Misaki^^^ had shown that polar solvents increased the 
conversion of a substrate to the fluorinated derivatives significantly, due to an increased 
electrophilicity of the fluorine, simultaneously scavenging any non-selective fluorine 
radicals, which lead to the degradation of the substrate; 
(ii) the use of trifluoroacetic acid obviates problems which could arise from side 
reactions, since fluorine can react with the solvent rather than the substrate; trifluoroacetic 
acid has a high degree of resistance to fluorination cf. acetic acid; 
(iii) the nucleoside (194) was readily soluble in trifluoroacetic acid, and showed no 
hydrolysis of the glycosidic linkage, by NMR, after two days in the medium. 
After aqueous work up of the crude reaction mixture the ^^ F NMR showed no 1-
(5-fluorouradyl)-4-(l,l,l,3,3-pentafluoropropyl)oxolane (195), however, Visser ei 
al?^^ showed in an elegant mechanistic study, utilising ^^¥2, that the mechanism for the 
fluorination of uracil proceeded as shown in scheme 5.12. 
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o 
O' 
CH,OOOH^ HN 
O 
H 
Rl= F or CF3O 
scheme 5.12 
To give predominantly the acetoxy compound (201), unless heat is applied, via path b. 
Thus after purification of the crude mixture by column chromatography (eluent 
ethyl acetate) two products were isolated and found to be 2-(5-fluoro-6-hydroxyuradyl)-
5-(l,l,l,3,3-pentafluoropropyl)oxolane (202) and unexpectedly uracil (203). 
Compound (202), a white solid, was present as the major product obtained in a yield of 
80%, while (203) was isolated in 8% yield. The formation of (202) could be 
rationalised by the mechanism outlined above, the intermediate 2-(5-fluoro-6-
trifluoroacetoxyuradyl)-5-( 1,1,1,3,3-pentafluoropropyl)oxolane (204) initially 
produced, undergoing subsequent hydrolysis upon work-up to give 2-(5-fluoro-6-
hydroxyuradyl)-5-(l,l,l,3,3-pentafluoropropyl)oxolane (202), since trifluoroacetate is 
an excellent leaving group (scheme 5.13). 
O 
0 0 0 F 
1 -CF30(0)0 ' 
OF. 
(204) (202) 
scheme 5.13 
The formation of (203) is much harder to envisage and may have resulted from 
acid cleavage of the glycosidic linkage,^^^ liberating the free polyfluoroalkyloxolane, 
which probably was not seen in the crude reaction mix due to its volatility (scheme 5.14). 
CF. 
R F 
CF. 0 , ^ 
scheme 5.14 
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Dehydration of (202) by heating under vacuum yielded 2-(5-fluorouradyI)-5-
(l,l,l,3,3-pentafluoropropyl)oxolane (195) in near quantitative yield, 94% (scheme 
5.15). 
HN 
O 
H2O 
(202) 
Scheme 5.15 
V.G MgthQdS pf Cpupling Pyring Ba?gS 
OF. 
O 
(195) 
The conditions used to couple the purine class of bases via the precursors 6-
chloropurine (144) and 2-amino-6-chloropurine (148) were as outlined in chapter I I I , 
and the results are summarised in table 5.7. 
CI 
CI 
N 
N. 
R ' - 'N ' ^ R- R' 
(144) or (148) (185)-(188) 
.CI DMF/ Yi 
(205l-(209) 
Base a-haloether product Yield (%) Anomeric 
ratio 
R=NH2 (148) RF=CF2CFHCF2 (185) 
R ' = R ' = H 
(205) 7 
R = H (144) RF=CF2CFHCF2 (186) 
R'=R'=-(CH2)2-
(206) 23 3:1 
R=NH2 (148) RF=CF2CFHCF2 (186) 
R'=R'=-(CH2)2-
(207) 11 -T 
R = H (144) RF -CF2CH2CF2 (187) 
R '=R '=- (CH2)2-
(208) 17 8:1 
R = H (144) RF=CF2CCiFH (188) 
R '=R '=- (CH2)2-
(209) 31 -t 
Yields of purinyl substituted polyfluoroethers 
table 5.7 
The yields for the purine class of heterocycles was much lower than that obtained 
for the pyrimidine bases. This fact could be rationalised by the greater steric bulk of the 
purine derivatives and the difference in the methodology used to couple the bases. 
Higher yields could, perhaps, have been realised by utilisation of the lithium salts of the 
t Ratio could not be determined by NMR. 
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purine bases, the production of the purinyl anion, a stronger nucleophile increasing both 
rate and yield of the desired products.^ 
As for the pyrimidine base substituted products (206)-(209) a mixture of 
stereoisomers are possible, thus it became important to assign the stereochemical outcome 
of the reaction both in terms of ci^- and trans- isomerism in the oxolane ring and N7 
versus N9 substitution in the purine ring. 
V . G . I Stereochemistry of the Purine Substituted Polvfluorinated a-
HalQgthgrs 
The assignment of the stereochemical outcome of the coupling reactions was 
determined by interpretation of NMR and UV spectra. For the acyclic purine substituted 
derivative 2-amino-6-chloropurinylmethoxy-l,l,2,3,3,3-hexafluorobutane (205) the 'H 
NMR spectrum showed only one stereoisomer, cf. uradylmethoxy-2,2,3,4,4,4-
hexafluorobutane (198) and 5-fluorouradyl-methoxy-2,2,3,4,4,4-hexafluorobutane 
(199). 
AH the oxolane derivatives showed cis- and trans- isomerism, but displayed a 
greater degree of stereospecificity than the equivalent pyrimidine coupled products. The 
fact that one isomer was favoured, to such a large extent, can only be explained by the 
greater steric bulk of the purinyl bases. 
The purine bases can, in principle, couple through either the N7 or N9 nitrogen 
atoms in the imidazole ring, this is particularly true for guanine derivatives. The UV 
spectra of the purinyl derivatives were, therefore, measured to determine whether N7 or 
N9 substitution had occurred. N9 substituted 6-chloropurinyl derivatives and 2-amino-6-
chloropurinyl derivatives display strong absorption in the 266nm^°° and 310nm^^^ 
regions respectively, thus the results summarised in table 5.8 show that exclusive N9 
substitution has taken place; the reasons for such substitution has been discussed 
previously (section lII.D.2.b and section III.D.2.e). 
CI 01 
t/ 6:^  
(205) (206) (207) (208) (209) 
248, 304nm 262nm 248,304nm 262nm 262nm 
table 5.8 
V.G.2 nenrotection of Purine Substituted Polyfluorinated «-Halogthgrs 
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V.G.2.a Deprotection of 2-Ainino-6-chloroDurinvlmethoxv- l .1 .2 .3 .3 .3-
hexafluorohutane (205) and 2-f2-Amino-6-chloroDurinvn-5-(l .1.2.3.3.3-
hexafluoroDroDvnoxolane (207) 
The niethodology for the deprotection of the 2-amino-6-chloropurinyl 
functionality to the guanyl functionality is a facile process and involved hydrolysis with 
dilute mineral acid (table 5.9)(see section in.D.2.f). 
C F 3 C F H C F 2 
1M HCI(aq) 
1^  
< 
C F 3 C F H G F 2 ^ N Y 
o 
' N H 
R2 
2-amino-6-chloropurine 
derivative 
R1/R2 Product Yield (%) 
(205) R1=R2=H (210) 73 
(207) R1=R2= -(CH2)2- (211) 85 
yields of purine nucleosides 
table 5.9 
Thus the reaction proceeded to yield the guanyl derivatives in high yield as white solids. 
V.G.2.b DgprQtggtiqn Qf 2-(0-Chl9r9purinYl)-g-p9lYfly9rQa'kYlQXQlan^ 
The deprotection of the 6-chloropurinyl functionality in the polyfluoroether 
derivatives (205),(206),(208) and (209) was accomplished utilising standard literature 
conditions (table 5.10) '^*^ No problems were encountered with this method, cf. the 
(diethoxyphosphinyl)difluoromethylene derivative (145)(section in.D.2.c). 
MH^/MeOH/l OCC ^ 
pi p2 
(212H214) 
6-Chloropurine 
derivative 
RF R1/R2 Product Yield (%) 
(206) CF2CFHCF3 R1=R2= -(CH2)2- (212) 85 
(208) CF2CH2CF3 R1=R2= -(CH2)2- (213) 80 
(209) CF2CFCIH R1=R2=: -(CH2)2- (214) 91 
table 5.10 
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Thus, excellent yields were obtained for all the derivatives and the products were 
subsequendy purified by normal phase silica gel chromatography (eluent ethyl acetate). 
V.H Biological Test Data on Purine and Pvrimidine Substituted 
Polvfluorinated «-Haloethers 
The compounds (192)-(199) and (212) are currently under test at SmithKline 
Beecham Laboratories (Great Burgh) for any in vitro antiviral activity. 
V.I C9ngly?i9n 
Polyfluorinated a-haloethers were successfully reacted with soft nitrogen 
nucleophiles i.e. substituted purines and pyrimidines. The yields, in all cases, were 
greater for the pyrimidine class of compounds, probably due to the pyrimidines being 
less sterically demanding, as well as the different coupling mechanism used. It was 
interesting to note that an attempt to couple a primary amine (ethylamine) resulted in no 
reaction with the polyfluorinated a-haloether (184). Given the higher basicity of 
ethylamine over the purines and pyrimidines used and the lack of any significant steric 
hindrance this result is somewhat anomalous. 
It was observed that l-chloromethoxy-2,2,3,4,4,4-hexafluorobutane (185) gave 
the lowest yield of all the polyfluorinated a-haloethers utilised, the other derivatives gave 
approximately the same yield irrespective of the polyfluoroalkyl group, this reactivity 
may be due to the greater stabilisation of the carbocation in the cyclic oxolane systems 
due to the positive inductive effect of the adjacent ring methylene units. 
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R X P E R I M F N T A L S E C T I O N 
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I N S T R U M E N T A T I O N 
Gas liquid Chromatography (g.c.) analysis was carried out on a Hewlett Packard 
5890A gas cromatograph fitted with a 25m cross-linked methyl silicone capillary column. 
Preparative g.c. was performed on a Varian Aerograph Model 920 (catharometer detector) 
gas chromatograph. 
Fractional distillation of products was carried out using a Fischer Spahltrohr 
MMS 255 small concentric tube apparatus. Boiling points were recorded during 
distillation. Melting points were carried out at atmospheric pressure and are uncorrected. 
Carbon, hydrogen and nitrogen elemental analyses were obtained using a Perkin-
Elmer 240 Elemental Analyser or a Carlo Erba 1106 Elemental Analyser. 
Ultraviolet spectra were recorded on a Perkin-Elmer Lambda 2 or a Pye-Unicam 
PU 8720 UVA^is spectrometer. 
Infra Red spectra were recorded on either a Perkin-Elmer 457 or 577 Grating 
Spectrophotometer using conventional techniques. 
Proton NMR spectra were recorded on a Hitachi Perkin-Elmer R-24B (60MHz), a 
Bniker AC250 (250MHz), and a Varian VXR400S (400MHz) NMR spectrometer. 
Fluorine NMR spectra were recorded on a Varian EM3601 (56.45MHz), a Briiker 
AC250 (235MHz) and a Varian VXR400S (376MHz) NMR spectrometer. 
Carbon NMR spectra were recorded on a Briiker AC250 (65MHz) and a Varian 
VXR400S (100.6MHz) NMR spectrometer. 
Phosphorus NMR spectra were recorded on a Briiker AC250 (101 MHz) NMR 
spectrometer. 
Mass Spectra of solid samples were recorded on VG 7070E spectrometer. G.c. 
mass spectra were recorded on the VG 7070E spectrometer linked to a Hewlett Packard 
5790A gas chromatograph fitted with a 25m cross-linked methyl silicone capillary 
column. 
R E A G E N T S 
In general chemicals were used as received from suppliers (Aldrich, Lancaster, 
Fluka, Fluorochem and Sigma) and solvents were dried by literature procedures. 
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C H A P T E R VI 
E X P E R I M E N T A L TO C H A P T E R H 
VI.A The Chemistry of fDiethoxvphosphinyndifluoromethvlene Zinc 
Bromide (94) 
VI.A.1 Preparation of (Diethoxyphosphinynbromodifluoromethane (94) 
A flask was charged with triethylphosphite (73.75g, 442mmol) in anhydrous 
ethoxyethane (300ml), cooled to 0°C and dibromodifluoromethane (lOOg, 478mmol) 
added dropwise. The reactants were left to warm up to room temperauire then refluxed at 
40°C for 24h. The solvent was removed under reduced pressure and the product purified 
by vacuum distillation to leave a colourless liquid (diethoxyphosphinyl)bromo-
difluoromethane (94)(107.65g, 90%); b.p 105°C/16.1 mmHg; (Found: C, 23.0; H, 
3.95. Calc. for C5HioBrF203P: C, 22.5; H, 3.8%); IR spectrum recorded; du 
(250MHz, CDCI3, TMS) 1.45 (6H, t, 3JHH=7.2HZ, CH3 ), 4.33 (4H, dq, 3JHH=7.2HZ, 
C / /2O); ap (237MHz, CDCI3, CFCI3) -60.63 (2F, d, 2jpF=93.1Hz, PCF2Br); m/z 
(CI+) 286 (MH++NH3, 98%), 284 (MH++NH3, 100%); as compared to literature data 
O F -61.9ppm).i43 
VI.A .2 Pr^paratiQn pf (Di^thQxyphQgphtnYljl^rQmQd'fluQrQm^thvl^n^ Ziny 
BrQmidg (95) 
(Diethoxyphosphinyl)bromodifluoromethane (94)(3.05g, 11.4mmol) was added 
dropwise to a stirred suspension of dry acid washed zinc dust (0.74g, 11.3mmol) in 
anhydrous monoglyme (6ml) at room temperature. After 12h the solution was filtered 
through a Schlenk-filter (No3) to remove any unreacted zinc. The colourless clear 
solution was then used without further purification. (Diethoxyphosphinyl)difluoro-
methylene zinc bromide (95)(coversion 100% by ^^F NMR); 3F(237MHZ, monoglyme, 
CFCI3) -125.9 (2F, d, 2jpp=92.9Hz, PCF2Zn); as compared to the literature value (d^ -
126.1ppm).i4^ 
The preparation was repeared many times, as the material was required. The 
reaction could be scaled up to 250mmol without any problems. In all the following 
reactions (diethoxyphosphinyl)bromodifluoromethylene zinc bromide will be referred to 
as Burton's reagent. 
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VI .A .3 Reactions of Ben/vl Bromide 
VI .A .3.a Reaction of Benzvl Bromide and Burton's Reayent (95) 
A flask was charged with a solution of Burton's reagent (95)(21.2mmol) in 
monoglyme, benzyl bromide (3.62g, 21.3mmol) and copper (I) bromide (0.05g, 
0.3mmol), under a nitrogen atmosphere. The solution was heated at 40°C for 12h then 
filtered to remove any copper (I) bromide and washed with 2M hydrochloric acid 
(2x20ml) followed by saturated sodium hydrogen carbonate until neutral. At this point a 
white precipitate was collected insoluble in both the ether and the water layer. The 
organic washings were then dried, magnesium sulphate, filtered and solvent removed 
under reduced pressure to yield a mixture of products. ^^F NMR spectra allowed 
identification of the products as (Z)-l,2-difluoroethenebisphosphonate (53%, by NMR); 
aF(237MHz, C D C I 3 , C F C I 3 ) -128.42 (2F, ddd, 2jpF=81.9, 3jpF=18.1, 3JFF=15.0HZ, 
PCF=PCF); as compared to literature (-128.3ppm),^^^ and (diethoxyphosphinyl)-
difluoromethane (20%, by NMR); aF(237MHz, C D C I 3 , C F C I 3 ) -136.11 (2F , dd, 
2jpF=91.6, 2JFH=49.2HZ, P C F 2 H ) compared to -136.01ppm for an authentic sample 
(section VI .B. l ) . 
The white solid was sublimed, and analyses showed it to be bibenzyl (100)(42%, 
0.79g); m.p. 49-50°C;288 I R spectra recorded; dn (250MHz, CDCI3, TMS) 2.33 (4H, s, 
CH2 CH2 ), 6.53 (lOH, s, Ph CH2); m/z (EI+) 182 (M+, 100%), 91 (M+-PhCH2). 
vi .A.2.b R^attipft 9f Bgn^yl Br9mi<lg flP^t CQppgr (I) Promi^ie 
A flask was charged with benzyl bromide (2.00g, 12mmol) and copper (I) 
bromide (0.06g, 0.4mmol) and stirred at 40°C for 12h. The crude reaction mixture was 
then tested by TLC (silica) against authentic bibenzyl (eluent 40-60 petroleum ether), no 
bibenzyl was observed. 
VI .A .2 .C i^mtion 9f Bgn/.Yl Bromide and Zinc 
A flask was charged with benzyl bromide (2.00g, 12mmol) and acid washed zinc 
powder (0.78g, 12mmol) and stirred at 40°C for 12h. The crude reaction mixture was 
then tested by TLC (silica) against authentic bibenzyl (eluent 40-60 petroleum ether), no 
bibenzyl was observed. 
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VI.A.4 Reactions of Allvlic Bromides and Burton's Reagent (95) 
VI.A.4 .a Preparation of 3-Bromocyciopentene (103)^^^ 
A flask was charged with cyclopentene (6.82g, lOmmol), A'-bromosuccinimide 
(17.80g, lOmmol) and a spatula tip of azobisisobutyrylnitrile (AIBN) in dry carbon 
tetrachloride (100ml) was heated until succinimide was observed floating on the top of the 
solution, after which the heat source was removed the exotiiermic reaction left until no N-
bromosuccinimide was observed. The reaction mixture was filtered through a celite plug 
and the solvent removed under reduced pressure. The crude product was purified by 
vacuum distillation to give a colourless liquid 3-bromocyclopentene (103)(5.26g, 
35.8%); b.p. 40-55°C/45mmHg; dn (250MHz, CDCI3, TMS) 2.495-2.360 (3H, m, ring 
CH2), (4H, dq, CH2O); m/z (EI+) 66 (M+-HBr, 100%). 
VI.A.4.b Preparation of 3-Bromocyclohexene (104) 158 
A mixture of cyclohexene (8.20g, lOmmol), A'-bromosuccinimide (17.80g, 
lOmmol) and a spatula tip of AIBN initiator in dry carbon tetrachloride (100ml) was 
heated until succinimide was observed floating on the top of the solution, after which the 
heat source was removed the exothermic reaction left until no A'-bromosuccinimide was 
observed. The reaction mixture was filtered through a celite plug and the solvent 
removed under reduced pressure. The crude product was purified by vacuum distillation 
to give a colourless liquid 3-bromocyclohexene (104)(8.1g, 50.34%); b.p. 81-
85°C/34mmHg; du (400MHz, CDCI3, TMS) 1.690 ( IH, m , equatorial ring H), 1.895-
2.096 (2H, m, equatorial ring CH2), 2.140-2.300 (3H, m, axial ring CH2) 4.849 ( IH, 
m, C//Br), 5.797-5.934 (2H, m, CH=); m/z (ER) 162 (MH+, 8%), 160 (MH+, 8%), 80 
(M+-HBr, 100%). 
VI.A .4 .C Preparation of 3-Bromocvcioheptene (105)^^^ 
A mixture of cycloheptene, 92%, (24.72g, 23.7mmol), A^-bromosuccinimide 
(37.91g, 21.3mol) and a spatula tip of AIBN initiator in dry carbon tetrachloride (100ml) 
was heated until succinimide was observed floating on the top of the solution, after which 
the heat source was removed the exothermic reaction left until no A'-bromosuccinimide 
was. observed. The reaction mixture was filtered through a celite plug and the solvent 
removed under reduced pressure. The crude product was purified by vacuum distillation 
to give a colourless liquid 3-bromocycloheptene (105)(14.97g, 40.1%); b.p. 
56°C/4mmHg; dn (270MHz, CDCI3, TMS) 1.477-2.362 (8H, m, ring CH2), 4.908 
( IH , td, CHBv), 5.690-5.954 (2H, m, C//=); m/z (E1+) 176 (M+, 1.6%), 174 (M+, 
1.8%), 95 (M+-HBr, 100%). 
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VI .A .4.d Reaction of 3-BromocvcloDentene (103) and Burton's Reagent 
(95) at •15°C 
A flask was charged with copper (I) bromide (0.05g, 0.3mmol) and 3-
bromocyclopentene (103)(1.01g, 6.8mmol) in anhydrous monoglyme (10ml), cooled to 
-15°C (ice/salt) and Burton's reagent (95) added dropwise (6.8mmol). The solution was 
stirred for 12h and then warmed to room temperature, filtered through a celite pad and 
washed with 10% HCl(aq) (2x20ml), then saturated sodium hydrogen carbonate until 
neutral. The product was then extracted with ethoxyethane (3x50ml) and dried 
(magnesium sulphate), filtered and isolated after removal of solvent by reduced pressure. 
The crude product was then run down a silica gel column (ethoxyethane/30-40°C 
petroleum ether 1:1) to yield 3-f(diethoxyphosphinyl)difluoromethyncyclopentene 
(106)(0.09g, 5%); [Found: C, 47.0; H, 6.7.(MH+ 255) C 1 0 H 1 7 F 2 O 3 P requires C, 
47.25; H, 6.7%]; b.p. 145°C/4mmHg; NMR spectrum 1; IR spectrum 1; mass spectrum 
1. 
VI.A.4.e Reaction of 3-BromocvcloDentene (103) and Burton's Reagent 
(95) at IQX 
The reaction was repeated as above at room temperature with Burton's reagent 
(95)(7.4mmol), copper (I) bromide (0.05g, 0.3mmol) and 3-bromocyclopentene (1.09g, 
7.4mmol), to give a blue black polymeric material which contained no fluorine. 
VI .A .4.f Reaction of 3-Bromocvclopentene (103) and Burton's Reagent 
(95) at -<?9°(; 
The reaction was repeated as above except the reaction flask cooled and 
maintained at -69°C for lOh (acetone/dry ice) with Burton's reagent (95)(50.1mmol), 
copper (I) bromide (0.05g, 0.3mmol) and 3-bromocyclopentene (2.32g, 15.8mmol), to 
give 3-r(diethoxyphosphinyl)difluoromethyncyclopentene (106)(0.35g, 8.9%). Data as 
section VI.A.4.d. 
VI .A .4.g Reaction of 3-Bromocvclohexene (104) and Burton's Reagent 
(95) at -^9°C 
To a cooled (acetone/dry ice) mixture of copper (I) bromide (0.05g, 0.3mmol) 
and 3-bromocyclohexene (104)(1.61g, lO.OmmoI) in anhydrous monoglyme (10ml), 
was added dropwise Burton's reagent (94)(9.3mmol). The solution was stirred for 12h 
and then warmed to room temperature, filtered through a celite plug, washed with 10% 
HCl(aq) (2x20ml), and saturated sodium hydrogen carbonate until neutral. The product 
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was then extracted with ethoxyethane (3x50ml), dried (magnesium sulphate), filtered and 
the solvent removed under reduced pressure. The crude product was then Kugelrohr 
distilled to give a colourless oil 3-r(diethoxyphosphinyl)difluoromethvllcyclohexene 
(107)(1.83g, 71%); [Found: C, 49.25; H, 6.8.(M+ 268) C 1 1 H 1 9 F 2 O 3 P requires C, 
49.2; H, 7.1%]; b.p. 125°C/0.3mmHg; NMR spectrum 2; IR spectrum 2; mass spectrum 
2. 
VI ,A .4.h Reaction of 3-Bromocyclohexene (104) and Burton's Reagent 
(95) at 86°C 
The reaction was repeated as above subsequentiy heating the solution to reflux for 
a further 4h, with copper (I) bromide (0.05g, 0.3mmol) and 3-bromocyclohexene 
(104) (16.226g, lOlmmol) in anhydrous monoglyme (30ml), to which Burton's reagent 
(94) (101mmol) was added, to give 3-r(diethoxyphosphinyl)difluoromethyllcyclohexene 
(107) (16.838g, 65%). Data as above. 
VI .A .4.i Reaction of 3-Bromocycloheptene (105) and Burton's Reagent 
(95) at -^9°C 
To a cooled (cardice/acetone) mixture of copper (I) bromide (0.05g, 0.3mmol) 
and 3-bromocycloheptene (105)(14.969g, 85mmol) in anhydrous monoglyme (20ml), 
was added Burton's reagent (95)(85mmol). The solution was stirred for 12h and then 
warmed to room temperature, filtered through a celite plug, washed with 10% 
hydrochloric acid (2x20ml), and saturated sodium hydrogen carbonate until neutral. The 
product was then extracted with ethoxyethane (3x50ml), dried with magnesium sulphate, 
filtered and the solvent under reduced pressure. The crude product was then Kugelrohr 
distilled to give a colourless oil 3-r(diethoxyphosphinyl)difluoromethyl1cycloheptene 
(108) (11.215g, 51.3%); [Found: C, 49.9; H, 7.2.(MH+ 283) C 1 2 H 2 1 F 2 O 3 P requires 
C, 51.0; H, 7.5%]; b.p. 125°C/0.06mmHg; NMR spectrum 3; IR spectrum 3; mass 
spectrum 3. 
VI .A .4.j Reaction of 3-Bromocycloheptene (105) and Burton's Reagent 
(95) at §0°C 
The reaction was repeated as above subsequentiy heating the solution to reflux for 
a further 4h, with copper (I) bromide (0.05g, 0.3mmol) and 3-bromocycloheptene 
(105) (1.61g, lO.Ommol) in anhydrous monoglyme (10ml), to which Burton's reagent 
(94)(9.3mmol) was added, to give 3-[(diethoxyphosphinyl)difluoromethyllcycloheptene 
(108) (1.83g, 65%). Data as above. 
130 
VLA.5 Attempted Palladium (0) Catalysed Reactions of Burton's Reagent 
with Allvlic Acetates and Phenyl Allvl Ethers 
VLA.5.a Preparation of Cvclohex-3-ene carboxvlic acid 164 
A steel autoclave (450ml capacity) was charged with acrylic acid (14.25g, 
200mmol) and butadiene (13.71g, 250mmol). The autoclave was heated, in a rocking 
furnace, at 160°C for 30mins. Excess butadiene was recovered (2.82g, 50mmol) and the 
product purified by vacuum distillation, to give a clear coUourless liquid cyclohex-3-ene 
carboxylic acid (22.8g, 100%); (found: C 66.7; H 8.2. Calc. for C 7 H 1 0 O 2 : C 67.0; H 
8.0%); b.p. 150°C/23mmHg; aH(60MHz, C D C I 3 , TMS) 2.13 (7H, m, ring CH2), 5.63 
(2H, m, CH=), 11.23 ( IH, s, CO2H). 
VLA.5.b The Synthesis of l-Iodo-6-oxa-bicvcIor3.2.11octan-5-one 163 
A mixture of cyclohex-3-ene carboxylic acid (22. Ig, ISOmmol), sodium 
hydrogen carbonate (14.75g, ISOmmol), and water (250ml) were mechanically stirred. 
After cessation of effervescence, potassium iodide (52.92g, 320mmol) and iodine 
(44.7g, 200mmol) were added and the contents left stirring for 5h. The reaction mixture 
was filtered, and the filtrate extracted with ethoxyethane (3x 100ml), and dried with 
magnesium sulphate. The solvent was removed under reduced pressure and the resulting 
solid combined with the filtrand. The iodolactone was then recrystallised from 
chloroform. The reacrion yielded pale yellow crystals of l-iodo-6-oxa-
bicyclo[3.2.1]octan-5-one (37.76g, 83%); du (250MHz, C D C I 3 , TMS) 1.827-2.452ppm 
(5H, m, ring C//2), 2.680 ( I H , m, CHC=0), 2.797 ( I H , d, 3JHH = 12 .3HZ, 
CHOCHe//aCHC=0), 4.512 ( I H , t, 3JHH=4.8HZ, CHI), 4.832 ( IH, t, 3JHH=5.0HZ, 
CHO); m/z (CI+) 270 (MH++17, 100%). 
VLA.5 .C The Synthesis of 6-Oxa-hicvcloL3.2.11octen-5-one (113) A 165 
A suspension of l-Iodo-6-oxa-bicyclo[3.2.1]octan-5-one (16.99g, 70mmol) and 
silver acetate (14.78g, 90mol) in anhydrous DMSO (120ml) was heated at 130°C for 3h 
under nitrogen, with mechanical stirring. The reaction mixture was then diluted with 
chloroform (500ml) and filtered through a celite pad to remove silver. The filtrate was 
washed with water, brine, dried with magnesium sulphateand filtered. After removal of 
the solvent under reduced pressure, the residual oil was distilled in vacuo to give a clear 
colourless oil 6-oxa-bicyclo[3.2.1]octen-5-one (113)(6.18g, 74%); 
b.p. 110°C/20mmHg; dn (250MHz, C D C I 3 , TMS) 2.105 ( IH, d, 3JHH=10.4HZ, 
CHOCHe//flCHC=0), 2.453-2.540 (3H, m, ring CH2), 2.918 ( IH, m, CHC=0), 
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4.772 ( I H , t, 3 J H H = 4 . 9 H Z , CHO), 5.825-6.270 (2H, m, CH=); m/z (CI+) 142 
(MH++17, 100%), 125 (MH+, 5%). 
V I . A . S . d The Synthesis of 6-Oxa-hicvclor3.2.nocten-5.one H n > Ri65 
A mixture of l-lGdo-6-oxa-bicyclo[3.2.1]octan-5-one (2.52g, lOmmol), and 1,5-
diaza[5.4.0]undecene (1.57g, lOmmol) in anhydrous benzene (300ml) was maintained at 
reflux for 6h, under nitrogen. The solution was then washed with water, dried with 
magnesium sulphate and filtered. The o i l obtained by evaporation of solvent under 
reduced pressure was distilled in vacuo to af ford 6-Oxa-bicyclo[3.2.1]octen-5-one 
(113)(0.31g, 25%), data as above. 
V I . A . S . e Thg gynth^gig pf C i s -3 -Hy^lr9xy-g -ga ' - t?9mgthQxv- l -Qvy lp -
hexene^^-^ 
6-Oxa-bicyclo[3.2.1]octen-5-one (113)(4.62g, 370mmol) and sodium methoxide 
(0.28g, 5mmoI) were stirred in anhydrous methanol (75ml) for 10 hr. The solvent was 
removed in vacuo and the residue partioned between ether (100ml) and 2% 
HCl(aq).(50ml). The aqueous phase was extracted with ether (2xl00ml), and the organic 
phases combined, dried with magnesium sulphate and filtered. The solvent was removed 
under reduced pressure to give a clear yellow o i l m-3-hydroxy-5-carbomethoxy-l-
cyclohexene (3.80g, 65%); dn (250MHz, CDCI3, TMS) 2.058-2.753 (4H, m, ring CH2 
) , 3.921 (3H, s, CH3 OC), 4.892 ( I H , m, CHO), 5.882 (2H, m, C//=); m/z (EI+) 156 
(M+, 41%), 97 (M+-OAC, 100%). 
V I . A . S . f The Synthesis of Cfs -3-Acetoxv-5-carbomethoxv- l -cvc lohexene 
(112)^^3 
To a cooled (ice/salt) mixture of cw-3-hydroxy-5-carbomethoxy-l-cyclohexene 
(3.80g, 240mol) in dichloromethane (50ml), and pyridine (3.6ml), was added over 
lOmin acetyl chloride (2.3ml, 0.033mol). The resulting white slurry was stirred for 
15min, neutralised with sodium hydrogen carbonate solution, and diluted with 
ethoxyethane (150ml). The organic phase was washed successively with saturated 
sodium hydrogen carbonate (3x50ml), 10% hydrochloric acid (2x50ml), sodium 
hydrogen carbonate solution (50ml), saturated sodium chloride (20ml), dried with 
magnesium sulphate and filtered. The solvent was removed under reduced pressure and 
the pale yellow liquid remaining purified by Kugelrohr distillation, to afford a clear 
colourless liquid c/5-3-acetoxy-5-carbomethoxy-l-cyclohexene (112)(2.48g, 53%); b.p. 
100-115°C/0.25mmHg; dii (250MHz, CDCI3, TMS) 1.794 ( I H , td, 3JHH=10.0HZ , ring 
CH2), 2.072 (3H, s, CH3OC), 2.352 (3H, m, ring CH2), 2.770 ( I H , m, CHC=0), 
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3.721 (3H, s, CH3CO), 5.427 ( I H , m, CHCOAc), 5.651-5.927 (2H, m. C//=); m/z 
(EI+) 139 (M+-OAC, 38%). 
Analysis of the product by g.c. revealed slight contamination by the rra/w-isomer, 
present in 3.6%. 
V I . A . S . g Thg Attgmpt^tl figattiQP Qf Ct•y-3-Acgt9?^y^5-gar^?o^^eth9xv-l^ 
cvclohexene (112) with Burton'.s Reagent (95) 
A mixture of cti '-acetoxy-S-carbomethoxy-l-cyclohexene (112)(1.5640g, 
7.899mmol), tetrakis(triphenylphosphine)palladium(0) (0.0600g, 0.042mmol), and 
oxolane (20ml) was stirred at room temperature for I h , under a nitrogen.atmosphere. 
Burton's reagent (95)(32mmol) was added and the mixture heated to reflux for 24h. ^^p 
N M R and silica gel TLC (ethyl acetate-hexane 3:1) showed no reaction, even after heating 
for a further 48h. 
V I . A . S . h Thg $vnthg$i§ CvglQP^nta^ligng 
In apparatus set up for a distillation into a cooled receiver flask (acetone/dry ice) 
dicyclopentadiene (200ml, 1480mmol) was heated to 160°C. The product distilled over 
at 57°C as a colourless clear liquid, cyclopentadiene (68.2g, 35%). The cyclopentadiene 
was used in the next step, without further purification. 
V I . A . S . i T h ^ gynth^?!? Qf j-ChlQrpgyclQpgnt^n^^^"^ 
A rapid stream dry hydrogen chloride was added to a weighed flask of 
cyclopentadiene (68.2g, lOSOmmol) equipped with a thermometer, gas inlet, and calcium 
chloride drying tube at -69°C. The reaction mixture was kept below 0°C and stirred, the 
flask being weighed from time to time, until the addition of hydrogen chloride was 10% 
short of the theoretical maximum. The 3-chlorocyclopentene was then used without 
further purification in the next step; aH (60MHz, CDCI3, TMS) 1.93-2.89 (4H, m, ring 
CH2), 4.93 ( I H , m, CHCl), 5.90 (2H, m, CH=). 
V I . A . S . j TH $Ynth^$i$ 9f j-PhgnQxcyylQpgnt^ng (114)^^^ 
A mixture o f phenol (55.84g, 590mmol) , and sodium hydroxide 
(23.64g,590mmol) in water (60ml) was stirred at 0 °C for 30min after which D M F 
(450ml) was added to the solution and the mixture again left to cool to 0°C. 3-
chlorocyclopentene (59.2g, 580mol) was then added dropwise to the solution of sodium 
phenoxide, and the reaction left 18h. The crude mixture was neutralised with sodium 
hydrogen carbonate solution followed by an ethoxyethane extraction (3x250ml). The 
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organic phases were combined, dried oyer magnesium sulphate and filtered. The solvent 
was then removed and the residual oi l distilled in vacuo, to yield a pale yellow oil 3-
phenoxycyclopentene (114)(9.6g, 11%); b.p. 85-86°G/0 .2mmHg; 9 H ( 250MHz, 
CDCI3, TMS) 1.73-2.59 (4H, m, ring CH2), 5.34 ( I H , m, CHO), 6.11 (2H, m, CH=), 
7.13 (2H, d, aromatic o-H), 7.22 ( I H , m, aromatic p-H), 7.44 (2H, dd, aromatic m-H 
); m/z (EI+) 160 (M+, 50%), 66 (M+-OPh, 100%). 
V L A . S . k The Attempted Reaction of 3-PhenoxcvcloDentene (114) and 
Burton's R^aggnt (95) 
A mixture o f 3-phenoxycyclopentene (114 ) (0 .2068g, 1.293mmol), 
tetrakis(triphenylphosphine)palladium(0) (0.0603g, 0.042mmol), and oxolane (20ml) 
was stirred at room temperature for Ih , under a nitrogen atmosphere. Burton's reagent 
(95)(6mmol) was added and the mixture heated to reflux for 24 hr. ^^p N M R and silica 
gel TLC (eluent ethyl acetate-hexane 1:3) showed no reaction. 
VLA.5.1 The Attempted Reaction of 6-oxabicvclor3.2.11octen-5-one (113) 
an<| Burton's R^aggnt (95) 
A mixture o f 6-oxabicyclo[3.2.1]octen-5-one (113)(0.4562g, 3.650mmol), 
tetrakis(triphenylphosphine)palladium(0) (0.0598g, 0.042mmol), and oxolane (20ml) 
was stirred at room temperature for I h , under a nitrogen atmosphere. To this solution 
was added Burton's reagent (95)(12mmol) and the mixture heated to reflux for 24h. ^^p 
N M R and silica gel TLC (eluent ethyl acetate-hexane 1:3) showed no reaction. 
V L B The Chgmistrv Qf (Di€th9xyplTOSPl)inYl)(Hfl»orgPethYlgiTg IH^'im 
V L B . l SvmhgSiS Qf (Dieth9?CYph9SPhiilYl)tliflH9rQmgthang (102)^89 
To a cooled (ice/water) solution of diethyl phosphite (138.Ig, lOmmol) in 
oxolane (400ml), under nitrogen atmosphere, sodium metal (22.9g, lOmmol). After all 
the sodium had reacted to give a cloudy grey solution dichlorodifluoromethane was 
passed at a moderate rate into the solution of sodium diethylphosphite at 30-35°C. The 
mixture was left stirring overnight and the precipitated sodium chloride removed by 
fi l trat ion (celite). The solvent was removed under reduced pressure and the residue 
dis t i l led under vacuum.to yie ld (diethoxyphosphinyl)difluoromethane (86.6g, 
46%)(102), b.p. 86°C/12mmHg (l i t b.p.85.6°C/12mmHg288); du (250MHz, CDCI3, 
TMS) 1.307 (6H, t, 3JHH=7.1HZ, CH3), 4.216 (4H, dq, 3JHH=7.1HZ, CH2O), 5.852 
( I H , dt, 2JFH=49.2, 3jpH=27.0Hz, PCF2H); ap (235MHz, CDCI3, CFCI3) -136.01 
(2F, dd, 2jpF=91.6, 2JFH=49.2HZ, PCF2H); m/z {E1+) 189 (MH+, 98%). 
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V I . B . 2 Preparation of (Diethoxvphosnhinyndifluoromethvlene L i t h i u m 
(96)148 
To a cooled (ice/salt) solution o f diisopropylamine (0.54g, 5.3 mmol) in 
anhydrous oxolane (20ml), under nitrogen, was added dropwise 3.65ml of 1.6M 
"Buty l l i th ium in hexanes (5.8 mmol) the temperature never exceeding -15°C. The 
solution was stirred for 15min, cooled to -84°C (l iquid nitrogen/ethyl acetate) and 
(diethoxyphosphinyl)difluoromethane (102)(1.02g, 5.3mmol) injected slowly into the 
flask, maintaining the temperature below -78°C. 
The solution of (96) was stirred for 30min then used in a variety of experiments 
by subsequent injection of the substrates detailed below. 
V L B . 3 Reaction of (DiethoxvDhosphinvndifluoromethylene Lithium (96) 
and Deuterium Oxide 
To a solution of (96)(5.3mmol) was added deuterium oxide (0.5ml)(0.50g, 
27.8mmol) the temperature never exceeding -78°C. The solution was left below -
78°C. for 2h then allowed to warm to room temperature. Excess "butyll i thium was 
destroyed by injecting water, and the product extracted into ethoxyethane (150ml), 
washed with saturated ammonium chloride (2x50ml), dried over magnesium sulphate, 
filtered and isolated after removal of solvent by reduced pressure. 
By N M R the products were (diethoxyphosphinyl)difluorodeuteromethane 
(119)(66%, by NMR); N M R spectrum 4, and (diethoxyphosphinyl)difluoromethane 
(102)(34%, by 19F NMR) ; data as section V I . B . l . 
V L B . 4 Reaction of fDiethoxynhosphinvDdifluoromethvlene Lithium (96) 
with Alkyl Halides 
V I . B . 4 . a Reaction of rPie thoxynhosnhinyDdif luoromethylene L i t h i y m 
(96) and Methyl Iodide 
To a solution of (96)(5.3mmol) was added methyl iodide (0.76g, 5.4mmol) the 
temperature never exceeding -78°C. The solution was left below -78°C.for 2h then 
allowed to warm to room temperature. Excess "butyl l i thium destroyed by injecting 
water, and the product extracted into ethoxyethane (150ml), washed with saturated 
ammonium chloride (2x50ml), dried over magnesium sulphate, filtered and isolated after 
removal of solvent by reduced pressure. The crude product was then purified using silica 
gel chromatography (eluent ethyl acetate) to afford a clear colourless l iquid 1-
(diethoxyphosphinyl)-l,l-difluoroethane (0.71g, 67%); an (250MHz, CDCI3, TMS) 
135 
1.307 (6H, t, 3JHH=7.1HZ, CH3), 4.216 (4H, dq, 3JHH=7.1HZ, C / / 2 O ) , 5.852 (3H, tt, 
3 J F H = 18.3Hz, PCF2C//3); ap (235MHz, CDCI3, CFCI3) -115.01 (2F, dq, 2jpp = 
91.6, 3JFH = 18.3Hz, PCF2CH3); m/z (E1-H) 203 ( M H + , 5%), 137 (M+-CF2Me, 39%). 
V L B . 4 . b R^agtipn pf (DjgthQXYphQgphinyDcIifluQromcthYlgng L i t h i y m 
(96) and Ethyl Ip l^idg'^ ^ 
The procedure was followed as above except ethyl iodide (0.45ml)(0.86g, 5.5 
mmol) was injected. The reaction yielded l-(diethoxyphosphinyl)-l,l-difluoropropane 
(0.47g, 47%), (found: C, 38.5; H , 6.8 Calc. for C7H15O3PF2: C, 38.9; H , 7.0%), 6F 
(235MHz; CDCI3) -114.12 ppm (2F, dt, PCF2 CH2), 5 H (250MHz; CDCI3) 1.045ppm 
(3H, t,3jHH=7.9Hz, C / / J C H 2 C F 2 ) , 1.305ppm (6H, t, % H = 6 . 9 H Z , C / / J C H 2 0 ) , 
2.019ppm (2H, tq, 3jpH=19.6, 3JJJH=7 .9HZ, C H 3 C / / 2 C F 2 ) , 4.19ppm (4H, dq, 
3JHH=7.9HZ, CH3C//2O); m/z ( E I + ) 217 (MH+, 1%), 137 (M+-CF2Et, 21%). 
V L B . 4 . C Thg Rmtipn pf (DigthQxyphQSphinyO^iifluQrQmgthylene Lithium 
(96) and 4-Nitrophenylethane Bromide 
The procedure was followed as above except a solution of 4-nitrophenylethane 
bromide (1.69g, 7.4mmol) in oxolane (5ml) was injected, and ^ H NMR showed 
none of the expected product, the spectra indicative of starting material. 
V L B . 4 . d The Reaction of (Diethoxyphosnhinyl)difluoromethylene L i t h i u m 
(96) and 2-Bromopronane 
The procedure was followed as above except a solution of 2-bromopropane 
(1.1 Ig , 9.0mmol) in oxolane (4ml) was injected. ^^F and NMR showed none of the 
expected product, the spectra indicative of starting material. 
VI .B .4 . e The Reaction of (Diethoxyphosphinyl)difluoromethylene Lithium 
(96) and Cvclobutyl Bromide 
The procedure was followed as above except a solution of cyclobutyl bromide 
(0.50g, 3.7mmol) in oxolane (5ml) was injected, l^p N M R (235MHz; CDCI3; CFCI3) 
showed a new product at -117.039ppm (2% by integration, dd, 2jpp= 126.2, 
3JFH= 19.3Hz, CnCF2?) which could not be isolated. 
V L B . 5 R e a c t i o n of B e n z v l i c and A l l y l i c H a l i d e s w i t h 
(Diethoxyphosphinvl)difluoromethylene Li th ium (96) 
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V L B . S . a The Reaction of (Diethoxvphosphinvndifliioromethvlene r.ifhiiim 
(96) and l-Br<)mo^thyl\}^n/,^n^ 
The procedure was fol lowed as above except l-bromoethylbenzene (1.36g, 
7.33mmol) was injected. 1 -(Diethoxyphosphinyl)-1.1 -difluoroethylbenzene ( 1 2 0 ) 
(0.64g,30%); [Found: C, 53.1; H , .6.7.(M+292) C13H19F2O3P requires C, 53.4; H , 
6.55%]; b.p. 125°C/0.3mmHg; N M R spectrum 5; IR spectrum 4; mass spectrum 4. 
V I . B . S . b The Reaction of (Diethoxvphosphinvl)difluoromethvlene L i t h i u m 
(96) an^l Aliyl Brgmi^lg 
The procedure was fo l l owed as above except a l ly l bromide 
(0.52ml)(0.86g, 6.0mmol) was injected. The reaction yielded l-(diethoxyphosphinyl)-
l , l - d i f l uo robu t -3 -ene ( 121 ) (0 .83g , 66%) (Found: C, 42.4; H , 6.4. Calc. for 
C8H14F2O3P: C, 42.3; H , 6.2%), 6p (376MHz; CDCI3) -111.88 (2F, dt, 2JFP=108.3, 
3 J F H = 1 9 . 5 H Z , C / ^ 2 C H 2 ) , 5 H ( 4 0 0 M H Z ; CDCI3) 1.341 (6H, t, 3 J H H = 7 . 2 H Z , 
C//JCH2) , 2.796 (2H , m, CF2CH2), 4.242 (4H, dq, 3JHH=7.2HZ, CH2O), 5.15ppm 
( I H , br s, vinylic H) , 5.35ppm ( lH,br s, vinylic H) , 5.58-6.15ppm ( I H , m, vinylic H); 
m/z (EI+) 229 ( M H + , 100%); as compared to literature (5p.-l 11.7ppm).i55 
V L B . 5 . C The Reaction of (Diethoxvphosphinvl)difluoromethvlene L i t h i u m 
(96) and j-BrprnQgycliipgntgn^ (103) 
The procedure was followed as above, except 3-bromocyclopentene (103)(1.09g 
, 4.5mmol ) was injected slowly. Flash silica chromatography (ethyl acetate) yielded 
bis(diethoxyphosphinyl)difIuoromethane (121)(0.19g, 18%) (Found: C, 33.4; H , 6.3. 
Calc. for C9H14F2O6P2 : C, 33.3; H , 6.2%), 5p (235MHz; CDCI3; CFCI3) -
122.07ppm (2F, t, 2jpp=86.4Hz, PCF2P) and 5 H (400MHz; CDCI3) 1.175ppm (12H, 
m, 3 J H H = O C H 2 C / / 5 ), 4.118ppm (8H, m, O C / / 2 C H 3 ) ; m/z (C1+) 342 (MH++17, 7%); 
as compared to literature (5p.-122.4ppm).^^^ 
V L B . S . d T h e React ion of (Diethoxvnho.snhinvDdif luoromethviene 
Lithium (96) and 3-Bromocvclohexene (104) 
The procedure was fo l lowed as above, except 3-bromocyclohexene 
(104 ) (1 .34g, 8.3mmol ) was injected slowly. Flash silica chromatography (ethyl 
acetate) yielded 3-|"(diethoxyphosphinyl)difluoromethyl1cvclohexene (107)(1.14g, 51%), 
data as recorded previously. 
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V L B . S . e The Reaction of (Diethoxyphosphinyndiflnnromethylene T^ithinm 
(96) and Brpming 
The procedure was followed as above, except bromine (3.7Ig, 20.6mmol) was 
injected slowly. Excess "butyl l i thium destroyed by injecting water, and the product 
extracted into ethoxyethane (150ml), washed wi th saturated ammonium chloride 
(2x50ml), dried over magnesium sulphate, filtered and isolated after removal of solvent 
by reduced pressure. The o i l contained by l^F N M R (diethoxyphosphinyl)bromo-
difluoromethane (94)(11.9%, by integration); dp (235MHz, CDCI3, CFCI3) -60.63 (2F, 
d, 3jpF=93.1Hz, PCF2Br); (diethoxyphosphinyl)difluoromethane (102)(60.5%, by 
integration); aF(235MHz, CDCI3, CFCI3) -136.01 (2F, dd, 2jpF=91.6, 2JFH=49.2HZ, 
PCF2H); and bis[(diethoxyphosphinyl)]difluoromethane (122)(27.6%, by integration); 
B F (235MHz, CDCI3, CFCI3) -122.94 (2F, t, 3jpF=86.4Hz, PCF2P); as compared to 
literature (5F.-122.4ppm).'^2 
V L B . 6 The Reaction of (DiethoxyphosphinvDdifluoromethylene Lithium 
(96) with Diacetone-D-glucose (123). a Sugar Model 
V L B . 6 . a Preparation of 1 . 2 : 5 . 6 - D i - 0 - i s o p r o p y l i d e n e - 3 - 0 - t o l u e n e - p -
s u l p h o n y l - « - D - g / « c o f u r a n o s e (124)^^^ 
Diacetone-D-glucose (123)(5.96g, 22.8mmol) was dissolved in pyridine (40ml) 
and cooled to 0°C. Tosyl chloride (14.0g, 73.4mmol) in pyridine (20ml) was added 
dropwise. The solution was then stirred at room temperature for 2 days. Next water 
(4ml) was added and the solution left to stand for 20min. It was then poured into 
ice/water (300ml) and the crude tosylate filtered of f . This was recrystallised f rom 
aqueous ethanol to yield l,2:5,6-di-(9-isopropylidene-3-0-toluene-p-sulphonyl-a-D-
g/wcofuranose (124)(6.68g, 81%); white crystals; (Found: C, 55.1; H , 6.1. Calc. for 
C19H26O7S: C , 55.1; H , 6.3% ) , 5 H (250MHZ; CDCI3, TMS) 1.15, 1.19, 1.31, and 
1.48 (3H, S, ( C / / J ) 2 C ) , 2.46 (3H, s, AT-CHJ ), 3.91, 4.01, 4.78, and 4.83 (multiplets, 
other C-H), 5.92 ( I H , d, C-H), 7.59 (4H, A B system, Ar-H); m/z (CI+) 415 (MH+, 
100%). 
V I . B . 6 . b Preparation o f 1 . 2 : 5 . 6 - D i - ^ - i s o p r o p y l i d e n e - 3 - Q - t r i f l i c - a - D -
g/MCQf»ran9§g (125)1^^ 
Diacetone-D-glucose (123)(1.83g, 7mmol) and pyridine (2.5g, 32mmol) were 
dissolved in CH2CI2 (50ml) and the solution was cooled down under dry nitrogen to 0°C 
by an ice/salt bath. Tr i f l i c anhydride (5.1g, ISmmol) was added dropwise and the 
solution was stirred at 5°C for 30min. A white solid was deposited and the solution went 
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a pale yellow. The solution was then washed sequentially with ice-cold 2 M hydrochloric 
acid and water. The organic layer was dried over magnesium sulphate, filtered and 
evaporated to leave a solid, l,2:5,6-di-(9-isopropylidene-3-(?-triflic-a-D-^/MCofuranose 
(125)(2.17g, 79%), Sp (56MHz; pyridine) -76ppm (3F, s, C F j -Ar) . The solid was 
used immediately. 
V L B . 6 . C Attempted Reaction of (Diethoxvphosnhinvndif luoro-methvlene 
Lithium (96) and 1.2:5.6-Di-0-isonropvlidene-3-()-toltiene-o-sulphonvl-Q:-
D-allofuranose (124) 
The experimental procedure was followed as VI.B.4.a and tosylated diacetone-D-
glucose (124)(3.00g, 7.2mmol) dissolved in oxolane (4ml) was injected. 19p N M R 
showed no product. 
V L B . 6 . d Attempted Reaction of (Diethoxvphosphinvl)difluoro-methvlene 
L i t h i u m ( 9 6 ) and l , 2 ; 5 . ^ - D i - 0 - i s p p r p p yl i d g n g - 3 - 0 - t r i f l i g - « - D -
allofurano.se (125) 
The experimental procedure was followed as above except triflated diacetone-D-
glucose (125)(2.00g, 5.45mmol) dissolved in oxolane (4ml) was injected. ^9p N M R 
showed no product. 
V L B . 7 Reaction of (Diethoxvpho.sphinvl)difluoromethvlene Lithium (96) 
9n EpQxidg? 
V L B . V . a The Reaction of (Diethoxvphosphinvl)difluoromethvlene L i t h i u m 
(96) and Oxirane 
The experimental procedure was fol lowed as above except oxirane (1.69g, 
5.75mmol) was bubbled into the reaction mixture. The crude ^^F NMR showed a new 
product at -114.1ppm (dt, 2jpp=93, 3jpj^=i8_5Hz, CHCF2P) which could not be 
isolated.by flash silica chromatography, eluent dichloromethane-ethyl acetate (7:3), but 
assumed to be l - (d ie thoxyphosphinyl) - l , l -d i f luoropropan-3-ol (126)(42% by ^^F 
NMR, 56MHz). 
V L C . R^agtiQns Qf 3-[(Digth9XYphQ?phinvl)^lifluQrQm^thvlkYgl9hgx^ng 
11071 
V L C . l The Synthesis of l -r (Diethoxvphosphinvl )d i f luoromethvn-2 .3-
gp9xyQycl9hgx?ng (127) 
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V l . C . l . a The Reaction of Magnesium monoperoxvnhthalate and 3-
[(Diethoxvphosphinvndifluoromethvllcvclohexene (107) 
A flask was charged with 3-[(Diethoxyphosphinyl)difluoromethyl]cyclohexene 
(107)(2.08g, 7.8mmol) and magnesium monoperoxyphthalate (90%)(4.26g, 7.8mmol) 
and acetonitrile (20ml). The flask was stirred for 24h and examined by NMR. ^H NMR 
showed no reaction. 
V l . C . l . b T h £ React ion of C a l c i u m Q7(ych)9ri<ig msl h. 
[(Digth9XYph9Sphinvl)tiiflu9r9niethYl1tYgl9hgxgng (107) 
A flask was charged with 3-[(Diethoxyphosphinyl)difluoromethyl]cyclohexene 
(107)(1.01g, 3.8mmol) and calcium oxychloride (1.16g, S . l lmmol) and acetonitrile 
(20ml). The flask was stirred for 48h, and the contents then partitioned between 
chloroform (100ml) and water (40ml). The lower organic layer was retained, dried over 
magnesium sulphate, filtered and solvent removed under reduced pressure to yield l i 
[(diethoxyphosphinyl)difluoromethyll-2.3-epoxycyclohexene (127)(0.56g, 52.3%); 
[Found: C, 46.5; H , 6.8.(MH+285) C11H19F2O4P requires C, 46.5; H , 6.7%]; b.p. 
78°C/0.5mmHg; NMR spectrum 6; IR spectrum 5; mass spectrum 5. 
V L C . l . c The React ion of m - C h l o r o p e r b e n z o i c ^<^i^ an(l 3-
r(Diethoxvphosphinvl)difluoromethvllcvclohexene (107) 
A flask was charged with 3-[(Diethoxyphosphinyl)difluoromethyl]cyclohexene 
(107)(1.12g, 4.0mmol) and m-chloroperbenzoic acid (50-60%)(1.44g, 16.7mmol) and 
dichloromethane (20ml). The flask was stirred for 48h, and the contents then partitioned 
between chloroform (100ml), I M potassium hydroxide (40ml) and water (40ml). The 
lower organic layer was retained, dried over magnesium sulphate, filtered and solvent 
removed under reduced pressure to yield l-r(diethoxyphosphinyl)difluoromethvl1-2,3-
epoxvcvclohexene (127)(0.56g, 52.3%); (Found: C, 46.5; H , 6.8. C11H19F2O4P 
requires C, 46.5; H , 6.7%); b.p. 78°C/0.5mmHg; data as above. 
V L C . 2 The Reaction of P A S T and l - r ( D i e t h o x v p h o s p h i n v D -
difluoromethvll-2.3-epoxvcvclohexene (127) 
A flask was charged with DAST (lml)(1.26g, 7.82mmol) and heated with stirring 
to 55°C. l-[(diethoxyphosphinyl)difluoromethyl]-2,3-epoxycyclohexene (127)(2.02g, 
7.1 Immol) was added dropwise and the reaction left stirring for Ih . ^^p N M R showed 
none of the desired product. 
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V I . C . 3 Tl i£ Reaction af O s m i u m T e t r o x i d e and 3-
r(Diethoxyphosphinyl)difluoromethyllcvclohexene (107) 
A flask was charged with 3-[(Diethoxyphosphinyl)difluoromethyl]cyclohexene 
( I07 ) (2 .52g , 9.1mmol), A^-methylmorpholine-A^-oxide (2.03g, 18.2mmol), osmium 
tetroxide (2.5% w/v) (0.33ml)(8.3mg, 0.03mmol) and acetone-water (20ml) ( l : l ) . The 
flask was stirred for 48h, and examined by NMR. ^^F N M R showed no reaction. 
V I . C . 3 T h e R e a c t i o n of S i l v e r A c e t a t e / W a t e r and 2^ 
r(DigthQXYphQ§phinYl)difl»9rQmgthYlkYglphgxgng (107) 
A flask was charged with 3-[(Diethoxyphosphinyl)difluoromethyl]cyclohexene 
(107)(2.68g, lOmmol), silver nitrate (3.72g, 22mmol), iodine (2.52g, 9.9mmol) and 
glacial acetic acid (65ml). The flask was stirred for 4.5h, and then wet acetic acid , 
containing water 0.2ml ( l l m m o l ) was added and the mixture refluxed for Ih . After 
cooling the solids were filtered o f f and washed with glacial acetic acid (20ml). The 
washings were combined with the filtrate and evaporated under reduced pressure, diluted 
with water (20ml) and exffacted with diethyl ether (50ml). The organic layer was washed 
with ammonia solution (5ml) and then the solvent removed under reduced pressure. The 
residue was refluxed with concentrated hydrochloric acid (10ml) for I h , evaporated to 
dryness and finally extracted into chloroform and again evaporated to dryness. ^^F NMR 
showed no reaction. 
141 
C H A P T E R V I I 
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V I L A The Reaction of 3 - r ( D i e t h o x y p h o s p h i n y l ) d i f l u o r o m e t h y l l c y c l o -
hexene (107) and Selenium Dioxide 
A flask was charged with 3-[(diethoxyphosphinyl)difluoromethyl]cyclohexene 
(107)(2.398g, 8.59mmol), selenium dioxide (1.084g, 9.77mmol) and dioxane-acetic 
acid ( l l : l ) ( 1 2 0 m l ) . The mixture was heated under reflux for 17h, filtered through a 
celite plug and solvent removed in vacuo. The residue was partitioned between 
chloroform (100ml) and brine (30ml), and the organic phase then dried with magnesium 
sulphate. Af ter removal o f solvent the o i l was refluxed for 2h with 2 M H2SO4 (10ml) in 
acetonitrile (50ml), the solvent mixture remove in vacuo.and the crude reaction mixture 
run down a silica column with acetone-hexane (1:1) as the eluent to yield three fractions 
3-[(diethoxyphosphinyl)difluoromethyl]cyclohexene (107)(0.310g), a mixture of (107) 
and 6-r(diethoxyphosphinyl)difluoromethyl1cyclohexen-3-ol (141)(0.326g) and pure 61 
r(diethoxyphosphinyl)difluoromethyllcyclohexen-3-ol (141)(0.297g, 15.9%); a clear 
colourless o i l ; b.p. 1 8 7 ° C / 2 m m H g , [Found C, 46.4; H , 6.7. (M+-18, 276) 
C11H19F2O4P requires C, 46.5; H , 6 .7%]; N M R spectrum 7, IR spectrum 6, mass 
spectrum 6. 
V I L B Thg I^gactipn Qf 3 - f ( D i ^ t h p x y p h Q S p h i n Y O d i f l U p r p r n g t h Y l ] g Y g » P -
h^xen^ (107) and A^-BrprnQSuyginimidg 
A flask was charged with 3-[(diethoxyphosphinyl)difluoromethyl]cyclohexene 
(107)(9.497g, 35.4mmol), N-bromosuccinimide (6.305g, 35.4mmol), a catalytic 
amount o f A I B N and carbon tetrachloride (50ml). The mixture was heated under reflux 
until succinimide was seen floating on the surface of the solvent, filtered through a celite 
plug and solvent removed in vacuo. The residue was partitioned between chloroform 
(100ml) and brine (30ml), the organic phase then dried (magnesium sulphate). Removal 
of solvent, and silica gel chromatography with acetone-hexane (2:3) as the eluent yielded 
3-bromo-6-r(diethoxyphosphinyl)difluoromethyllcyclohexene (142)(9.520g, 77.5%); a 
clear colourless o i l ; b.p. 145°C/0.5mmHg; [Found C, 38.0; H, 5.2; Br, 23.0. (M+, 347) 
Ci iHi8BrF203P requires C, 38.1; H, 5.2; Br, 23.0%]; NMR spectrum 8; IR spectrum 
7; mass spectrum 7. 
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V I L C The Reaction of 3-hromo-6-r(diethoxvnhosnhinvl)difluoromethvll. 
cvclohexene (142) and 6-Chloropurine (144) 
A flask was charged with 3-bromo-6-[(diethoxyphosphinyl)difluoromethyl]-
cyclohexene (142)(5.41035g, 15.59mmol), 6-chloropurine (144 ) (2 .41248g, 
15.60mmol) and potassium carbonate (2.17143g, 15.60mmol) in dimethylformamide 
(DMF)(150ml) and stirred at room temperature for 12h. Solvent was removed under 
reduced pressure and the residue was partitioned between chloroform (100ml) and brine 
(30ml), the organic phase dried (magnesium sulphate). Removal of the solvent, and 
silica gel chromatography eluent ethyl acetate yielded a white solid 3-[A^9-(6-
chloropurinyl])l-6-[(diethoxyphosphinyl)difluoromethyncyclohexene as two seperable 
isomers, eluent hexane-ethyl acetate (2:3), (145a) and (145b)(2.443g, 46.1%); 
m . p . l 5 9 ° C , [Found C, 45.9; H , 4.9; CI, 8.4; N , 13.1. (MH+, 421) C16H20CIF2N4O3P 
requires C, 45.7; H , 4.8; CI, 8.4; N , 13.3%]; ?imax (CH3CN) 265nm (logioe 5.8); NMR 
spectrum 9; ER spectrum 8; mass spectrum 8. 
V I L D The Attempted Synthesis of 3 - r y V 9 - ( A d e n v l ) 1 - 6 - [ ( d i e t h o x v -
phQsphinyl)<liflu9r9mgthYl1cycl9hgxgng (147) 
V I I . D . l Thg R m t i 9 n 9f 9 - ( ^ - C h I p r g p u r i p y l ) ] [ ( < l i g t h g x y -
phosphinyDdifluoromethvllcvclohexene (145) and Sodium Azide 
A flask was charged with sodium azide (114.68mg, 1.76mmol) and 3-[A'9-(6-
chloropurinyl)]-6-[(diethoxyphosphinyl)difluoromethyl]cyclohexene (145)(471.02mg, 
1.12mmoI) in D M F (30ml) and heated at 70°C for 18h. The solution was extracted with 
chloroform (100ml), washed wi th water (2x50ml), and the organic phase dried 
(magnesium sulphate). The solvent was removed under reduced pressure and the crude 
oi l purified by silica gel chromatography with acetone-hexane-methanol (4:2:1) as the 
eluent to yield a white solid assumed to be the azide (0.396g, 82.8%). This was used 
immediately in the next stage. 
V I I . D . 2 The Reaction of 3 - f A ^ 9 - ( 6 - A z i d o p u r i n v l ) 1 - 6 - r ( d i e t h o x v -
phosphinvDdifluoromethvllcvclohexene and Triphenvlphosphine 
A mixture of 3-[/V9-(6-azidopurinyl)]-6-[(diethoxyphosphinyl)difluoromethyl]-
cyclohexene (222mg, 0.519mmol), and triphenylphosphine (238.72mg, 0.91 Immol) in 
dimethyl sulphoxide (30ml) were stirred for 5h. The solvent was removed under reduced 
pressure, the solid residue added to a mixture o f water (10ml) and 2 M hydrochloric acid 
(5ml) and stirred for 15h. A white precipitate, triphenylphosphine, was filtered of f and 
the solvent removed under reduced pressure.from the filtrate. The crude solid was 
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purified by silica gel chromatography with dichloromethane-methanol (5:1) as the eluent 
to yield an unidentified white solid 183.1 Img, which was not the desired product. 
V I I . D . 3 The Reaction of 3 - r A ^ 9 - ( 6 - C h l o r o p u r i n v m - 6 - r ( d i e t h o x v . 
phosphinyDdifluoromethyllcyclohexene (145) and Sodium Amide 
A flask was charged with sodium amide (4.2mg, O.lOSmmol) and 3-[A^9-(6-
chloropurinyl)]-6-[(diethoxyphosphinyl)difluoromethyl]cyclohexene (145)(44.7mg, 
0.106mmol) in anhydrous D M F (20ml), under nitrogen, and stirred for 18h. A TLC 
(silica)(eluent ethyl acetate) indicated no reaction. 
V I I . D . 4 Thg R m t i p n pf 3 - f A ^ 9 - f ^ - C h H ) r Q p H r i n y l ) 1 - ^ - r ( d i g t h Q X Y . 
DhosphinyDdifluoromethyncyclohexene (145) and Liquid Ammonia 
A quartz tube was charged wi th 3 - [ A ^ 9 - ( 6 - c h l o r o p u r i n y l ) ] - 6 -
([diethoxyphosphinyl)difluoromethyl]cyclohexene (145)(17.2mg, 0.041mmol) and 
liquid ammonia condensed into the tube, using vacuum line techniques. The tube was 
sealed and rocked for 18h. The tube was frozen, the top removed and then left to warm 
to room temperature. A silica T L C (eluent ethyl acetate) of the remaining white solid 
indicated no reaction. 
V I I . D . 5 The Reaction of 3 - r A ^ 9 - ( 6 - C h l o r o p u r i n y l ) 1 - 6 - r ( d i e t h o x y -
phosphinvDdif luoromethyl lcyclohexene (145) and Alcoholic Ammonia 
Solution 
A solution o f 3-[A'9-(6-chloropurinyl)]-6-[(diethoxyphosphinyl)difluoromethyl]-
cyclohexene (I45)(216.49mg, 0.5ISmmol) in fresh saturated methanolic ammonia 
solution (30ml) was heated in an autoclave tube for 6h at 100°C. Solvent was removed 
under reduced pressure and the crude residue purified by silica gel chromatagraphy with 
chloroform-methanol (5:1) as eluent to yield a white solid 3-(A^9-adenyl)-6-
[ (d ie thoxyphosphinyl )d i f luoromethyl lcyc lohexene (147)(2.31mg. 1.1%); NMR 
specffum 10; IR spectrum 9; mass spectrum 9. 
V I I . D . 6 The Reaction of 3 - f A ^ 9 - ( 6 - C h l o r o p u r i n y n i - 6 - f ( d i e t h o x v -
phosphinvl)difluoromethyllcvclohexene (145) and Silver (I) Fluoride 
A flask was charged with silver (I) fluoride (18.5mg, 0.146mmol) and 3-[A'9-(6-
chloropurinyl)]-6-[(diethoxyphosphinyI)difluoromethyl]cyclohexene (145)(39.4mg, 
0.094mmol) in toulene (20ml) and heated at reflux for 1.5h. A TLC (silica)(eluent ethyl 
acetate) indicated no reaction. 
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V I I . D . 7 The Reaction o f 3 - r / V 9 - ( 6 - C h l o r o p u r i n y l ) l - 6 - r ( d i e f h o x v -
phosph inyDdi f luo romethy l l cvc lohexene (145) and Silver ( I I ) Fhjoride 
A flask was charged with silver (II) fluoride (12.9mg, 0.089mmol) and 3-[A'9-(6-
chloropurinyl)]-6-[(diethoxyphosphinyl)difluoromethyl]cyclohexene (145)(37.2mg, 
0.089mmol) in chloroform (30ml) and heated at reflux for 8h. A T L C (silica)(eluent 
ethyl acetate) indicated a complex mixture. 
V I I . D . 8 The React ion o f 3 - r A ^ 9 - ( 6 - C h l o r o p u r i n y n i - 6 . r ( d i e t h o x y -
p h o s p h i n v D d i f l u o r o m e t h y l l c v c l o h e x e n e (145) and Aqueous A m m o n i a 
/DiQ^an S9»»ti9n 
A solution of 3-[A^9-(6-chIoropurinyl)]-6-[(diethoxyphosphinyl)difluoromethyl]-
cyclohexene (145)(5.410g, 15.6mmol) in dioxan-0.88 ammonia solution ( l : l ) (10ml ) 
was heated in a sealed tube for 12h at 100°C. The contents of the tube were frozen and 
the top removed, after thawing they were transfered to a flask; solvent was removed 
under reduced pressure and the residue chromatagraphed on silica gel with chloroform-
methanol (5:1) as eluent to y ie ld a whi te sol id 3 - ( N 9 - a d e n y l ) - 6 -
[(diethoxyphosphinyl)difluoromethyncyclohexene (147)(2.443g, 66.1%); m.p.234-
236°C, [Found C, 47.9; H, 5.4; N , 17.6. (M+, 401) C16H22F2N5O3P requires C, 47.9; 
H, 5.5; N , 17.45%]; Xmax (CH3OH) 262nm (logioe 4.7); N M R spectrum 10; IR 
spectrum 9; mass spectrum 9. 
V I L E The Reaction of 3 - ( A ^ 9 - A d e n y n - 6 - r ( d i e t h o x v o x y p h o s p h i n y l ) -
d i f luoromethyl lcvc lohexene (147) and T r i m e t h y l s i l y l Bromide 
A suspension of 3-(A^9-adenyI)-6-[(diethoxyphosphinyl)difluoromethyl]-
cyclohexene (147)(1.341g, 3.34mmol) in trimethylsilyl bromide (5.120g, 33.44mmol), 
under nitrogen, was stirred for 16h. The solvent was removed under reduced pressure 
and the crude solid material was added to 2 M hydrochloric acid (10ml) and stirred for a 
further 3h. Again the solvent was removed under reduced pressure and the residue 
chromatagraphed on C18 reverse phase silica gel, eluent water, to yield 3-(A^9-adenyl)-6-
[(dihydroxyphosphinyDdifluoromethyllcvclohexene (139)(0.843g, 73.2%); a white 
solid; m.p .254°C, [Found C, 41.7; H, 4 .1 ; N , 20.6. (M+, 345) C12H14F2N5O3P 
requires C, 41.7; H, 4.1; N , 20.3%]; Xmax (CH3OH) 262nm (logioe 5.3); NMR 
spectrum 11; IR spectrum 10; mass spectrum 10. 
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V I L E The Reaction of 3-hromo-6.r(diethoxvphosnhinvl)di f luoromethyl l -
cvclohexene (142) and 2-amino.6.chloropurine (148) 
A mixture of 3-bromo-6-[(diethoxyphosphinyl)difluoromethyl]cyclohexene ( 142 ) 
(1.514g, 4.4mmol), 2-amino-6-chloropurine (148)(0.753g,4.4mmol) and potassium 
carbonate (0.616g, 4.5mmol) in D M F (100ml) was stirred at room temperature for 12h. 
Solvent was removed under reduced pressure and the residue was partitioned between 
chloroform (100ml) and brine (30ml) and the organic phase dried (magnesium sulphate). 
Removal of the solvent, and silica gel chromatography with ethyl acetate as eluent yielded 
3-rA'^9-(2-amino-6-chloropurinyl)1-6-r(diethoxyphosphinyl)difluoromethyllcyclohexene 
( 1 4 9 ) as two inseperable isomers (0.428g, 30.6%); m .p . l 69°C , [Found C, 43.5; H , 
4.8; N , 15.7; CI , 8.0. (MH+, 436) C16H21CIF2N5O3P.O.25H2O requires C, 43.6; H , 
4.8; CI, 8.1; N , 15.9%]; W ( C H 3 C N ) 247, 306nm (logioe 6.1, 5.5); N M R spectrum 
12; IR spectrum 11; mass spectrum 11. 
V I I . G Thg Rmtipn pf 3-r(diethQ^Yph9SphinYl)difl»QrQniethyll-^-(/V?-
guanvDcvclohexene (149) and Aqueous Hydrochloric Acid 
A suspension of 3-[(diethoxyphosphinyl)difluoromethyl]-6-(A'9-guanyl)-
cyclohexene (149)(0.83g, 1.9mmol) in 2 M hydrochloric acid (10ml) and water (100ml) 
was heated at reflux for 3h. The solution was evaporated to dryness to leave an off-
white/yellow soUd. The crude material was purified by CI8 silica gel choromatography, 
eluent water, to yield 3 - r ( e t h o x y h y d r o x y p h o s p h i n y l ) d i f l u o r o m e t h y l ] - 6 - ( N 9 -
euanvDcvclohexene (151)(0.61g, 83.0%); a white solid; m.p.210-211°C, [Found C, 
42.9; H , 4.9; N , 17.9. (M+, 389) C 1 4 H 1 8 F 2 N 5 O 4 P requires C, 43.2; H , 4.7; N , 
18.0%]; ^max ( C H 3 O H ) 256nm (logioe 4.1); N M R spectrum 13; IR spectrum 12; mass 
spectrum 12. 
V I L H The Reaction of 3-r(ethoxyhydroxyphosphinyl)difluoromethvn-6-
(A^9-guanyl)cyclohexene (151) and Trimethylsilvl Bromide. 
A suspension of 3-[(ethoxyhydroxyphosphinyl)difluoromethyl]-6-(A'9-guanyl)-
cyclohexene. (151)(0.46g, 1.2mmol) in trimethylsilyl bromide (8.47g, 55.3mmol) was 
stirred for 16h. Solvent was removed under reduced pressure and the crude solid added 
to 2 M hydrochloric acid (10ml) and stirred for a further 3h. The solvent was removed 
under reduced pressure and the residue chromatagraphed on CI8 reverse phase silica gel, 
eluent water, to yield 3-[(dihydroxvphosphinyl)difluoromethyll-6-guanylcyclohexene 
(140)(0.38g, 87.7%); a white solid; m.p.245°C, [Found C, 39.9; H , 3.9; N , 19.1. 
(M+, 361) C12H14F2N5O4P requires C, 39.9; H , 3.9; N , 19.4%]; W (CH3OH) 
255nm (logioe 4.3); NMR spectrum 14; IR spectrum 13; mass spectrum 13. 
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V I I L A General Method to Charge a Carius Tube 
A Carius tube (60ml) was first charged with the liquid reagents and consequently 
degassed by the freeze-thaw method, three cycles, utilising vacuum line techniques and 
sealed in vacuo. 
V I L B Vtili?ins Qamma-ray Irra^liat'Qn 
V I I I . B . l The Reaction of (Diethoxyphosphinyl)bromodifluoromethane 
(94) an^ l Cycl9h?x^ng 
A Carius tube was charged with (diethoxyphosphinyl)bromodifluoromethane 
(94 ) (2 .37g , 8.8mmol) and an excess o f freshly disti l led cyclohexene (7.80g, 
95. Immol) . The tube was irradiated at a fixed distance from a ^Oco gamma-ray source, 
for a total of 9.3MRads, and the opened and the contents heated at 70°C for 4h under fu l l 
vacuum to remove any cyclohexene. The crude reaction mixture was then distilled in a 
Kugelrohr apparatus to yield l -bromo-2-[ (d ie thoxyphosphinyl )d i f luoromethyl ] -
cyclohexane (153)(0.34g, 41.2%); a clear colourless oi l ; b.p. 134°C/0.1mmHg; [Found 
C, 38.0; H , 5.9. (M+ 348/350) C i iH2o03BrF2P requires C, 37.8; H , 5.8%]; N M R 
s p e c t r u m 16; IR s p e c t r u m 15; mass spec t rum 15, and 
(diethoxyphosphinyl)difluoromethane (102)(0.21g, 44.4%); b.p. 88°C/12mmHg (lit 
b.p.85.6°C/12mniHg288); m/z ( E I + ) 187 (M+-1 , 100%). 
V I I L B . 2 The Synthesis of [Bis(trimethylsiloxy)phosphinyllbromo-
difluoromethane (155) 
A mixture of (diethoxyphosphinyl)bromodifluoromethane (94)(3.38g,12.7mmol) 
and trimethylsilyl bromide (5.00g, 32.7mmol) was stirred for 18h and then refluxed for 
30min, under nitrogen. The crude mixture was then distilled under vacuum to yield 
rbis(trimethylsiloxy)phosphinyl]bromodifluoromethane (155)(2.39g, 53.5%) as a clear 
colourless oi l ; b.p.61-63°C/0.4mmHg; N M R spectrum 15; IR spectrum 14. 
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VIII.B.3 The Synthesis of (DihvdroxvDhosDhinvnhromodifluoromethane 
(154) 
A flask was charged with [bis(trimethylsiloxy)phosphinyl]bromodifluoromethane 
(155)(2.39g, 6.8mmol) and water (40ml), then the mixture was stirred for 48h. The 
volatiles were removed under vacuum to afford a viscous liquid, which was left in a 
vacuum dessicator, over phosphorus pentoxide, until of constant mass, yielding 
(dihydroxyphosphinyDbromodifluoromethane (154)(1.15g. 78.8%); viscous liquid; 
(MH++NH3 229), NMR spectrum 16; IR spectrum 15; mass spectrum 14. 
VIII.B.4 The Rgagtign pf (Dihy<ir9XYph9§phinYl)l?r9mp(lifluQr9methane 
(154) and Cvclohexene 
A Carius tube was charged with (dihydroxyphosphinyl)bromodifluoromethane 
(154)(1.15g, 5.3mmol), an excess of freshly distilled cyclohexene (4.35g, 53.0mmol), 
2,2,2-trifluoroethanol (4ml). The tube was irradiated at a fixed distance from a ^^Co 
gamma-ray source, for a total of 9.3MRads, and then removed, opened and the contents 
heated at 70°C for 4h under fu l l vacuum to remove any cyclohexene and 2,2,2-
trifluoroethanol. The crude reaction mixture was purified by CI8 reverse phase 
chromatography, eluent water, to yield (dihydroxyphosphinyl)difluoromethane 
(157)(0.21g, 44.4%); ap (235MHz, CDCI3, CFCI3) -116.75 (2F, dd, 2jpF=112.5, 
2jpH=13.4Hz, PCF2H) and l-bromo-2-[(dihydroxyphosphinyl)difluororoethyl]-
cyclohexane (156)(0.34g, 41.2%); b.p. 145°C/0.05mmHg; [Found C, 28.1; H, 5.0 
(M++NH3 309/311) CiiH2o03BrF2P requires C, 28.7; H, 4.1%]; NMR spectrum 17; 
IR spectrum 16; mass spectrum 15. 
V I I I . C Utilising U,V, Irra^liatipn 
V I I I . C . l The Reaction of (DiethoxvDhosDhinvl)bromodifluoromethane 
(94) and Cvclohexene 
A Carius tube was charged with (diethoxyphosphinyl)bromodifluoromethane 
(94)(7.98g, 29.9mmol) and an excess of freshly distilled cyclohexene (8.1 Ig, 
98.9mmol). The tube was then irradiated at a fixed distance from a medium pressure 
mercury arc lamp for a total of 72h, opened and the contents heated at 70°C for 4h under 
ful l vacuum to remove any cyclohexene. The crude reaction mixture was then distilled 
under vacuum to yield l-bromo-2-r(diethoxvphosphinyl)difluoromethyl)cyclohexane 
(153)(2.28g, 35.8%); data as above, and (diethoxyphosphinyl)difluoromethane 
(102)(0.31g, 9.0%); data as section V I . B . l . 
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VIII .C.2 The Reaction of fDiethoxvnhosnhinvDbromodinuoromethane 
(94). Cvclohexene and Benzonhenone 
A Carius tube was charged with (diethoxyphosphinyl)bromodifluoromethane 
(94)(7.60g, 28.5mmol), an excess of freshly distilled cyclohexene (9.32g, 113.7mmol) 
and benzophenone (0.35g, 1.9mmol). It was then irradiated at a fixed distance from a 
medium pressure mercury arc lamp for a total of 72h, opened and the contents heated at 
70°C for 4h under fu l l vacuum to remove any cyclohexene. ^^F NMR revealed 
(diethoxyphosphinyl)bromodifluoromethane (94)(72.7% yield by integration), 1-bromo-
2-[(diethoxyphosphinyl)difluoromethyl)cyclohexane (153)(18.2% yield by integration) 
and (diethoxyphosphinyl)difluoromethane (102)(9.1% yield by integration). Al l 
chemical shifts were in agreement to authentic samples. 
VIII .C.3 The Synthesis of rDiethoxvnho.sphinvDdifluoroiodomethane 
a m 
Under a nitrogen atmosphere a mixture of (diethoxyphosphinyl)-
bromodifluoromethane (94)(23.67g, 88.7mmol), cadmium dust (9.97g, 88.7mmol) in 
DMF" (100ml) was for 18h. To this solution was then injected iodine (22.54g, 
88.7mmol) in DMF (40ml). The solution was left stirring for a further 24h. The crude 
mixture was distilled under vacuum to remove DMF and then extracted with ethoxyethane 
(2x50ml), saturated sodium metabisulphite (2xl00ml) and dried with magnesium 
sulphate. Vacuum distillation yielded (diethoxyphosphinyi)difluoroiodomethane 
(118)(12.09g, 43.4%) as a clear pale yellow oil; b.p.61-63°C/0.4mniHg; (Found C, 
19.1; H, 3.1. Calc for C11H20F2IPO3: C, 19.1; H, 3.2%); IR spectrum recorded; dn 
(250MHz, CDCI3, TMS) 1.45 (6H, t, 3JHH=7.2HZ, CH3), 4.33 (4H, dq, 3JHH=7.2HZ, 
C//2O); dp (235MHz, CDCI3, CFCI3) -60.63 (2F, d, 2jpF=93.1Hz, PCF2I); m/z (CI+) 
314 (MH++NH3, 98%), 284 (MH++NH3, 100%); as compared to literature data dp-
58.6ppm.i42 
VIII .C.4 The Reaction of (DiethoxvDhosnhinvl)difluoroiodomethane (118) 
and Cvclohexene 
A Carius tube' was charged with (diethoxyphosphinyl)difluoroiodomethane 
(118)(7.98g, 25.4mmol) and an excess of freshly distilled cyclohexene (8.11g, 
98.9mmol). It was then irradiated at a fixed distance from a medium pressure mercury 
arc lamp for a total of 72h, opened and the contents heated at 70°C for 4h under full 
vacuum to remove any cyclohexene. The crude reaction mixture was then Kugelrohr 
distilled under vacuum to yield l-[(diethoxyphosphinyl)difiuoromethyl]-2-
iodocyclohexane (159)(4.98g, 53.2%); b.p. 125°C/0.05mmHg; [Found C, 33.5; H, 
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5.1. (M+ 396) Calc for Ci 1H20F2IPO3: C, 33.35; H, 5.1%]; NMR spectrum 18; IR 
spectrum 17; mass spectrum 16 and (diethoxyphosphinyl)difluoromethane (102)(0.87g, 
19.6%); data as section VI .B . l . 
VIII .C .5 The Reaction of (DiethoxvDhosDhinvl)difluoroiodomethane M l 8 ) 
anq CYClQPgntgng 
A Carius tube was charged with (diethoxyphosphinyl)difluoroiodomethane (118) 
(7.97g, 25.4mmol) and an excess of freshly distilled cyclopentene (7.90g, 116.1mmol). 
It was irradiated at a fixed distance from a medium pressure mercury arc lamp for a total 
of 72h, opened and the contents heated at 70°C for 4h under full vacuum to remove any 
cyclopentene. The crude reaction mixture was then Kugelrohr distilled under vacuum to 
yield l-r(diethoxyphosphinyl)difluoromethvl1-2-iodocyclopentene (160)(2.30g, 33.9%); 
b.p. 120°C/0.05mmHg; [Found C, 31.4; H, 4.8. C10H18F2IPO3 requires C, 31.4; H, 
4.75%]; NMR spectrum 19; IR spectrum 18; mass spectrum 17. and 
(diethoxyphosphinyl)difluoromethane (102)(1.52g, 30.4%); b.p. 76°C/8mmHg (lit 
b.p.85.6°C/12mmHg288). 
VIII .C.6 Thg Reactipn pf (DiethQXYph9§phinvl)din»Qr9iQ(l9mgthane (118) 
and Cvcloheptene 
A 60ml Carius tube was charged with (diethoxyphosphinyl)difluoroiodomethane 
(118)(8.41g, 26.8mmol) and an excess of freshly distilled cycloheptene (8.40g, 
87.5mmol). It was then irradiated at a fixed distance from a medium pressure mercury 
arc lamp for a total of 72h, opened and the contents heated at 70°C for 4h under full 
vacuum to remove any cycloheptene. Then the crude reaction mixture was Kugelrohr 
distilled under vacuum to yield 1 -F(diethoxyphosphinyl)difluoromethyn-2-
iodocycioheptane (161)(6.33g, 67.0%); b.p. 125°C/0.05mmHg; [Found C, 35.1; H, 
5.6. (MH+411) C12H22F2IPO3 requires C, 35.1; H, 5.4%]; NMR spectrum 20; IR 
spectrum 19; mass spectrum 18; and (diethoxyphosphinyl)difluoromethane (102)(0.46g, 
10.5%); b.p. 75-77°C/8mmHg (lit b.p.85.6°C/12mmHg288). 
VIII .C.7 The Reaction of (Diethoxvphosphinvl)difluoroiodomethane (118) 
an l^ 2,3-Dihy^lr9furan 
A Carius tube was charged with (diethoxyphosphinyl)difluoroiodomethane 
(118)(3.27g, 10.4mmol) and an excess of 2,3-dihydrofuran (4.68g, 66.9mmol). It was 
irradiated at a fixed distance from a medium pressure mercury arc lamp for a total of 72h, 
then opened and the contents heated at 70°C for 4h under full vacuum to remove any 2,3-
dihydrofuran. ^^F NMR showed no evidence of reaction. 
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V I I I . C . 8 The Reaction of (Diethoxvphosnhinvndifluoroiodomethane n i 8 ) 
and 3.4-Dihvdrofuran 
A Carius tube was charged with (diethoxyphosphinyl)difluoroiodomethane (118) 
(7.67g, 24.4mmol) and an excess of 2,5-dihydrofuran (13.41g, 98.9mmol). It was 
irradiated at a fixed distance from a medium pressure mercury arc lamp for a total of 72h, 
and then opened and the contents heated at 70°C for 4h under full vacuum to remove any 
3,4-dihydrofuran. ^^p n m R showed a 4% conversion to the products 3-
r(diethoxyphosphinyl)difluoromethyl1-4-iodooxolane (163)(50% yield by integration) 
NMR spectrum 21; and (diethoxyphosphinyl)difluoromethane (102)(50% yield by 
integration) data section VI .B . l . 
V I I L C . 9 Thg Rgactipn pf (DigthQxyphQgphinyQ^lifluQroiQclQmgthan^ (118) 
and Furan 
A Carius tube was charged with (diethoxyphosphinyl)difluoroiodomethane 
(118)(7.63g, 24.3mmol) and an excess of furan (S.l lg, 119.3mmol). It was irradiated 
at a fixed distance from a medium pressure mercury arc lamp for a total of 72h, and then 
opened and the contents heated at 70°C for 4h under full vacuum to remove any furan. 
l^F NMR showed a 2% conversion to the products 3-r(diethoxyphosphinyl)difluoro-
methyl1-2.3-dihydro-2-iodooxolane or 2-r(diethoxyphosphinyl)difluoromethyn-2,3-
dihydro-3-iodooxolane (164)(50% yield by integration) NMR spectrum 22; and 
(diethoxyphosphinyl)difluoromethane (102)(50% yield by integration) data section 
V I . B . l . 
VIII .D S E T Reactions 
V I I I . D . l The Attempted Reaction of (Diethoxvphosphinvl)bromodifluoro-
m(;than^ (94) an l^ CvglQh^x^n^ Utilising Cppp^r Catalv§i$ 
A flask charged with (diethoxyphosphinyl)bromodifluoromethane (94)(2.46g, 
9.2mmol), cyclohexene (4.93g, 60.1mmol) and DMF (10ml) was stirred at 70°C for 
18h. 19p NMR of the crude mixture showed no evidence of reaction. 
VIII .D.2 The Attempted Reaction of (Diethoxvphosphinvi)bromodifluoro-
methane (94) and Cvclohexene utilising Samarium Diiodide 
Under a nitrogen atmosphere samarium diiodide-oxolane solution (2.5ml, O.IOM) 
was injected into a flask charged with (diethoxyphosphinyl)bromodifluoromethane 
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(94)(1.46g, 5.5mmol), cyclohexene (0.49g, 6.0mmol) and oxolane (6ml). The mixture 
was left stirring for Ih and then a further 24h, l^p NMR showed no evidence of reaction. 
VIII.D.3 The Attempted Reaction of (Diethoxvphosphinvl)difluoroiodo-
methane (118) and Cvclohexene utilising Samarium Diiodide 
Under a blanket of nitrogen, samarium diiodide-oxolane solution (0.5ml, O.IOM) 
was injected into a flask charged with (diethoxyphosphinyl)difluoroiodomethane 
(118)(0.28g, 0.9mmol), cyclohexene (O.lOg, 1.2mmol) and oxolane (6ml). The 
mixture was left stirring for Ih and then a further 48h, ^^F NMR showed no evidence of 
reaction. 
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C H A P T E R IX 
E X P E R I M E N T A L TO C H A P T E R V 
IX.A General Pr9Cgtl»re f9r thg Synthesis 9f Flu9nnate(l Fthers 
Free radical addition was initiated by gamma-ray irradiation (ca. 9.3MRads), 
achieved, by exposure at room temperature to a ^Oco source, housed in a purpose-built 
chamber. Al l addition reactions were carried out in glass Carius tubes of ca. 100ml. The 
liquid reagents were added to the tube and degassed. Gaseous reagents were vacuum 
transfered into the tube. Degassing was accomplished by three freeze thaw cycles. 
Normal vacuum line techniques were used for these procedures. The tube was sealed 
with the reactants frozen (liquid air) and under vacuum. 
IX.B Synthesis of Acvclic Fluoroethers 
I X . B . l Synthesis Qf MgthQxy-2,2,3.4.4,4-hexaflu9r9l?Utane (173)^^1 
A mixture of methoxymethane (13.1g, 0.285mol) and hexafluoropropene (HFP) 
(15.91g, 0.1 Imol) was irradiated at a fixed distance from a ^ Oco gamma source. After 4 
days (9MRads of radiation) the tube was removed and the excess ether was allowed to 
evaporate to leave a colourless liquid. Distillation gave l-methoxy-2,2,3,4,4,4-
hexafluorobutane (173)(16.0g, 75%); b.p. 87°C, (Found C, 30.5; H, 3.1. Calc. for 
C5H6F6O: C, 30.6; H, 3.1%); NMR spectrum 25;.m/z (EU) 196 (MH++NH3, 98%), 
284 (MH++NH3, 100%). 
IX.B.2 Synthesis of l-Methoxy-2.2.4.4.4-Dentafluorohutane (174) 
A mixture of methoxymethane (2.17g, 47.1mmol) and pentafluoropropene 
(5.30g, 40.0mmol) was irradiated at a fixed distance from a ^^Co gamma source. After 
4 days (9MRads of radiation) the tube was removed and the excess ether was allowed to 
evaporate to leave a colourless liquid. Distillation gave l-methoxy-2.2.4.4,4-
pentafluorobutane (174)(0.59g, 8.3% ); b.p. 75°C/51mmHg, [Found C, 33.7; H, 4.4 
(M+-1 177) C5H7F5O requires C, 33.7; H, 4.0%]; NMR spectrum 26; IR spectrum 22; 
mass spectrum 21. 
IX.B.3 Attempted Synthesis of l-Methoxy-4.4.4-trifluorobutane (175) 
A mixture of methoxymethane (3.50g, 76mmol) and trifluoropropene (3.15g, 
32.8mmol) was irradiated at a fixed distance from a ^OCo gamma source. After 4 days 
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(9MRads of radiation) the tube was removed and the excess ether was allowed to 
evaporate to leave a viscous colourless liquid which was not l-methoxy-4,4,4-
trifluorobutane but a high polymer (175)[Found C, 38.5; H, 3.5; F, 54.4%. (M+ >261) 
Empirical formula C14 3H15 5F12.8O]; NMR spectrum 27; IR spectrum 23; mass 
spectrum 22. 
IX.B.4 Competition Reactions 
IX.B.4 .a Cpmp^titign Q( 3i3i3-Triflu9roDr9pgng an0 Hg?^afl»9r9prQP^ng 
fQr MgthQXYmgthang 
A mixture of 3,3,3-trifluoropropene (3.41g, 35.5mmol), hexafluoropropene 
(5.35g, 35.7mmol) and methoxymethane (0.39g, 8.3mmol) was irradiated at a fixed 
distance from a ^^Co gamma source. After 4 days (9MRads of radiation) the tube was 
removed and the excess ether was allowed to evaporate to leave the viscous colourless 
liquid the polymeric 3,3,3-trifluoropropene adduct (175) as the only product verified by 
19f NMR. 
IX.B .4 .b CQmpgt i t iQn of l , l ,3 ,3,3-PgntaflU9r9pr9pgpg and 
Hexafluoropropene for Methoxvmethane 
A mixture of 1,1,3,3,3-pentafluoropropene (4.36g, 33.0mmol), 
hexafluoropropene (4.95g, 33.0mmol) and methoxymethane (0.3Ig, 6.6mmol).was 
irradiated at a fixed distance from a ^^Co gamma source. After 4 days (9MRads of 
radiation) the tube was removed and the excess ether was allowed to evaporate to leave 1-
methoxy-2,2,3,4,4,4-hexafluorobutane (173), verified by 
19f NMR. and gas 
chromatography. 
I X . B . 4 . C Competition of 3.3.3-Trifluoropropene and 1.1.3.3.3-Penta-
flt^QfQprQpgng fQr MgthQxymgthang 
A mixture of 3,3,3-trifluoropropene (2.96g, 30.8mmol), 1,1,3,3,3-
pentafluoropropene (4.08g, 30.9mmol) and methoxymethane (0.30g, 6.4mmol) was 
irradiated at a fixed distance from a ^^Co gamma source. After 4 days (9MRads of 
radiation) the tube was removed and the excess ether was allowed to evaporate to leave.he 
viscous colourless liquid the polymeric 3,3,3-trifluoropropene adduct (175) as the only 
product verified by ^^F NMR. 
I X . C Synthesis of Cyclic Fluoroethers 
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I X . C . l Synthesis of 2-n.l.2.3.3.3-Hexafluoropronynoxolane (176)^53 
A mixture of oxolane (9.04g, 0.126mol) and hexafluoropropene (13.52g, 
0.09mol) was irradiated at a fixed distance from a ^Oco gamma source. After 4 days 
(9MRads of radiation) the tube was removed and the excess ether was allowed to 
evaporate to leave a colourless liquid. Distillation gave 2-(l,1,2,3,3,3-
Hexafluoropropyl)oxolane (176)(12.0g, 80.7%); b.p. 45-48°C/20mmHg; (Found: C, 
37.5; H, 3.8. Calc. for CyHgFgO: C, 37.85; H, 3.6%); dn (400MHz, CDCI3, TMS) 1.9 
( IH , dt, 2JHH=20.0, % H = 5 . 6 H Z , ring CH), 2.0 ( I H , dt, 2JHH=20.0, 3JHH-5.6HZ, 
ring CH), 2.069 ( I H , dd, 2JHH=23.6, 3JHH=5.6HZ, ring CH), 2.174 ( I H , ddd, 
2JHH=13.6, 3JHH-13.2, 3JHH=5.6HZ, ring CH), 3.882 ( IH , d, 2JHH=6.9HZ, ring 
CH2O), 3.912 ( I H , d, 2JHH=6.9HZ, ring CH2O), 4.305 ( I H , dtt, 3JHH = 13.2, 
3JHF=12.8, 3JHF=4.4HZ, ring CHCF2), 5.082 ( I H , ddq, 2JHP=42.8, 3JHF=20.8, 
3JHF=6.4HZ, ring C//CF2); 9F (376MHz, CDCI3, CFCI3) -74.19 (3F, dddd, 
3JFH=22.2, 3JFF=10.5, 4JFF=6.4, 4JFF=0.8HZ, CF3), -120.10 (IF, ddqd, 2JFF=269.8, 
3JFF=9.0, 4JFF=9.0, 3JFF=4.5HZ, CF2), -124.26 (IF, ddqdd, 2JFF=269.8, 3JFF=12.5, 
4JFF=12.5, 3JFH=12.5, 3JFH = 12.5HZ, CF2), 213.29 (IF, ddqdd,2jFH=42.8, 
3JFF=14.3, 3JFF=10.5, 3JFF=10.5, 4JFH=3.8HZ, C F H ) ; m/z (EI+) 221 (M+-1, 0.7%), 
71 (M+-C3F6H, 100%). 
IX.C.2 Synthesis 9f 2.(l,1.3,3,3-P?ntafl»9r9Pr9PVl)9X9lane (177) 
A mixture of oxolane (23.06g, 0.320mol) and pentafluoropropene (16.12g, 
0.122mol) was irradiated at a fixed distance from a ^^Co gamma source. After 4 days 
(9MRads of radiation) the tube was removed and the excess ether was allowed to 
evaporate to leave a colourless liquid. Distillation gave 2-(1.1.3.3.3-pentafluoropropyl)-
oxolane (177)(18.61g. 75%); b.p. 52°C/21mmHg; [Found: C, 37.9; H, 3.6 (M+-1 203) 
C7H9F5O requires C, 37.85; H, 3.6%]; NMR spectrum 28; IR spectrum 24; mass 
spectrum 23. 
IX.C.3 Synthesis of 2-(2-Chloro-1.1.2-trifluoroethyl)oxolane (178)^^^ 
A mixture of oxolane (22.87g, 0.318mol) and chlorotrifluoroethene (17.69g, 
0.152mol) was irradiated at a fixed distance from a ^Oco gamma source. After 4 days 
(9MRads of radiation) the tube was removed and the excess ether was allowed to 
evaporate to leave a colourless liquid. Distillation gave 2-(2-chloro-1,1,2-trifluoro-
propyI)oxoIane (178)(11.74g, 41%); b.p. 81°C/49mmHg; [Found: C, 38.50; H, 3.78. 
Calc. for C6H8CIF3O: C, 37.85; H, 3.63%]; NMR spectrum 29; m/z (CI+) 191 (MH+, 
1.7%), 189 (MH+, 0.45%), 71 (M+-C2CIF3H). 
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IX.D HalQgenation of FInorinated Ethers 
I X . D . l Synthesis of 1-Chloromethoxv-2.2.3.4.4.4-hexafluorohutane 
0851269 
A mixture of compound (173)(4.67g, 23.9mmol), chlorine (1.65g, 23.2mmol) 
and carbon disulphide (20ml) was left in sunlight for 12h. The gaseous by-products 
were allowed to evaporate to leave a colourless liquid. Preparative gas chromatography 
gave l-chloromethoxy-2,2,3,4,4,4-hexafluorobutane (185)(2.60g, 47.2%); b.p. 
35°C/16mmHg; NMR spectrum 30; m/z (EI-i-) 195 (M+-C1, 40%), 49 (100%). 
IX.D.2 Synthesis of 2.Chloro-5-(1.1.2.3.3.3-hexafluoropronynoxoIane 
11861 
A mixture of compound (176)(5.32g, 24.0mmol), chlorine (1.65g, 23.2mmol) 
and carbon disulphide (20ml) was left in sunlight for 12h. The gaseous by-products 
were allowed to evaporate to leave a colourless liquid. Distillation gave 2-chloro-5-
(1.1.2.3.3.3-hexafluoropropvl)oxolane (186)(5.15g. 83.6%); b.p. 52-54°C/8mmHg; 
NMR spectrum 31; IR spectrum 25; mass spectrum 24; m/z (EI+) 223 (MH+-C1, 1.6%), 
71 (100%). 
IX.D.3 Synthesis of 2-Chloro-5-(1.1.3.3.3-pentafluoropropyl)oxoiane 
0871 
A mixture of compound (177) (3.19g, 15.6mmol), chlorine (1.65g, 23.2mmol) 
and carbon disulphide (20ml) was left in sunlight for 12h. The gaseous by-products 
were allowed to evaporate to leave a colourless liquid. Distillation gave 2-chloro-5-
(1.1.3.3.3-pentafluoropropvl)oxolane (187)(1.94g, 52.1%); b.p. 68-70°C/12mmHg; 
NMR spectrum 32; IR spectrum 26; mass spectrum 25; m/z (EI+) 203 (M+-C1, 100%). 
IX.D.4 Synthesis of 2-Chloro-5-(2-chloro-1.1.2-trifluoroethyl)oxQlane 
0881 
A mixture of compound (178) (4.67g, 23.9mmol), chlorine (1.65g, 23.2mmol) 
and carbon disulphide (20ml) was left in sunlight for 12h. The gaseous by-products 
were allowed to evaporate to leave a colourless liquid. Distillation gave 2-chloro-5-(2-
chloro-1.1.2-trifluoroethvl)oxolane (188)(3.32g, 62.3%); b.p. 76°C/13mmHg; NMR 
spectrum 33; IR spectrum 27; mass spectrum 26; m/z (El-t-) 257 (M+-1,100%). 
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IX.D.5 The Reaction of 2 -Chloro .5-r i .1.2.3.3.3-Hexafluoropronyn. 
oxolane (176) and Sodium Hydroxide 
A thick walled pyrex tube was charged with 2-chloro-5-(l,1,2,3,3,3-
hexafluoropropyl)oxolane (176)(910mg, 3.55mmol) and freshly powdered sodium 
hydroxide (142mg, 3.55mmol), then the tube sealed under vacuum. The tube was then 
heated to 80°C for 12h. The contents were frozen in liquid air and the tube opened, 
molecular distallation gave 2 - ( l . 1.2.3.3.3-hexafluoropropyl)-2.3-dihydrofuran 
(189)(0.41g, 52.8%); b.p. 45-47°C/5mmHg; NMR spectrum 33; IR spectrum 27; mass 
spectrum 26; m/z (EI+) 221 (MH+, 100%). 
IX .E .The Coupling of Nucleoside Bases to Polyfluorinated a-Haloethers 
I X . E . l gilylatipn qf Pyrimiding Bagg?^^^ 
I X . E . l . a Silyiatipn qf Uracil (190) 
A mixture of uracil (lO.OOg, 89.2mmol), hexamethyldisilylizane (50ml) and a 
catalytic amount of ammonium sulphate (40mg, 0.3mmol) were heated at 160°C for 18h. 
The excess hexamethyldisilylizane was then distilled off, in vacuo, to leave a colourless 
liquid 1,3-disilyloxypyrimidine (190). This was used without further purification. 
I X . E . l . b Silvlation of 5-Fluorouracil (191) 
A mixture of 5-fluorouracil (lO.Og, 76.9mmol), hexamethyldisilyUzane (50ml) 
and a catalytic amount of ammonium sulphate (40mg, 0.3mmol) were heated at 160°C for 
18h. The excess hexamethyldisilylizane was then distilled off, in vacuo, to leave a 
colourless liquid 5-fluoro-1,3-disilyloxypyrimidine (191). This was used without 
purification for further experiments. 
IX.E.2 General Procedure for Coupling of Pyrimidine Bases^ "^^  
A mixture containing a chlorinated polyfluoroether and a silylated base in dry 
acetonitrile (20ml) was cooled to -15°C. Trimethylsilyl triflate (1ml) was added dropwise 
and the reaction monitored by silica TLC with ethyl acetate as the eluent. On completion, 
the reaction was diluted with dichloromethane (100ml) and quenched with saturated 
sodium hydrogen carbonate (50ml) and dried over magnesium sulphate. Evaporation of 
solvent gave a white solid purified by flash silica gel chromatography with ethyl acetate as 
eluent. Al l yields are quoted as pure isolated products. 
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IX.E.2 .a Reaction of 2-Chloro-5-r2.chloro-1.1.2-trifliioroethvl)oxolane 
(188) and L3-Disilvloxvpyriniidine n90) 
Chlorinated polyfluoroether (188)(1.67g, 7.49mmol) and base (190)(3.63g, 
14.99mmol) gave 2-uradvl-5-(2-chloro-1.1.2-trifluoroethvl)oxolane (192)(1.06g. 
47.4%) as a white solid; m.p. 197-199°C; [Found: C, 40.2; H. 3.35; N, 9.4 (MH+, 299) 
C10H10CIF3N2O3 requires C, 40.2; H, 3.4; N, 9.4%]; X^ax (CH3CN) 258nm (logioe 
5.7); NMR spectrum 35; IR spectrum 29; mass spectrum 28. 
IX.E.2.b Reaction of 2-Chloro-S-(2-chloro-1.1.2.trifluoroethvl)oxolane 
(188) an<l 5-FI»9r9-l,3-<iisilYl9XYpYrimi(ling (191) 
Chlorinated polyfluoroether (188)(1.14g, 5.11mmol) and base (191)(2.60g, 
9.99mmol) gave 2-(5-fluorouradvl)-5-(2-chloro-1.1.2-trifluoroethvl)oxolane (193) 
(0.73g, 45.1%) as a white solid; m.p. 203°C; [Found: C, 39.7; H, 3.0; N, 8.9 (MH+, 
317) C10H9CIF4N2O3 requires C, 39.8; H, 3.0; N, 8.85%]; Xmax (CH3CN) 263nm 
(logioe 4.8); NMR spectrum 36; IR spectrum 30; mass spectrum 29. 
I X . E . 2 . C Reaction of 2-Chloro-5-(1.1.3.3.3-pentafluoropropyl)oxolane 
(187) and l,3-Disi»Yl9xypYrimi<line (190) 
Chlorinated polyfluoroether (187)(2.27g, 9.51mmol) and base (190)(4.66g, 
19.24mmol) gave 2-uradvl-5-(l.l,3.3.3-pentafluoropropyl)oxolane (194)(1.56g. 
52.2%) as a white solid; m.p. 212°C; [Found: C, 41.95;.H, 3.7; N, 8.9 (MH+, 315) 
C11H11F5N2O3 requires C, 42.05; H, 3.5; N, 8.9%]; X^ax (CH3CN) 256nm (logioe 
4.7); NMR spectrum 37; IR spectrum 31; mass spectrum 30. 
IX.E.2 .d Reaction of 2-Chloro-5-(1.1.3.3.3-pentafluoropropyl)oxolane 
(187) an^l g-FlM9'-9-l,3-<lisilY'9xypYrinii(iine (191) 
Chlorinated polyfluoroether (187)(1.64g, 6.87mmol) and base (191)(3.32g, 
12.76mmol) gave 2-(5-f]uorouradyl)-5-(1.1.3.3.3-pentafluoropropyl)oxolane (195) 
(1.12g, 49.1%) as a white solid; m.p.223-224°C; [Found: C, 39.8; H, 3.05; N, 8.4 
(MH+, 333) C11H10F6N2O3 requires C, 39.8; H, 3.0; N, 8.4%]; X^ax (CH3CN) 
263nm (logioe 5.5); NMR spectrum 38; IR spectrum 32; mass spectrum 31. 
IX.E.2.e Reaction of 2.Chloro-5-(1.1.2.3.3.3-hexafluoropropyl)oxolane 
(186) and 1.3-Disilyloxypvrimidine (190) 
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Chlorinated polyfluoroether (186)(0.93g, 3.62mmol) and base (190)(1.34g, 
5.53mmol) gave 2-uradvl-5-(1.1.2.3.3.3-hexafluoropropvnoxolane ('196V0.87g. 
72.3%) as a white solid; m.p. 233-235°C; [Found: C, 39.5; H, 3.2; N, 8.4 (MH+, 333) 
C11H10F6N2O3 requires C, 39.8; H, 3.0; N, 8.4%]; Xrmx (CH3CN) 255nm (logioe 
4.3); NMR spectrum 39; IR spectrum 33; mass spectrum 32. 
lx .E .2 . f Reaction of ?-Chlor9-5-f l .L2,3.3J-he?caflu9r9propYi)Q^Qiang 
(186) anq g-F|tfQr9-l,3-tfisilYlQXYPyrimi(lipe (191) 
Chlorinated polyfluoroether (186)(0.95g, 3.70mmol) and base (191)(1.92g, 
7.38mmol) gave 2-(5-fluorouradyl)-5-(l,1.2,3,3.3-hexafluoropropyl)oxolane 
(197)(0.82g, 63.3%) as a white soUd; m.p. 242°C; [Found: C, 37.7; H, 2.58; N, 7.2 
(MH+, 351) CnH9F7N203 requires C, 37.7; H, 2.6; N, 7.1%]; X^ax (CH3CN) 262nm 
(logioe 5.2); NMR spectrum 40; IR spectrum 34; mass spectrum 33. 
IX.E.2.g Reaction of l-Chloromethoxy-2.2.3.4.4.4-hexafluorobutane 
(185) and 1.3-Disilyloxypyrimidine (190) 
Chlorinated polyfluoroether (185)(1.63g, 7.07mmol) and base (190)(3.39g, 
14.00mmol) gave l-uradvlmethoxv-2.2.3.4.4.4-hexafluorobutane (198)(0.72g, 33.3%) 
as a white solid; m.p. 187°C; [Found: C, 35.3; H, 2.6; N, 9.15 (MH+, 307) 
C9H8F6N2O3 requires C, 35.3; H, 2.6; N 9.3%]; X^ax (CH3OH) 257nm (logioe 5.1); 
NMR spectrum 41; IR spectrum 35; mass spectrum 34. 
IX.E.2 .h R^actipn 9f l-Chl9r9meth9xy-2,2,3,4,4,4-hexaflp9r9l?titan^ 
(185) and 5-FJuoro-1.3-disilyloxvpvrimidine (191) 
Chlorinated polyfluoroether (185)(I .16g, 5.03mmol) and base (191)(2.63g, 
lO.l lmmol) gave 1 -(5-fluorouradyl)methoxy-2.2,3.4.4.4-hexafluorobutane (199) 
(0.41g, 25.1%) as a white solid; m.p. 192°C; [Found: C, 33.4; H, 2.2; N, 8.6 (MH+, 
325) C9H7F7N2O3 requires C, 33.35; H, 2.2; N, 8.6%]; X^ax (CH3OH) 265nm 
(logioe 4.9); NMR spectrum 42; IR spectrum 36; mass spectrum 35. 
IX .E .3 Reaction of 2-Chloro-5-(1.1.2.3.3.3-hexafluoropropvl)oxolane 
(186) and 1.3-Disilvloxypvrimidine (190) with Tin (IV) Chloride 
To a stirred solution of chlorinated polyfluoroether (186)(0.95g, 3.70mmol) and 
base (190)(1.34g, 5.53mmol) in dry dichloromethane (20ml), tin (IV) chloride 
(7.45mmol) was added. The reaction was stirred for 6 h at -15°C, and then poured on to 
saturated aqueous sodium hydrogen carbonate. The aqueous layer was extracted with 
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dichloromethane (3x150ml) and the extracts dried, magnesium sulphate. Evaporation of 
the solvent and flash column chromatography (eluent ethyl acetate) gave 2-uradyl-5-
(l,l,2,3,3,3-hexafluoropropyl)oxolane (196)(0.83g, 67.8%) as a white solid; data as 
IX.E.2.e. 
IX.E.4 General Procedure for Coupling Purine Bases 
A mixture containing a chlorinated polyfluoroether, a protected purine base and 
potassium carbonate in dry DMF (100ml) was stiired for 18h. The solvent was then 
removed in vacuo, and the oil was diluted with dichloromethane (100ml) and washed 
with saturated sodium chloride (50ml) and dried over magnesium sulphate. Evaporation 
of solvent gave a white solid purified by flash silica gel chromatography with ethyl acetate 
as eluent. Al l yields are quoted as pure isolated products. 
IX.E.4 .a Rgact'pn of l-Chloromethoxv-2.2.3.4.4.4-hexafluorobutane 
(185) and 2-Amino-6-chloropurine (144) 
Chlorinated polyfluoroether (185)(1.37g, 5.94mmol), base (148)(1.01g, 
5.95mmol) and potassium carbonate (0.92g, 5.90mmol) gave 1-(2-amino-6-
chloropurinyl)methoxy-2.2.3.4.4.4-hexafluorobutane (205)(147.0mg, 6.8%) as a white 
solid; m.p.l76°C; [Found: C, 33.3; H, 2.2; N, 19.3 (MH+, 364) CiQHgClFgNsO 
requires C, 33.0; H, 2.2; N, 19.25%]; Xmax (CH3OH) 250, 310nm (logioe 5.8, 4.1); 
NMR spectrum 43; IR spectrum 37; mass spectrum 36. 
IX.E.4.b Reaction of 2-Chloro-5-(1.1.2.3.3.3-hexafluoropropyl)oxolane 
(186) ana ^-Chlprppuring (144) 
Chlorinated polyfluoroether (186)(2.82g, 10.95mmol), base (144)(1.96g, 
12.68mmol) and potassium carbonate (1.98g, 12.69mmol) gave 2-(6-chloropurinvl)-5-
(1.1.2.3.3.3-hexafluoropropvl)oxolane (206)(0.94g. 22.9%) as a white solid; 
m.p.244°C; [Found: C, 38.5; H, 2.4; N, 9.7 (M+, 374) C12H9CIF5N4O requires C, 
38.5; H, 2.4; N, 9.5%]; Xmax (CH3OH) 262nm (logioe 4.1); NMR spectrum 44; IR 
spectrum 38; mass spectrum 37. 
I X . E . 4 . C Reaction of 2-Chloro-5-(1.1.2.3.3.3-hexanuoropropyl)oxolane 
(186) and 2-Amino-6-chloropurine (148) 
Chlorinated polyfluoroether (186)(0.81g, 3.16mmol), base (148)(1.01g, 
5.95mmol) and potassium carbonate (0.97g, 6.22mmol) gave 2-(2-amino6-
chloropurinvl)-5-(l.1.2.3.3.3-hexafluoropropvl)oxolane (207)(0.14g. 11.4%) as a 
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white solid; m.p. 258°C; [Found: C, 37.0; H, 2.8; N, 9.2 (MH+, 390) 
C12H10CIF6N5O requires C. 37.0; H, 2.6; N, 9.0%]; Xmax (CH3OH) 250, 307nm 
(logioe 5.8, 4.1); NMR spectrum 45; IR spectrum 39; mass spectrum 38. 
IX .E .4.d RmtiQn 9f 2.Chl9r9-5-f ia .3i3,3-pentafl»9r9pr9PYl)QX9lan^ 
(187) and d-Chloropurine (144) 
Chlorinated polyfluoroether (187)(3.19g, 13.37mmol), base (144)(2.03g, 
13.13mmol) and potassium carbonate (2.1 Ig, 13.53mmol) gave 2-(6-chloropurinyl)-5-
(1.1.3.3.3-pentafluoropropvl)oxolane (208)(0.81g. 17.0%) as a white solid; 
m.p.254°C; [Found: C, 40.4; H, 2.8; N, 9.9 (MH+, 357) C12H10CIF5N4O requires C, 
40.4; H, 2.8; N,9.9%]; X^ax (CH3OH) 262nm (logioe 4.1); NMR spectrum 46; IR 
spectrum 40; mass spectrum 39. 
IX.E.4.e Reaction of 2-Chloro.5-(2-chloro-1.1.2-trifluoroethyl)oxolane 
(188) and 6-Chloropurine n44) 
Chlorinated polyfluoroether (188)(1.94g, 8.70mmol), base (144)(1.92g, 
12.42mmol) and potassium carbonate (1.94g, 12.4mmol) gave 2-(6-chloropurinyl)-5-(2-
chloro-1.1.2.-trifluoroethvl)oxolane (209)(0.92g, 31.0%) as a white solid; m.p. 237°C 
[Found: C, 38.5; H, 2.8; N, 20.9 (M+, 341) C11H9CI2F3N4O requires C, 38.7; H, 2.7 
N, 20.8%]; ^max (CH3CN) 262nm (logioe 4.7); NMR spectrum 47; IR spectrum 41 
mass spectrum 40. 
IX.E.5 Depr9tmi9n 9f 2-Amin9-^-chl9r9pyrinvl Dgriyative? 
IX.E.5.a T9 2-(ia,2,3.3,3-HgxaflU9r9Prppvl)-g-(guanYl)9X9lane (210) 
A suspension of 2-(2-amino-6-chloropurinyl)-5-( l ,1 ,2,3,3,3-
hexafluoropropyl)oxolane (207)(0.11g, 0.28mmol) in 2M hydrochloric acid (10ml) and 
water (100ml) was heated at reflux for 3h. The solution was evaporated to dryness to 
leave an off-white/yellow solid. The crude material was purified by silica gel 
choromatography, eluent chloroform-methanol (5:1), to yield 2-(l,1,2.3.3.3-
hexafluoropropyl)-5-(guanyl)oxolane (210)(66.9mg, 64.4%); a white solid; m.p.210-
211°C, [Found C, 38.9; H, 3.0; N, 18.8 (MH+, 372) C12H11F6N5O2 requires C, 38.8; 
H, 3.0; N, 18.9%]; ?imax (CH3OH) 256nm (logioe 4.1); NMR spectrum 48; IR 
spectrum 42; mass spectrum 41. 
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IX.E.S.b To l-Guanylmethoxy-2.2.3.4.4.4.hexafhiorobiitane (211) 
1- (6-chloropurinyl)methoxy-2,2,3,4,4,4-hexafluorobutane (205)(45.6mg, 
0.13mmol) gave l-guanylmethoxy-2.2.3.4.4.4-hexafluorobutane (211)(36.6mg. 
82.0%); a white solid; m.p.210-211°C, [Found C, 35.35; H, 2.8; N, 20.3 (MH+, 344) 
C10H10F6N6O requires C, 35.0; H, 2.6; N, 20.4%]; Xmax (CH3OH) 255nm (logioe 
4.4); NMR spectrum 49; IR spectrum 43; mass spectrum 42. 
IX.E.6 General Method for the Denrotection of 2-(6-Ch»oropurinyl)-5-
P9lYflU9r9alkY»gthgrs 
A solution of the 6-chloropurinyIpoIyfluoroaIk;ylether in fresh saturated 
methanolic ammonia solution (30ml) was heated in an autoclave tube for 6h at 100°C. 
Solvent was removed under reduced pressure and the crude residue purified by silica gel 
chromatagraphy with chloroform-methanol (5:1) as eluent to yield a white solid Al l 
yields are quoted as pure isolated products. 
IX.E.6.a T9 2-Atignyl-5-(l,l,2,3,3,3-hgxaf|u9r9pr9PYl)9X9lan? (212) 
2- (6-chloropurinyl)-5-(2,2,3,4,4,4-hexafluoropropyl)oxolane (206)(90.1mg, 
0.24mmol) gave 2-adenyl-5-(2.2.3.4.4.4-hexafluoropropyl)oxolane (212)(72.5mg, 
85%); a white solid; m.p.210-211°C, [Found C, 40.9; H, 3.1; N, 20.0 (MH+, 356) 
C 1 2 H 1 1 F 6 N 5 O requires C, 40.6; H, 3.1; N, 19.7%]; ^max ( C H 3 O H ) 263nm (logioe 
4.6); NMR spectrum 50; IR spectrum 44; mass spectrum 43. 
IX.E.6.b T9 2-A(lgnYi-5-(l,l,3,3,3-P^ntan»9r9pr9PYl)QX9lang (213) 
2-(6-chloropurinyl)-5-(l,l,3,3,3-pentafluoropropyl)oxolane (208)(60.2mg, 
0.17mmol) gave 2-adenyl-5-(1.1.3.3.3-pentafluoropropyl)oxolane (213)(45.8mg. 
79.9%); a white solid; m.p.210-211°C, [Found C, 42.4; H, 3.4; N, 20.8 (MH+, 338) 
C12H12F5N5O requires C, 42.7; H, 3.6; N, 20.8%]; ^max (CH3OH) 262nm (logioe 
4.8); NMR spectrum 51; IR spectrum 44; mass spectrum 43. 
I X . E . 6 . C To 2-Adenyl-5-(2-chloro-1.1.2-trifluoroethyl)oxo!ane (214) 
2-(6-chloropurinyl)-5-(2-chloro-l,l,2,-trifluoroethyl)oxolane (209)(89.5mg, 
0.26mmol) gave 2-adenyl-5-(2-chloro-1.1.2.-trifluoroethyl)oxolane (214)(75.8mg, 
90.6%); a white solid; m.p.21G-211°C, [Found C, 41.5; H, 3.5; N, 22.0 (MH+, 322) 
C11H11CIF3N5O requires C, 41.1; H, 3.45; N , 21.8%]; W (CH3OH) 262nm (logioe 
4.8); NMR spectrum 52; IR spectrum 45; mass spectrum 44. 
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I X . F The Direct FInorination of l.furadyn-4-(1.1.1.3.3-pentafluoro-
propyDoxolane (194) 
Into a solution of l-(uradyl)-4-(l,l,l,3,3-pentafluoropropyl)oxolane 
(194)(320mg, 0.91mmol) in trifluoroacetic acid (20ml) was bubbled fluorine-nitrogen 
(l:19)(482mg, 12.6mmol), then nitrogen gas to purge the solution. The mixture was 
then extracted with chloroform {50ml), 2M sodium hydroxide (5x50ml) and water 
(100ml). The solvent was removed in vacuo, to leave a white solid. Silica gel 
chromatography with ethyl acetate as the eluent gave l-(5-fluoro-5.6-dihvdro-6-hydroxy-
uradvl)-4-( 1.1.1.3.3-pentafluoropropvl)oxolane (202)(254mg, 79.7%); a white solid; 
m.p.240°C, [Found C, 37.9; H, 3.5; N, 7.6 (MH+, 351) C11H12F6N2O4 requires C, 
37.7; H, 3.5; N, 7.1%]; Xmax ( C H 3 O H ) 226nm (logioe 3.6); NMR spectrum 53; IR 
spectrum 46; mass spectrum 45 
I X . F . l Th^ D^hy^lratipn 9f l-(g-fl»9r9-5,<i-<lihY<lr9-^-hy^lr9xy-
uradvl)-4-(1.1.1.3.3-pentafluoronropynoxolane (202) 
1 -(5-fluoro-5,6-dihydro-6-hydroxy-uradyl)-4-( 1,1,1,3,3-pentafluoropropyl)oxolane 
(202)(200mg, 0.57mmol) was heated under dynamic vacuum at 60°C/0.07mmHg for 30 
mins. The solid was then run down a silica gel column with ethyl acetate as eluent and 
gave 2-(5-fluorouradvl)-5-(1.1.3.3.3-pentafluoropropvl)oxolane (195)(178mg, 49.0%) 
as a white solid; m.p.223-224°C; [Found: C, 39.4; H, 3.2; N, 8.3. C 1 1 H 1 0 F 6 N 2 O 3 
requires C, 39.8; H, 3.0; N, 8.4%]; data as section IX.E.2.d. 
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Appendix One 
IDNMRData 
No. 1 3-(DiethoxyphosphinyI)difluoromethyIcyclopentene (106) 
No. 2 3-(Diethoxyphosphinyl)difluoromethylcyclohexene (107) 
No. 3 3-(Diethoxyphosphinyl)difluoromethylcycloheptene (108) 
No. 4 (Diethoxyphosphinyl)difluorodeuteromethane (119) 
No. 5 l-Metiiyl-(diethoxyphosphinyl)-2,2-difluoroethylbenzene (120) 
No. 6 l-(Diethoxyphosphinyl)difluoromethyl-2,3-epoxycyclohexene (127) 
No. 7 3-(Diethoxyphosphinyl)difluoromethyIcycIohexen-6-ol (141) 
No. 8 3-Bromo-6-(diethoxyphosphinyl)difluoromethylcyclohexene (142) 
No. 9 3-[/V9-(6-chloropurinyl)]-6-(diethoxyphosphinyl)difluoromethyl-
cyclohexene (145) 
No. 10 3-(A^9-Adenyl)-6-(diethoxyphosphinyl)difluoromethyl-
cyclohexene (147) 
No. 11 3-(A'9-Adenyl)-6-(dihydroxyphosphinyl)difluoromethyl-
cyclohexene (139) 
No. 12 3-[A'9-(2-amino-6-chIoropurinyl)]-6-(diedioxyphosphinyl)difluoro-
methylcyclohexene (149) 
No. 13 3-(Etiioxyhydroxyphosphinyl)difluoromethyl-6-(A^9-guanyl)-
cyclohexene (151) 
No. 14 3-(iV9-Guanyl)-6-(dihydroxyoxyphosphinyl)difluoromethyl-
cyclohexene (140) 
No. 15 l-Bromo-2-(diethoxyphosphinyl)difluoromethylcyclohexane (153) 
No. 16 [Bis(trimethylsiloxy)phosphinyl]bromodifluoromethane (155) 
No. 17 (Dihydroxyphosphinyl)bromodifluoromethane (154) 
No. 18 l-Bromo-2-(dihydroxyphosphinyl)difIuoromethylcyclohexane (156) 
No. 19 l-(Diethoxyphosphinyl)difluoromethyl-2-iodocyclohexane (159) 
No. 20 l-(Diethoxyphosphinyl)difluoromethyl-2-iodocyclopentane (160) 
No. 21 l-(Diethoxyphosphinyl)difluorometiiyl-2-iodocycloheptane (161) 
No. 22 3-[(Diethoxyphosphinyl)difluoromethyl]-4-iodooxolane (163) 
No. 23 3-[(Diethoxyphosphinyl)difluoromethyl]-4,5-dihydro-2-iodooxolane or 
2-[(diethoxyphosphinyl)difluoromethyl]-4,5-dihydro-3-iodooxolane (164) 
No. 24 Methoxy-2,2,3,4,4,4-hexafluorobutane (173) 
No. 25 Methoxy-2,2,4,4,4-pentafluorobutane (174) 
No. 26 Oligmers based on methoxy-4,4,4-trifluorobutane (175) 
No. 27 2-(l,l,3,3,3-Pentafluoropropyl)oxoIane (177) 
No. 28 2-(2-Chloro-l,l,2-trifluoroethyl)oxolane (178) 
No. 29 Chloromethoxy-2,2,3,4,4,4-hexafluorobutane (185) 
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No. 30 2-Chloro-5-(l,l,2,3,3,3-hexafluoropropyl)oxolane (186) 
No. 31 2-Chloro-5-(l,l,3,3,3-pentafluoropropyI)oxolane (187) 
No. 32 2-Chloro-5-(2-chIoro-l,l,2-trifluoroethyl)oxolane(188) 
No. 33 2-(l,l,2,3,3,3-hexafluoropropyl)-4,5-dihydrofuran (189) 
No. 34 2-(2-Chloro-l,l,2-trifluoroethyl)-5-uradyloxolane (192) 
No. 35 2-(2-Chloro-l,l,2-trifluoroethyl)-5-(5-fIuoro_uradyl)oxolane (193) 
No. 36 2-(l,l,3,3,3-Pentafluoropropyl)-5-uradyloxolane (194) 
No. 37 2-(l,l,3,3,3-Pentafluoropropyl)-5-(5-fluorouradyl)oxolane (195) 
No. 38. 2-(l,l,2,3,3,3-HexafluoropropyI)-5-uradyloxoIane (196) 
No. 39 2-(l,l,2,3,3,3-Hexafluoropropyl)-5-(5-fluorouradyl)oxolane (197) 
No. 40 Uradylmethoxy-2,2,3,4,4,4-hexafluorobutane (198) 
No. 41 5-Fluorouradylmethoxy-2,2,3,4,4,4-hexafluorobutane (199) 
No. 42 2-Amino-6-chloropurinylmethoxy^2,2,3,4,4,4-hexafluorobutane (205) 
No. 43 2-(6-Chloropurinyl)-5-(l,l,2,3.3,3-hexafluoropropyl)oxolane (206) 
No. 44 2-(2-Aniino-6-chloropurinyl)-5-(l,l,2,3,3,3-hexafluoropropyl)-
oxolane (207) 
No. 45 2-(6-Chloropurinyl)-5-(l,l,3,3,3-pentafluoropropyl)oxolane (208) 
No. 46 2-(2-Chloro-l,l,2-trifluoroethyl)-5-(6-chloropurinyl)oxolane (209) 
No. 47 Guanylmethoxy-l,l,2,3,3,3-hexafluorobutane (210) 
No. 48 2-(l,l,2,3,3,3-Hexafluoropropyl)-5-guanyloxolane (211) 
No. 49 2-Adenyl-5-(l,l,2,3,3,3-hexafluoropropyl)oxolane (212) 
No. 50 2-Adenyl-5-(l,l,3,3,3-pentafluoropropyl)oxolane (213) 
No. 51 2-Adenyl-5-(2-chloro-l,l,2-trifluoroethyl)oxolane (214) 
No. 52 2-(l,l,3,3,3-Pentafluoropropyl)-5-(5-fluoro-5,6-dihydro-6-
hydroxyuradyl)oxoIane (202) 
165 _ 
All spectra were run in d -chloroform unless otherwise stated. 
Chemical shifts are quoted in ppm relative to an internal tetramethylsilane 
reference (^ H and ^^c spectra) or an external trichiorofluoromethane reference (^ ^F 
spectra) with downfield shifts positive. 
For an AB system , chemical shifts are quoted as the 'centre of gravity,' 
calculated from: 
5 l - 5 3 = < 5 2 - ( 5 4 = V ( A v 2 + / 2 ) 
Where dn is the chemical shift of the nth peak, Dn is the difference in chemical shifts 
between the two resonances of the nucleii and / is the coupling constant. 
The following abrieviations are used: 
s = singlet 
d = doublet 
t = triplet 
q = quanet 
m = mulriplet 
Al l ^^C nmr and ^ip nmr spectra are recorded broad band proton decoupled. 
The following spectra were run in d6-dimethylsulphoxide 10,11, 13,14 and 47 
to 51, while de-acetone was used to run spectra 34 to 41. 
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No.l 3-(Diethoxyphosphinyl')difluoromethvlcvclopentene (106) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.415 t 3JHH=7.1 6 a 
2.084 t 2JHH=9.5 2 i 
d 3JHH=3.2 
t 3JHH=2.1 
2.408 AB 2JHH=12.6 2 h 
d 3JHH=3.2 
t 3JHH=1.3 
3.435 m 1 e 
4.299 d 3JHP=7.3 4 b 
q (5 lines) 3JHH=7.3 
5.764 m 1 f 
6.064 m 1 g 
31p 
6.824 t 2jpp=113.5 1 c 
-115.104 AB 2JFF=301.3 1 d 
d 2JFP= 113.2 
d 3JFH=17.4 
-115.586 AB 2JFF=301.3 1 d 
d 2JFP= 113.2 
d 3JFH=17.4 
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No.2 3-(Diethoxyphosphinyndifluoromethylcyclohexene (107) 
ChemicaJ 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.384 t 3JHH=6.8 6 a 
1.544 d 3JHH=7.2 I ''axial 
d 3JHH=2.8 
1.702 d 3JHH=12.8 1 jaxial 
d 3JHH=12.4 
d 2JHH=12.4 
d 3JHH=2.8 
1.850 m I •axial 
1.971 m 1 Jequa tonal 
2.017 to m 2 h.'equatorial 
2.039 
2.913 I 3JHF=18.8 1 e 
d 3JHH=12.4 
d 3JHH=6.4 
d 3JHH=3.2 
4.273 d 3JHP=6.8 4 b 
q(5 lines) 3JHH=6.8 
5.779 AB 3JHH=9.8 1 g 
5.946 AB 3JHH=9.8 1 f 
~13c 
16.293 d 3JCP=14.8 a 
20.978 t 3JcF=4.5 j 
d 3jcp=2.2 
21.925 s i 
24.680 s h 
40.834 t 2jcF=19.1 e 
d 2jcp=15.3 
64.373 d 2jcp=I5.3 b 
d '^JCF=6.8 
121.442 I 1JCF=264.0 d 
d lJCP=211.7 
121.470 t 3JCF=5.7 f 
d 3jcp=4.2 
131.575 s g 
3Jp 
6.733 t 2jpF= 109.3 1 c 
19f 
-113.274 AB 2JFP=300.0 1 d 
d 2 J F P = 110.5 
d 3JFH=16.1 
-115.547 AB 2JFF=300.0 1 d 
d 2 J F P = 109.2 
d 3JFH=18.6 
168 
No.3 3-(Diethoxyphosphinyl)difluoromethylcycloheptene (108) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1 . 3 9 9 
1 .251 to 
1 .900 
2 . 0 0 0 to 
2 . 2 6 0 
3 . 0 5 1 
4 . 2 5 8 
5 . 9 0 0 to 
6 . 0 1 0 
31p 
19p 
1 6 . 2 9 3 
2 5 . 7 8 2 
2 6 . 0 4 2 
2 8 . 0 7 4 
3 0 . 3 5 1 
4 5 . 3 0 3 
6 4 . 3 0 3 
1 2 1 . 5 1 8 
1 2 7 . 7 9 1 
1 3 3 . 6 5 8 
6 . 9 3 4 
- 1 0 9 . 0 4 0 
- 1 0 9 . 3 8 0 
t 
m 
m 
t 
d 
d 
d 
q (5 lines) 
m 
d 
t 
d 
s 
s 
s 
t 
d 
d 
d 
t 
d 
t 
d 
s 
AB 
d 
d 
AB 
d 
d 
3 J H H = 7 . 1 
3 J H F = 2 0 . 3 
3 J H H = 1 3 . 5 
3 J H P = 1 3 . 5 
3 J H P = 7 . 2 
3 J H H = 7 . 2 
3JCP=5.2 
3JcF=4.1 
3jcp=2.2 
2JCF=18.6 
2jcp=14.5 
2jcp=12.5 
'•JCF=6.2 
1JCF=263.1 
1JCP=210.3 
3jcF=6.2 
3 J C P = 3 . 2 
2jpF= 110.5 
2 J F F = 2 9 8 . 4 
2 J F P = 1 1 1 . 0 
3 J F H = 1 7 . 7 
2 J F F = 2 9 8 . 4 
2 J F P = 1 1 1 . 8 
3 J F H = 2 1 . 4 
6 
4 
4 
I 
4 
2 
h, ij .kaxial 
h.ijjcgqua tonal 
b 
f.g 
a 
k 
j 
h 
e 
b 
d 
f 
g 
169 
No.4 (DiethoxyphosphinyPdifluorodeuteromethane (119) 
(CH3CH20)2P(0)CF2D 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.399 
4.367 
19f 
-135.141 
t 
d 
q (5 lines) 
d 
d 
3JHP=7-2 
3JHH=7.2 
2JFP=80.00 
3JFD=6.59 
6 
4 
a 
b 
No.5 1-Methvl-fdiethoxvphosphinvndifluoroethvlbenzene (120) 
OCH2CH3 
CXJHXHa 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
31p 
I9p 
1.095 
1.234 
1.479 
3.468 
4.367 
4.367 
7.163 to 
7.389 
6.859 
-113.663 
-115.463 
t 
t 
d 
m 
d 
q (5 lines) 
d 
q (5 lines) 
m 
t 
AB 
d 
d 
AB 
d 
d 
3JHH=7.3 
^JHH=7.3 
3JHH=7.2 
3JHH=7.3 
3JHP=7.3 
3JHH=7.3 
2jpF= 106.5 
2JFF=299.4 
2JFP= 109.9 
3JFH=16.0 
2JFF=299.4 
2JFP=106.1 
3JFH=19.5 
a w e 
e (va 
h 
g 
borf 
forb 
ij.k.l.m 
170 
No.6 l-fDiethoxvphosphinvndifluoromethvl-2.3-epoxvcvclohexene (127) 
F 
o 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
1.325 t 3JHH=7.2 6 a 
1.199 to m 1 h or iaxial 
1.288 
1.401 to m 4 h or iaxial 
1.500 
1.651 m 1 ^equatorial 
1.737 m 1 Jaxial 
2.053 m 1 Jequatorial 
2.501 t 3JHF=19.2 1 e 
d 3JHP=17.2 
d 3JHH=6.0 
d 3JHH=6.0 
f 3.135 d 3JHH=4.0 1 
t 3JHF=1.6 
3.357 d 3JHH=4.0 1 g 
4.228 
m 
d 3JHP=7.2 
4 b 
q (5 lines) 3JHH=7.2 
16.413 d 3jcp=5.7 a 
16.518 s i 
20.471 I 3jcF=4.9 j 
d 3jcP=l-9 
24.233 s h 
40.709 t 2JCF=19.1 e 
d 2jcp=14.5 
f 50.241 t 3JCF=8.3 
d 3JcP=5.3 
64.636 d 2jcp=l3.3 b 
d 4jcF=6.8 
120.983 t 1JCF=263.5 d 
d 1JCP=211.7 
3Ip 
6.910 t 2jpF= 109.8 1 c 
I9f 
-113.389 A B 2JFF=306.0 1 d 
d 2 J F P = 108.3 
d 3JFH=18.1 
-117.193 A B 2JFF=306.0 1 d 
d 2JFP=110.4 
d 3JFH=14.1 
171 
Nn.7 3-(Diethoxvphosphinvndifluoroinethvl-cvclobp.xp.n-6-ol (141) 
F 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1 3 3 1 t 3JHH=7 .2 
1.500 to m 
2.320 
3.012 m 
4 2 3 2 d 3JHP=7.2 
q (5 lines) 3JHH=7.2 
4 .422 br m 
5.744 A B 3JHH=11-3 
5.828 A B 3JHH=9.5 
6 
4 
1 
4 
2 
2 
2 
a 
j . k 
e 
b 
h.i 
g 
f 
m 
172 
No.8 3-Bromo-6-(die<lioxvphosphiiivndinuororoelhvlcvclohexene major knmfir n42^ 
Br 
a 1 O 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
1.398 t 3JHH=7.0 6 a 
1.928 to m 2 laxial> Jaxial 
2.041 
2.071 to m 2 lequatorial. 
Jequatorial 
3.020 m 1 e 
4.295 d 3JHP=7.3 4 b 
q (5 lines) 3JHH=7.3 
4.496 br m 1 h 
5.942 N& 3JHH=10.4 1 g 
6.122 AB 3JHH=10.4 1 f 
t 3JHF=3.7 
16.434 d 3JCP=5.2 a 
19.879 m j 
31.090 s i 
41.240 t 2jcF=20.7 e 
d 2jcp=15.5 
46.160 s h 
64.650 d 3jcp=11.4 b 
d 3JCF=7.3 
118.312 t lJCF=271.2 d 
d 1JCP=203.4 
f 125.012 t 3JcF=7.2 
d 3jcp=4.2 
131.819 s g 
31p 
6.518 t 2jpF= 109.2 1 c 
19F 
-114.625 AB 2JFF=302.5 1 d 
d 2JFP=109.2 
d 3JFH=12.9 
-116.087 AB 2JFF=302.5 1 d 
d 2JFP=104.5 
d 3JFH=18.6 
173 
No.8 3-Bromo-6-(diethoxyphosphinyl)difluoromethylcyclohexene minor i.somer (142) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.398 t 3JHH=7.0 6 a 
1.928 to m 2 laxiah Jaxial 
2.041 
2.071 to m 2 •equatorial! 
Jequatorial 
3.020 m 1 e 
4.295 d 3JHP=7.3 4 b 
q (5 lines) 3JHH=7.3 
4.765 br m 1 h 
5.942 AB 3JHH=10.4 1 g 
d 3JHH=3.4 
6.122 AB 3JHH=10.4 1 f 
t 3JHH=3.1 
3lp 
6.538 t 2jpF=89.2 1 c 
19p 
-113.963 AB 2JFF=302.8 1 d 
d 2JFP=87.3 
d 3JFH=19.1 
-114.795 AB 2JFF=302.8 1 d 
d 2JFP=87.3 
d 3JFH=16.9 
174 
Nn.9 3-r/V9-f6-chloroDurinvm-6-(diethoxvphosphinvl)difluoromethvl-
ryr.lnhp.vpnp.fi 45b) 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
1.429 t 
d 
d 
3JHH=6.8 
3JHP=2.4 
3JHF=0.4 
6 a 
1.923 d 
d 
d 
d 
2JHH=13.6 
3JHH=13.6 
3JHH=9.6 
3JHH=2.8 
1 Oaxial 
2.044 d 
d 
d 
d 
2JHH=12.8 
3JHH=12.8 
3JHH=10.8 
3JHH=2.4 
1 "axial 
2.227 m 1 ^equatorial 
2.497 m 1 "equatorial 
3.197 m 1 e 
4.295 d 
q (5 lines) 
3JHP=6.8 
3JHH=6.8 
4 b 
5.430 br m 1 h 
6.043 AB 3JHH=10.4 1 f 
6.349 AB 3JHH=10.4 1 g 
8.170 s 1 m 
8.767 s 1 j 
16.408 d 3JCP=5.2 a 
20.526 m 0 
29.342 s n 
40.527 I 
d 
2jcF=20.7 
2jcp=15.6 
e 
51.177 s h 
64.768 d 
d 
3jcp=13.5 
3JCF=6 .2 
b 
120.751 t 1JCF=284.4 d 
d ljcp=227.1 
f 128.463 m 
128.722 s g 
143.299 s i 
143.819 s k 
151.168 s m 
151.413 s j 
1 151.902 s 
175 
31p 
19p 
5 .876 t 2jpF= = 107.9 1 c 
114.280 AB 2JFF= =301.8 1 d 
d 2JFP= =107.6 
d 3JFH= = 15.8 
115.507 AB 2JFF- 301.8 1 d 
d 2JFP= 105.7 
d 3JFH= =17.3 
176 
No.9 3-[A/9-(6-chloropurinvl)]-6-(diethoxvphosphinyl)difluoromethvl-
cvclnhexene (145a) 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
1.403 t 3JHH=7.2 6 a 
d 3JHP=1.6 
d 3JHF=0.4 
1.770 d 2JHH=14.0 1 Oaxial 
d 3JHH=14.0 
d 3JHH=12.0 
d 3JHH=3.6 
2.013 m 1 laxial 
2.120 m 1 Oequatorial 
2.175 m 1 lequatorial 
3.082 m 1 e 
4.317 d 3JHP=7.2 4 b 
q (5 lines) 3JHH=7.2 
5.430 br m 1 h 
6.135 AB 3JHH=10.4 1 f 
d 3JHH=2.8 
6.349 AB 3JHH=10.0 1 g 
8.319 s 1 m 
8.767 s 1 j 
16.439 d 3JCP=5.3 a 
17.041 m 0 
27.373 s n 
40.931 t 2JCF=20.2 e 
d 2jcp=15.7 
48.393 s h 
64.885 d 3jcp=14.5 b 
d 3JCF=6.8 
120.678 t 1JCF=264.4 d 
d lJCP=211.3 
126.121 s g 
130.657 t 
A 
3JcF=8.8 f 
132.155 
U 
s k 
144.770 s i 
151.070 s m 
151.760 s j 
151.764 s 1 
31p 
177 
6.045 t 2jpp= 106.1 1 c 
19p 
-111.419 AB 2jpp=297.6 1 d 
d 2jpp=112.5 
-113.152 AB 2jpp=297.6 1 d 
d 2jpp=ni.6 
178 
No. 10 3-W9-Adenvn-6-rdiethoxvphosphinvl)difluoromethvlcvclohexene (147) 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/D.D.m. Constant/Hz 
1.317 t 3JHH=7.0 6 a 
1.883 m 2 O.Paxial 
2.080 m 1 0 or Pequatorial 
2.348 m 1 0 or Pequatorial 
3.097 m 1 e 
4.228 d 
q (5 lines) 
3JHP=7.3 
3JHH=7.3 
4 b 
5.179 m 1 h 
5.944 AB 3JHH=10.5 1 f 
6.181 AB 3JHH=10.5 1 g 
6.308 br s(D20 ex) 2 1 
7.753 s 0.5 j or n 
7.688 s 0.5 j or n 
8.184 s 1 j or n 
31p 
6.319 t 2jpF= 109.3 1 c 
19p 
-115.114 AB 
d 
2JFF=309.7 
2JFP= 107.3 
1 d 
-116.639 AB 
d 
2JFF=309.7 
2JFP=107.3 
1 d 
179 
No.10 3-W9-Adenvn-6-(diethoxvphosphinvndifluoromethYlf'vHr>heYPnp (147') 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.328 t 3JHH=6.8 6 a 
1.699 m 1 0 or Paxial 
1.883 m 1 0 or Paxial 
2.080 m 2 0. Pequatorial 
3.097 m 1 e 
4.240 d 3JHP=6.5 4 b 
q (5 lines) 3JHH=6.5 
5.179 m 1 h 
6.023 AB 3JHH=9.6 1 f 
6.283 AB 3JHH=9.6 1 g 
6.308 br s(D20 ex) 2 1 
7.821 s 0.5 j or n 
7.894 s 0.5 j or n 
8.314 s 1 j orn 
31 p 
6.319 t 2jpF= 112.3 1 c 
-112.658 AB 2JFF=302.2 1 d 
d 2JFP= 112.5 
-116.639 AB 2JFF=302.2 1 d 
d 2JFP=112.5 
180 
No. 11 S-fA^g-AdenyD-e-fdihydroxyoxvphosphinvDdifluoromethylcvclohexene 
m i l 
NH2 
J 
•N. 
f e 
Fv . a 
, . b / ( O H ) 2 
II 
0 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
" ^ r r 
1.739 m 1 n or Oaxial 
1.910 d 2JHH=11.6 1 n or Oaxial 
d 3JHH=11.6 
d 3JHH=1.9 
2.050 m 1 n or Oequatorial 
2.170 m 1 n or Oequatorial 
2.975 m 1 d 
3.671 br s(D20 ex) 2 a 
5.099 m 
3JHH=10.4 
1 g 
5.778 AB 1 e 
6.249 AB 3JHH=10.0 1 f 
6.870 br s(D20 ex) 2 k 
7.959 s 0.5 1 or n 
8.001 s 0.5 1 or n 
8.026 s 1 1 or n 
31p 
1.446 t 2jpF=90.2 1 b 
-114.679 AB 2JFF=281.4 1 c 
d 2JFP=87.3 
d 3JFH=17.7 
-115.878 AB 2JFF=281.4 1 c 
d 2JFP=87.7 
d 3JFH=16.2 
181 
No. 11 3-(A^9-Adenyl)-6-(dihydroxyoxvphosphinyl)difluoromethylcyclohexene (139) 
N 
0 Fv ; a 
b ^ ( 0 H ) 2 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
1.739 
1.910 
31p 
19p 
2.050 
2.170 
2.975 
3.671 
5.044 
5.953 
6.408 
6.870 
7.878 
8.043 
8.094 
1.446 
-110.710 
-112.967 
m 
d 
d 
d 
m 
m 
m 
br s(D20 ex) 
m 
AB 
m 
AB 
br s(D20 ex) 
s 
s 
s 
t 
AB 
d 
AB 
d 
2JHH=11.6 
3JHH=11.6 
3JHH=1.9 
3JHH=10.4 
3JHH=10.4 
2jpF=90.2 
2JFF=276.9 
2JFP=92.6 
2JFF=277.7 
2JFP=92.6 
1 
1 
1 
2 
1 
1 
1 
2 
1 
0.5 
0.5 
1 
1 
1 
n or Oaxial 
n or Oaxial 
n or Oequatorial 
n or Oequatorial 
d 
a 
g 
e 
f 
k 
i or m 
i or m 
i or m 
/ 
182 
No. 12 3-rA^9-(2-amino-6-chloropurinvl)1-6-(diethoxyphosphinyl)difluorotnethvl-
cyclohexene ( W ) 
H , N ^ i ^ N ' ' i ^ N 
Chemical 
Shifl/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.392 t 3JHH=7.2 6 a 
1.819 m 1 Oaxial 
2.018 m 1 Paxial 
2.157 m 1 0 or Pequatorial 
2.425 m 1 0 or Pequatorial 
3.241 m 1 e 
4.312 d 3JHP=7.2 4 b 
q (5 lines) 3JHH=7.2 
5.169 m 1 h 
5.332 br s(D20 ex) 2 k 
5.987 AB 3JHH=10.1 1 f 
6.281 AB 3JHH=10.1 1 g 
7.792 s 1 n 
16.362 d 3JcP=5.2 a 
20.495 m P 
29.067 s 0 
40.612 t 2JCF=20.7 e 
d 2JCP=15.5 
50.230 s h 
64.764 d 3jcp=13.5 b 
d 3JcF=6.2 
122.000 t 1JCF=288.2 d 
d lJCP=237.3 
f 126.614 m 
129.318 s g 
140.259 s n 
140.776 s m 
151.260 s i 
153.369 s j 
158.976 s 1 
31p 
3.524 t 2jpF=94.3 1 c 
19f 
-114.693 AB 2JFF=245.2 1 d 
d 2JFP=93.4 
d 3JFH=16.2 
-115.083 AB 2JFF=314.7 1 d 
d 2JFP=91.8 
183 
d - 3JFH=16.0 
184 
No. 12 3-rA^9-(2-amino-6-chloropurinvl)1-6-(diethoxvphosphinvl)difluoromethvl-
cyclohexene (149) 
CI 
X 
H 2 N ' j N-i 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.402 t 3JHH=7.2 6 a 
1.819 m 1 Oaxial 
2.018 m 1 Paxial 
2.157 m 1 0 or Pequatorial 
2.425 m 1 0 or Pequatorial 
3.307 m 1 e 
4.312 d 3JHP=7.2 4 b 
q (5 lines) 3JHH=7.2 
5.100 m 1 h 
5.332 br s(D20 ex) 2 k 
6.075 AB 3JHH=12.15 1 f 
6.430 
m 
AB 3JHH=10.1 1 g 
7.920 s 1 n 
15.219 m a 
17.027 m P 
27.142 s 0 
40.550 t 2JCF=20.7 e 
d 2jcp=15.5 
47.647 s h 
64.764 d 3jcp=13.5 b 
d 3JcF=6.2 
122.000 t ^JCF=288.2 d 
d lJcp=237.3 
127.605 m f 
129.807 s g 
140.776 s m 
141.695 s n 
151.260 s i 
153.201 s j 
158.976 s 1 
Sip 
3.310 t 2jpF=92.4 1 c 
19p 
-115.669 AB 2JFF=291.1 1 d 
d 2JFP=92.7 
d 3JFH=16.5 
-117.060 AB 2JFF=291.1 1 d 
185 
2JFP=93.0 
3JFH=17.7 
186 
N o . n 3-rEthoxvhvdroxvphosphinvl')difluoromethvl-6-(/V 9-guanvncvcIohp-xp,np. (151) 
4 O II 
d \ OH 
c 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
iH 
1.562 t 
2.126 m 
2.344 m 
2.370 m 
2.584 m 
3.419 m 
4 .312 d 
q (5 lines) 
4 .820 br s ( D 2 0 ex) 
5.360 m 
6.285 AB 
6.689 AB 
7.635 br s ( D 2 0 ex) 
9 .105 s 
9.868 br s ( D 2 0 ex) 
3JHH=7.2 
3JHP=7.2 
3JHH=7.2 
3JHH=10.0 
3JHH=10.2 
a 
laxial 
Taxial 
q or requatorial 
q or requatorial 
f 
b 
c 
i 
g 
h 
1 
P 
m 
31p 
19p 
4.562 
-110.684 
-114.773 
I 
AB 
d 
AB 
d 
2JFP=92.4 
2JFF=305.9 
2JFP=93.7 
- J F F = 3 0 5 . 9 
-JFP=90 .0 
187 
No.l3 3-(Ethoxvhvdroxvphosphinvl)difluoromethvl-6-fN9-guanvl)cvclohexene(15i) 
m 
HN 
O 
^ C F 2 - P -
* e d^oH 
b a 
OCH2CH3 
Chemical 
Shift/p.p.m. 
Multiplicity 
1.535 
2 .126 
2 .344 
2 .370 
2.584 
3 .419 
4 .312 
4 . 8 2 0 
5 .430 
6 .382 
6 .689 
7 .635 
9.048 
9 .752 
t 
m 
m 
m 
m 
m 
d 
q (5 lines) 
br s ( D 2 0 ex) 
m 
m 
AB 
br s ( D 2 0 ex) 
s 
br s ( D 2 0 ex) 
Coupling 
Constant/Hz 
Relative Intensity Assignment 
^JHH=6.8 
3JHP=7.2 
^JHH=7.2 
3JHH=10.2 
qaxial 
faxial 
q or requatorial 
q or requatorial 
f 
b 
c 
i 
g 
h 
1 
P 
m 
31p 
19p 
4 .526 
-111 .282 
-111.818 
t 
AB 
d 
AB 
d 
2JFP=92.4 
2JFF=235.3 
2JFP=93.7 
2JFF=229.9 
2JFP=93.7 
188 
No.l4 3-W9-Guanvl)-6-("dihvdroxvoxvphosphinvndifluoromethvlcvclnhexene (140) 
b ^ ( O H ) 
c 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
1.755 
1.915 
2 .029 
2 .225 
3 .055 
4.441 
5.042 
5.866 
6.189 
7.219 
8.783 
11.623 
m 
m 
m 
m 
m 
brs 
m 
AB 
AB 
brs 
s 
br s 
3JHH=10.0 
3JHH=10.8 
0 or Paxial 
P or Oaxial 
Pequatorial 
Oequatorial 
d 
a (D2O ex) 
g 
e 
f 
m (D2O ex) 
n 
k (D2O ex) 
31p 
1.441 -JFP=90.2 
19p 
•113.441 
-114.835 
AB 
d 
d 
AB 
d 
d 
2JFF=288.5 
-JFP=93.3 
3JFH=16.6 
-JFF=287.8 
-JFP=92.9 
3JFH=17.3 
189 
No. 14 3-(/V9-GuanvD-6-(dihvdroxvoxvphosphinvl)difluoromethvlcvclohexene (140) 
P Fv / a 
b / ( O H ) 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
1.755 m 1 0 or Paxial 
1.915 m 1 P or Oaxial 
2.029 m 1 Pequaiorial 
2.225 m 1 Oequaiorial 
2.900 m 1 d 
4.441 br s 2 a (D2O ex) 
4.988 m 1 g 
5.940 .AB 3JHH=10.8 1 e 
6.331 
m 
AB 3JHH=10.4 1 
f 
7.281 br s 2 m (D2O ex) 
8.793 s 1 n 
11.733 br s 1 k (D2O ex) 
31p 
1.437 t -JFP=90.2 b 
19p 
-109.674 A B 2JFF=287.1 1 c 
d 2JFP=91.4 
d 3JFH=16.6 
-110.725 A B 2JFF=287.8 1 c 
d 2JFP=90.3 
d 3JFH=14.3 
190 
No. 15 1 -Bromo-2-fdiethoxvphosphinvl)difluoromethylcvclohexane (153) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.416 
1.519 to 
2.269 
3.221 
4.364 
4.639 
m 
m 
m 
m 
m 
a 
g.h. ij 
e 
b 
f 
31p 
6.334 2jpF=110.0 
19p 
-104.453 
-106.657 
-113.777 
-115.149 
AB 
d 
d 
AB 
d 
d 
AB 
d 
d 
AB 
d 
d 
2JFF=302.2 
2JFP=110.7 
3 J F H - 2 6 . 4 
2JFF=302.0 
2JFP=110.7 
3JFH=21.6 
2JFF=300.0 
2JFP=110.0 
3JFH=19.8 
2JFF=304.1 
2JFP=110.1 
3JFH=21.6 
191 
No. 16 rBis(trimethylsilyloxy)phosphinynbromodifluoromethane (155) 
a b 
[ (CH3)3SiO]2P (0 )CF2Br 
Chemical Multiplicity Coupling Relativelnlensity Assignment 
Shift/p.p.m. Constant/Hz 
hi 
0.17 s 9 a 
19p 
-57.45 d 2jpp=g7o 
No. 17 (Dihvdroxyphosphinvl)bromodifluoromethane (154) 
(HO)2P(0)CF2Br 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
4.74 b r s ( D 2 0 e x ) 2 a 
19p 
-62.261 d 2jpp=95.] 2 c 
192 
No. 18 l-Bromo-2-('dihydroxyphosphinyl)difluoromethylcyclohexane (156) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.251 to 
2.183 
3.392 
4.746 
m 
m 
m 
f.g.h.i 
31p 
J9p 
1.003 
116.746 
2jpF=111.8 
d 2jpp= 112.5 
d 3jp^:,13 4 
193 
No.19 1 -[(diethoxyphosphinyl)difluoroinethyl1-2-iodocyclohexane (159) 
31p 
19p 
11 V 
Chemical Multiplicity Coupling Relaiivelntensily Assignment 
Shift/p.p.m. Constant/Hz 
1.404 m -6 a 
1.806 to m 8 g.h.i.j 
2.322 
3.101 m 1 e 
4.323 m 4 b 
5.085 m 1 f 
6.564 t 2jpp=io8.7 
-104.261 AB 2jpp=303.8 
d 2jpp^]09.9 
d 3jpj^=113 
-106.335 AB 2jpp=3oi.o 
d 2jpp= 106.1 
d 3jpj^=]9] 
-113.527 AB 2jpp^304 5 
d 2jpp^j09.8 
d 3jpj^=196 
-115.475 AB 2jpp=305.3 
d 2jpp= 102.9 
194 
No. 20 l-("Diethoxyphosphiny])difluoromethyl-2-iodocyclopentane (160) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
hi 
1.347 
1.520 to 
2.238 
3.010 
4.119 
4.574 
t 
m 
m 
d 
q(5 lines) 
m 
3JHH=7.0 
3JHP=7.0 
3JHH=7.0 
6 
6 
1 
4 
a 
g.h,i 
e 
b 
3Ip 
6.338 2jpF= 108.5 
19p 
-118.066 
-121.804 
AB 
d 
d 
AB 
d 
d 
2JFF=301.2 
2JFP=109.7 
3JFH=15.3 
2JFF=301.2 
2JFP= 108.3 
3JFH=20.7 
195 
No. 21 1 -('Diethoxyphosphinyl)difluoromethyl-2-iodocyc]oheptane (161) 
Chemical 
Shifi/p.p.m. 
Mulliplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.473 
1.527 to 
2.351 
3.203 
4.416 
6,133 
t 
m 
m 
m 
m 
3JHH=7.0 6 
1 0 
1 
4 
1 
g,h,i,j and k 
e 
b 
f 
31p 
6.910 2jpF=109.8 
19p 
-110.376 
-115.480 
AB 
d 
d 
AB 
d 
d 
2JFF=301.0 
2JFP=104.7 
3JFH=14.4 
2JFF=301.3 
2JFP=105.9 
3JFH=19.3 
196 
No. 22 3-r('Diethoxyphosphinyl)difluoromethyl1-4-iodooxo]ane (163) 
, 0 . 
r CF2P(0)(OCH2CH3)2 
a 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constanl/Hz 
Relative Intensity Assignment 
J9f 
- 1 1 1 . 1 9 d 2JFP=85.0 2 a 
d 3JFH=17.9 
No. 23 3-[(Diethoxyphosphinyl)difluoromethyl1-4.5-dihydro-2-iodooxolane or 
2-r(diethoxyphosphinyl)difluoromethyl1-4.5-dihvdro-3-iodooxolane (164') 
. 0 . 0 
CF2P(0)(OCH2CH3)2 or 
CF2P(0)(OCH2CH3)2 
a 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
19p 
-108.77 d 2JFP=104.0 2 a 
197 
No. 24 Methoxv-2,2.3.4.4.4-hexafluorobutane (173) 
19p 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shifi/p.p.m. Constant/Hz 
3.467 s 3 a 
3.675 AB 2jj^H=ll-4 ' b 
d 3jj^F=ll-4 
d ^JHF=2.4 
3.813 AB 2jj^H=ll-4 1 b 
d 3j^P^22.8 
d 3jj^p,64 
d 4 j ^ j _ 3 6 
5.027 d 2jj^P=42.2 1 d 
d 3jj^j^21.2 
q 3j^P=6.0 
d 3 j j^ j_48 
59.830 s a 
70.055 d 2j^F=33.6 b 
d 2j^P=13 0 
83.353 d lJCF=194.1 d 
q 2 j j . j _347 
d 2j( .p,347 
d 2j^ j_25.1 
117.000 t lJCF=250.1 c 
d 2j^P^24.4 
120.895 q ljCF=276.2 e 
d 2j(.p=25.7 
-74.545 s 3 e 
-117.708 AB 2jpj_276.1 1 c 
m 
-121.538 AB 2jpp,276.5 1 c 
m 
-214.758 d 2jpj^^42.i 1 d 
m 
198 
No. 25 Methoxy-1,13.3.3-pentafluorobutane (174) 
e R F 
b / 0 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.822 
3.443 
3.621 
3JHF=14.4 
3JHF=10.4 
3JHF=12.4 
37.890 
59.867 
72.787 
119.134 
124.076 
2jcF=30.2 
2jcF=26.3 
2JCF=31.3 
4jCF=l-2 
lJCF=244.5 
3JCF=3.0 
IjCF=276.2 
3JcF=5.7 
19p 
-62.799 
-104.101 
199 
No. 26 Methoxy-4.4.4-tTifluorobutane (175) 
+ oligmers 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
1.544 to 
3.000 
2.055 
3.681 
br m 
q 
s 
3JHF=2.7 
b,c,d 
d 
a 
'3C 
21.751 to 
22.019 
28.902 to 
31.694 
38.779 to 
39.659 
54.960 
128.137 and 
129.077 
m 
m 
m 
s 
q 
q 
lJCF=280.0 
lJCF=280:0 
bord 
b o r d . 
a 
e 
19p 
-64.04 and_ 
-67.60 m 
• ) 
200 
No. 27 2-(l.1.3.3.3-Pentafluoropropvl)oxolane (177) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.074 2 c 
2.858 t 3JHF=20.7 2 f 
q 3JHF=9.4 
d 4JHH=1.1 
3.837 d 2JHH=22.0 ' " \ "• ' a 
t 3JHH=7.2 
3.891 d 2JHH=22.0 I a 
t 3JHH=7.2 
4.082 d 3JHF=24.8 I d 
3JHH=8.4 
3JHF=6.4 
3JHH=2.8 
-
24.755 d 4jcF=2.1 c 
25.656 s b 
37.780 q •^JCF=30.1 f 
d 3jcF=23.6 
69.520 s - - a 
78.462 d 2JCF=33.2 d 
d 2JCF=0.7 
119.791 d 1JCF=253.5 e 
d 1JCF=246.3 
q 3jcF-2.9 
126.811 q 1JCF=276.8 g 
d 3jcF=7.4 
19p 
-74.960 3JFH=13.9 3 
d 4JFF=13.9 
d 4JFF=5.6 
-118.130 A B 2JFP?276.2 1 e 
t 3JFH=17.8 
q 4JFF=10.9 — — - - - - - -
d 3JFH=4.9 
-121.880 A B 2JFF=276.2 1 " ' " " e ' 
t 3JFH=18.4 
q 4JFF=6.8 
201 
No. 28 2-(2-Chloro-1.1.2-trifliioroethvl)oxolane (RS/SR)m7) 
R F 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Consiani/Hz 
Relative Intensity Assignment 
1.978 m 2 b 
2.119 m 2 c 
3.837 d 2JHH=22.0 1 a 
t 3JHH=7.2 
3.902 d 2JHH=14.8 1 a 
t 3JHH=7.2 
4.321 d 3JHH-11.6 1 • d 
6.383 
m 
d 2JHF=47.2 1 f 
d 3JHH=14.4 
d 3JHF=1-6 
24.892 d 4jcF=3.4 c 
25.648 s b 
69.790 s a 
75.288 d 2JcF=32.7 d 
d 2JCF=24.8 
96.850 d lJCF=244.9 f 
d 2jcF=41.2 
d 2jcF=27.9 
116.334 d 1JCF=254.1 e 
d 'JCF=251.7 
d 2jcF=27.1 
J9f 
-126.399 A B 2JFF=264.2 1 e 
d 
m 
3JFF=3.4 
-127.458 
111 
A B 2JFF=264.2 1 e 
d 3JFF=22.2 
d 3JFH=9.4 
-152.787 d 2JFH=47.4 1 f 
d 3JFF=15.1 
d 3JFF=9.8 
d 4JFH=3.0 
202 
No. 28 2-(2-Chloro-1.1.2-trifluoroethvl)oxolane (RR/SS)m7) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.942 m 2. b 
2.119 m 2 c 
3.857 d 2JHH=14.0 1 a 
t 3JHH=6.8 
3.892 d 2JHH-14.0 1 a 
t 3JHH=6.8 
4.377 d 3JHH=16.8 1 d 
6.335 
m 
d 2JHF=48.8 1 f 
d 3JHF=12.8 
d 3JHF=3.6 
24.955 d '*JCF=3.1 c 
25.610 s b 
69.790 s a 
76.088 d 2JCF=31.3 d 
d 2JCF=24.0 
96.210 d 1JCF=252.9 f 
d 2JcF=35.1 
d 2JCF=27.5 
117.736 t ljCF=254.1 e 
d 2JCF=19.0 
19f 
-126.072 A B 2JFF=255.5 1 e 
d 3JFH=12.4 
d 3JFF=12.4 
-128.202 A B 2JFF=255.5 1 e 
d 3JFH=19.6 
d 3JFF=19.6 
-160.697 d 2JFH=48.9 1 f 
t 3JFF=14.1 
203 
No. 29 Chloroinethoxv-2.2.3.4.4.4-hexafluorobutane (185) 
F. F 
e 
CF: 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
>H 
3.675 AB 2 J H H - 1 1 . 0 1 b 
d 3JHF=10.3 
d 3JHF=2.5 
4 .082 AB 2JHH=11.0 I b 
d 3JHF=7.0 
d 3JHF=3.3 
4 .984 d 2JHF=43.25 1 d 
d 3JHF=21.0 
q 3JHF=5.8 
d 3JHF=0.8 
5.551 m 2 a 
}9p 
-74.527 s e 
-116.948 AB 2JFF=279.4 c 
m 
-121.636 AB 2JFF=280.3 c 
m 
-214.033 d 2JFH=40.7 d 
m 
204 
No. 30 2-Chloro-5-( 1.1.2.3.3.3-hexafluoropropvl)oxolane (major isomer)(l 85) 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.143 m 2 bore 
2.402 d 2jj^j^=15.1 2 bore 
d 3j^^=15.1 
4.653 t 3 j^p ,95 1 d 
m 
4.945 d 2j^P=42.7 1 f 
d 3j^p,21.8 
q 3jj^P=5.5 
6.351 m 1 a 
19p 
-75.117 m 3 g 
-125.098 AB 2jpp=272.5 1 e 
m 
-131.704 AB 2jpj-272.3 1 e 
m 
-213.219 d 2jpj^=42.i 1 f 
m 
205 
No. 31 2-Chloro-5-(1.1.3.3.3-pentafluoropropyl)oxolane (major isomer)(187) 
R F 
Chemical 
Shifi/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.221 
2.363 
2.797 
4.495 
6.323 
m 
d 
d 
d 
m 
d 
d 
d 
d 
m 
2 J H H - 9 . 6 
3JHH=9.6 
3JHH=3.5 
3JHF=22.1 
3JHH=5.9 
3JHF=4.2 
3 J H H - 4 . 2 
b ore 
b or c 
19F 
-62.805 
-109.650 
-117.337 
m 
AB 
d 
t 
AB 
d 
t 
2JFF=270.2 
3JFH=14.8 
3JFH=14.8 
2JFF=272.3 
3JFH=22.8 
3JFH=22.8 
206 
No. 32 2-Chloro-5-(2-chloro-1.1.2-trifluoroethyl)oxolane (major isomer)(l88) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.240 to m 4 b,c 
3.276 
4 .775 d 3JHF=20.8 d 
m 
6.269 d 2JHF=50.0 1 f 
d 3JHF=15.0 
d 3JHF=1.0 
6.343 m a 
19p 
-126.396 A B 2JFF=261.5 1 e 
m 
-129.391 A B 2JFF=261.5 e 
m 
-153.195 d 2JFH=48.0 1 f 
m 
207 
No. 33 2-(1.1.2.3.3.3-Hexafluoropropvl)-4.5-dihvdrofuran (189) 
Chemical 
Shifi/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
1.998 to 
2.339 
4.378 
6.269 
5.456 
m 
m 
d 
m 
m 
2JHF=43.0 
b,c 
d 
f 
208 
No.34 2-(2-Chloro-1.1.2-trifluoroethvl)-5-uradvloxolane (a) (192) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.128 m 1 g 
2.329 A B 2JHH=8.0 1 h 
2.370 A B 2JHH=8.0 1 h 
2.601 d 2JHH=6.4 1 g 
d 3JHH=6.4 
d 3JHH=6.4 
d 3JHH=6.4 
4.810 m 1 i 
5.787 d 3 JHH=80 1 b 
6.111 or t 3JHH=^.4 1 f 
6.151 
6.289 m 1 k 
7.237 or d 3JHH=8.0 1 a 
7.248 
9.240 hr s 1 d 
23.502 m h 
30.507 s g 
75.978 d 2jcF=69.8 i 
d 2jcF=8.75 
86.031 s f 
94.720 m k 
102.814 s b 
116.764 m j 
139.332 s a 
150.286 s e 
162.806 s c 
-127.050 A B 2JFF=272.0 1 J 
d 3JFF=13.9 
d 3JFH=4.1 
-128.123 A B 2JFF=267.5 1 j 
d 3JFH=19.9 
d 3JFF=10.2 
-154.421 d 2JFH=47.4 1 k 
d 3JFF=13.2 
d 3JFF=10.2 
d 3JFH=2.6 
/ 
209 
No.34 2-(2-Chloro-1.1.2-trifluoroethvl)-5-uradvloxolane (192) 
F h " g 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.040 m 1 g 
2.322 A B 2JHH=8.4 1 h 
2.361 AB 2JHH=8.4 1 h 
2.449 d 2JHH=6.4 1 g 
d 3JHH=6.4 
d 3JHH=6.4 
d 3JHH=6.4 
4.532 m 1 i 
5.819 d 3JHH=8.4 1 b 
6.289 or t 3JHH=6.4 1 f 
6.309 
6.289 m 1 k 
7.321 or d 3JHH=8.0 1 a 
7.372 
9.240 br s 1 d 
-127.008 A B 2JFF=254.0 1 j 
d 3JFF=11.7 
d 3JFH=11.7 
-128.562 AB 2JFF=260.4 1 j 
d 3JFH=13.2 
d 3JFF=12.2 
-154.692 d 2JFH=47.0 1 k 
t 3JFF=12.4 
d 3JFH=3.0 
210 
No.34 2-(2-Chloro-1.1.2-trifluoroethvn-5-uradvloxolane (a) (192) 
F h " g 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.128 m 1 g 
2.329 AB 2JHH=8.0 1 h 
2.370 A B 2JHH=8.0 1 h 
2.601 d 2JHH=6.4 1 g 
d 3JHH=6.4 
d 3JHH=6.4 
d 3JHH=6.4 
4.810 m 1 i 
5.787 d 3JHH=8.0 1 b 
6.111 or t 3JHH=6.4 1 f 
6.151 
6.289 m 1 k 
7.237 or d 3JHH=8.0 1 a 
7.248 
9.240 br s 1 d 
23.642 m h 
30.484 s g 
75.636 d 2jcF=59.4 i 
d 2JCF=15.4 
f 85.982 s 
97.493 m k 
103.364 s b 
116.764 m j 
139.264 s a 
149.990 s e 
163.030 s c 
19p 
-129.045 m 2 j 
-161.231 d 2JFH=48.5 1 k 
t 3jpF=13.2 
211 
No.34 2-f2-Chloro-1.1.2-trifluoroethvn-5-uradvloxolane (B)(192) 
F ri— 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.040 m 1 g 
2.322 A B 2JHH=8.4 1 h 
2.361 A B 2JHH=8.4 1 h 
2.449 d 2JHH=6.4 1 g 
d 3JHH=6.4 
d 3JHH=6.4 
d 3JHH=6.4 
4.532 m 1 i 
5.819 d 3JHH=8.4 1 b 
6.289 or t 3JHH=6.4 1 f 
6.309 
1 6.289 m k 
7.321 or d 3JHH=8.0 1 a 
7.372 
9.240 br s 1 d 
-129.045 m 2 j 
-162.263 d 2JFH=48.9 1 k 
t 3JFF=13.9 
212 
No.35 2-(2-Chloro-] .1 .l-trifluoroethvlVS-fS-fluorouradynoxolane (a) (193) 
F h'—'g 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
^HJi 
1 g 2.117 m 
2.350 m 2 h 
2.613 m 1 g 
4.839 d 3JHF=16.0 1 i 
d 3JHF=8.0 
d 3JHH=8.0 
d 3JHH=5.6 
6.164 d 3JHH=5.2 1 f 
6.338 
m 
d 2JHF=47.2 
1 k 
7.323 
m 
d 3JHF=6.0 
1 b 
7.377 or d 3JHF=6.0 1 a 
7.379 
9.594 br s 1 d 
23.067 m h 
31.462 s g 
76.000 m i 
86.375 s f 
96.275 d 1JCF=246.5 k 
t 2JCF=32.9 
116.430 m j 
123.452 d 2jcF=34.0 a 
140.712 d 1JCF=239.6 b 
149.041 s e 
156.604 s c 
19f 
-120.055 A B 2JFF=268.3 1 j 
m 
-121343 A B 2JFF=268.6 1 j 
d 3JFH=20.3 
d 3JFF=9.8 
-147.874 d 2JFH=47.4 1 k 
d 3JFF=12.8 
d 3JFF=9.8 
d 3JFH=2.3 
1 -157.971 m b 
/ 
213 
No.35 2-(2-Chloro-1.1.2-trifluoroethvn-5-f5-fluorouradvnoxolane (B) (193) 
o 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.042 m 1 g 
2.350" m 2 h 
2.449 m 1 g 
4.546 m 1 i 
6.147 d 3JHH=4.8 1 f 
6.338 
m 
d 2JHF=47.2 1 
k 
7.323 
tn 
d 3JHF=6.0 1 b 
7.435 or d 3JHF=6.0 1 a 
7.437 
9.594 Iw s 1 d 
-119.959 A B 2JFF=260.4 1 j 
d 3JFF=11.7 
d 3JFH=11.7 
d 3JFH=5.6 
d 3JFH=5.6 
-121.467 A B 2JFF=260.4 1 j 
-148.152 
m 
d 2JFH=47.4 
1 k 
t 3JFF=12.0 
d 3JFH=3.0 
-158.072 m 1 b 
214 
No.35 2-(2-Chloro-1.1.2-trifluoroethvn-5-(5-fluorouradvnnxPlane rn!U193) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
19F 
2.117 
2.350 
2.613 
4.791 
6.164 
6.319 
7.312 
7.377 or 
7.379 
9.594 
23.421 
30.495 
76.000 
88.363 
%.275 
116.430 
123.487 
140.860 
149.692 
156.869 
-122.212 
-154.141 
-159.055 
m 
m 
m 
d 
d 
d 
d 
d 
m 
d 
m 
d 
d 
br s 
m 
s 
m 
s 
d 
t 
m 
d 
d 
s 
s 
m 
d 
t 
m 
3JHF=8.2 
3JHF=5.1 
3JHH=5.I 
3JHH=33 
3JHH=53 
2JHF=48.4 
3JHF=5.6 
3JHF=6.0 
1JCF=246.5 
2JCF=32.9 
2jcF=34.0 
lJCF=238.9 
2JFH=48.5 
3JFF=12.4 
g 
h 
g 
i 
f 
k 
b 
a 
h 
g 
i 
f 
k 
j 
a 
b 
e 
c 
j 
k 
215 
No.35 2-(2-Chloro-1.1 •2-trifluoroethvn-5-(5-fluorouradvnoxolane (3X193) 
O 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.042 m 1 g 
2.350 m 2 h 
2.449 m 1 g 
4.500 m 3JHF=16.0 1 i 
6.147 d 
m 
3JHH=4.8 1 f 
6.319 d 
m 
2JHF=48.4 1 k 
7.312 d 3JHF=5.6 1 b 
7.435 or d 3JHF=6.0 1 a 
7.437 
9.594 br s 1 d 
J9F 
-122.356 
-155.580 
-159.066 
m 
d 
t 
m 
2JFH=48.9 
3JFF=12.0 
2 
1 
216 
No.36 2-(1.1.3.3.3-Pentafluoropropvn-5-uradvloxolane ra)fl94) 
h ' — ' g 
Chemical 
Shift/p.p.m. 
19p 
2.013 
2.295 
2.423 
2.914 
4.248 
5.818 
6.299 
7.358 
9.426 
23.366 
30.950 
38.413 
78.861 
88.499 
102.745 
118.668 
123.572 
138.789 
150.126 
163.264 
-61.408 
-109.863 
-114.920 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity 
m 
m 
d 
d 
t 
t 
q 
t 
d 
d 
t 
d 
br s 
d 
s 
t 
q 
d 
d 
s 
s 
t 
q 
q 
d 
s 
s 
s 
s 
AB 
m 
AB 
m 
2JHH=6.4 
3JHH=6.4 
3JHH=6.4 
3JHF=17.6 
3JHF=10.0 
3JHF=22.8 
3JHH=6.4 
3JHH=8.4 
3JHH=6.4 
3JHH=8.0 
3JCF=4.2 
2jcF=29.0 
2JcF-9.3 
2jcF=36.6 
2jcF=25.5 
ljCF=255.2 
3JCF=2.6 
1JCF=277.0 
3JCF=5.7 
2JFF=259.6 
2JFF=259.4 
Assignment 
cisg 
h 
trans g 
b 
f 
a 
d 
h 
g 
k 
217 
No.36 2-(1.1.3.3.3-Pentafluoropropvn-5-uradvloxo]ane (p)(194) 
o 
• A 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
Jj-I 
19f 
2.130 
2.295 
2.580 
2.914 
4.548 
5.748 
6.141 
7.256 
9.426 
23.497 
30.662 
38.413 
78.516 
85.973 
103.397 
118.668 
123.458 
139.392 
150.452 
163.018 
-61.408 
-109.312 
-114.304 
m 
m 
d 
d 
t 
t 
q 
d 
d 
d 
d 
d 
d 
d 
br s 
d 
s 
t 
q 
d 
d 
s 
s 
t 
q 
q 
d 
s 
s 
s 
s 
AB 
m 
AB 
m 
2JHH=7.2 
3JHH=7.2 
3JHH=7.2 
3JHF=16.0 
3JHF=8.8 
3JHF=16.8 
3JHH=10.4 
3 J H F - 1 0 . 4 
3JHH=8.0 
3JHH=6.4 
3JHH=4.8 
3JHH=8.0 
3jcF=3.8 
2jcF=29.0 
2jcF=9.3 
2jcF-36.3 
2jcF=24.8 
ljCF=255.2 
3jcF=2.6 
1JCF=288.5 
3jcF=9.2 
2JFF=259.4 
2 J F F - 2 5 9 . 4 
cisg 
h 
irans g 
218 
No. 37 2-r 1.1 J.S.S-Pentafluoropropvn-S-CS-fluorouradvDoxolane (195) 
0 
Chemical 
Shifl/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
19p 
2.072 
2.142 
2.169 
2.339 
3.338 
4.273 
6.108 
7.740 
9.603 
23.533 
31.428 
76.681 
84.400 
87.145 
118.224 
122.191 
125.381 
141.505 
149.978 
157.400 
-61.628 
-110.282 
-115.150 
-167.934 
m 
AB 
m 
AB 
m 
d 
d 
d 
t 
q 
d 
d 
t 
t 
m 
d 
br s 
d 
s 
d 
d 
m 
s 
t 
d 
q 
d 
d 
d 
s 
s 
s 
AB 
m 
AB 
m 
s 
2JHH=7.6 
2JHH=7.6 
2JHH=7.0 
'HH=7.0 3j 
3JHH-7.0 
3JHF=14.4 
3JHF=11.0 
3JHH=15.6 
3JHH-7.8 
3JHF=7.8 
3JHH=6.4 
3JHH=8.0 
3jcF=4.2 
2jcF-35.9 
2jcF=22.9 
1JCF=241.4 
2jcF=22.9 
lJCF=281.2 
2JCF=25.5 
2JCF=34.4 
lJCF=233.4 
2JFF=257.7 
2JFH=42.1 
219 
No. 38 2-f 1.1 •2.3.3.3-Hexafluoropropvn-5-uradvloxolane (a) (196) 
O 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.157 m 1 g 
2.364 AB 2JHH=8.4 1 h 
2.376 
m 
AB 2JHH=8.4 1 h 
2.602 
m 
d 2JHH=6.8 1 g 
d 3JHH=6.8 
d 3JHH=6.8 
d 3JHH=6.8 
4.721 m 1 i 
5.054 d 2JHF=43.2 1 k 
d 3JHF=21.2 
q 3JHF=6.4 
5.793 d 3JHH=8.0 1 b 
6.178 or t 3JHH=6.4 1 f 
6.158 
7.237 d 3JHH=8.4 1 a 
9.603 brs 1 d 
21.978 d 3JCF=3.4 h 
29.323 s g 
74.479 d 2JcF=35.9 i 
d 2JCF=23.3 
83.155 m k 
84.786 s f 
102.643 s b 
115.501 t lJCF=251.3 j 
d 2JcF=19.8 
119.554 q lJCF=286.5 1 
d 2jcF=24.8 
138.303 s a 
149.447 s e 
161.956 s c 
19p 
-75.818 d 3JFH=10.9 3 1 
d 3JFF=10.9 
t '•JFF=10.9 
-128.052 AB 2JFF=273.5 1 j 
d 3jpF=21.4 
d 3JFH=21.4 
t '*JFP=10.9 
/ 
220 
-131.739 AB 2jpj-272.4 
d 3jpp=io.8 
d 3jp^^l0.8 
d 4JFF=10.8 
-214.166 d 2jpj^^433 
t 3jpp=i2.8 
d 3jpp=2.8 
221 
No. 38 2-(1.1.2.3.3.3-Hexafluoropropvn-5-uradvloxolane (B) (196) 
O 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.059 d ^JHH=6.4 1 g 
d 3JHH=6.4 
d 3JHH=6.4 
d 3JHH=6.4 
2.330 AB 2JHH=8.4 1 h 
2.376 
m 
AB 2JHH=8.4 1 h 
2.448 
m 
d 2JHH=6.8 1 g 
d 3JHH=6.8 
d 3JHH=6.8 
d 3JHH=6.8 
4.415 m 1 i 
5.054 d 2JHF=43.2 1 k 
d 3JHF=21.2 
q 3JHF=6.4 
5.800 d 3JHH=8.0 or 7.2 1 b 
5.834 
6.309 or t ^JHH=6.4 1 f 
6.361 
7.299 or d 3JHH=8.4 1 a 
7.373 
9.618 br s 1 d 
-75.818 d 3JFH=10.9 3 1 
d 3JFP=10.9 
t '*JFF=10.9 
-126.199 AB 2JFF=272.0 1 j 
d 3JFF=21.4 
d 3JFH=21.4 
t '*JFF=10.5 
-130.871 AB 2JFF=272.4 1 j 
d 3JFF=9.0 
d 3JFH=9.0 
d '^ JFF=9.0 
-214.503 d 2JFH=43.3 1 k 
t 3JFF=12.8 
222 
No. 38 2-( 1.1.2.3.3.3-Hexafluoropropvn-5-uradvloxolane (aU196) 
o 
19F 
F ri—b 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.157 m 1 g 
2.364 AB 2jj^j^^84 1 h 
m 
2.376 AB 2 j j ^ . 4 1 h 
m 
2.602 d 2jjjj^^.8 1 g 
d 3jj^y=5.8 
d 3 j j ^ . 8 
d 3jj^„=6.8 
4.721 m 1 ' 
5.054 d 2 j j ^ 3 . 2 1 k 
d 5JHF=21.2 
q 3 j j ^6 .4 
5.793 d 3jjjjp8.0 1 b 
6.178 or t ^JHH=6-4 1 f 
6.158 
7.237 d hm^A 1 a 
9.603 brs I d 
21.714 d 3jj,p,38 h 
29.380 s « 
77.378 d 2jj.p=3i.3 i 
d 2j^j_24.4 
83.158 m ^ 
85.135 s f 
101.903 s ^ 
115.501 t 1JCF=251.3 j 
d 2j^,p=i9.8 
119.554 q 1JCF=286.5 • 
d 2jj,p=24.8 
138.413 s 2 
149.143 s e 
162.267 s 
-76.330 d 3JFH=8.7 
d 3jpj_8.7 
t 4jpj_8.7 
-122.103 AB 2jpj_273.1 
m 
-125.790 AB 2jpp=272.4 
m 
223 
-218.680 d 2jp^^44.4 
q 3jpp=io.9 
224 
No. 38 2-n.l.2.3.3.3-Hexafluoropropvn-5-uradvloxolane (S) (196) 
O 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.059 d 2JHH=6.4 1 g 
d 3JHH=6.4 
d 3JHH=6.4 
d 3JHH=6.4 
2.330 AB 2JHH=8.4 1 h 
2.376 
m 
AB 2JHH=8.4 1 h 
2.448 
m 
d 2JHH=6.8 1 g 
d ^JHH=6.8 
d 3JHH=6.8 
d 3JHH=6.8 
4.415 m 1 i 
5.054 d 2JHP=43.2 1 k 
d 3JHF=21.2 
q 3JHF=6.4 
5.800 d % H = 8 . 0 or 7.2 1 b 
5.834 
6.309 or t 3JHH=6.4 1 f 
6.361 
7.299 or d 3JHH=8.4 1 a 
7.373 
9.618 br s 1 d 
19f 
-75.818 d 3JFH=10.9 3 1 
d 3JFF=10.9 
t '*JFF=10.9 
-122.545 AB 2JFF=271.6 1 j 
-125.505 
m 
AB 2JFF=270.1 1 j 
-219.635 
m 
d 2JFH=44.0 1 
k 
q 3JFF=10.5 
225 
No. 39 2-n.l.2.3.3.3-Hexafluoropropvn-5-(5-fluorouradvnoxolane (a) (\91) 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.286 m 1 g 
2.428 d 3JHH=11.4 2 h 
t 3JHH=11.4 
2.529 m 1 g 
4.971 m 1 i 
5.800 d 2JHF=40.2 1 k 
6.314 
m 
t 3JHH=5.1 1 f 
7.914 d 3JHF=8.0 1 a 
10.006 br s 1 d 
23.533 d 3JCF=4.2 h 
31.428 s g 
76.681 d 2JCF=35.9 i 
d 2JCF=22.9 
84.400 m k 
87.145 s f 
118.224 t 1JCF=241.4 j 
d 2jcF=22.9 
122.191 q 1JCF=281.2 1 
d 2JcF=25.5 
125.381 d 2jcF=34.4 a 
141.505 d lJCF=233.4 b 
149.978 s e 
157.400 s c 
19f 
-74.595 d 3JFH=22.2 3 1 
d 3JFF=10.5 
t 4JFF=5.3 
-126.471 AB 2JFF=265.6 1 j 
-129.412 
m 
AB 
m 
2JFF=265.6 1 j 
-168.202 
III 
m 1 b 
-214.457 d 2JFH=411 1 k 
d 3JFF=10.5 
q 3JFF=10.5 
d 4JFH=3.0 
226 
No. 39 2-fl.l.2.3.3.3-Hexafluoropropvn-5-(5-fluorouradvnoxolane (p) (191) 
o 
Chemical Multiplicity Coupling Relative Intensity Assignment 
2.350 m 1 g 
2.428 d 3JHH=11.4 2 h 
t 3JHH=11.4 
2.543 m 1 g 
4.564 m 1 j 
5.800 d 2JHF=40.2 1 k 
6.279 
m 
t 3JHH=5.1 
1 f 
7.664 d 3JHF=6.9 1 a 
10.006 br s 1 d 
19p 
-74.595 d 3JFH=22.2 3 1 
d 3JFF=10.5 
t 4JFF=5.3 
-125.176 AB 2JFF=265.6 1 j 
m 
-128.824 AB 2JFF=265.6 1 j 
m 
-167.330 m 1 b 
-214.457 d 2JFH=42.1 1 k 
d 3JFF=10.5 
q 3JFF=10.5 
d 4JFH=3.0 
/ 
227 
No. 39 2-( 1.1.2.3.3,3-Hexafluoropropvn-5-('5-nuorouradvnoxolane (a)(191) 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.286 m 1 g 
2.428 d 3JHH=11.4 2 h 
t 3JHH=11.4 
2.529 tn 1 g 
5.042 m 1 i 
5.864 d 2JHP=40.0 1 k 
6.264 
m 
t 3JHH=5.7 
1 f 
7.791 d 3JHF=8.0 1 a 
10.006 br s 1 d 
23.609 d 3JCF=4.2 h 
31.598 s g 
77.765 d 2JCF=35.5 i 
d 2JCF=23.3 
84.400 m k 
87.399 s f 
118.224 t ljCF=241.4 i 
d 2jcF=22.9 
122.191 q 1JCF=281.2 1 
d 2JCF=25.5 
124.605 d 2jcF=34.0 a 
141.558 d 1JCF=232.6 b 
149.7% s e 
157.662 s c 
19f 
1 -75.011 m 3 
-122.611 A B 2JFF=274.5 1 j 
-124.470 
m 
A B 
2JFF=274.5 1 j 
-168.202 
fn 
m 
1 b 
-217.604 d 2JFH=43.6 1 k 
d 3JFF=19.8 
q 3JFF=11.5 
228 
No. 39 2-ri.l.2.3.3.3-Hexafluoropropvn-5-(5-fluorouradvnoxolane (3) (197) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
19p 
2 .350 
2 .428 
2.543 
4 .629 
5.864 
6 .279 
7.686 
10.006 
-75.011 
-122.611 
-124.470 
-167.476 
-217.835 
m 
d 
t 
m 
m 
d 
m 
t 
d 
br s 
m 
A B 
m 
A B 
m 
m 
d 
d 
q 
3JHH=11.4 
3jHH=n.4 
2JHF=40.0 
3JHH=5.1 
3JHF=8.0 
2JFF=274.5 
2JFF=274.5 
2JFH=43.6 
3JFF=19.8 
3JFF=11.5 
g 
i 
k 
f 
a 
d 
1 
j 
j 
b 
229 
No. 40 Uradvlmethoxv-2.2.3.4.4.4-hexafluorohutane (198) 
O .A 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
'3c 
19p 
3.991 A B 2jHH=n.2 I g 
d 3JHF-8.8 
d 3JHF=2.4 
4.054 d 3JHF=21.0 1 g 
A B 2JHH=11.6 
d 3JHF=8.0 
d 4JHF=3.6 
4.978 d 2JHF=43.2 1 i 
I 3JHF=10.8 
q 3JHF=4.8 
5.243 s f 
5.827 d 3JHH=8.0 1 b 
7.275 d 3JHH=7.6 1 a 
9.051 br s 1 d 
67.620 d 2JCF=34.4 g 
d 2jcF=26.8 
73.798 s f 
83.666 d 'JCF=195.3 i 
t 2JCF-35.1 
d 2jcF=26.4 
104.017 s b 
116.416 t lJCF=250.9 h 
d 2JcF=25.2 
120.628 q ljCF=281.5 j 
d 2jcF=24.7 
142.947 s a 
151.132 s e 
163.159 s c 
-69.746 d 3JFH=10.5 3 j 
d 3JFF=10.5 
d 4JFF=9.4 
d 4JFF=5.6 
112.119 A B 2JFF=278.8 1 h 
m 
116.579 A B 2JFF-287.1 1 h 
m 
230 
-209.177 d 2jp^=42.9 
q 3jpj_6.4 
t 3jpj_2.6 
231 
No. 41 5-Fluorouradvlmethoxv-2.2.3.4.4.4-hexafluorobutane (199) 
C R 
O 
F 
NHd 
b 
Chemical 
Shifl/p.p.m. 
Multiplicity Coupling 
Consiant/Hz 
Relative Intensity Assignmeni 
19p 
3 . 8 1 5 
4 .182 
4 .984 
5 .551 
7 .668 
9 .986 
-74.527 
-116.948 
-121 .636 
-167.344 
-214.033 
AB 
d 
d 
AB 
d 
d 
d 
d 
q 
d 
s 
d 
br s 
s 
AB 
m 
AB 
m 
m 
d 
m 
2j 
3j 
HH=no 
HF=10.3 
3JHF=2.5 
2JHH=11.0 
3JKF=7.0 
5JHF=3.3 
^ HF=43 .25 2j 
- I I I 
3JHF=21.0 
3JHF=5.8 
3 JHF-0 .8 
3JHF=8.4 
2JFF=276.4 
2JFF=276.3 
2JFH=40.7 
232 
No. 42 2-Amino-6-chloropuriny]methoxy-2,2.3.4.4.4-hexafluorobutane ( 2 0 5 ) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
//-/ 
4.222 and 
4 .247 
5 .642 
5.727 
5.183 
8.183 
d 
d 
d 
d 
d 
d 
d 
d 
d 
br s 
s 
s 
3JHF=23.2 
2 J H H = ] 0 . 5 
3JHF=10.5 
4JHF=9.2 
^JHH=3.2 
2JHF=42.0 
3JHF=16.8 
3JHF=6.4 
3JHF=4.8 
19p 
-74.495 
-117.749 
-121.544 
-215.126 
s 
AB 
m 
AB 
m 
d 
m 
2JFF=274.2 
2JFF-273 .7 
2JHF=31.1 
233 
No. 43 2-('6-Chloropurinvn-5-( 1.1.2.3.3.3-hexafluoropropvnoxolane (206) 
F rt—'g 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.499 m 1 g 
2.819 m 2 h 
2.845 m 1 g 
5.073 d 
m 
3JHF=20.4 1 i 
5.697 d 
m 
2JHF=42.0 1 k 
6.708 m 1 f 
8.693 s 1 a 
8.767 s 1 d 
19f 
-74.248 s 3 1 
-125.500 AB 
m 
2JFF=267.1 1 j 
-129.351 AB 
m 
2JFF=271.1 1 j 
-214.032 d 
m 
2JFH=31.1 1 k 
/ 
234 
No. 43 2-f6-ChloropuiinvD-5-n. 1 •2.3.3.3-hexafluoropropvl)oxolane (206) 
N- N 
R F <f I 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.499 m 1 g 
2.819 m 2 h 
2.845 m 1 g 
5.073 d 
m 
3JHF=20.4 1 i 
5.697 d 2JHF=42.0 1 k 
m 
f 6.831 m 1 
8.585 s 1 a 
8.753 s 1 d 
19f 
-74.692 s 3 1 
-121.206 A B 
m 
2JFF=267.3 1 j 
-124.421 A B 
m 
2JFF=240 .0 1 j 
-217.239 d 
m 
2JFH=32.7 1 k 
235 
No. 44 2-(2-Amino-6-chloropuiinyl)-5-(1.1.2.3.3.3-hexafluoropropyl)oxolane (207) 
CI 
R F < i 1 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
hi 
2.143 m I h 
2.402 m 2 i 
2,679 m 1 h 
4.653 t 
m 
3JHF=9.5 j 
4,945 d 
m 
2JHF=42.7 1 
5,332 br s ( D 2 O ex) e 
6.351 m 1 g 
7.792 s 1 a 
19[7 
-75.117 m m 
-125.098 AB 
m 
2JFF=272.5 k 
-131.704 AB 
m 
2JFF-272.3 k 
-213.219 d 
m 
2JFH=42.1 1 
236 
No. 45 2-(6-Chloropurinvn-5-(1.1.3.3.3-pentafluoropropvnoxolane (208) 
a / / 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.406 m I g 
2.744 m 2 h 
2.823 m 1 g 
3.198 d 3JHF-22.8 1 k 
d 3JHF=10.8 
d 3JHF=1.2 
3.266 d 3JHF=10.4 1 k 
d 3JHF=10.4 
d 3JHF=10.4 
4.869 t 3JHF=7.2 1 i 
d 3JHH=7.2 
d 3JHH=6.6 
6.669 d 3JHH=6.0 1 f 
d 3JHH=3.6 
8.675 s 1 a 
8.755 s 1 d 
J9f 
-61.279 s 3 1 
-109.479 AB 2JFF=254.9 1 j 
m 
-115.104 AB 2JFF=255.1 1 j 
m 
237 
No. 46 2-(2-Chloro-1.1.2-trifluoroethvl)-5-(6-chloropurinvl)oxolane (a) (209) 
N- N 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.464 m 2 g 
2.664 m 2 h 
4.601 d 3JHF=15.5 1 i 
t 3JHH=8.7 
6 .184 d 2JHF=44.6 1 k 
m 
6 .372 t 3JHH=4.9 1 f 
8.124 s 1 d 
8.196 or s 1 a 
8 .230 
19F 
-126.094 
-153.135 d 
m 
2JFH=47.8 
2 
1 
/ 
238 
No. 46 2-(2-Chloro-1.1.2-trifluoroethvl)-5-(6-chloropurinvl)oxolane (a) (209) 
CI 
F h " g 
Chemical 
Shift/p.p.m. 
19F 
-127.507 
-159.428 
Multiplicity 
m 
d 
t 
Coupling 
Constant/Hz 
Relative Intensity 
2JFH=48.2 
3JFF=13.2 
2 
1 
Assignment 
2.464 m 2 g 
2.664 m 2 h 
4.601 d 3JHF=15.5 1 i 
t 3JHH=8.7 
6.184 d 2JHF=44.6 1 k 
m 
6 .372 t 3JHH=4.9 1 f 
8.124 s 1 d 
8.196 or s 1 a 
8.230 
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No. 46 2-(2-Chloro-1.1.2-trifluoroethvl)-5-(6-chloropurinvDoxolane (p) (209) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.599 
2.664 
4 .883 
6.184 
6 .437 
8.124 
8.196 or 
8.230 
m 
m 
m 
d 
m 
t 
s 
s 
2JHF=44.6 
3JHH=5.3 
g 
h 
i 
k 
f 
d 
a 
19p 
-125.819 
-160.813 
m 
d 
t 
2JFH=49.2 
3JFF=13.6 
J 
k 
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No.47 Guanylmethoxy-L1.2.3.3.3-hexafluorobutane (210) 
C F 3 . g 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
'H 
A.221 and d 3JHF=23.2 2 e 
4.247 d 2JHH=10.8 
d 3JHF=10.8 
d 4JHF=9.2 
d 4JHH=3.3 
5.199 s 2 d 
5.633 d 2JHF=37.6 1 g 
d 3JHF=16.8 
m 
6.522 br s ( D 2 O ex) 2 c 
7.656 s 1 a 
10.450 br s ( D 2 O ex) I b 
19F 
-74.948 d 3JFF=10.2 3 k 
d 3JFH=10.2 
d 4JFF=10.2 
d '*JFF=6.4 
-118.246 A B 2JFF=273.9 1 i 
d ^JFForH=26.3 
q 4JFF=7.4 
d ^JFHorF=3.8 
-121.920 A B 2JFF=273.9 1 
d 3jFForH=20.3 
q 4JFF=10.5 
d ^JFHorF=5.6 
-215.566 d 2JHF=44.8 1 j 
m 
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No.48 2-(l,l.2.3.3.3-Hexaf]tioropropvl)-5-guanvloxolane (211) 
O 
R F <i r 
J I 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.144 m I i 
2.437 m 2 j 
2.653 m 1 i 
4.653 m I k 
5.005 d 2JHF=42.3 1 m 
m 
6.522 br s ( D 2 O ex) 2 f 
6.651 m I g 
7.692 s I a 
10.670 br s ( D 2 O ex) 1 d 
19F 
-74.896 s 3 n 
-125.644 A B 2JFF=276.5 1 1 
m 
-131.449 AB 2JFF=281.7 1 1 
-213.303 
m 
d 2JFH=37.7 
1 m 
m 
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No.49 2-Adenvl-5-(1.1.2.3.3.3-hexafluoropropvl)oxolane(212) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.278 m 1 h 
2.618 m 2 i 
2.685 m 1 h 
4.880 m 1 j 
6.167 d 2JHF=42.0 1 1 
6.445 
m 
t 3JHH=3.2 1 g 
7.411 br s(D20 ex) 2 d 
8.180 s 1 aacc 
8.353 s 1 eora 
J9f 
-74.702 d 3JFF=10.9 3 m 
d 3JFH=10.9 
d 3JFF=10.9 
d 4JFF=6.0 
-125.978 AB 2JFF=269.8 1 k 
d 3JFH=11.3 
d 3JFF=11.3 
q 4JFF=11.3 
-129.704 AB 2JFF=269.8 1 k 
d 3JFF=12.0 
d 3JFH=12.0 
d 3JFH=12.0 
t 4JFF=4.1 
-214.475 d 1JFH=41.4 1 1 
q 3JFF=10.2 
t 3JFF=3.8 
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No.49 2-Adenvl-5-( 1.1.2.3.3.3-hexafluoropropynoxolane (212) 
. • < : r ; . 
g 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constant/Hz 
2.359 m 1 h 
2.618 m 2 i 
2.685 m 1 h 
4.583 m 1 j 
6.030 d 2JHF=41.6 1 1 
6.460 
m 
t %H=3.2 1 g 
7.383 br s(D20 ex) 2 d 
8.180 s 1 acH e^ 
8.345 s 1 ecra 
19p 
-75.122 d 3JFF=11.3 3 m 
d 3JFH=11.3 
d 3JFF=11.3 
d 4JFF=5.3 
-121.689 A B 2JFF=270.5 1 k 
d 3JFH=9.0 
d 3JFF=9.0 
q 4JFF=9.0 
-129.704 A B 2JFF=270.5 1 k 
d 3JFF=8.3 
d 3JFH=8.3 
d 3JFH=8.3 
d 4JFF=8.3 
t '»JFF=3.8 
-217.702 d 1JFH=42.5 1 1 
t 3JFF=10.9 
d 3JFF=8.3 
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No.50 2-Adenvl-5-fl.l.3.3.3-pentafluoropropvnoxolane (213) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.200 
2.549 
2.120 
3.290 
4.675 
6.417 
6.870 
7.959 
8.001 
8.026 
-65.920 
-114.143 
-119.702 
t 
m 
m 
m 
d 
d 
I 
d 
d 
br s(D20 ex) 
s 
s 
s 
t 
t 
AB 
t 
q 
d 
AB 
t 
q 
3JHH=7.2 
3JHH=12.4 
3JHH=6.4 
3 J H F - 6 . 4 
3JHH=7.2 
3JHH=4.4 
4JFF=9.4 
3JFH=9.4 
2JFF=263.0 
3JFH=18.4 
3JFF=9.4 
3JFH=3.8 
2JFF=263.4 
3JFH=19.6 
3JFF=9.4 
1 
2 
1 
2 
1 
1 
2 
0.5 
0.5 
1 
3 
1 
k 
1 or n 
1 or n 
1 or n 
m 
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No. 51 2-Adenvl-5-('2-chloro-1.1.2-trifluoroethvnoxo]ane (a) (2U) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
2.364 
2.620 
2.668 
4.606 
6.351 
7.000 
7.376 
8.167 
8.262 
m 
m 
m 
m 
m 
d 
m 
br s (D2O ex) 
s 
s 
2JHF=46.1 
1 
2 
1 
I 
1 
1 
2 
1 
1 
h 
i 
h 
j 
g 
1 
d 
aOTc 
ecM-a 
J9p 
-125.996 
-153.133 
m 
d 
m 
2JFH=46.8 
2 
1 
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No. 51 2-Adenvl-5-(2-chloro-1.1.2-trinuorocthvnoxolane for) (214) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
19p 
2.364 m 
2.620 m 
2.668 m 
4.944 m 
6.351 m 
7.091 d 
m 
7.376 brs(D20 
8.167 s 
8.341 or s 
8.334 
-127.511 m 
-159.443 d 
t 
2JHF=47.3 
2JFH=47.2 
3JFF=13.0 
1 
2 
1 
1 
1 
1 
2 
1 
1 
2 
1 
1 
h 
j 
g 
1 
d 
acre 
eora 
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No. 51 2-Adenyl-5-(2-ghlorQ-l.l,2-trifluQr9gthyl)oxol3ng (g) ( 2 H ) 
Chemical 
Shift/p.p.m. 
Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
19p 
2.260 m 
2.620 m 
2.668 m 
4.944 m 
6.433 m 
7.091 d 
m 
7.376 brs (D20 
8.167 s 
8.341 or s 
8.334 
-125.812 m 
-160.793 d 
t 
2JHF=47.3 
2JFH=47.2 
3JFF=13.6 
1 
2 
1 
1 
1 
1 
2 
1 
1 
2 
1 
h 
i 
h 
j 
g 
1 
d 
aore 
eor a 
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No. 52 2-(l,1.3.3.3-Pentafluoropropvn-5-(5-fluoro-5.6-dihvdro-6-
hydroxyuradyDoxolane (trans)(202) 
Chemical Multiplicity Coupling Relative Intensity Assignment 
Shift/p.p.m. Constani/Hz 
1.518 m 3 h,i 
2.636 t 3JHH=7.0 I h 
3.128 m 2 I 
4.248 t 3JHF=22.8 1 j 
d 3JHH=2.3 
5.071 d 2JHF=49.0 1 c 
d 3JHH=3.3 
5.231 d 3JHF=5.1 1 b 
d 3JHH=3.3 
5.692 t 3JHH=8.0 I g 
9.426 br s ( D 2 O ex) I e 
J9f 
-61.836 s 3 m 
-113.662 A B 2JFF=274.6 I k 
-131.101 
m 
A B 2JFF=274.9 
1 k 
-148.950 
m 
s c (cis orirans) 
-150.839 s j c {irans oicis) 
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No. 52 2-n.l.3.3.3-Pentafluoropropvl)-5-("5-fluoro-5.6-dihvdro-6-
hydroxyuradyPoxolane (cis)(202) 
Chemical Multiplicity Coupling 
Constant/Hz 
Relative Intensity Assignment 
19p 
1.518 m 3 h,i 
2.868 t 3JHH=7.0 1 h 
3.128 m 2 1 
4.248 t 3JHF=22.8 1 j 
d 3JHH=2.3 
5.375 d 2JHF=49.0 1 c 
d 3JHH=3.3 
5.231 d 3JHF=3.3 1 b 
d 3JHH=3.3 
5.692 t 3JHH=8.0 1 g 
9.426 br s ( D 2 O ex) 1 e 
-61.836 s 3 m 
-113.662 A B 2JFF=274.6 1 k 
m 
-131.101 A B 2JFF=274.9 1 k 
m 
-148.950 s c {cis ourans) 
-150.839 s j c {irans oxcis) 
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Appendix Two 
Infra Rgd Sp^gra 
No. 1 3-(Diethoxyphosphinyl)difluoromethylcyclopentene (106) 
No. 2 3-(Diethoxyphosphinyl)difluoromethylcyclohexene (107) 
No. 3 3-(Diethoxyphosphinyl)difluoromethylcycloheptene (108) 
No. 4 l-Methyl-(diethoxyphosphinyl)-2,2-difluoroethylben2ene (120) 
No. 5 l-(Diethoxyphosphinyl)difluorornethyl-2,3-«poxycyclohexeiie (127) 
No. 6 3-(Diethoxyphosphinyl)difluoromethylcyclohexen-6-ol (141) 
No. 7 3-Bromo-6-(diethoxyphosphinyI)difluoromethylcyclohexene (142) 
No. 8 3-[A'9-(6-chloropiirinyl)]-6-(diethoxyphosphinyl)difluorornethyl-
cyclohexene (145) 
No. 9 3-(A^9-Adenyl)-6-(diethoxyphosphinyl)difluoromethyl-
cyclohexene (147) 
No. 10 3-(/V9-Adenyl)-6-(dihydroxyphosphinyl)difluoromethyl-
cyclohexene (139) 
No. 11 3-[A'9-(2-aniirio-6-chloropuririyl)]-6-(diethoxyphosphinyl)difluoro-
methylcyclohexene (149) 
No. 12 3-(Ethoxyhydroxyphosphinyl)dif]uoromethyl-6-(N9-guanyl)-
cyclohexene (151) 
No. 13 3-(A'9-Guanyl)-6-(dihydroxyoxyphosphinyl)difluoromethyl-
cyclohexene (140) 
No. 14 l-Bromo-2-(diethoxyphosphinyl)difluoromethylcyclohexane (153) 
No. 15 |3is(tTimethylsiloxy)phosphinyl]brornodiQuororriethane (155) 
No. 16 (Dihydroxyphosphinyl)bromodifluoromethane (154) 
No. 17 l-Bromo-2-(dihydroxyphosphinyl)difluoromethylcyclohexane (156) 
No. 18 l-(Diethoxyphosphinyl)difluoromethyl-2-iodocyclohexane (159) 
No. 19 i-(Diethoxyphosphinyl)dif]uoromethyl-2-iodocyclopentane (160) 
No. 20 l-(Diethoxyphosphinyl)difluoromethyl-2-iodocycIoheptane (161) 
No. 21 Methoxy-2,2,4,4,4-pentafluorobutane (174) 
No. 22 Oligmers based on methoxy-4,4,4-tri£luorobutane (175) 
No. 23 2-(l,l,3,3,3-PentafIuoropropyl)oxolane (177) 
No. 24 2-Chloro-5-(l,l,2,3,3,3-hexafluoropropyl)oxolane (186) 
No. 25 2-Chloro-5-(l,l,3,3.3-pentafluoropropyl)oxolane (187) 
No. 26 2-Chloro-5-(2-chloro-l,l,2-trifluoroediyl)oxolane (188) 
No. 27 2-(l,l,2,3,3,3-hexafluoropropyl)-4,5-dihydrofuran (189) 
No. 28 2-(2-Chloro-l,l,2-trifluoroethyl)-5-uradyIoxolane (192) 
No. 29 2-(2-Chloro-l,1,2-trifluoroethyl)-5-(5-fluorouradyl)oxolane (193) 
No. 30 2-(l,l,3,3,3-PentafluoropropyI)-5-uradyloxolane (194) 
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No. 31 2-(l,l,3,3,3-Pentafluoropropyl>-5-(5-fluorouradyl)oxolane (195) 
No. 32 2-(l,l,2,3,3,3-Hexafluoropropyl)-5-iiradyloxolane (196) 
No. 33 2 - ( l ,1,2,3,3,3-Hexafluoropropyl)-5-(5-fluorouradyl)oxolane (197) 
No. 34 Uradylinethoxy-2,2,3,4,4,4-hexafluorobutane (198) 
No. 35 5-Fluorouradylmethoxy-2,2,3,4,4,4-hexafluorobutane (199) 
No. 36 2-Anuno-6-chloropurinyIrnethoxy-2,2,3,4,4,4-hexafluorobutane (205) 
No. 37 2-(6-Chloropurinyl)-5-(l,l,2,3.33-hexafluoropropyl)oxolane(206) 
No. 38 2-(2-Amino-6-chIoropurinyl)-5-< 1,1,2,3,3,3-hexafluoropropyl)-
oxolane (207) 
No. 39 2-(6-Chloropurinyl)-5-(l,l,3,33-pentafluoropropyl)oxolane (208) 
No. 40 2-(2-Chloro-l,l,2-trifluoroethyl)-5-(6-chloropurinyl)oxolane (209) 
No. 41 Guanylmethoxy-l , l ,2 ,3,3,3-hexa£luorobutane (210) 
No. 42 2-(l,l,2,3,3,3-Hexafluoropropyl)-5-guanyloxolane (211) 
No. 43 2-Adenyl-5-(l,l,2,3,3,3-hexafluoropropyl)oxolane (212) 
No. 44 2-Adenyl-5-(l,l,3,3,3-pentafluoropropyl)oxolane (213) 
No. 45 2-Adenyl-5-(2-chloro-l,l,2-trifluoroethyI)oxolane (214) 
No. 46 2-(l,l,3,3,3-Pentafluoropropyl)-5-(5-fluoro-5,6-dihydro-6-
hydroxy\iTadyl)oxolane (202) 
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Appendix Three 
Mass Spectra 
No. 1 3-(Diethoxyphosphinyl)difluoromethylcyclopentene (106) 
No. 2 3-(Diethoxyphosphinyl)difluoromethylcyclohexene (107) 
No. 3 3-(Diethoxyphosphinyl)difluoromethylcycloheptene (108) 
No. 4 l-Methyl-(diethoxyphosphinyl)-2,2-difluoroethylbenzene (120) 
No. 5 l-CDiethoxyphosphinyl)difluoromethyl-2,3-epoxycyclohexene (127) 
No. 6 3-(Diethoxyphosphinyl)difluoromethylcyclohexen-6-ol (141) 
No. 7 3-Bromo-6-(diethoxyphosphinyl)difluoromethylcyclohexene (142) 
No. 8 3-[A'9-(6-chloropurinyl)]-6-(diethoxyphosphinyl)difluoromethyl-
cyclohexene (145) 
No. 9 3-(A^9-Adenyl)-6-(diethoxyphosphinyl)difluoromethyl-
cyclohexene (147) 
No. 10 3-(A^9-Adenyl)-6-(dihydroxyphosphinyl)difluoromethyl-
cyclohexene (139) 
No. 11 3-[A^9-(2-amino-6-chloropurinyl)]-6-(diethoxyphosphinyl)difluoro-
methylcyclohexene (149) 
No. 12 3-(Ethoxyhydroxyphosphinyl)difluoromethyl-6-(iV9-guanyi)-
cyclohexene (151) 
No. 13 3-(A^9-Guanyl)-6-(dihydroxyoxyphosphinyl)difluoromethyl-
cyclohexene (140) 
No. 14 l-Bromo-2-(diethoxyphosphinyl)difluoromethylcyclohexane (153) 
No. 15 (Dihydroxyphosphinyl)bromodifluoromethane (154) 
No. 16 l-Bromo-2-(dihydroxyphosphinyl)difluoromethylcyclohexane (156) 
No. 17 l-(Diethoxyphosphinyl)difluoromethyl-2-iodocyclohexane (159) 
No. 18 l-(Diethoxyphosphinyl)difluoromethyl-2-iodocyclopentane (160) 
No. 19 l-(Diethoxyphosphinyl)difluoromethyl-2-iodocycloheptane (161) 
No. 20 Methoxy-2,2,4,4,4-pentafluorobutane (174) 
No. 21 Oligmers based on methoxy-4,4,4-trifluorobutane (175) 
No. 22 2-(l,l,3,3,3-Pentafluoropropyl)oxolane (177) 
No. 23 2-Chloro-5-(l,l,2,3,3,3-hexafluoropropyl)oxolane (186) 
No. 24 2-Chloro-5-(l,l,3,3,3-pentafluoropropyl)oxolane (187) 
No. 25 2-Chloro-5-(2-chloro-l,l,2-trifluoroethyl)oxolane (188) 
No. 26 2-(l,l,2,3,3,3-hexafluoropropyl)-4,5-dihydrofuran (189) 
No. 27 2-(2-Chloro-l,l,2-trifluoroethyl)-5-uradyloxolane (192) 
No. 28 2-(2-Chloro-1,1,2-trifluoroethyl)-5-(5-fluorouradyl)oxoIane (193) 
No. 29 2-(l,l,3,3,3-Pentafluoropropyl)-5-uradyloxolane (194) 
No. 30 2-(l,l,3,3,3-Pentafluoropropyl)-5-(5-fluorouradyl)oxolane (195) 
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No. 31 2-(l,l,2,3,3,3-Hexafluoropropyl)-5-uradyloxolane (196) 
No. 32 2-(l,l,2,3,3,3-Hexafluoropropyl)-5-(5-fluorouradyl)oxolane (197) 
No. 33 Uradyimethoxy-2,2,3,4,4,4-hexafluorobutane (198) 
No. 34 5-Fluorouradylmethoxy-2,2,3,4,4,4-hexafluorobutane (199) 
No. 35 2-Amino-6-chloropurinylmethoxy-2,2,3,4,4,4-hexafluorobutane (205) 
No. 36 2-(6-Chloropurinyl)-5-(l,l,2,3,3,3-hexafluoropropyl)oxolane (206) 
No. 37 2-(2-Amino-6-chloropurinyl)-5-(l,l,2,3,33-hexafluoropropyl)-
oxolane (207) 
No. 38 2-(6-Chloropurinyl)-5-(l,l,3,3,3-pentafluoropropyl)oxolane (208) 
No. 39 2-(2-Chloro-l,l,2-trifluoroethyl)-5-(6-chloropurinyl)oxolane (209) 
No. 40 Guanylmethoxy-l,l,2,3,3,3-hexafluorobutane (210) 
No. 41 2-( 1,1,2,3,3,3-Hexafluoropropyl)-5-guanyloxolane (211) 
No. 42 2-Adenyl-5-(l,l,2,3,3,3-hexafluoropropyl)oxolane (212) 
No. 43 2-Adenyl-5-(l,l,3,3,3-pentafluoropropyl)oxolane (213) 
No. 44 2-Adenyl-5-(2-chloro-l,l,2-trifluoroethyl)oxolane (214) 
No. 45 2-(l,l,3,3,3-Pentafluoropropyl)-5-(5-fluoro-5,6-dihydro-6-
hydroxyuradyl)oxolane (202) 
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Spectrum No.l(EI+) 
NCP454LI3<» x l BgdM 15-tlRV-95 11 56-8 8 3 16 PBE 
Bpn=8 I M . e v Hii=431 TIC=48I2IB8B flcnt 
NIGEL PflKKiNSON 
S y s R C E HBR: 18?4B8B 
PI= 8' Cal PFKBIIflrS ftRSS 255 
l e a , 59 
85 
E B . 
4 8 . 
8 . I J ^ J L 
58 
Mass '/. Base 
42 02 17 89 
44 03 6 55 
45 02 87 78 
46 04 6 45 
53 03 3 54 
54 05 3 44 
55 04 3 36 
58 03 8 67 
59 03 91 04 
60 02 3 SO 
62 03 8 99 
63 03 8 84 
64 02 48 40 
65 03 22 35 
66 02 68 61 
67 02 46 64 
68 03 33 43 
69 02 5 03 
135 00 5 11 
136 99 45 76 
138 00 82 57 
139 02 22 76 
162 02 2 11 
182 02 2 02 
183 03 2 04 
184 03 2 04 
1 88 03 43 00 
189 02 2 43 
191 03 8 76 
192 02 24 19 
193 02 3 00 
245 03 6 54 
246 02 5 99 
249 00 10 01 
255 01 100 00 
256 02 26 21 
262 02 23 98 
263 03 7 55 
?55 
138 
IL 
158 288 258 388 358 
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Mass Spectrum No. 2 (CI+) 
KCPSBlHi Kl BgdM 7-rCB-32 15 85-8 88 <1 78E f l -
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258 388 
•48 78E Cl« 
358 458 588 
I B L 
Rent: Sys:[l£[ 
PI= 8" Cal^PFHSlJRN RflSS^ 
269 
289 
189 
286 
58 158 
HCPSmiB* x l B g M ?-rEfl-32 15:85-
Bpll=B I=312iM 11M489 TiC=18183888 
N. PIKKIKSOH 
258 
:51 78t 
Rent: 
388 
C I -
359 488 458 588 
PT= 8' 
Sys^RCE 
Cal^PfniJRK 
262 
IfflL 
2« 
I 
262 
159 239 
223 
281 331 
58 
Mass 
58. 03 
59. 02 
81. 02 
91. 00 
108. 00 
108. 98 
109. 99 
110. 98 
125. 96 
137. 96 
138. 98 
154. 96 
155. 99 
161. 02 
168. 97 
182. 96 
183. 97 
187. 93 
188. 92 
189. 93 
205. 94 
206.94 
210. 97 
212. 95 
218. 93 
219. 93 
247.94 
267. 92 
268. 92 
269. 94 
270. 95 
282. 92 
284.95 
285.96 
286.96 
299. 93 
159 288 258 388 358 458 5BB 
7. Sate 
12 
91 
56 
19 
1. 79 
1.63 
0. . 44 
1.28 
1. 29 
2. 56 
1. 28 
2.56 
1. 33 
1. 50 
1.28 
18. 15 
28 
28 
25. 59 
1 
14 
1 
0 
2 
1 
1 
3 
3. 84 
100.00 
12. 80 
2.50 
45 
16 
28 
51 
56 
28 
28 
16 
21 
36 
8. 96 
28 
78 
266 
Spectrum No.3(CI+) 
MOSS SPfTCTRUM D a t f l T i l e : G 9 1 i 1 . 7 ^ 0 
S a m p l e : I I . PORK I I ISOH NCP1<&? t H l l l O H I R 
RT 0 ' Q 3 " C I ( P o s . ) GC Ze.5C B P : m / z 
Scai - i# ( 1 .1 ) 
nOOO 
1 0 0 
R 
e 
1 
a 
t 
i 
R 
b 
no numeric data 
267 
Mass Spectrum No. 4 (EI+) 
95 
9B 
85 
HCP4enSII8B7. x l Bgd=12B; 3-nflY-9e 18-
Bpll=B IMBu H«=294 T1C=33BB51888 
rfl3 8.1 IBEC 
•XI-0 
185 
• 6 ^ 8 85 7K E I -
RcntflKEORG Sys^ PW-KlMSDN 
a-- m° u .pri;!6.HH 
HUB 
llfiSS 
G55X889 
185 
77 . 
138 
132 
IBB 
IGI 
272 
J L L . 
12B l e e 288 228 248 2S8 288 38B 
Mass 
65. 13 
77. 22 
78. 23 
79. 24 
81. 17 
82. 18 
91. 25 
103.29 
105. 31 
ICS. 31 
109. 26 
110. 25 
1 1 1. 25 
127 28 
132. 24 
138. 32 
140. 32 
154.35 
160. 31 
161.32 
188. 36 
271. 48 
272. 46 
273. 47 
274.47 
277. 46 
291.47 
292. 46 
293. 47 
294. 49 
Base 
G. 37 
12. 42 
5. 14 
5. 98 
10. 54 
10. 56 
5. 12 
5. 80 
100. 00 
8. 94 
9. 03 
7. 35 
23. 10 
7. 64 
19. 45 
54. 03 
6. 43 
8. 13 
8. 47 
10. 96 
17. 03 
0. 07 
13. 71 
2. 00 
0. 22 
0. 09 
0 12 
1. 49 
0. 33 
0. 04 
268 
Spectrum No.5(EI+) 
NCP454LI34* x l BgdM IS-HflV-S? 11 56-8 83 16 7BE E I * 
BpH^B IM.Bm H«=431 IIC= 4B 1 2 1B 8B flcnt^ Sus flCE HHR 
NIGEL PflRKINSON P h 8° Cal PFCeilflYS flflSS 
285 
31234686 
285 
58 188 I S B 2BB 258 
NCP454LI35« x l Bgd=14 15-(lfly-32 11 56-8 83 22 ? B E 
8p«=8 1=2.5v Hm382 TIC= 2 2B 5 3BBB flcnt ^ 
N I G E L P H R U N S O N P T = 8" 
188, 285 
68 
C I -
358 
SysRCE 
Cal PfKBHHYS 
456 
H«R- 16381888 
285 
28 J 
58 
Mass 
188 
•/. Base 
41 25 0 82 
53 17 0 77 
65 06 0 77 
77 04 0 82 
79 06 0 82 
81 00 0 82 
91 05 0 74 
97 09 0 82 
99 06 0 77 
109 05 0 82 
1 1 1 06 0 82 
127 07 0 82 
129 08 0 83 
138 08 0 39 
139 07 0 33 
146 08 0 82 
147 10 0 82 
153 1 1 0 36 
155 1 1 1 81 
161 15 1 64 
219 08 0 33 
228. 09 0 61 
229 04 0 36 
236. 08 0. 33 
239. 07 0 77 
245 09 0 77 
247. 04 2 64 
248 09 0 54 
255. 09 0 35 
257. 08 0. 82 
264. 09 0. 85 
265. 08 1. 17 
267. 21 4. 92 
285. 04 100. 00 
X 
ISB 2BB 258 458 
269 
Spectrum No.6 (EI+) 
NCP454I7* x l B9d=l 15-llf lY-92 11 38-
Bpfl=B l=3.By H«=7?9 IiC=2?72768B8 
NIGEL PHRKINSON 
I 139 
58 78E 
Rent: 
PI--
Sys HCE 
Cat ?mms 
mi-
HHSS 
58 ^= " 183 
288 
257 
388 588 
NCP454I8* x l B9d=2 15-llf lY-32 l l SB-B Bl ^ 78£ c i -
BpH--8 IMB^i H»=614 TICM1B4438BB Rent: Sys flCE 
NIGEL PRRUNSON PT= 
GBJ 
28 
274 
383 
U PfKBIWYS llflSS: 
183 
4G _ 288 228 
8 288 
M l 
331 
19778888 
139 
8856888 
383 
388 
Mass 
40. 24 
41. 24 
42. 23 
43. 21 
44. 19 
45. 19 
46. 20 
47. 13 
47. 21 
49. 15 
50. 15 
51. 15 
52. 15 
Base 
1 
7 
2 
5 
2 
9 
1 
2 
4 
2. 
29 
91 
59 
33 
71 
06 
29 
59 
69 
59 
12. 94 
9 43 
1 . 57 
53 . 14 3 . 89 
54 . 15 1 . 65 
55 13 6 . 47 
57 13 5 . 18 
58 13 1 29 
59 12 2 84 
60 08 1 29 
61 07 1 46 
62 08 1 29 
63 08 3 91 
64 07 1 30 
65 06 7 77 
66 07 1 58 
67 08 5 60 
68 06 2 59 
69 06 2 75 
70 05 5 18 
71 04 2 59 
72 03 1 29 
73 02 3 88 
74 02 8 23 
75. 02 20 71 
76. 02 7 77 
77. 02 15. 66 
78. 03 3. 91 
79. 04 9. 80 
80. 04 2. 59 
81. 01 4. 22 
81. 98 3. 88 
82. 99 5. 18 
84. 00 1. 43 
85. 02 6. 47 
86. 02 1. 29 
87. 00 1. 29 
89. 02 1. 29 
90. 02 2. 59 
91. 03 5. 53 
92. 04 2. 59 
Mass 
93. 03 
94. 04 
95. 05 
96. 05 
97. 06 
98. 07 
99. 01 
100.04 
101. 00 
102.03 
103. 03 
104. 03 
105. 03 
106. 03 
107. 04 
108.04 
109. 02 
110. 01 
111. 00 
112. 00 
112. 99 
114.01 
115. 03 
116. 04 
117. 05 
118. 05 
119. 05 
121.03 
122. 04 
123. 04 
124.05 
125. 06 
126.05 
127. 02 
128.03 
129.04 
130. 05 
131.05 
131. 98 
133. 02 
135. 09 
136.08 
137. 04 
138.04 
138.99 
140. 00 
140. 99 
142.01 
143. 05 
145. 04 
146.04 
147. 05 
Base 
4. 00 
1 31 
3. 81 
2. 59 
9. 40 
7, 77 
10. 35 
29 
59 
18 
59 
49 
56-
97 
47 
59 
06 
19 
28. 55 
6. 48 
9. 06 
2. 59 
3.88 
1. 29 
2. 59 
29 
31 
77 
29 
59 
50 
9. 06 
2. 59 
10. 35 
5. 18 
12. 94 
4. 22 
50 
88 
30 
81 
17 
59 
1 
3 
1 
2 
1 
2 
12. 94 
100.00 
8. 12 
32. 36 
3. 11 
2. 59 
2. 59 
5. 87 
3. 93 
Mass 
151.03 
152. 07 
153. 06 
154.05 
155. 03 
155.99 
156.99 
157. 98 
159. 00 
160. 00 
161.07 
162. 07 
167. 05 
169.05 
170. 06 
171. 08 
172.06 
173.02 
174.06 
175. 03 
177. 04 
179. 02 
181.04 
182.03 
183. 06 
184 . 05 
185. 04 
186.03 
187. 02 
188. 02 
189. 04 
190.01 
191. 01 
192. 03 
193.03 
199. 05 
201.04 
203. 04 
205. 04 
207.02 
208. 02 
209. 01 
210. 01 
211 
213 
215 
216. 04 
217. 06 
218. 04 
219. 04 
220.05 
221.05 
. 02 
. 04 
. 03 
588 
7. Base 
- 1. 35 
5. 18 
3. 88 
1. 29 
18. 14 
46. 60 
18. 73 
15. 70 
7. 77 
5. 18 
5. 19 
1 29 
1 29 
1. 29 
1.31 
9. 30 
2. 59 
2. 61 
2. 59 
1. 53 
1. 29 
1. 33 
1. 29 
1. 29 
15. 53 
2. 59 
1. 29 
1. 29 
3. 80 
4 08 
4. 20 
1. 57 
3. 47 
1. 29 
I . 29 
1.58 
1. 29 
1.29 
1. 29 
1. 49 
1. 29 
1. 48 
1. 29 
3. 88 
2. 59 
2. 59 
1. 22 
2. 35 
1. 47 
• 5. 18 
1.52 
1.29 
Hasi 
227.03 
228. 04 
229.02 
230.04 
231.04 
233. 05 
235. 03 
236.04 
237. 03 
238.03 
239. 03 
240.03 
241. 03 
243. 02 
244.05 
245.04 
247.05 
248. 05 
249. 01 
251. 03 
255.02 
256.04 
257. 04 
258.04 
259. 04 
261. 05 
263.04 
264.05 
265. 05 
266.02 
267. 05 
268.06 
269. 04 
273. 05 
274. 05 
275. 05 
277.05 
279. 04 
281. 03 
283.03 
284. 04 
285.05 
286. 05 
287, 04 
291 03 
292. 07 
293. 03 
295. 03 
296.04 
297. 05 
298. 05 
-/. Base 
2. 59 
1. 29 
4. 32 
1. 29 
1. 29 
1. 29 
1. 98 
2. 59 
2. 59 
2. 88 
7. 99 
2. 59 
1. 29 
2. 59 
1. 29 
1. 29 
2. 98 
2. 59 
1.29 
1. 47 
2. 59 
2.59 
40. 86 
4. 19 
1. 29 
29 
53 
99 
59 
1. 29 
7. 77 
6. 61 
2.46 
1. 29 
1. 29 
1 . 29 
2. 34 
2. 59 
1. 29 
7. 77 
11. 65 
29. 71 
3. 88 
1. 29 
0 . 49 
1. 29 
1. 29 
1. 29 
0. 42 
3. 88 
0. 54 
270 
Spectrum No.7(CI+) 
MASS SPECTRUM D a t a F i l e : G 9 1 1 3 3 0 G 
S a m p l e : fS . PARK I fSSON MCP180 hMMONIR 
RT 0 ^ 1 7 " C I ( P o s . ) GC 0 . 0 c 
S c a n * ( 4 ) 
BP: m./z 3 6 4 . 0 0 0 0 
1 0 0 
R 
e 
1 
a 
t 
i 
V 
e 
P 
b 
u 
n 
d 
a 
n 
c 
e 
1 0 0 2 0 0 3 0 0 
no numeric data 
4 0 0 
271 
Spectrum No.8 
! ; C P n e H I 2 2 » x l B g d M 26-SEP-91 IB 2 5 - 8 - 8 2 M 8 7 B £ 
Bpn=B I - - 2 . 9 U H«=G8B 110=141381888 Rcnt^ 
N . PRRKINSOH PT= 8 ° 
Sys^flCC 
U P F T O E P 
4 2 1 
HHP ifAim 
miSS '!21 
6 B 1 8 9 
7 9 
6 5 
i i 
2 6 7 
1 5 5 
129 183 233 
.Li 
283 
2 8 8 38B 5 8 8 788 
l ( C P 1 9 9 H I 2 E » x l 8 9 d - - 2 B 2 6 - S E P - 9 1 1 6 ^ 2 5 - 9 ^ 6 2 : 3 9 7 B E C l -
Bpl1=8 1 = 1 B m H « = 5 B 2 1 1 6 = 4 2 7 5 5 2 9 8 8 flcnt ^ Sys^RCE 
N . PRRHNSON P I = 8 ° C 3 L : P r K 2 8 S E P 
1 8 8 , 1 8 3 
4 2 1 
Hll f - 577B3C80 
llfiSS 183 
1 5 5 
2 6 7 
I I ,L , - r - . 
2 8 B 58e 688 
Mass 
43. 
44. 
46. 
58. 
59. 
120. 
122. 
123. 
148. 
149. 
154. 
155. 
156. 
163. 
164. 
164. 
182. 
183. 
. 184. 
185. 
191. 
192. 
193. 
198. 
232 
233 
234 
246 
255 
266 
267 
282 
283 
284 
386. 
419 
420 
421 
422 
423 
. 424 
434 
v. Base 
98 
98 
01 
03 
03 
98 
00 
00 
99 
98 
91 
94 
91 
00 
00 
98 
95 
93 
92 
92 
93 
98 
99 
98 
. 92 
. 94 
. 93 
. 94 
. 94 
. 90 
. 92 
. 88 
. 93 
. 91 
. 79 
70 
77 
77 
77 
76 
93 
82 
13 
1 
29 
88 
9 
32 
61 
18 
1 
68 
14 
24 
85 
73 
55 
58 
19 
25 
16 
17 
60 
56 
80 
73 
56 
27 
22 
97 
17 
02 
06 
13 
00 
97 
20 
. 13 
. 08 
. 40 
. 18 
. 95 
. 52 
34 
34 
70 
00 
82 
20 
74 
98 
, 07 
. 66 
. 69 
. 94 
. 39 
272 
Spectrum No.9(FAB+) 
HCP32BI5* x l Bgd=l 7-N0g-91 H ^ I B - B BB^SB 7aE E B -
Bpll=B 1 = 9 . W H M 8 9 5 116=718318976 ficnt: Sys^EflB HflR: 
K . PRRKINSON PT= 9 ° CaL:PFK1406I llflSS-. 
188, 1?'' 
59892888 
164 
136 
118 
481 
373 
192 
2BB 3SB 599 
FB-
68B 788 388 
NCP328l8t x l B9d=6 7-N0V-91 .14:15-8 81:28 7BE 
Bpn=8 1=1.6u Hii=884 TIC=I22618888 R e n t : Sys:FflB 
N. PRRKINSBN P r = e ° CaL:PFK140CT BflGS: 399 
188, 371 
393 
79 
134 162 
juulu 
236 
*»•• far •' ' 
588 688 
Mass 7. Base 
192. 69 4. 66 
193. 70 4. 28 
194.66 1. 71 
201. 68 2. 16 
213. 65 3. 16 
214. 67 1. 38 
215. 65 2. 20 
225. 58 2. 00 
238. 59 1. 88 
239. 62 1. 87 
240. 62 1. 12 
241. 64 4. 70 
242.64 1. 42 
243. 65 2. 50 
244.62 0. 86 
263. 58 2. 57 
264.58 1. 98 
265. 58 2. 03 
290. 57 0. 57 
291.58 4. 75 
292. 59 3. 00 
293. 58 2. 02 
372. 45 1. 87 F 
373. 46 41. 53 F 
374. 46 11.01 F 
375.47 4 . 44 F 
399. 45 1. 71 F 
400. 43 3. 06 F 
401. 46 67. 95 F 
402.46 16.41 F 
403. 48 5.56 F 
404.47 1. 28 F 
405.47 1. 27 F 
288 788 988 
Mass 
46. 82 
50. 77 
52. 79 
53. 79 
54. 79 
55. BO 
56. 80 
• 57.82 
58. 81 
59. 80 
SO. 79 
64. 78 
S5. 81 
66. 82 
67. 82 
68. 83 
69. 84 
70. 84 
72. 83 
73. 81 
73. 88 
74. 83 
75. 83 
76. 82 
77. 83 
78. 84 
79. 83 
80. 83 
81. 31 
82. 82 
88. 81 
89. 81 
90. 82 
91.81 
92. 82 
93. 81 
94. 81 
95. 81 
96 81 
103. 79 
104,79 
!05.79 
106.73 
107. 79 
Base 
1. 
2. 
2. 
2. 
5. 
4. 
22. 
2. 
2. 
1 . 
5. 
3. 
2. 
4. 
2. 
3, 
4. 
6. 
24. 
1 . 
5. 
2. 
7. 
2. 
3. 
2. 
2, 
2 
1 
10 
2 
54 
6 
3 
2 
2 
1 
99 F 
12 
76 
99 
23 
70 
14 
56 
65 
36 
16 
09 
13 
71 
01 
61 
77 
99 
12 
30 
02 
07 
29 
94 
39 
07 
18 
42 
10 
70 
39 
95 
46 
27 
35 
61 
30 
56 
96 
72 
23 
70 
00 
16 
Mass 
108.78 
109. 81 
110.79 
114.76 
115.81 
116.78 
117. 77 
118.75 
119.75 
120.76 
121.76 
122. 77 
126.74 
127.76 
128. 74 
129. 80 
130.75 
131.-71 
132.70 
133.76 
134.74 
135.74 
136. 74 
137.78 
138. 76 
146.72 
147.72 
148. 70 
149.72 
150. 72 
151.72 
159.69 
ISO.71 
161.71 
162.71 
163.72 
164. 72 
165.72 
175. 69 
176.69 
177. 70 
189. 68 
190 65 
191.71 
y. Base 
11. 90 
25. 88 
5. 13 
2. 68 
3. 77 
2. 58 
1. 79 
9. 17 
13 
20 
84 
81 
. 71 
. 38 
7. 
9. 
2. 
2. 
5.
1 
16. 93 
3. 65 
1. 73 
2. 28 
1. 81 
2. 76 
18. 75 
83. 42 
10. 72 
9. 96 
2. 61 
2. 57 
11. 16 
10. 05 
3. 61 
1. 90 
2. 40 
1. 79 
. 1. 58 
13. 75 
9. 64 
100.00 
12. 30 
3. 97 
12 
73 
1. 87 
3. 42 
86 
71 
Spectrum No.lO(FAB+) 273 
NCPfiOFI2* 
Bpl1=8 
NIGEL P . 
x l 
=325«g 
Bgd=l 
H.=1B13 
2B-JUL-32 16:B2>B ! 
I l C : 3 0 8 ' < l B f l f l 
41 7BL 
flcnt 
r e -
S g s T f l B H I m?. 
C a l ^ P r K B J U L S nflSS 
JIBBBB 
• X I O ' O 
I 
316 
135 
382 
itMLiyliiiillltiL L L i i l l i l l n f t i i l i l i , . ! lliiliiiiiikii u l i . d l i l U i l . 
343 
I5B dm 258 
Mas5 y. Base Mass V. Base Mass y. Base 
40 08 12,71 63, 03 44, 16 93 02 3 19 
40, 14 4, 97 S4, 03 14 , 96 93 89 0 94 
40. 26 1, 08 64 23 ! , 45 93 97 2 02 
40 99 1, 08 65, 03 6. 05 94 81 1 36 
41,10 1, 97 66. 05 4, 17 95 20 1 50 
41,15 IS, 17 67. 24 1. 08 96 00 2 02 
42, 13 15, 75 67, 84 1. 08 96 51 1 36 
42 52 1, 17 68, 45 1 , 45 97 88 1 17 
43, 13 18. 19 68, 99 4 , 03 , 97 99 2 67 
43, 30 1,17 69. 06 3 , 05 ' • 98 97 2 02 
44, 1 3 17, 39 70. 03 2, 58 100 98 4 36 
45, 08 100, 00 71 00 3, 84 103. 02 2 25 
45, 14 5, 91 71 . 32 1,17 106. 04 2 44 
45, 69 1, 22 71. 95 1,83 1 1 1 03 2 48 
4S, 08 33, 43 72. 93 1, 73 112. 99 2 95 
46, 16 7, 69 74 , 01 3, 05 114. 01 l ' 64 
47, 09 51 , 65 74 22 1 , 17 114. 09 1 83 
47. 36 1 , 08 75, 00 6, 33 115, 01 3 14 
47, 99 1 , 27 75, 57 1.17 1 16, 03 2 39 
48. 07 1 1 , 39 76, 01 10. 97 116, 16 1 17 
49, 08 6, 33 77, 01 10. 03 116, 75 1 41 
51,11 10,64 78, 00 14, 77 116, 97 1 45 
51.81 1 , 45 78, 42 1 , 08 1 18 85 1 78 
52. 1 1 5, 91 78, 77 1 , 88 1 19 03 2 34 
52, 74 1 - 22 79, 00 72, 86 120 05 1 69 
53, 1 1 9, 70 79, 99 6, 24 1 20 97 1 92 
53, 70 1,17 80, 98 2. 06 1 22 99 1 73 
54, 1 1 3, 28 
1 , 09 
2. 95 
1 , 64 
82, 01 2, 34 1 24 36 1 1 7 
54, 19 
55. 09 
55. 17 
82, 97 
83, 50 
83, 54 
• 1 , 45 
1 , 03 
0, 80 
124 
131 
132 
93 
96 
BB 
2 
1 
6 
16 
50 
89 
55. 99 1. 92 84, 62 1 . 03 .' J3 00 3 14 
56. 01 2, 30 85. 00 3, 52 135 02 18 00 
56. 06 1 . 73 
2, 77 
86. 00 1 , 03 136 01 2 20 
56. 12 87, 00 3, 84 139 97 2 53 
57, 07 5, 44 87, 18 0. 98 141 02 1 88 
57, 48 1 , 08 
1 , 03 
87, 35 1 , 59 147, 00 2. 39 
58, 00 87, 97 1 , 22 149, 01 2. 77 
58, 05 7, 03 88, 14 I 64 153, 03 2. 44 
58, 1 1 3, 19 
7, 31 
2, 48 
88, 98 3, 19 163. 14 1. 59 
59, 05 
59. 1 1 
89, 93 1 , 36 173. 92 2. 44 
90, 00 
90, 56 
1,41 
1.31 
177. 
177. 
01 
85 
1. 
1. 
97 
64 
60, 05 
61,05 
9. 94 91. 02 3. 28 178. 02 2. 91 
37, 27 91, 38 1 . 03 178, 93 1. 59 
62, 05 
62, 57 
51 , 01 
1,17 
91 84 
92, 00 
1. 08 
2. 5^ 
180. 
193. 
05 
78 
4. 
1 . 
64 
59 
t i M i i M ; 1 B i l l 
398 359 
Ma 5 5 '/. Base 
201 97 1 55 
202. 96 1 55 
206. 47 2. 02 
211. 08 1 92 
214. 07 1 59 
214. 97 2 58 
219 97 1 73 
223 04 2 16 
224 01 2 53 
228 1 1 1 69 
251 99 1 55 
261 28 1 59 
273 07 2 58 
276 05 1 73 
313 24 1 55 
314 83 0 75 
316 06 2 72 
318 96 1 13 
321 84 1 36 
324 79 1 27 
324 99 1 41 
326 41 0 80 
327 73 1 78 
330 70 1 27 
333 03 1 55 
333 70 1 59 
336 74 1 22 
338 42 0 80 
339 80 0 94 
344 55 1 08 
348 06 1 13 
349 10 1. 69 
350 85 0. 80 
355 48 0. 98 
358 99 I . 17 
372. ,18 0. 94 
373. 94 0. 94 
375. 46 0. 94 
385. 88 1. 41 
387. 75 1. 13 
389. 33 0. 89 
392. 86 1. 17 
Spectrum No.ll(FAB+) 274 
NCP422 l28 t x l ' Bgd=6 
Bpll=8 I=7B«g Hii=B88 
NIGEL PRRCINSOH 
1 8 8 , 91 193 
5 - l l f l Y - 3 2 
116=9416888 
1 4 : 1 7 - 8 : 8 2 : 4 6 78E 
R e n t : 
F 8 -
PT= 
Sys :F f lB 
6aL:PFK5BRY 
i BflSS: 
512888 
183 
G B J 
28 
123 349 
7 275 
486 
434 
388 488 
H C P 4 2 2 I 2 N x l B9d=15 5 - f lRV-92 1 4 : 1 7 - 8 62 :54 78E 
Bpfl=8 I = 4 6 8 « v HM891 TIC=742398B8 R e n t : 
NIGEL PARKINSON PT= 
188, 9,3 
178 436 
588 
F B -
Sys :F f lB m-
Cal:PFK5llRY HflSS: 
788 
3872B8B 
93 
28 
Mass 
50. 90 
52. 92 
53. 92 
54. 92 
55. 92 
56. 93 
57. 95 
53. 95 
59. 94 
60. 94 
51. 95 
62. 94 
64. 92 
S5. 97 
66. 99 
57. 98 
58. 97 
73. 00 
73. 99 
75. 00 
76. 01 
76. 10 
77. 00 
78. 01 
79. 02 
30. 01 
80. 99 
81. 97 
82. 98 
85. 00 
89. 99 
91. 02 
92. 01 
93. 01 
94. 01 
95. 01 
96. 02 
97. 01 
98. 02 
99. 00 
100. 29 
100.96 
102. 00 
103.01 
104 00 
104. 99 
129 
2G7 
482 
494 
288 
Base 
2 44 
3 06 
2 28 
8 33 
3 33 
30 24 
1 69 
2 83 
8 33 
25 00 
2 12 
1 33 
16 67 
1 86 
4 36 
2. 77 
2 86 
5 1 1 
8 33 
33 46 
2 28 
0 81 
8 33 
2. 31 
16. 67 
4. 46 
8. 1 1 
8. 33 
8. 33 
2. 34 
2 64 
16 67 
. 1 89 
100 00 
8 33 
3 48 
3 19 
2. 73 
1 73 
3. 06 
0. 91 
6. 87 
1 . 30 
2. 96 
1 . 32 
7. 32 
388 468 
Mass '. Base 
107 . 00 16 . 67 
108 . 01 3 . 55 
109 . 00 19 . 99 
110 . 01 8 . 33 
111 01 24 . 45 
112 . 02 2 . 70 
112 . 99 2 . 54 
115 . 00 8 . 1 1 
115 96 2 08 
117 00 3 33 
118 01 1 79 
119 00 3 06 
120 00 2 12 
120 99 8 40 
122 01 2 28 
123 01 2 93 
124 01 2 38 
125 00 4 62 
126 00 2 08 
126 99 25 00 
128 01 8 07 
129 00 S6 67 
130 00 3 40 
130. 98 3. 37 
131. 94 8. 95 
133. 00 T 45 
133. 99 16. 67 
135. 00 16. 67 
136. 00 50. 00 
137. 00 8. 63 
138. 01 8. 33 
138. 98 2. 80 
140. 99 2. 90 
142. 02 1. 69 
142. 98 2. 54 
144. 00 3. 61 
144. 99 2. 73 
145. 99 2. 90 
146. 98 T 32 
147. 99 a. 33 
149. 01 8. 33 
150. 01 8. 33 
151 . 01 3. 71 
152. 01 a. 33 
152. 98 2. 77 
153. 99 2. 47 
464 
i » III^MA,*/ fi'^ ' I K • i V M U n i | H l i n , l i l | l | i | 
588 
Mass •/. Base 
155 . 01 15 . 53 
156 01 2 21 
156 98 3 05 
159 . 01 2 25 
159 97 3 58 
160 98 3 74 
162 01 3 72 
163 01 8 33 
164 02 9 02 
155 00 8 33 
166 00 8 33 
167 00 3 15 
168 00 3 32 
158 95 15 67 
169 95 92 87 
170 95 16 57 
171 95 33 33 
172 97 8 1 1 
174. 02 3 39 
174. 98 3. 32 
176. 01 2. 83 
178. 01 8. 33 
178. 99 3. 03 
181. 97 3. OS 
182. 98 3. 65 
183. 94 2. 80 
135. 01 50. 00 
186. 00 8. 33 
187. 98 7. 85 
188. 97 3. 42 
1 90. 95 16. 67 
191. 98 5. 31 
192. 96 7. 85 
194. 00 3. 81 
195. 98 3, 33 
196. 97 8. 33 
197. 97 33. 33 
198. 97 3. 40 
199. 97 1 1 . 39 
200. 98 3. 61 
205. 99 2. 64 
207. 99 2. 73 
210. 00 2 99 
210. 93 2, 99 
214. 01 3. 33 
215. 00 3. 29 
218. 97 9. 05 
238. 98 6. 84 
Mass V. Base 
246 . 98 13 . 68 
247 . 96 16 . 67 
249 . 00 3 . 71 
250 . 00 8 . 33 
266 . 97 51 . 24 
267 . 98 1 1 98 
268 98 3 33 
277 . 01 5 . 05 
297 00 3 03 
297 94 6 61 
298 96 5 24 
299 93 3 55 
350 . 93 2 . 67 
358 98 2 28 
400 94 8 33 
401 94 25 00 
402 95 8 33 
403 94 8 33 
414 94 2 28 
415 93 4 13 
416 96 2 51 
417 97 3 32 
430. 99 2 51 
431. 98 3. 33 
432. 97 2. 64 
433. 95 8. 33 
434. 90 B. 33 
435. 33 91 . 67 
435. 83 33. 33 
437. 88 35. 09 
438. 38 10. 16 
439, 94 9 70 
441. 94 1. 55 
461. 93 3. 94 
462. 98 2. 38 
463. 97 16. 57 
454. 98 3. 87 
465. 98 4. 20 
466. 96 2. 15 
491. 98 3. 33 
492. 93 6. 58 
493. 97 34. 02 
494. 96 8. 40 
495. 95 8. 33 
496. 97 1. 66 
Spectrum No.l2(FAB+) 
275 
NCPGUIIIB* x l Bgd=8 ;-JUL-9e lE e8>9^8^4't ?K r e -
8pfl=e I=148ini H « = i a i J IIC=1B85BB30 ficnt^ Sus^FflSHI HHR-
N i c a pr= a» u - p r a j u i s f i f l s s 
L 31 
EBJ 
59 71 l a ; !5fl i33 
l | r I I . I I I 
31 
383 
L'33 
i t ! l l i i u , i l l liii . i i ^ i i , l i . M i l l , p'l I I III II III ill ill I I I i I III 11 
5B 159 203 ?58 399 359 •159 
N C P C U H I U x l Bgd=l 7-JUL-3a IG 2B-B^81 52 ,"'8E 
Bpfl--8 1=1.5ci Hii=1131 riC=186315a9B Rent 
NIGEL PT= 8' 
33 
- Qtl 
Sys^fflBHl Wm-
CaUPFKBJULS IfflSS^ 
9;P8BgB 
152 
189 
123 
185 
iLiiiiJlliiim a Ui.l|li>aiiii.iBliLi . i J i h h i Ii in I 
2 S ; 
^19 
158 258 
M a s s •/. B a s e Mass •/. B a s e 
5 0 . 0 1 0 . 8 6 1 0 6 . 9 6 3 . 2 5 
5 1 . 0 1 2 . 6 5 1 0 7 . 9 5 2 . 53 
5 2 . 0 1 1 . 3 6 1 0 8 . 9 6 1 5 . 4 2 
5 3 . 0 2 2 . 7 9 1 0 9 . 23 0 . 37 
5 4 . 0 2 2 . 5 6 1 0 9 . 9 6 7 . 8 9 
5 5 . 0 1 7 . 9 6 1 1 0 . 9 7 5 . 4 1 
5 6 . 0 1 5, 8 1 1 1 1 . 97 1 . 2 5 
5 7 . 0 2 5 2 . 6 3 1 1 2 . 9S 1 . 4 5 
5 8 . 0 2 3 . 3 3 1 1 3 . 9 5 0 . 5 6 
5 9 . 0 2 2 . 6 3 1 1 4 . 94 5 . 2 6 
6 0 . 0 1 5 . 15 1 1 5 . 9 2 0 . 7 8 
6 1 . 0 1 1 0 . 5 3 1 1 6 . 9 6 2 . 63 
6 2 . 0 1 0 . 6 6 1 1 7 . 4 1 0 . 3 2 
6 3 . 0 1 1 . 4 6 1 1 7 . 9 8 1 . 03 
6 6 . 0 2 1 . 3 6 1 1 8 . 9 7 2 . 6 3 
S 7 . 0 2 2 . 6 3 1 2 0 . 96 2 . 3 4 
6 8 . 0 2 0 . 8 7 1 2 1 . 9 7 1 . 3 2 
6 9 . 0 2 2 . 6 3 1 2 2 . 9 6 2 . 63 
7 0 . 0 2 1 . 1 1 1 2 3 . 9 7 2 . 63 
7 1 . 0 2 1. 4 3 1 2 4 . 9 6 1 57 
7 2 . 0 0 2 . 10 1 2 5 . 9 7 2 4 9 
7 3 . 0 0 5. 4 7 1 2 6 . 9 5 8 74 
7 4 . 0 0 5 . 7 7 1 2 7 . 9 6 1 . 26 
7 5 . 0 1 4 7 . 5 3 1 2 8 . 9 5 2 1 . 0 5 
7 6 . 0 1 2 . 6 6 1 2 9 . 9 6 2 . 86 
7 7 . 0 0 7 . 8 9 1 3 0 . 93 2 . 73 
7 8 . 0 1 2 . 6 3 1 3 1 . 8 9 3 . 2 0 
7 9 . 0 2 8 . 5 2 1 3 3 . 9 4 2 . 63 
8 0 . 0 1 2 . 63 1 3 4 . 5 1 0 . 4 1 
8 0 . 9 8 2 . 6 3 1 3 4 . 9 2 1 5 . 7 9 
8 1 . 7 4 0 . 3 9 1 3 5 . 9 5 5. 8 1 
8 1 . 9 6 2 . 6 8 1 3 6 . 94 5 . 2 5 
8 2 . 9 8 3 . 0 0 1 3 7 . 9 5 2 , 63 
8 4 . 9 9 • 1. 33 1 3 8 . 9 4 1 . 3 7 
8 9 , 9 7 1 . 1 3 1 3 9 . 9 6 0 . 9 0 
9 0 . 9 9 5. 73 1 4 0 . 9 5 2 . 63 
9 1 . 9 8 1 . 4 6 1 4 1 . 9 6 0 . 6 4 
9 2 . 9 8 9 5 . 3 8 1 4 2 . 94 1 . 0 1 
9 3 . 9 8 5. 4 6 1 4 5 . 9 4 1 . 05 
9 4 . 9 7 2 . 6 3 1 4 6 . 9 4 1 . 1 4 
9 5 . 9 8 1 . 3 1 1 4 8 . 93 5 . 2 6 
9 6 . 9 7 2 . 6 3 1 4 9 . 9 6 1 . 1 1 
9 7 . 9 8 I . 3 1 1 5 0 . 9 2 1 9 . 15 
9 8 . 9 5 2 . 6 3 1 5 1 . 9 3 1 0 0 . 0 0 
1 0 0 . 9 1 2 . 6 3 1 5 2 . 9 2 1 0 . 53 
1 0 4 s e 2 6 3 1 5 3 . 9 4 5 . 2 6 
1 5 4 . 9 5 2 . 6 3 
1 8 6 . 93 
1 8 9 . 9 0 
8 8 
8 9 
8 9 
8 9 
9 0 
9 0 
9 2 
1 9 0 
191 
1 9 2 
193 
194 
2 0 0 
2 0 1 
2 0 6 . 9 2 
2 0 7 . 91 
2 1 1 . 3 8 
2 1 4 . 8 9 
2 1 8 . 8 8 
2 1 9 . 9 1 
2 2 2 . 8 7 
2 2 3 . 9 0 
2 2 9 . 9 1 
2 4 6 . 8 9 
2 4 7 . 9 0 
2 5 8 
2 5 9 
2 6 6 
2 6 7 
. 7 9 
. 8 8 
. 8 7 
8 9 
359 
1. 2 7 
2 . 6 3 
5. 2 9 
1 . 2 8 
1 . 2 1 
2 . 4 9 
1. 12 
1 . 0 8 
1 . 0 3 
1. 0 3 
2 . 6 3 
2 . 33 
1. 8 4 
3. 16 
1 . 12 
2. 63 
1 . 3 2 
5. 2 6 
5 . 2 6 
2 . 6 3 
1 . 0 1 
1 . 1 1 
1 0 . 5 5 
2 . 63 
•159 598 
Mass B a s e Mass •/. B a s e 
156 9 5 1 13 2 7 6 9 2 2 63 
159 9 0 2 63 2 7 7 8 8 2 0 7 
160 9 1 I 7 5 2 7 8 8 9 1 17 
161 9 4 1 4 2 2 7 9 8 8 2 63 
162 9 4 2 63 2 8 0 8 8 3 3 8 
163 93 3 2 1 2 8 1 8 9 2 63 
164 9 4 2 6 8 3 6 1 7 4 1 15 
155 9 4 2 6 9 3 7 3 8 2 1 00 
166 94 0 9 6 3 8 8 . 7 9 2 63 
157 93 2 6 3 3 8 9 . 76 3 9 5 1 
170 9 0 I 10 3 9 0 . 7 7 12 85 
171 9 1 0 7 7 3 9 1 . 12 0 3 5 
172 8 8 I 3 7 3 9 1 . 77 5. 26 
176 92 1 2 1 3 9 2 . 7 9 1 01 
177 9 4 3 2 8 3 9 7 . 75 1. 00 
178 9 2 2 63 4 1 6 . 82 1. 2 7 
179 93 10 5 4 4 1 7 . 78 3 1 . 58 F 
1 8 0 . 93 2 7 0 4 1 8 . 7 9 8. 5 7 F 
181 93 2 63 4 1 9 . 80 5. 26 
1 3 4 . 9 5 3 4 . 4 8 4 2 0 . 82 1. 0 6 
1 8 5 . 9 5 2 . 63 4 2 1 . 83 0. 8 9 
Spectrum No.l3(FAB+) 
276 
NCPCUFJGt x l B9d=5 8B-JUL-92 15^3;-
Bpn=8 l=8.5u HM1816 TIC=3455J899a 
NIGEL P. 
•XSO'O 
p 78 
flcnl.: 
FB' 
Sys^FRBHI 
Ca l^PFmULS' 
urn-
fIflSS-
XSO'O* 
55778889 
78 
35 
85 
55 
58 . 
45. 
48 
55 
38 
25 
18 
45 
383 
157 
117 
i lUuU ii.ll I I I III Ihi . Ii 
58 188 158 
M a s s B a s e M a s s •/. B a s e 
4 0 0 8 , 4 4 4 9 3 . 0 1 1 . 4 7 
4 1 0 7 2 9 2 F 1 0 0 . 9 6 0 . 4 9 
4 1 14 2 3 2 F 1 0 2 . 93 0 . 4 6 
4 2 14 2 9 11 1 0 8 . 4 5 3 4 . 7 4 
4 3 13 2 3 2 1 16 . 9 5 0 . 7 5 
4 4 0 7 5 9 8 F 1 3 4 . 9 5 0 . 3 4 
4 4 14 0 5 6 F 1 3 9 . 0 0 0 . 4 0 
4 5 0 8 6 2 16 F 1 4 0 . 9 7 0 . 4 8 
4 5 13 1 8 4 F 1 5 5 . 9 9 0 . 5 3 
4 6 0 8 19 4 7 1 5 6 . 9 9 2 . 3 3 
4 7 0 9 2 1 5 7 1 5 9 . 0 0 0 . 3 4 
4 8 0 6 14 3 7 1 8 0 . 0 5 0 4 4 
4 9 0 7 2 8 8 1 8 0 . 9 3 0 . 4 6 
5 0 0 6 1 0 3 3 0 3 . 0 5 2 . 7 5 
5 1 0 8 0 4 5 3 0 4 . 0 9 0 3 2 
5 3 11 0 9 2 
5 4 10 0 3 7 
5 5 10 0 9 2 
5 6 0 3 0 6 1 
5 6 1 1 0 3 9 
5 7 0 3 2 . 9 1 F 
5 7 10 0 . 9 2 F 
5 8 0 4 1. 8 4 
5 9 . 0 4 2 . 2 2 
6 0 0 4 0 . 6 0 
6 1 0 5 2 2 . 2 1 
S 2 . 0 4 1 7 . 3 2 
5 3 . 0 2 7 1 6 5 
6 4 . 0 2 4 . 8 8 
6 5 0 0 3 . 14 F 
6 5 0 6 0 7 0 F 
6 7 0 5 0 4 1 
6 8 0 5 0 3 4 
6 9 0 0 0 6 8 
7 1 0 0 0 4 6 
73 0 1 0 3 1 
7 5 0 0 0 6 5 
7 7 0 0 1 7 5 
7 7 . 9 8 1 0 0 . 0 0 
7 8 9 9 5 2 . 6 6 
7 9 9 8 6 . 13 
8 0 9 9 2 . 4 7 
8 2 . 9 8 0 . 4 6 
8 4 . 9 6 0 . 4 0 
8 6 . 9 5 0 . 4 5 
258 388 358 408 
277 
Spectrum No.l4 (EI+) 
N C P 1 5 9 « 9 6 8 t f xl B9d :951 2 2 - M A R - 9 1 15: 47+0: 18: 45 7 0 E [!• 
B b M = 0 1 = 7 . S v 
N'. P R R K I N S O N 
H « = 2 7 2 T I 0 = 6 9 6 7 5 0 0 0 0 
28 
13B 108 
1** 
58 
161 
188 158 288 258 
Rent: 
P T = 8" 
1 
S y i : M U L L I 
C a l : P F K 2 2 
388 358 ' 458 
M a s s 
4 0 . 8 8 
4 1 . 8 9 
4 2 . 8 6 
4 2 . 9 0 
4 3 . 8 7 
4 4 . 8 8 
4 5 . 8 8 
4 6 . 8 2 
4 6 . 8 8 
- 4 7 . 8 3 
4 9 . 8 7 
5 0 . 8 7 
5 1 . 8 9 
5 2 . 9 0 
5 3 . 91 
5 4 . 9 2 
5 5 , 9 3 
5 6 . 8 9 
5 8 , 9 0 
6 3 . 8 9 
6 4 . 8 7 
6 5 . 9 2 
6 6 . 8 6 
6 6 . 9 5 
6 7 . 9 5 
6 8 . 9 5 
7 0 , 9 3 
7 1 , 9 4 
7 2 , 9 4 
7 4 , 91 
7 5 , 9 0 
7 6 , 9 2 
7 7 , 9 3 
7 8 , 9 5 
7 9 , 9 5 
8 0 , 8 7 
8 0 , 9 7 
8 1 , 8 9 
8 2 , 8 9 
8 2 . 9 9 
8 3 , 8 9 
8 4 . 9 3 
8 5 , 9 4 
8 8 , 91 
8 9 , 9 2 
9 0 , 91 
9 1 , 9 2 
9 2 , 91 
9 3 , 9 3 
9 4 , 9 2 
9 3 . 91 
9 6 , 9 2 
9 7 . 9 3 
9 8 . 9 3 
1 0 0 . 8 6 
1 0 2 . 9 0 
1 0 3 . 9 2 
B a s e 
5 7 . 5 2 
6 . 0 0 
6. 3 0 
3 , 5 3 
1 , 3 9 
11 , 91 
1 
6 
3 
1 
1 
, 0 6 
, 18 
. 2 7 
18 
. 3 6 
10, 6 7 
2 , 61 
12 , 8 3 
11 , 4 5 
2 3 , 5 2 
10 . 0 7 
5 . 13 
3 4 . 41 
2 . 3 2 
1. 8 9 
16 . 3 4 
6. 5 7 
2 . 7 0 
4. 71 
5 . 41 
10 . 3 7 
9 5 
0 3 
3 2 . 5 7 
2 . 2 7 
9 0 
3 4 
4 1 . 6 2 
12 . 5 2 
2 9 . 2 0 
18 . 2 7 
6 7 
94 
14 
2 4 
4 2 
10 . 14 
14 . 4 5 
2 . 6 6 
2 7 . 2 8 
3 3 
2 9 
1. 2 3 
2 . 5 8 
0 . 4 3 
1 . 3 9 
16 . 9 8 
3 . 8 5 
2 , 0 5 
M a s s 
1 0 8 . 8 7 
1 0 9 . 8 8 
1 1 0 . 88 
1 1 1 . 9 0 
1 1 2 . 9 3 
1 1 3 . 9 4 
1 1 4 . 9 0 
1 2 9 . 9 2 
1 3 0 . 9 1 
1 3 1 . 8 3 
1 3 2 , 8 5 
1 3 6 . 8 8 
1 3 7 , 8 9 
1 3 8 , 9 0 
1 3 9 , 9 0 
1 4 2 , 9 3 
1 5 6 , 8 7 
1 5 7 , 9 2 
1 5 8 , 8 7 
1 5 9 , 8 3 
1 6 0 . 8 3 
1 6 1 , 84 
1 7 4 . 86 
1 8 7 . 84 
1 8 8 . 84 
1 9 2 . 8 4 
1 9 3 . 8 5 
2 1 4 . 8 4 
2 2 1 , 8 5 
2 4 2 , 8 5 
2 4 9 , 8 6 
2 5 0 . 8 7 
2 6 9 . 8 4 
2 7 0 . 8 5 
2 7 1 . 8 6 
-/. B a s e 
3 6 . 98 
14 . 5 6 
4 0 . 9 9 
3 . 0 3 
14. 2 3 
. 8 3 
. 04 
9 2 
6 6 
8 9 . 3 5 
13 . 18 
9 . 3 1 
9 6 . 26 
1. 7 9 
1. 8 7 
1, 17 
4. 6 8 
2 . 8 8 
0. 6 8 
4 4 . 0 2 
? 7 . 11 
9 6 
31 
100 . 0 0 
5 . 81 
1. 3 7 
9 0 
7 7 
5 4 
4 5 
12 . 76 
1. 5 9 
1. 9 2 
9 . 4 7 
1. 19 
278 
Spectrum No.l5(CI+) 
188., 
G8 
28 
NCP348t4* x l Bgd=2 31-JflN-92 18:25*8 88:42 78E 
Bpl!=B l=5.1v H«=53E TIC=147885888 flcnt^ 
N. PRRKINSON 
227 
C I * 
Sys^RCE HIIR: 
PT= 8' CaUPFC31JRN HRSS: 
2B7438BB 
227 
219 
, l | J . I 
288 58 188 
M a s s 7. B a s e 
5 1 . 9 6 1,53 
5 7 . 9 7 1,53 
6 3 . 9 9 6,14" 
6 8 . 9 7 8 .59 
—85 .99 2 .40 
9 6 . 0 0 1 2 . 2 7 
9 6 . 9 9 3 .32 
1 3 1 , 9 7 6 .44 
1 4 8 , 9 9 7 .67 
1 9 3 , 8 8 1.60 
1 9 5 , 8 8 1.57 
2 0 9 , 8 3 4 5 . 4 6 
2 1 0 , 8 4 3 . 0 7 
2 1 1 , 8 3 4 4 . 5 0 
2 1 2 , 8 5 3 . 0 7 
2 2 6 . 8 6 1 0 0 . 0 0 
2 2 7 . 8 7 6 .44 
2 2 8 . 8 7 9 8 . 1 7 
2 2 9 . 8 8 6 ,14 
158 258 388 358 
279 
Spectrum No.l6(CI+) 
B p n = B 1=3.Iv 
N. PRRKINSON 
Bgd=2 7-FEB-92 
Hn=239 T1C=B4258B88 
15 85*8:88:46 7eE 
Rent: 
211 
C I * 
PT= 8° 
Sys:flCE 
Cal:PFK31JRN 
191 
228 
SB 108 
M a s s 7. B a s e 
5 7 . 9 6 1.53 
5 8 . 9 6 4 . 0 3 
8 0 . 9 7 3 . 0 9 
9 0 . 9 6 2 . 0 3 
1 2 9 . 9 7 4 . 6 7 
1 3 7 , 9 9 4 . 1 8 
1 5 5 , 0 1 4 . 8 7 
1 9 0 , 0 0 1 8 . 7 0 
2 1 1 , 0 1 1 0 0 . 0 0 
2 1 2 , 0 0 - 13 .65 
2 2 8 . 0 0 2 6 . 3 2 
2 2 9 . 0 1 3 . 3 8 
150 208 258 388 359 409 
280 
Spectrum No.l7 (EI+) 
1 . C P 7 6 . 1 3 3 5 . B , d . l 3 i r g - S E P - 9 0 1 0 . 3 9 * 0 : 1 8 : 4 5 7 0 E 
B p l I = B I = 4 . B M H M 2 6 9 T I C = 1 3 4 1 8 8 0 0 0 A c n t : S y s : P A R K l N S C 
N . PflRKINSOH GC= 216 C a l : P F K 1 7 S E P 
I 8 B L 
4 8 
2 8 J 
5 9 
1 1 1 1 3 8 
8 1 
1 6 1 2 4 8 
JlULi 
1 8 8 
2 2 8 
2 G 8 
5 8 1 8 8 1 5 8 2 8 8 
M a s s '/. B a s e M a s s '/. B a s e 
5 1 . 04 . 7. 31 131 . 16 16 . 54 
5 2 . 06 3 . 9 9 132 . 0 7 - 9 5 . 4 8 
5 3 . 0 7 14. 7 3 133 . 08 13 . 60 
5 4 . 0 8 6. 9 7 135 . 12 4 . 7 7 
5 5 . 08 3 . 04 136 19 0 6 0 
5 7 . ^ 5 2 . 86 1 3 7 14 3 4 9 
5 9 . 0 7 4. 8 8 138 13 6 3 51 
6 3 . 0 7 1. 3 9 1 3 9 16 10 2 5 
6 4 . 06 2 t 3 5 140 17 0 6 4 
6 5 . 0 2 - 3 3 . 88 141 15 0 84 
- 6 5 . 08 8. 21 143 16 6 2 7 
6 6 . 0 9 4. 4 0 145 0 9 0 5 7 
6 7 . 0 2 0. 70 155 17 0 4 9 
6 7 . 10 6. 21 156 19 10 7 9 
7 1 . 08 1. 7 9 157 16 8 16 
7 5 . 06 1. 7 5 158 19 2 20 
7 6 . 0 7 0. 3 7 160 11 30 2 7 
7 7 . 08 2 3 . 38 161 12 3 6 80 
7 8 . 0 9 4. 6 4 162 14 0 81 
7 9 . 10 5 8 . 10 1 6 3 16 1 3 7 
8 0 . 11 15 . 0 2 171 14 0 9 3 
8 1 . 0 2 3 4 . 0 0 1 7 2 . 15 3 5 0 
8 1 . 12 8 1 . 6 3 1 7 3 . 16 1. 38 
8 2 . 0 3 5 7 . 6 5 1 7 4 . 15 0 5 0 
8 2 . 12 5 . 3 3 1 8 8 . 16 2 7 . 8 2 
8 3 . 0 4 3 3 . 9 2 1 8 9 . 18 1. 14 
8 4 . 0 5 4. 0 3 1 9 1 . 16 7. 9 7 
8 5 . 0 8 3 . 7 7 1 9 2 . 16 19. 5 9 
8 8 . 0 7 0. 5 6 1 9 3 . 17 2 . 5 9 
8 9 . 0 9 0. 9 8 194 . 16 0. 71 
9 0 . 0 9 5 . 14 1 9 5 . 17 1. 94 
9 1 . 0 9 17. 3 9 1 9 9 . 18 0. 76 
9 2 . U 2 . 41 2 0 0 . 19 0. 38 
9 3 . 0 7 14 . 4 8 2 0 1 . 19 0. 7 3 
9 4 . 0 8 3 . 2 7 2 0 5 . 18 1. 4 5 
9 5 . 0 9 4. 6 7 2 1 1 . 18 0. 3 6 
9 6 . 0 9 2 . 4 3 2 1 9 . 20 2 . 4 5 
9 7 . 10 10. 36 2 2 0 . 21 19. 2 7 
9 8 . 12 0. 5 4 2 2 1 . 2 2 1. 4 0 
9 9 . 12 1. S 2 2 2 3 . 2 2 0. 5 8 
1 0 1 . 0 5 16. 6 8 2 2 5 . 21 0. 4 2 
1 0 2 . 0 9 1. 34 2 4 0 . 2 3 2 . 11 
1 0 3 . 10 4. 4 0 2 4 7 . 26 0. 6 0 
1 0 5 . 11 1. 70 2 4 8 . 2 5 3 4 . 3 7 
1 0 7 . 12 4. 3 7 2 4 9 . 2 6 3 . 90 
1 0 8 . 12 11 . 4 9 2 6 8 . 2 7 2 6 . 5 5 
1 0 9 . 10 2 8 . 8 6 2 6 9 . 2 8 5 . 8 8 
110 . 0 9 2 8 . 4 2 
1 1 1 . 0 9 9 1 . 6 5 
1 1 2 . 13 11 . 5 7 
1 1 3 . 11 2 . 4 2 
1 1 4 . 10 1. 6 9 
1 1 5 . 11 2 1 . 8 5 
1 1 6 . 1 1 1. 44 
1 1 8 . 16 1. 5 6 
1 2 1 . 13 2 . 6 8 
1 2 7 . 13 8. 4 0 
1 2 8 . 15 2 4 . 2 3 
1 2 9 . 13 3 3 . 3 6 
1 3 0 . 15 1 0 0 . 0 0 
2 5 8 3 5 8 4 5 8 
281 
Spectrum No.l8(EI+) 
no picture 
M a s s 7. B £ s e 
4 1 . 0 2 0 . 3 5 
4 4 . 0 3 0 . 7 5 
4 5 . 0 2 0 . 5 1 
4 6 . 0 4 0 . 6 6 
5 8 . 0 3 1.12 
5 9 . 0 2 3 . 9 1 
6 0 . 0 2 0 . 3 3 
6 7 . 0 2 2 . 5 6 
7 3 . 0 3 0 . 4 9 
7 4 . 0 2 0 . 3 2 
7 5 . 0 4 0 , 5 5 
7 6 . 9 9 0 , 4 6 
7 8 . 0 0 0 , 7 1 
7 9 . 0 1 0 , 5 2 
8 0 . 0 2 0 . 6 2 
9 1 . 0 0 1.19 
9 3 . 0 1 0 . 3 9 
9 4 . 0 1 0 . 4 3 
9 5 . 9 9 0 . 3 9 
9 7 . 9 6 0 . 4 9 
1 0 6 . 9 9 0 . 3 1 
1 0 8 . 0 0 1.79 
1 1 0 . 9 8 1.28 
11 2 . 0 0 0 . 6 4 
1 1 4 . 9 7 0 . 4 0 
1 2 0 . 9 8 0 . 3 2 
1 2 5 . 9 6 1.29 
1 2 6 . 9 6 0 . 4 7 
1 2 7 . 9 8 0 . 6 5 
1 2 8 . 9 8 0 . 9 8 
1 2 9 . 9 8 2 . 5 6 
1 3 1 . 0 0 0 . 6 2 
1 3 6 . 9 9 0 . 3 7 
1 3 7 . 9 6 2 . 5 6 
1 3 8 . 9 8 1.28 
1 4 2 . 9 7 0 . 3 5 
1 5 4 . 9 6 2 . 5 6 
1 5 5 . 9 9 1.33 
1 5 6 . 9 7 0 . 5 4 
1 6 1 . 0 2 1.50 
1 6 8 . 9 7 1.28 
1 7 1 . 9 6 0 . 3 2 
1 8 1 . 9 6 0 . 4 4 
1 8 2 , 9 6 1 8 . 1 4 
1 8 3 , 9 7 1.28 
1 8 7 , 9 3 1.28 
1 8 8 , 9 2 2 5 . 5 9 
1 8 9 , 9 3 1.45 
1 9 8 , 9 5 2 . 5 6 
1 9 9 , 9 3 1.28 
2 3 3 , 9 4 3 . 1 6 
2 3 4 , 9 5 0 . 6 9 
2 3 8 , 9 5 0 . 7 7 
2 4 8 , 9 5 0 . 4 6 
2 5 0 , 9 4 0 . 3 0 
2 5 2 , 9 3 0 . 7 9 
2 5 4 , 9 2 3 . 8 4 
2 5 5 , 9 4 1 0 0 . 0 0 
2 5 6 . 9 5 1 2 . 8 0 
2 5 7 . 9 4 2 . 5 0 
2 5 8 . 9 2 1.21 
Spectrum No.l9 (CI+) 
282 
N C P 3 4 B I 3 * x l B9d=2 7 - F E B - 9 2 15 85* 
Bpll=8 l = 3 . 1 u H M 3 7 6 T I C = 6 4 2 5 B 0 B 8 
N . PRRKINSBN 
48 
189 
2 B E 
46 7BE C I * . 
R e n t : S y s : f l C E 
PT= 8 ° C a L : P F K 3 1 J f l N 
2 8 3 
262 
HflR: 
HRSS: 
31234808 
283 
58 188 
M a s s 7. B a s e 
" 58.03 1.12 
59,02 3.91 
94,99 2.56 
95,99 1.19 
108,00 1.79 
108,98 1.63 ' 
125.96 1.29 
124.98 1.28 
129.98 2.56 
137.96 2.56 
138.98 1.28 
142.97 2.56 
154.96 2.56 
155.99 1.33 
182.96 18.15 
183.94 - 1.28 
187.93 1.28 
188.92 25.59 
189.93 1.45 
205.94 14.16 
206.94 1.28 
261.92 31.00 
262.94 3.16 
281.92 3.84 
282.92 100.00 
283.94 12.80 
284.95 2.50 
299.96 35.67 
300.93 6.34 
158 258 388 358 458 
Spectrum No.20(CI+) 
283 
NCP329I4» x l Bgd=l 5 -FEB-92 14:19*8:88:41 78E E I * 
Bpll=B I=8.5v H M 3 2 6 TIC=1I7B72BB8 Rent: Sus:fiCE H?IR: 
N . i f l R K I I I S O N P T = B » Cal:PFK31JflN m S S : 
1 8 8 , 4 5 
45 
4 B 
2 8 J 
,1 
95 
58 158 25B 358 
C I * NCP329J5» x l B9d=2 5-FEB-92 14:19*B:flB:4G 78E 
9pfl=8 I=2.4u H«=194 TIC=559B4BB9 Rent: Sgs:flCE HIIR: 
N. PflRKINGBH PT= 8° C a l:PFniJflN BflSS: 
1 B 8 , « 
28 
58 188 158 
NCP323fG. x l Bgd=3 5 - F E B - 9 2 14:19*9:1 
BpB=fl I=553«w Hm411 T I C = 1 2 7 1 1 B B B 
H. PflRKINGOH 
I 127 
288 
I B : 5 2 7BE 
Rent: 
258 
C I -
388 
PT= 8° 
S y r f l C E 
CaL:PFi;31JflH 
HIIR: 
n f l s s : 
358 
3B25BB8 
127 
28 141 168 3 E 5 
189 159 2BB 258 35fl 
M a s s V. B a s e 
4 4 . 0 4 0 5 8 
4 9 . 0 2 100 0 0 
4 6 . 0 3 2 9 4 
4 7 . 0 4 0 5 9 
5 8 . 0 4 0 4 9 
5 9 . 0 3 0 4 5 
6 0 , 0 3 0 8 3 
6 3 , 01 0 . 9 4 
6 8 , 9 8 0 8 4 
7 4 , 0 3 1 8 6 
7 4 , 9 9 0 3 9 
7 6 . 01 1 61 
7 7 . 0 0 3 2 2 
8 8 . 0 5 0 3 3 
9 2 . 01 0 7 7 
9 4 . 0 0 0 81 
9 4 . 9 9 6 61 
1 0 7 . 0 0 3 2 2 
1 0 8 . 0 4 0 3 6 
1 1 2 . 9 7 0 8 3 
1 2 2 . 9 7 0 3 8 
1 5 6 . 9 8 1 61 
1 7 5 . 98 3 2 2 
1 7 6 . 98 3 9 6 
1 9 4 . 9 6 0 5 7 
284 
Spectrum No.21(CI+) 
NCP23C»3. x l 8 
Bp)l=8 1=3.3v H«=G. 
N.PRRUNSON 
B-l1flR-98 1G:28'I 
IIC=25G8558B8 
:31 7BF 
Rent: Sys:flCE 
Cal:PFK2nRR fIRSS: 
J17828B8 
45 
28 
B i l l 
149 
B8 77 
U i i U . i J * i i . i | l n i i m J l i i . i i i l . i . 1.1 
288 
.^w-.i"- V f." 
m 
c i -NCP23CI8t x l Bgd=B G-flflR-38 1G:28'8:88:52 78F 
8pH=8 I=18u H«=549 I1C=48525881G Rent: Sy5:RCE HflR: 
N.PflRUNSBN P r = 8 ° Cat :PFK2I1RR flflSS: 
85534888 
78 
28 124 
273 
288 188 
M a s s 7. B a s e M a s s 7. B a s e 
4 4 0 2 14 0 8 1 1 1 0 2 1 3 3 
4 5 0 2 3 8 9 1 1 2 0 3 1 8 2 
4 6 0 4 2 8 3 1 1 3 0 2 1 8 8 
4 9 0 5 1 0 4 1 1 4 0 2 3 2 0 
5 2 0 6 16 7 8 1 1 5 0 2 3 3 1 
5 6 0 2 1 3 7 1 1 6 0 2 6 93 
5 8 0 3 7 3 0 1 1 7 0 4 1 7 7 
5 9 0 3 2 0 9 1 18 0 2 5 9 6 
6 0 0 1 3 0 6 1 1 9 0 3 1 6 5 
6 0 0 5 1 9 1 1 2 0 0 2 2 15 
6 1 0 0 5 6 9 6 1 2 1 0 1 1 8 1 
6 2 0 1 1 2 4 1 2 2 0 2 1 8 1 
7 0 0 2 5 1 1 1 2 3 0 2 2 0 1 
7 2 0 3 2 4 9 1 2 4 0 1 2 0 6 6 
73 0 3 1 0 1 1 2 5 0 2 2 6 2 
7 4 0 2 3 6 9 I 1 2 6 0 2 1 3 0 
7 6 0 0 3 3 2 ' 1 2 7 0 2 1 6 9 
7 7 0 2 5 7 7 1 2 8 0 3 2 2 5 
7 8 0 3 1 0 0 0 0 1 2 9 0 2 1 0 4 
7 9 0 2 3 2 7 1 3 0 0 4 2 7 5 
8 0 0 1 1 5 1 1 3 1 0 4 1 5 7 
8 2 0 2 1 5 5 1 3 2 0 3 4 7 5 
8 4 0 2 2 . 7 8 1 3 3 03 2 2 4 
8 5 0 2 2 8 . 6 9 1 3 4 0 3 1 5 7 
8 6 0 3 2 . 73 1 3 5 0 2 1 2 1 
8 8 . 0 2 3 . 0 8 1 3 6 0 2 1 3 7 
8 9 0 3 I . 0 1 1 3 8 0 3 1 13 
9 0 . 0 1 2 3 . 8 3 1 3 9 0 3 2 3 9 
9 1 . 0 3 3 . 3 8 1 4 0 0 2 1 0 4 
9 3 . 0 1 2 . 11 1 4 3 0 0 1 2 9 
9 4 . 0 1 5 . 2 7 1 4 4 0 4 2 0 6 
9 5 . 0 1 3 . 2 6 146 0 2 1 8 2 
9 6 . 0 2 1 . 7 0 1 4 7 0 4 1 0 4 
9 7 . 0 2 1. 23 1 5 0 0 1 1 3 8 
9 8 . 0 3 1 . 4 5 1 5 8 0 4 1. 3 0 
9 9 . 0 3 1 . 6 7 1 6 6 . 0 2 1 . 15 
1 0 0 . 0 4 1 . 8 8 1 6 9 . 0 3 1 . 6 3 
1 0 1 . 0 2 2 . 0 4 1 7 0 . 0 9 3 . 7 0 
1 0 2 . 0 4 4 . 3 2 1 8 0 . 0 4 1 . 5 3 
1 0 3 . 0 3 1 . 8 4 1 8 1 . 0 1 1 . 6 5 
1 0 4 . 0 2 1. 4 7 1 8 3 . 0 0 1 . 2 3 
1 0 5 . 0 4 1 . 9 9 1 9 4 . 0 2 2 . 6 0 
1 0 6 . 0 1 1. 18 2 0 0 . 0 4 2 . 4 3 
1 0 7 . 0 3 5 . 2 8 2 1 5 . 9 9 5 . 7 0 
1 0 8 . 0 2 1 2 . 10 2 2 2 . 0 0 2 . 3 9 
1 0 9 0 2 2 . 3 7 2 7 9 . 0 3 1 2 . 6 5 
1 1 0 . 0 2 3 . 0 7 
388 588 
285 
Spectrum No.22 (CI+) 
NCP331I5« x l BgdM 31-JflN-32 1P37-8:B8:47 7BE E l * 
Bpn=B I=lBu H«=285 TIC=294542B16 Rcnt^ Sys^RCE mi-
K. PflfiUHSOH PT= 9° Cal^PFOlJflH (IRSS^ 
IBB, ^1 
B5534BBB 
71 
28 
j i " i , l i i l l I I • .1. 
58 158 288 258 3BB 
HCP331I6* x l Bgd=2 31-JflH-32 11:3?«8: 
8pn=e l--\iv HM285 TICM38483B88 
N. PRJKINSflll 
li 71 
28 
58 
5B 
|:52 78E C h 
Rent: Sys^flCE HBR^  
PT= 9 ' CaUPFWlJRH ARSS^  
158 288 258 3BB 
M a s s /. B a s e 
4 1 . 0 1 3 . 5 2 
4 2 . 0 2 0 . 3 9 
4 3 . 0 3 1. 5 6 
4 4 . 0 2 0 . 5 2 
5 6 . 0 2 0 . 6 0 
5 8 . 0 4 6 . 7 6 
5 9 0 2 0 . 7 1 
6 8 9 8 0 4 2 
7 0 0 2 0 3 9 
7 1 0 1 6 2 5 0 
7 2 0 2 2 9 8 
73 0 1 0 3 9 
7 4 0 1 0 4 0 
7 6 9 8 0 9 0 
8 8 0 3 0 7 8 
8 9 9 8 0 3 9 
9 0 9 9 0 4 5 
9 4 0 0 0 3 9 
9 4 9 7 0 4 9 
9 7 0 0 0 3 9 
9 8 9 8 0 3 9 
1 0 2 9 8 0 3 9 
1 1 2 9 5 0 3 9 
1 1 4 9 9 0 7 8 
116 9 9 0 4 5 
1 2 4 9 8 0 4 6 
1 4 4 9 7 0 4 2 
1 5 2 9 9 0 4 1 
163 9 7 0 4 9 
1 6 4 9 7 0 7 8 
183 9 6 3 10 
1 8 4 9 7 1 7 0 
2 2 1 9 8 0 4 9 
Spectrum No.23(EI+) 
286 
NCP319I5. x l e g d = l 17-0CI-31 11M5'9:8B^4G 78E E l ' 
Bpn=8 1=5.3ci Hii=224 110=151819398 Rent: Sys^RCE 
N.PRRUNSON P I ^ B " Cal^PFKlBOCF 
IBB, -^1 
SB J 
51 
1,1 .1,1 I I I I I I I.. 
58 158 299 
C I -
259 . 399 
NCP319I1B. x l Bgd=G 17-0CT-91 1P45-9 91-M2 79E 
BpN=9 I=19v H(i=llG IIC=69G34389 Rcnt^ Sys^ RCE 
N.PRRHNSON PI= 9° Cal .PFKigGCr 
•133, ? 
98 
1B2 115 
59 • 1! 
M a s s 7. B a s e 
4 0 . 03 4 . 0 3 
. ..' '1 . 0 4 5 1 . 4 8 
4 2 . 0 1 3 . 14 
4 2 . 0 5 15 . 5 1 
4 3 . 0 6 8 5 . 8 2 
4 4 . 0 5 2 . 7 2 
4 7 . 0 4 7 2 4 
5 0 . 0 2 0 75 
5 1 . 0 2 10 4 9 
5 2 . 0 4 0 3 4 
5 3 . 0 5 1 7 2 
5 5 . 0 7 2 2 8 
5 7 . 03 1 5 9 
5 9 . 0 5 3 4 8 
6 3 . 03 1 5 1 
5 4 . 0 4 1 4 9 
6 5 . 0 5 3 5 1 
6 8 . 0 4 0 3 5 
6 9 . 0 2 18 0 5 
7 0 . 0 5 0 5 1 
7 1 . 0 7 1 0 0 0 0 
7 2 . 0 8 a 8 7 
7 3 . 0 7 2 4 3 
7 5 . 0 3 1 4 7 
7 7 . 0 5 5 9 0 
8 2 . 03 2 9 9 
8 9 . 0 5 1 0 5 
9 0 . 0 6 0 8 6 
9 1 . 0 7 8 16 
. 9 5 . 0 5 ^ 1 9 1 
1 0 1 . 0 5 I 5 2 
1 0 3 . 0 8 1 , 5 0 
1 0 4 . 0 8 0 , 33 
1 0 9 . 0 7 1 , 32 
1 1 3 . 0 4 2 . 9 0 
1 1 5 . 0 8 3, 0 1 
1 2 7 . 0 7 1 . 75 
1 3 1 . 0 5 0 . 5 1 
1 3 2 . 05 0 , 33 
1 3 3 . 0 7 5. 15 
1 3 5 , 0 9 1 . 54 
1 4 1 . 0 5 1 . 8 2 
1 5 1 . 0 5 2 . 0 5 
1 6 i ; 0 7 2. 6 2 
2 2 1 . 13 il 
2 2 3 . 15 1 . 57 
159 299 259 
287 
Spectrum No.24 (EI+) 
N C P P F P I 7 8 2 * x l Bgd=S92 18- f iPR-92 1 5 : 5 1 * 8 : 8 8 : 4 3 7BE E I * 
BpH=8 I = 3 . 8 w ' H « = 2 2 1 TIC=1383BB8BB R e n t : Sys:PRRI!INSON HNR: 
Ffl3 8 . 1 I I S E C GC= 1 1 6 ° C a l PFKlBRPR " I S S : 
1 8 8 , 133 
19456888 
133 
28 
69 
185 
.77 
283 
149 
U . U ,1 
58 
M a s s 
4 9 . 00 
5 0 . 0 3 
5 1 . 0 3 
5 3 . 0 5 
5 5 . 04 
5 6 . 04 
5 7 . 04 
5 9 . 0 5 
6 1 . 0 2 
6 3 . 01 
6 4 . 0 3 
6 5 . 0 2 
6 7 . 01 
6 8 . 0 4 
6 9 . 0 2 
7 0 . 0 5 
7 1 . 0 5 
7 3 . 0 2 
7 5 . 0 2 
7 6 . 0 2 
7 7 . 0 3 
7 8 . 0 3 
7 9 . 0 3 
8 1 . 0 3 
8 2 . 0 2 
8 3 . 0 5 
8 4 . 0 7 
8 5 . 0 0 
8 6 . 9 9 
8 8 . 0 4 
8 9 . 0 4 
9 0 . 0 5 
9 1 . 0 5 
9 2 . 0 6 
9 3 . 0 3 
9 3 . 0 4 . 
9 9 . 03 
101 . 0 5 
1 0 3 . 06 
1 0 5 . 04 
1 0 6 . 04 
1 0 7 . 0 3 
108 . 04 
1 0 9 . 0 5 
1 11 . 0 2 
1 1 3 . 0 3 
114 . 0 5 
1 1 5 . 0 7 
1 1 7 . 0 5 
1 1 9 . 0 5 
1 2 1 . 0 6 
1 2 5 . 0 3 
1 2 7 . 0 3 
1 2 9 . 0 3 
1 3 1 . 0 3 
1 3 3 . 0 4 
1 3 4 . 0 5 
1 3 5 . 0 7 
1 3 7 . 0 4 
1 4 1 . 0 5 
1 4 2 . 0 5 
1 4 3 . 0 5 
1 4 9 . 0 1 
188 
7. B a s e 
4. 14 
1. 3 2 
4. 28 
1. 51 
2 . 6 3 
1. 0 2 
3 . 9 5 
3 . 9 5 
1. 3 8 
13 . 3 9 
9 . 21 
5 . 4 6 
1. 3 2 
2 . 6 3 
6 5 . 7 9 
6 3 
68 
90 
13 . 6 2 
1. 3 2 
4 8 . 78 
2 . 6 3 
14. 7 2 
1. 3 2 
1. 3 2 
2 . 6 3 
1. 3 2 
5 . 7 7 
1. 64 
1. 3 2 
5 . 6 9 
2 . 6 3 
10. 11 
1. 3 2 
1. 3 2 
2 . 6 3 
1. 3 2 
1. 3 2 
1. 3 2 
7 1 . 1 8 
3. 26 
2 3 . 6 8 
2 . 6 3 
2 . 6 3 
2 . 7 3 
13 . 71 
1. 3 2 
6 . 58 
2 . 88 
2 . 6 3 
1. 3 2 
2 . 6 3 
1. 0 2 
1. 3 2 
1. 3 2 
1 0 0 . 0 0 
2 . 8 4 
5 . 2 6 
1. 3 3 
2 . 6 3 
1. 0 0 
1. 3 2 
10 . 5 3 
158 
M a s s 
1 5 1 . 0 2 
1 5 5 . 08 
1 6 3 . 08 
1 8 3 . 0 9 
1 8 4 . 10 
2 0 1 . 06 
2 0 2 . 0 8 
2 0 3 . 0 9 
2 0 4 . 10 
2 0 5 . 12 
2 1 9 . 0 9 
288 
7. B a s e 
3 . 9 5 
9 . 3 5 
3 . 08 
5. 26 
1. 3 2 
1. 3 2 
8. 0 5 
8 6 . 8 9 
6. 58 
0. 31 
1. 3 2 
258 388 358 
288 
Spectrum No.25 (EI+) 
NCPIFEI1BG7* x l B9d=097 lB-HPR-92 12 39*8 13 14 7BE E I -
Bpl1=8 I=175« u HM224 TIC=12329BB8 flcnt^ Sys-PRRKINSON 
Ffl3 B . I H S E C GC= l E l " C a l^PFKieRPR 
IBB. 221 
75 139 
HfIR: 
m s s ^ 
1152868 
221 
6B 
2B 
G7 117 
.ill I 1 
1B3 
III i|i 
125 
153 
^ l l i . Ii . l i . Ill 
5B IBB 15B 
M a s s 7. B a s e M a s s V. B a s e 
4 7 9 8 2 . 0 0 1 3 7 9 8 2 4 3 
4 8 9 9 2 2 . 2 2 1 3 8 9 6 8 8 9 8 
5 0 0 0 2 . 0 8 1 3 9 9 6 4 17 
5 1 0 1 2 2 . 2 2 1 4 0 9 5 5 2 3 4 
5 5 0 1 3 . 13 1 4 1 9 5 1 5 6 
5 7 . 0 1 7 . 6 4 1 4 2 9 5 7 9 0 
5 9 . 0 3 8 . 5 1 1 4 9 0 0 1 5 6 
6 0 . 9 8 3 . 6 5 1 5 2 9 5 10 0 7 
6 1 . 9 9 1. 7 4 1 5 4 9 6 4 4 3 
6 2 . 9 8 6 . 6 0 1 5 6 9 8 7 0 3 
6 4 0 1 3 . 73 1 5 8 9 8 2 4 3 
6 4 . 9 7 2 . 3 4 1 6 4 9 8 4 0 8 
6 5 0 2 2 6 9 1 6 6 9 7 2 2 6 
6 6 9 7 4 4 4 4 1 7 2 9 6 4 3 4 
6 8 0 2 4 5 1 1 7 4 9 6 2 2 6 
6 8 9 8 2 2 . 2 2 1 8 4 9 8 9 6 4 
7 0 0 1 1 . 5 6 1 8 5 . 9 8 1 . 6 5 
7 1 . 0 2 7 . 2 9 1 8 6 . 9 9 1. 5 6 
7 2 9 8 2 . 9 5 2 0 0 . 9 4 3 . 7 3 
7 4 9 9 8 8 . 8 9 2 0 2 . 9 4 3 . 13 
7 5 . 9 9 1 0 . 2 4 2 2 0 . 9 5 1 0 0 . 0 0 
7 6 9 9 4 4 4 4 2 2 1 . 9 5 7 . 8 1 
7 7 9 9 4 0 8 2 2 2 . 9 5 6 6 . 7 5 
8 1 0 0 1 8 2 2 2 3 . 9 5 3 . 3 0 
8 1 9 9 7 2 9 2 2 4 . 9 5 1 0 . 9 4 
8 2 9 4 2 6 0 
8 3 0 1 2 6 0 
8 4 9 5 6 7 7 
8 6 9 7 2 7 8 
8 9 0 1 2 2 2 2 
9 0 0 2 3 4 7 
9 0 9 9 6 6 0 
9 2 9 8 17 4 5 
9 4 9 9 5 0 3 
9 6 9 5 1 4 8 
9 7 9 7 2 2 6 
9 9 0 1 4 4 3 
101 0 1 2 2 2 2 
1 0 2 0 2 1 7 4 
1 0 2 9 9 2 8 3 9 
1 0 3 9 9 2 9 5 
1 0 4 9 9 10 6 8 
105 9 9 1 7 4 
106 9 9 1 74 
108 9 5 2 7 8 
1 0 9 9 6 1 3 9 
1 10 9 6 2 2 2 2 
1 1 2 9 6 3 73 
116 9 7 4 4 4 4 
1 17 9 6 2 17 
119 0 0 2 2 2 2 
1 1 9 9 6 1 2 2 
1 2 1 0 1 6 8 6 
1 2 2 9 9 2 6 9 
1 2 4 9 8 2 2 4 8 
1 2 5 9 9 1 5 6 
1 2 6 9 8 9 2 9 
1 3 2 9 3 1 3 9 
1 3 4 9 7 1 5 6 
136 9 8 4 4 4 4 
2BB 259 
289 
Spectrum No.26(EI+) 
IBB. 
N C P 3 0 8 » 1 2 6 9 # x l B g d = i 2 5 5 1 7 - F E B - 9 2 12:39*8 13:14 79E E I * 
Bpl1=B 1=6. i v Hii=308 T i c = 6 6 0 3 3 0 0 0 R e n t : Sys:Pf iRi; iNSON 
Ffl3 B.inSEC . GC= 161° Cal:PFI(;31Jf lN 
221 
40 
21) 
69 91 
59 
M a s s 
5 1 . 0 1 
5 7 . 0 3 
5 9 . 0 4 
6 5 . 0 3 
6 9 . 0 2 
7 7 . 0 3 
8 7 . 0 5 
9 1 . 0 4 
1 0 9 . 0 3 
1 2 7 . 0 3 
1 3 3 . 0 4 
1 5 3 . 0 5 
1 7 3 . 0 5 
2 2 1 . 0 4 
2 2 2 . 0 5 
127 
B a s e 
' 1. 6 7 
1 
3 
1 
4 
1 
2 
3 
1 
6 
1. 7 1 
2 . 3 2 
3 . 4 1 
1 0 0 . 0 0 
7 . 7 2 
2 8 
8 4 
7 3 
7 3 
9 5 
0 2 
5 8 
3 3 
4 8 
173 
158 2BB 258 
2 9 0 
Spectrum No.27 (FAB+) 
NCP43U1N x l B9d= 
8pl1=8 I=3.9u H«=878 
NIGEL PRRUHSaN 
188, 113 
5-nRV-32 
T1C=182GG8889 
14:3G'8 81 42 7BE 
Rent: 
PT= 8" 
Sys:FHB 
Cal:PFK5BflV HBR: IIRSS: 
25748888 
113 
28 
93 
299 
187 
NCP431I28* x l Bgd=l 
8pll=B I=131<ig H«=859 
NIGEL PRRUNSGN 
188, 
5-nfly-32 14:36-8:82:47 78E 
TIC=G223a88 Rent: 
297 
589 G8I 
FB-
Sgs:FfiB 
8° Cal:Prt:5nHY 
789 
mi 
nflss: 297 
31111 
291 254 
iiiuuu 
333 
.III, .11.1 I . . . I I .> .Hi i . l | l . ,1.1. . .1.1) .1,11 .1.11111 , . . l u l l I .1. .1 . .1 . I 
288 788 
M a ^ s 
5 0 . 8 8 
5 2 . 9 1 
5 3 . 9 1 
5 4 . 9 1 
5 5 . 9 2 
5 6 . 9 3 
5 8 . 93 
6 0 . 9 4 
6 2 . 9 2 
6 4 . 9 4 
6 6 . 9 5 
6 7 . 9 7 
6 8 . 9 7 
6 9 . 9 7 
7 0 . 9 9 
7 1 . 9 9 
7 2 . 9 9 
7 4 . 9 8 
7 6 . 9 8 
8 3 . 0 0 
3 4 0 0 
8 5 . 0 0 
9 1 . 0 0 
9 2 . 9 9 
9 4 . 0 0 
9 4 9 8 
9 5 . 9 8 
9 7 . 0 0 
1 0 2 . 9 9 
1 1 1 9 8 
1 1 2 . 9 8 
1 1 3 . 9 8 
1 1 4 . 9 8 
1 1 6 . 9 7 
1 1 8 . 9 6 
1 2 6 9 8 
1 3 8 . 9 8 
1 4 8 . 9 6 
1 5 2 . 9 8 
1 8 4 . 9 8 
1 8 5 . 9 6 
1 8 6 . 9 2 
1 8 7 . 9 2 
1 8 8 . 9 1 
7. B a s e 
1 2 0 
1. 3 4 
1. 18 
2 . 3 7 
1 . 2 2 
5 . 2 6 
5 . 16 
2 . 9 8 
1 . 0 8 
2 7 
2 3 
1 . 17 
4 . 3 4 
4 . 2 8 
1. 17 
1 . 0 1 
1. 2 2 
4 . 1 1 
6 . 9 6 
1. 9 9 
1. 0 3 
1. 9 9 
1. 0 9 
1 0 . 16 
0 . 7 2 
1. 9 9 
Mass 7. B a s e 
2 5 3 . 8 9 1. 8 8 
2 6 4 . 9 4 1. 9 9 
2 6 5 . 9 4 0 . 3 7 
2 6 6 . 9 6 1 . 0 4 
2 9 7 . 8 8 1 . 0 2 
2 9 8 . 8 7 2 6 . 8 1 
2 9 9 8 8 5 . 9 7 
3 0 0 8 7 9 . 9 5 
3 0 1 8 8 1. 9 9 
3 0 2 . 9 0 0 . 6 3 
5 9 6 . 73 2 . 3 1 
5 9 7 . 73 0 . 9 9 
5 9 8 . 7 2 1. 9 9 
5 9 
19 
5 5 
13 
1 0 0 . 0 0 
5 . 9 7 
1 . 9 9 
1. 0 6 
1 . 1 1 
1 . 9 9 
2 . 3 2 
1 . 9 9 
1 . 9 9 
2 . 9 8 
0 . 5 4 
1 9 . 8 9 
1 . 9 9 
6 . 9 6 
291 
S p e c t r u m No .28 (FAB+) 
rds0220001 Scan 6 RT=0:34 100%=129490 mv 7 Jul 93 15:12 
LRP +FABNCP 77 718708 POS-FAB-MSGLY 
100- 187 
50 
0 — 1 
200 
lnl..i„...iil 
250 300 350 400 450 
no numeric data 
292 
S p e c t r u m No.29(FAB+) 
NCP435I18* x l 
Bpn=e l = 195«u H M 
KiGEL fmmm 
188. 
S - l1 f ly -32 U - -S1-9-B1 35 M 
r i C = 3 3 3 a 8 8 9 Rent -
313 
f B -
P I = 8 ° Cal P f M Y 
I ? 8 e 8 0 6 
313 
28 
2 ; B 
I iiiMi iilfiimJ ••iiJi.iiiitt I m i l , I I I ,11.1,(1,1,1.11,111.1 I I , I I I m i l l I I I i .11.1,1, . 1 ,1 ,1 , . . 1 1 . 1 , 
aea 
NCP435I1U x l Bgd=l 5 - m - 9 2 14^51-8^ 
Bp«=8 l=lBv HMBGB I lC=25B554Be8 
NIGEL PflRUNSBK 
1 6 8 , 113 
28 
283 
^42 ; 8 E E B -
Rent : S y s E R B 
P r = 8 ° C a l ^ P E M V 
H U B : e548;888 
NRSS: 113 
315 
2B8 
M a s s v. B a s e 
5 0 8 9 1 9 4 
5 1 9 0 0 7 8 
5 2 . 9 1 1 1 7 
5 3 . 9 2 1 8 6 
5 4 . 9 2 2 . 4 5 
5 5 . 9 3 1 1 6 
5 6 9 3 1 9 5 
5 7 . 9 5 1 5 6 
5 8 . 9 4 2 7 4 
6 0 . 9 5 3 . 3 2 
6 4 . 9 6 1 5 6 
6 6 . 9 8 1 1 7 
6 7 . 9 8 1 9 5 
6 8 . 9 7 5 6 0 
6 9 . 9 8 5 5 5 
7 0 . 9 9 1 . 9 2 
7 2 . 0 0 1 . 1 7 
7 4 . 9 9 1 1 7 
7 6 . 9 9 2 3 5 
8 0 . 0 1 1 1 7 
8 2 0 2 1 1 7 
8 3 0 1 1 1 7 
8 4 . 0 1 1 1 7 
8 5 . 0 1 1 5 6 
9 1 . 0 0 8 . 9 9 
9 2 . 0 1 0 7 8 
9 3 0 2 1 5 6 
9 4 0 1 0 7 8 
9 4 9 9 2 7 0 
9 5 9 9 3 9 1 
9 7 0 0 4 8 5 
9 8 0 1 1 1 7 
1 0 9 0 0 1 6 2 
1 1 1 9 9 1 1 7 
1 1 2 9 9 1 0 0 0 0 
1 1 3 9 9 5 8 6 
1 1 4 9 9 5 8 6 
1 2 6 0 0 1 1 7 
1 2 6 9 9 2 3 5 
1 3 2 9 6 5 0 8 
1 3 3 9 9 0 4 1 
1 3 4 9 9 3 1 3 
1 3 8 9 9 2 3 5 
M a s s 
1 5 4 . 9 8 
1 8 2 9 7 
2 0 2 . 9 5 
2 0 3 9 6 
2 6 9 . 9 2 
3 1 2 . 9 9 
3 1 3 . 9 0 
3 1 4 . 9 0 
3 1 5 . 9 0 
3 1 6 9 3 
3 1 7 . 9 3 
B a s e 
6 6 5 
1 . 2 4 
2 5 . 4 5 
2 . 0 4 
2 . 4 4 
1 . 5 6 
1 . 1 7 
1 9 . 5 3 
3 . 7 8 
1 . 5 6 
0 . 3 8 
293 
Spectrum No.30 (FAB+) 
rds0210001 Scan 6 RT=0:33 100%=142260 mv 7 Jul 93 15:06 
LRP +FAB NCP 78 718707 POS-FAB-MS GLY 
100- 203 
50 H 
185 
333 
261 
il.'ill ' 
315 
. • I - I ..I.... ..Ill.lly 
347 
200 250 350 
425 
405 
300 
no numeric data 
400 450 500 
S p e c t r u m No.31(FAB+) 
294 
N C P 4 E 4 I 1 B . x l B 
Bpn=8 i=a33«v H«=a 
Nica pmmsm 
=G 5-HflY-32 1 1 : 4 5 - 8 : 8 1 35 78E 
r i C = G 9 8 3 8 B 8 flcnt^ 
331 
p r = 8" BflSS: 
15;BBB9 
331 
111 B88 
m H u i l I I J , , i | .11.i> .». .it 
BBS 
rM .«! . 1 . I.I. U . ) . L U M -
288 
N C P 4 2 4 f l l » x l B9d= l 5- l l f lY-92 1 1 : 4 5 - 8 : 8 1 43 ? B E 
Bpn=8 I=18m H«=891 I 1 C = 2 5 1 8 2 2 8 8 B flcnt: 
N IGEL PfiEKlNSON 
L 113 
588 
F B -
P I = 8 ° 
S y s ^ f f l B mi-
CaL:PFt:5nf lV flflSS: 
G5534888 
113 
B I, i J i i i i , g , 
333 
221 
IBS 288 388 
• M a s s •/. B a s e 
J 9 2 1 3 5 8 
5 1 9 5 3 0 8 
5 d 1 3 3 5 8 
S 5 9 4 4 9 3 
7 4 4 2 3 8 2 
7 7 8 9 3 2 1 
3 2 9 9 3 9 5 
9 3 0 4 3 9 5 
9 1 0 1 5 5 5 
9 2 9 7 3 6 3 
9 3 3 6 3 3 3 
9 5 0 7 3 2 1 
9 5 9 7 4 4 4 
1 0 7 0 0 4 0 7 
1 0 8 0 1 5 9 2 
1 0 8 9 7 4 9 3 
1 1 0 9 8 5 3 1 3 
1 1 1 9 8 o 0 4 
1 1 2 3 5 4 0 7 
1 1 5 0 2 4 5 S 
1 2 2 0 3 2 9 6 
1 2 4 8 0 3 0 8 
1 3 0 , 5 5 4 0 7 
1 3 0 . 9 7 • 4 . 5 5 
1 3 6 . 0 3 5 1 8 
1-52. 3 0 3 . 3 3 
1 5 2 . 3 6 3 . 7 0 
1 5 9 . 3 7 3 . 7 0 
1 5 9 . 9 8 4 9 3 
I S O . 8 0 -3 5 8 
1 7 2 . 9 9 3 . 3 3 
1 8 1 . 0 4 3 . 4 5 
1 8 4 . 3 1 3 2 1 
1 9 9 . 0 2 3 . 3 3 
I 9 9 . 9 0 4 . 0 7 
2 0 1 . 3 8 3 . 4 5 
2 1 2 . 9 9 5 . 3 0 
2 1 5 . 9 6 3 5 8 
2 2 1 . 0 0 4 , 0 7 
2 2 6 . 0 0 3 , 4 5 
2 2 8 . 0 4 4 4 4 
2 2 9 . 0 0 4 . 4 4 
2 5 4 . 3 3 3 . 2 1 
2 6 1 . 2 5 3 . 3 3 
M a s s V. B a s e 
2 6 8 . 4 8 3 . 0 8 
2 8 7 . 9 8 3 5 . 3 9 
2 8 9 . 0 0 1 8 
3 0 8 . 8 9 2 5 8 
3 1 1 . 0 5 6 . 4 1 
3 1 1 . 6 4 4 . 5 6 
3 1 3 . 0 5 3 , 3 2 
3 2 0 . 2 4 5 8 
3 3 1 . 0 2 ! 0 0 . 0 0 
3 3 2 . 0 6 3 1 . 5 7 
3 5 3 . 7 5 J 5 3 
S p e c t r u m No .32 (FAB+) 
295 
NCP423J5* x l Bgd=l 5- l l f lY-92 1 2 : 4 3 - B : 8 8 : 5 9 M 
8pfl=B l=B64«u H«=B79 TlC=31Bfl7BBB flcnl: 
NIGEL PRRKIKSOH 
I B B , 131 
221 
E B ^ 
Sys^ERB HfIR: 4352BB8 
P I= fl" C a L ^ P E M Y IIRSS^ 131 
93 153 
' ilaiiiiliiiii. 
351 
189 
NCP423I6 . 
888 
x l B9d=G 5 -BRY-92 1 2 : 4 3 ' 8 : B P B G 7BE 
Bpfl=B l=4B«u H.=B88 I IC=2B33B8B Rcnt^ 
NIGEL PARKINSON PI= B° 
1 349 
5Bfl 
E B -
768 
Sys^ERB 
C a L ^ P E M Y 
HNl!: 
NRSS- 349 
129 
5G 9,1 1G2 257 385 395 684 ? 1 1 ; B 5 844 
1 
188 288 
M a s s 7. B a s e 
4 7 8 9 1 8 2 
4 9 8 7 4 4 3 
5 0 8 8 8 4 3 
5 2 9 1 2 8 7 
5 3 9 1 3 2 6 
5 4 9 1 5 8 8 
5 5 9 2 5 7 0 
5 6 9 3 1 1 7 6 
5 7 9 4 5 8 8 
5 8 9 4 1 2 2 0 
5 9 9 4 4 6 2 
6 0 9 4 1 3 5 8 
6 1 9 4 I 2 9 
6 2 9 4 1 9 3 
6 4 9 6 5 8 8 
6 6 9 9 1 9 8 
6 7 9 8 2 3 7 
6 8 9 6 18 1 5 
6 9 9 7 5 8 8 
7 0 9 9 5 8 8 
7 1 9 9 2 2 1 
7 2 9 9 5 6 3 
7 3 9 9 1 7 9 
7 5 0 0 6 3 0 
7 6 0 0 1 1 3 
7 6 9 9 6 8 7 
8 0 0 2 2 0 0 
3 1 0 2 1 5 6 
8 2 0 0 2 1 1 
8 3 0 1 3 1 3 
3 4 . 0 2 2 1 3 
3 5 . 0 2 2 2 3 
8 6 . 0 3 1 5 6 
8 7 0 1 1 5 4 
8 8 0 0 4 0 4 
8 9 . 0 0 1 . 7 0 
8 9 . 2 0 0 6 2 
9 0 . 0 1 2 . 2 1 
9 1 . 0 1 1 1 . 7 5 
9 3 . 0 2 1 3 . 9 5 
9 4 . 0 3 1 . 6 3 
9 5 . 0 1 5 7 2 
9 6 . 0 1 1 7 5 
9 7 0 1 2 6 7 
3B8 
M a s s •/. B a s e 
9 8 . 0 1 2 . 2 7 
9 9 . 0 2 7 8 
9 9 . 9 8 2 . 2 5 
1 0 1 . 0 0 1 . 1 7 
1 0 2 . 0 1 I . 4 9 
1 0 3 . 0 1 5 . 8 8 
1 0 4 . 0 2 1 . 1 5 
1 0 5 . 0 1 1 . 5 2 
1 0 6 . 0 1 1 . 0 3 
1 0 7 . 0 1 1 . 2 9 
1 0 8 . 0 2 1 . 0 6 
1 0 9 . 0 0 5 . 8 8 
1 1 0 . 0 3 3 . 8 8 
1 1 1 . 0 2 1 . 7 2 
1 1 1 . 9 9 1 . 8 6 
1 1 3 . 0 0 1 1 . 7 6 
1 1 3 . 9 8 5 . 8 8 
1 1 5 . 0 0 5 . 8 8 
1 1 6 . 0 0 1 . 4 2 
1 1 7 . 0 2 2 . 3 7 
1 1 8 . 9 8 I 7 2 
1 2 1 . 0 0 1 . 1 9 
1 2 1 . 9 8 1 . 3 8 
1 2 3 0 2 1 7 9 
1 2 4 0 1 1 3 3 
1 2 5 0 0 5 8 8 
1 2 6 0 1 1 7 5 
1 2 6 9 8 1 3 9 0 
1 2 8 0 1 1 5 6 
1 2 9 0 0 2 2 5 
1 3 0 0 0 2 3 7 
1 3 0 9 9 1 0 0 0 0 
1 3 2 0 0 5 8 8 
1 3 2 9 9 5 8 8 
1 3 4 0 3 1 7 2 
1 3 7 0 1 1 6 5 
1 3 8 0 1 1 5 2 
1 3 9 0 2 3 1 3 
1 4 1 0 0 5 8 8 
1 4 2 0 1 1 3 6 
1 4 2 . 9 9 1 3 6 
1 4 4 . 0 1 1 . 1 5 
1 4 5 . 0 0 5 . 8 8 
1 4 6 . 0 3 1 1 9 
568 666 
M a s s V. B a s e 
1 4 9 . 0 0 5 . 3 5 
1 5 0 . 9 6 2 . 4 6 
1 5 2 . 0 1 1 . 9 5 
1 5 3 . 0 1 1 3 . 6 5 
1 5 4 . 0 3 2 . 4 4 
1 5 5 . 0 0 5 . 8 8 
1 5 6 . 0 1 1 . 2 6 
1 5 7 . 0 1 2 4 6 
1 6 7 . 0 2 1 . 9 8 
1 6 8 . 0 5 1 . 5 2 
1 6 9 . 0 0 2 . 0 9 
1 7 0 . 0 1 0 . 6 7 
1 7 1 . 0 2 2 0 0 
1 7 3 . 0 0 5 . 8 8 
1 7 3 . 9 8 I 1 0 
1 7 5 . 0 1 1 . 4 7 
1 7 5 . 9 9 1 . 1 5 
1 8 0 . 9 7 1 5 4 
1 8 2 . 0 0 0 7 6 
1 8 3 0 3 1 3 3 
1 8 4 0 1 1 0 6 
1 8 5 0 3 5 8 8 
2 0 1 0 1 1 7 7 
2 0 3 0 1 4 2 3 
2 0 5 0 2 1 9 3 
2 0 7 0 5 1 7 0 
2 1 8 9 9 2 3 2 
2 2 0 0 1 1 4 2 
2 2 0 9 8 6 3 3 0 
2 2 2 0 0 5 8 8 
2 2 3 0 0 3 . ^ 4 
2 3 5 0 0 1 . 4 9 
2 3 6 0 1 1 . 8 8 
2 6 2 0 0 1 . 7 0 
3 0 5 9 6 1 . 6 1 
3 0 7 . 0 1 1 . 1 0 
3 1 2 . 9 9 1 . 1 7 
3 1 9 . 0 4 1 . 2 2 
3 3 0 9 8 1 5 4 
3 3 2 9 9 2 . 5 5 
3 4 8 9 9 1 5 4 
3 4 9 9 7 1 5 9 
3 5 0 9 6 1 7 6 5 
3 5 1 9 9 2 9 2 
M a s s 
3 5 3 . 0 8 
3 5 4 . 9 6 
3 6 2 . 9 9 
3 6 9 . 7 2 
3 7 2 . 9 9 
B a s e 
0 . 8 7 
0 
1 
0 
3 
7 6 
0 1 
8 0 
0 8 
296 
S p e c t r u m N o . 3 3 ( F A B + ) 
KCP428 I17 . x l B9d=9 5-NflY-32 1 1 : 2 2 - 8 : 8 2 : 2 5 ?BE 
Bpll=8 l=287.u H.=891 T1CM1413BBB R e n t : 
KIGEL PflRIIIKSON PI= 8° 
» 385 
5ys:rflB 
CaL:PFt;5«flY 
HNR: 
KflSS: 385 
28 
2B2 
1 ' 141 
i i i . i l i » > » * l < . b , . H I 
288 
> l | t . t H . > I H , > I I I.,11. 
588 
F 8 -
G I 
t • I . .1 H I , i . " . I . l i . 
N C P 4 2 6 I 1 ! . x l B9d=5 5 - n f l Y - 9 2 1 1 : 2 2 - 8 : 8 1 : 4 2 7BE 
Bpfl=fl I=? .2v Hi.=8G4 r i C = 2 3 4 5 3 G 8 B 8 R e n t : S y s : F R B 
N IGEL PRRKINSON PI= 8 ° CaL:PFK5nf lY 
) 3 8 ? 
HBR-
nflSS 
4G9I28B8 
28 
82 125 
. l i l i l l U 
195 
M a s s 
5 0 . 8 7 
5 1 . 8 9 
5 2 . 8 9 
5 3 9 1 
5 4 . 9 1 
5 5 9 2 
5 6 9 3 
5 7 . 9 3 
S O . 9 3 
6 7 . 9 7 
6 8 . 9 5 
6 9 . 9 7 
7 0 . 9 8 
7 1 . 9 8 
7 2 . 9 8 
7 4 . 0 0 
7 4 . 9 9 
7 6 . 9 7 
8 0 . 9 9 
8 1 . 9 8 
8 2 . 9 8 
8 4 . 0 0 
8 4 . 9 9 
9 3 . 0 0 
9 4 . 9 6 
9 5 . 9 6 
9 6 . 9 8 
9 7 9 8 
9 8 . 9 9 
1 0 8 . 9 7 
1 0 9 9 8 
1 1 0 . 9 9 
1 1 1. 9 7 
1 1 2 . 9 7 
1 1 3 . 9 8 
1 1 4 . 9 7 
1 2 2 . 9 4 
1 2 4 . 9 5 
1 2 5 . 9 6 
1 2 6 . 9 7 
1 2 7 . 9 8 
288 
•/. B a s e 
5 . 5 0 
1. 0 9 
1. 1 9 
1. 6 4 
3 . 4 6 
2 . 1 8 
4 . 
1. 
4 . 
1 . 
5 . 
3 . 
388 
. 3 7 
. 0 9 
. 4 8 
. 4 4 
6 4 
3 0 
1. 0 9 
1. 7 3 
1. 6 4 
1 0 9 
3 . 2 7 
8 3 
3 3 
3 
1 
2 2 . 2 9 
4 . 3 7 
M a s s 
1 4 0 . 9 4 
1 4 1 . 9 5 
1 4 2 . 9 3 
1 4 8 . 9 4 
1 5 6 . 9 6 
1 8 4 . 9 7 
1 8 6 . 9 5 
1 9 4 . 8 9 
1 9 5 . 9 1 
2 1 6 . 9 4 
2 6 1 . 8 5 
2 9 0 . 8 6 
3 0 4 . 8 4 
3 0 5 . 8 2 
3 0 6 . 8 2 
3 0 7 . 8 3 
3 0 8 . 8 5 
3 0 9 . 8 7 
3 1 0 . 8 8 
7. B a s e 
3 . 8 2 
1 . 0 9 
3 . 8 2 
2 . 1 8 
2 
2 
1 
1 1 
1 
2 
7 3 
2 0 
6 4 
4 6 
0 9 
6 5 
2 . 7 3 
2 . 7 3 
1 . 2 9 
2 . 1 8 
1 0 0 . 0 0 
1 1 . 4 6 
1 . 7 4 
0 . 4 1 
0 . 5 5 
2 8 
1 0 
1 9 
8 . 7 4 
3 . 3 8 
2 . 3 5 
1. 6 4 
1. 1 4 
1. 2 8 
1 . 6 4 
1. 0 9 
1. 1 0 
8 . 7 3 
1. 1 4 
1 . 2 4 
2 . 1 8 
2 2 . 5 0 
1 1 . 9 8 
6 . 6 9 
1 . 0 9 
; B B 
S p e c t r u m No .34 (FAB+) 
297 
NCP429I18» x l Bgd=G 5-nRY-92 1 1 : 3 4 - 8 : 8 1 : 3 5 ; B E F B -
8pn=8 l=245«i i H«=87G TIC=;888B68 Rent : 
NIGEL PRRKINSON PT= 8° 
188, 323 
S y s : F R B 
CaL:Pri ;5nRY 
HflR: 
U R S S : 323 
28 
141 
iL l i . l ) i > i ) i . | t H . > , l l . l . l l . l , ,1. ; i . i . [ . Ill I, U 
188 288 38B 5BB 
F B -N C P 4 2 9 f l l . x l B9d=4 5-llfly-92 11:34-8:81 :43 7BE 
BpB=8 1=2.3u H M893 riC=1398G2888 Ren t : Sys:FRB HNR: 
NIGEL PRRKIHSON PI= 8° CaL:PFK5nRY ms 
188, 9.3 
28 
57 75 
1B5 325 
143 
3B8 
M a s s v. B a s e M a s s 7. B a s e 
4 9 . 8 7 1 . 6 9 9 7 . 9 8 2 . 1 0 
5 0 . 8 7 5 . 1 9 9 8 . 9 8 3 . 4 4 
5 2 . 9 0 1 . 7 2 9 9 . 9 6 6 . 8 8 
5 3 . 9 1 1 . 2 9 1 0 0 . 9 8 2 . 1 2 
5 4 . 9 1 5 . 2 1 l O i . 9 9 3 . 4 4 
5 5 . 9 2 5 . 1 6 1 0 3 . 0 0 3 . 5 9 
5 6 . 9 2 3 4 . 3 8 1 0 3 . 9 9 1 . 1 1 
5 7 . 9 3 5 . 1 6 1 0 4 . 9 9 1 . 7 3 
5 8 . 9 4 2 1 . 7 7 1 0 7 0 0 1 . 7 2 
5 9 . 9 3 3 . 4 6 1 0 7 . 9 9 1 5 7 
6 0 . 9 3 1 2 . 8 6 1 0 8 9 9 1 . 7 2 
6 4 . 9 5 1 . 7 2 1 0 9 9 9 1 . 7 2 
6 5 . 9 6 0 . 7 0 1 1 0 9 9 1 . 8 6 
6 6 . 9 8 1 . 7 2 1 1 1 9 8 1 . 7 2 
6 7 . 9 7 1 . 8 8 1 1 2 9 8 3 . 5 0 
6 8 9 5 7 . 4 1 1 1 3 9 6 2 . 2 6 
6 9 . 9 8 2 . 3 6 1 1 4 9 6 3 . 4 4 
7 0 . 9 9 3 . 4 4 1 1 5 9 6 1 . 7 2 
7 1 . 9 8 5 . 1 6 1 1 6 9 8 3 . 9 7 
7 2 . 9 8 7 . 5 0 1 1 7 9 8 1 . 4 0 
7 3 . 9 8 7 . 1 0 1 1 8 9 8 1 . 7 2 
7 4 . 9 9 3 6 . 6 5 1 1 9 9 9 1 . 0 2 
7 6 . 0 0 1 . 8 5 1 2 0 9 9 1 . 3 2 
7 6 . 9 8 5 . 1 6 1 2 1 9 8 1 . 0 6 
7 9 . 0 0 1 . 7 2 1 2 2 9 5 3 . 4 4 
7 9 . 9 9 i . 0 5 1 2 3 9 8 1 . 7 2 
8 1 . 0 0 2 . 0 7 1 2 4 9 6 5 . 2 3 
8 1 . 9 9 5 . 1 6 1 2 5 9 7 3 . 4 4 
8 2 . 9 8 3 . 4 4 1 2 6 9 6 5 . 1 6 
8 4 . 0 0 3 . 4 4 1 2 7 9 7 1 . 7 3 
8 4 . 9 9 3 . 4 4 1 2 8 9 7 1 . 7 2 
8 6 . 0 1 1 . 7 6 1 2 9 9 6 1 . 7 4 
8 7 . 0 0 3 . 4 4 1 3 0 9 5 6 . 8 8 
8 7 . 9 8 1 . 7 2 1 3 1 9 8 1 . 7 2 
8 8 . 9 9 1 . 9 3 1 3 2 9 8 1 . 7 2 
8 9 . 9 8 1 . 7 6 1 3 3 9 8 1 . 1 1 
9 0 . 9 9 1 . 9 7 1 3 4 9 8 1 . 7 2 
9 2 . 0 0 0 . 5 0 1 3 5 9 8 1 , 7 7 
9 3 . 0 0 1 0 0 . 0 0 1 3 6 9 8 1 . 7 2 
9 4 . 0 0 3 . 9 3 1 3 7 9 7 1 . 7 2 
9 4 . 9 7 3 . 5 9 1 3 8 9 6 2 . 3 9 
9 5 . 9 8 2 . 1 0 1 4 0 9 6 2 . 3 5 
9 6 . 9 9 3 . 4 4 1 4 1 9 6 1 . 7 2 
588 888 788 888 
M a s t 7. B a s e . M a s s •/. B a s e 
1 4 2 9 3 2 1 . 0 6 2 6 2 9 3 1 . 7 2 
1 4 3 . 9 5 8 . 6 5 2 5 3 8 9 0 . 4 1 
1 4 4 . 9 5 7 . 0 8 2 5 4 9 2 0 . 8 9 
1 4 5 . 9 6 1 . 7 2 2 5 5 9 2 0 . 4 6 
1 4 6 . 9 9 3 . 4 4 2 6 5 9 1 0 . 6 5 
1 4 8 . 9 5 7 . 6 5 2 6 7 9 0 0 . 5 2 
1 4 9 . 9 6 1 . 8 7 2 6 8 9 1 0 . 5 0 
1 5 0 . 9 7 1 . 7 2 2 5 9 9 1 0 . 4 0 
1 5 1 9 7 1 . 7 2 2 7 0 9 2 0 . 5 5 
1 5 2 9 6 1 . 8 3 2 7 1 9 3 0 . 3 4 
1 5 3 9 7 1 . 7 2 2 7 2 9 1 0 . 8 3 
1 5 4 9 5 2 . 2 7 2 7 3 9 2 0 . 3 8 
1 5 5 9 7 1 . 5 7 2 7 4 9 4 0 . 9 7 
1 5 6 9 6 3 . 4 4 2 7 5 9 2 0 . 3 2 
1 5 7 9 8 1 . 3 0 2 7 6 9 3 1 . 8 2 
1 5 8 9 4 1 9 1 2 7 8 9 5 2 . 3 3 
1 6 4 9 6 1 9 3 3 0 4 3 5 '. 6 4 
1 6 5 9 7 1 4 2 3 0 5 3 3 0 . 6 7 
1 6 6 9 5 2 . 3 3 3 0 6 8 5 3 . 5 9 
1 6 7 9 6 1 6 9 3 0 7 3 7 1 . 7 2 
1 6 8 9 3 1 . 7 5 
1 3 5 
1 7 2 9 4 1 . 7 2 
3 0 8 8 6 
1 7 3 9 6 1 1 1 2 ! 8 8 7 
1 7 2 
1 7 4 9 5 3 . 6 2 3 1 9 7 7 
0 . 4 2 
1 9 4 9 0 1 3 . 7 5 3 2 0 8 9 ! . 2 5 
1 9 5 9 3 1 . 7 2 3 2 1 . 3 7 
0 . 5 8 
1 9 6 9 4 1 . 7 2 3 2 2 . 8 4 1 7 2 
1 9 8 9 6 1 . 7 2 3 2 3 3 4 3 . 4 4 
1 9 9 9 6 0 . 9 9 3 2 4 . 3 2 4 1 . 2 5 
2 0 0 9 5 1 . 7 2 3 2 5 . 8 2 5 1 6 
2 0 1 9 7 0 . 6 0 3 2 6 . 8 6 1 . 7 2 
2 0 2 9 4 1 . 7 2 3 2 7 . 9 2 0 . 3 6 
2 0 3 9 8 0 . 6 6 
2 0 4 9 3 3 . 7 5 
2 2 8 . 9 3 1 . 5 9 
2 3 2 9 1 1 . 8 4 
2 3 3 8 9 0 . 4 8 
2 3 4 9 2 6 . 0 2 
2 3 5 9 1 1 - 7 2 
2 4 0 9 6 1 . 7 2 
2 4 4 9 1 1 . 7 2 
2 4 5 9 1 0 . 6 2 
2 4 6 9 2 1 . 7 2 
298 
Spectrum No.35 (F A B+) 
NCP344I8 . x l 8gd=G 5-I IRY-32 1B:54 -8 :81 ^21 7BE E B -
Bpll=B l=4G«g H«=833 T IC=8e71888 Rcnt^ ^ Sys^ERB 
NIGEL PRRKINSON PT= 8" C i l P E K 5 f l R Y 
542 578 
326 
B51 G7S 785 742 226 272 453 4:'e 513 813 856 
NCP344I11. x l Bgd^l 5-BflY-32 18:54.6^81 42 78E 
Bpll=6 1=4, Iv H«=832 IIC=36816G81G Rent : 
NIGEL PflRKlKSOH 8 
168, 3 " 
Sys^ERB 
C a l ^ P E M V 
182 
95 
5,1 63 I 135 
llL i i i U 
336 
L L 
266 
M a s s 7. B a s e 
5 0 . 8 8 1 7 . 2 8 
5 2 . 9 1 2 . 9 2 
5 3 . 9 2 2 . 8 7 
5 4 . 9 2 3 . 8 3 
5 6 . 9 4 6 . 2 1 
6 0 . 9 4 1 0 . 5 4 
6 2 . 9 4 2 . 2 7 
6 4 . 9 5 2 . 2 4 
6 6 . 9 7 2 . 8 7 
6 7 . 9 8 2 . 0 0 
6 8 . 9 5 1 5 . 3 3 
7 4 . 9 9 3 . 3 3 
7 6 . 9 8 1 1 . 4 9 
7 9 . 0 0 2 . 0 2 
3 1 . 0 0 2 . 7 1 
8 1 . 9 9 2 . 8 7 
9 1 . 9 9 2 . 2 6 
9 3 . 0 1 5 7 5 
9 4 0 0 3 8 3 
9 4 9 8 2 3 9 5 
1 0 8 0 0 2 8 7 
1 0 9 0 0 2 9 7 
1 1 2 9 6 2 8 7 
1 1 4 9 7 2 8 7 
1 1 8 9 8 4 7 4 
1 1 9 9 9 2 8 7 
1 2 1 - 0 0 5 7 5 
1 2 2 0 0 1 9 9 
1 2 2 9 6 6 7 4 
1 2 6 . 9 6 2 . 1 8 
1 3 2 . 9 8 3 . 8 3 
1 3 3 . 9 8 1 2 . 3 6 
1 3 4 . 9 9 4 . 3 7 
1 3 6 . 0 0 1 6 . 2 8 
1 3 6 . 9 9 2 . 4 1 
1 3 8 . 0 0 2 . 6 4 
1 4 2 . 9 4 1 1 7 4 
1 4 3 . 9 5 1 8 3 
1 4 4 . 9 6 2 . 9 3 
1 4 5 . 9 8 9 . 8 3 
1 4 6 . 9 8 3 . 8 3 
1 4 7 . 9 9 1 5 . 3 3 
1 4 8 . 9 8 7 . 6 6 
1 5 0 . 0 0 4 . 9 2 
1 5 0 . 9 8 2 . 8 7 
3Bfl 
M a s s 
1 5 9 . 9 8 
1 6 0 . 9 7 
1 6 1 . 9 8 
1 6 2 . 9 9 
1 6 3 . 9 8 
1 6 4 . 9 6 
1 6 5 . 9 8 
1 6 8 . 9 3 
1 6 9 . 9 3 
1 7 0 . 9 3 
1 7 1 . 9 3 
1 7 2 . 9 5 
1 7 3 . 9 7 
1 7 5 . 9 7 
•/. B a s e 
3 . 8 3 
2 . 8 7 
4 . 3 3 
2 . 8 7 
4 . 7 9 
2 . 
2 . 
4 . 
. 8 7 
0 8 
7 9 
2 8 . 8 4 
4 . 7 9 
1 1 . 4 2 
2 . 2 7 
0 4 
8 7 
1 7 7 . 9 8 2 . 8 8 
1 8 1 . 9 2 3 0 . 6 5 
1 8 2 . 9 3 9 5 9 
1 8 3 . 9 2 1 4 . 3 1 
1 8 4 . 9 4 5 . 7 5 
1 8 5 . 9 5 2 . 7 8 
1 9 3 . 9 3 4 . 0 3 
1 9 4 . 9 2 2 6 . 8 2 
1 9 5 . 9 2 5 . 7 5 
1 9 6 . 9 4 2 0 5 
1 9 7 . 9 1 4 . 7 9 
1 9 9 . 9 3 8 7 
2 0 9 . 9 2 2 . 8 7 
2 9 7 . 8 7 4 7 9 
3 2 7 . 8 7 3 4 7 
3 2 8 . 8 7 4 7 9 
3 2 9 . 8 8 1 5 3 4 
3 3 0 . 8 9 3 9 0 
3 3 1 . 8 2 1 3 5 6 
3 3 2 . 8 5 1 9 5 
3 3 3 . 8 0 4 8 9 
3 4 1 . 8 5 6 . 8 3 
3 4 2 . 8 6 3 . 7 0 
3 4 3 . 8 2 4 . 7 9 
3 4 4 . 8 1 2 . 8 7 
3 4 5 . 8 2 4 . 2 5 
3 4 6 . 8 3 1 . 9 2 
3 4 7 . 8 2 . 2 3 
3 5 7 . 8 5 3 8 3 
3 5 8 . 8 4 1 . 9 2 
1 , i 
568 666 
M a s s •/. 8 a 5 e 
3 5 9 8 4 2 . 8 7 
3 6 0 8 2 1 . 9 2 
3 6 1 8 2 3 . 8 3 
3 6 2 7 9 1 3 . 4 1 
3 6 3 8 0 1 0 0 . 0 0 
3 6 4 8 0 2 4 . 9 1 
3 6 5 8 0 3 5 . 6 4 
3 6 6 8 1 7 . 0 1 
3 6 7 8 4 1 . 9 2 
3 7 5 7 1 1 0 . 5 4 
3 7 6 8 2 3 . 8 3 
3 7 7 8 1 5 . 7 5 
3 7 8 8 1 1 . 9 2 
3 7 9 8 4 1 . 9 2 
3 8 0 8 0 0 . 9 6 
S p e c t r u m No.36 (FAB+) 
299 
E B -NCP3B9I14* x l B9d=l 7-N0V-91 14:34.8":62:f l3 76E 
Bpll=8 I= lBu HMaSB nC=8e245S666 Rent': Sys^ERB 
N. Pf lmNSON P T = 8 ° Cal P E K H O C I 
166, - 155-
121 
2 8 . " 
. l i i i i 
221 
374 
348 
flfiSS: 
S55348B0 
155 
388 588 788 B8B 
NCP3a9JlG« x l Bgd^lB 7 -NQg -31 I 4 " 3 4 . 6 : 8 2 : 1 8 78E E B -
flpn=8 1=1.Em H«=877 r iC=973B4968 Bent : Sus^ERB 
H. PBRKINSON PT= 8 ° C a L ^ P E K U O C I 
153 
28 J 117 488 
368 
186 286 
M a s s 
-^7 '.' -5 
43 - . J 
5 0 7 5 
5 ! 7 5 
5 4 7 7 
5 5 . 7-3 
5 6 . 7 5 
5 8 ' 7 3 
5 9 7 -
5 3 . 7 7 
5 4 . 7 3 
•35 7 S 
3 6 . 7 9 
5 7 . 7 9 
6 8 7 2 
S 9 8 0 
7 0 . 3 0 
7 1 . 3 0 
7 2 . 7 9 
7 4 7 ? 
7 6 7 8 
7 7 . 7 3 
7 9 . 8 0 
7 9 S O 
9 0 7 9 
3 1 . 7 = 
3 2 . 7 9 
3 3 . 3 0 
3 4 . 7 3 
3 8 . 7 7 
3 9 . 7 7 
5 0 . 7 5 
? 1 . 7 3 
9 2 . 7 3 
5 3 . 7 7 
5 4 . 7 G 
9 5 . 7 7 
V. Base 
2 0 . 
S 1 
3 4 
3 J 
. 5 1 
. 0 6 
3 5 
1 9 
7 5 
. 9 0 
. 1 3 
. 9 3 
. 3 4 
. 4 3 
£ 2 
. 3 3 
. S 7 
1 7 
3 5 
. 0 0 
. 3 6 
3 7 
4 6 
. 7 3 
3 3 
1 0 
3 6 
. 3 2 
4 7 
0 9 
5 3 
G 3 
,1 
389 486 586 
M a s s v. B a s e M a s s 
: 0 2 7 4 1 5 5 . 6 1 
1 0 3 / 4 7 = 1 5 6 . 6 0 
; 0 4 7 4 - 4 1 ! 5 7 . S I 
1 0 5 7 4 5 4 1 5 8 . 6 3 
1 0 6 7 4 1 5 9 . 6 4 
• 0 7 7 4 1 6 0 . 6 2 
• O S 7 3 0 5 1 6 1 . 6 4 
i 0 9 ; 4 1 6 2 . 6 3 
: -.0 7 4 1 6 3 . 6 4 
1 1.2 7 1 . 2 0 2 1 6 4 . 6 3 
1 1 4 7 1 2 1 7 1 5 6 . 6 0 
1 1 6 7 0 3 2 1 1 6 7 . 5 9 
1 1 7 7 1 '^ 5 4 1 6 8 . 5 9 
1 1 8 7 1 1 5 0 0 1 5 9 . 6 1 
1 1 9 7 1 1 2 5 6 1 7 0 . 5 9 
1 2 0 7 1 7 5 0 2 1 7 1 . 6 0 
1 2 1 7 2 9 4 0 i 7 2 . 5 9 
1 2 2 7 2 5 7 3 1 7 3 . 6 1 
1 2 6 6 7 1 9 5 1 1 7 4 . 6 2 
1 2 7 6 7 i 6 5 ' 7 5 . 6 2 
1 2 8 6 8 2 0 0 1 7 8 . 5 9 
1 2 9 6 8 1 9 3 1 7 9 . 5 8 
1 3 0 6 7 2 2 8 1 8 0 . 5 8 
1 3 1 6 9 2 4 0 1 8 1 . 5 9 
1 3 2 6 3 3 7 4 1 8 2 . 5 8 
1 3 3 6 9 7 7 3 1 8 3 . 5 7 
1 3 4 . 6 8 3 1 0 1 8 4 . 5 0 
1 3 5 . 6 9 5 3 3 1 8 5 . 6 1 
1 3 6 6 8 3 . 0 8 1 8 6 . 5 7 
1 3 7 . 6 7 1 . 8 3 1 8 7 5 8 
1 3 8 . 6 7 2 . 3 3 1 8 8 . 5 8 
1 4 4 6 5 4 7 7 1 9 2 . 5 7 
1 4 5 . 6 6 3 . 5 1 1 9 4 . 5 7 
1 4 6 . 6 7 7 0 3 1 9 5 . 5 4 
1 4 7 . 6 7 4 . 7 9 1 9 6 . 5 6 
1 4 8 . 6 5 Q 0 4 1 9 7 5 6 
1 4 9 . 6 5 3. 9 1 1 9 8 . 5 7 
1 5 0 . 6 4 9 . 5 8 1 9 9 . 6 3 
1 5 1 . 6 5 1 . 6 8 2 0 0 . 5 7 
1 5 2 . 6 4 c 9 9 2 1 0 . 5 4 
1 5 3 . 6 3 3 . 5 5 2 . M . 5 5 
1 5 4 . 6 1 1 0 0 . 0 0 2 1 2 . 5 6 
mt: 18335808 
HflSS 153 
7. B a s e 
1 7 3 8 
5 8 1 1 
6 . 5 5 
4 . 5 6 
3 . 9 9 
3 . 3 7 
2 . 3 7 
4 6 9 
3 . 2 9 
2 . 0 8 
2 . 1 2 
3 . 3 7 
2 . 8 5 
2 . 2 1 
3 . 4 2 
2 . 5 7 
' 5 1 
2 . 0 2 
2 . 7 3 
1 . 6 6 
2 . 4 2 
1 . 5 6 
7 4 5 
1 . 3 9 
4 . 3 0 
1 . 6 5 
4 2 9 
2 . 2 3 
3 . 5 2 
1 . 6 4 
2 . 0 7 
2 . 7 3 
2 . 9 4 
1 . 9 9 
2 . 4 4 
1 . 8 4 
2 . 4 9 
2 . 1 7 
1 . 9 9 
4 . 0 5 
2 . 6 1 
3 . 3 4 
768 
M a s s 
2 1 3 . 5 5 
2 1 4 . 5 4 
2 1 8 . 4 9 
2 1 9 . 5 1 
2 2 0 . 5 0 
2 2 1 . 5 1 
2 2 2 . 5 3 
2 2 4 . 5 3 
2 2 5 . 5 4 
2 2 6 . 5 2 
2 3 6 . 5 0 
2 3 7 . 5 2 
2 3 8 . 5 2 
2 3 9 . 5 1 
2 4 0 . 5 1 
2 5 0 . 5 1 
. 2 5 1 . 4 9 
2 5 2 . 4 9 
2 5 3 . 5 1 
2 5 4 . 4 7 
2 6 4 . 4 8 
2 7 2 . 4 2 
2 7 3 . 4 2 
2 7 4 . 4 1 
2 7 5 . 4 2 
2 7 8 . 4 8 
2 7 9 . 4 7 
2 8 0 . 4 5 
2 9 8 . 4 0 
3 0 0 . 3 7 
3 3 8 . 3 2 
3 3 9 . 3 4 
3 4 0 . 3 3 
3 4 1 . 3 7 
3 4 2 . 3 6 
3 5 6 . 3 1 
3 7 2 . 2 6 
3 7 3 . 2 8 
3 7 4 . 2 5 
3 7 5 . 2 6 
3 7 6 . 2 5 
3 7 7 . 2 6 
3 7 8 . 2 8 
sea 
v. e a s e 
6 9 
9 6 
5 2 
3 5 
3 6 . 9 4 
4 . 1 2 
1 . 9 2 
2 . 4 7 
1 . 9 8 
2 . 0 3 
2 . 3 5 
1 . 9 6 
1 2 . 1 8 
4 3 9 
3 . 7 3 
1 . 7 5 
2 . 3 4 
2 . 7 5 
1 . 8 5 
5 6 
1 5 
8 2 
0 1 
1 3 
1. 6 1 
2 . 2 2 
1. 5 6 
1 . 8 1 
1. 5 6 
1. 7 6 
2 . 9 4 
1. 5 8 
1 2 . 8 6 
3 . 3 9 
1 . 9 8 
2 . 1 3 
2 . 7 4 
1 . 7 2 
2 7 . 4 4 
6 . 8 5 
1 0 . 5 5 
2 . 5 8 
I . 1 3 
\ 
300 
S p e c t r u m No .37 (FAB+) 
NCP343I18« xl Bgd=G 5 - n R Y - 9 2 1 8 : 2 8 - 8 : B | : 3 5 78E F B -
BpB=97 !=78ini H.=9GE 110=8859888 Rent : Sy5 : r f l 8 HflR: 
NIGEL PARKINSON Pt= 8° CaL PFKSIIRY n R S S : 
1 97 
512888 
97 
132 1GB 352 
378 424 
388 586 788 
F 8 -NCP343I15 . x l B9d=5 5 - n R Y - 9 2 18 :28 -8 :82 :11 78E 
8pn=178 l=G.Bii H«=1B27 110=338884888 Rent : 5 y s : F R B HflR: 
NIGEL PRRKINSBN PT= 8° C a l P F r a R Y fiRSS: 
1 8 8 , 1^9 
13G 
221 398 
2B8 388 
M a s s /. B a s e M a s s 7. B a s e 
4 7 . 8 6 1 . 3 1 1 1 2 . 9 9 1 . 3 1 
5 0 . 8 6 2 . 6 2 1 1 7 0 1 1 . 3 1 
5 1 . 8 8 1 . 3 1 1 1 9 0 0 2 . 0 7 
5 2 . 8 9 1 . 3 1 1 2 0 0 2 1 . 7 6 
5 3 . 9 0 1 . 9 7 1 2 1 0 2 2 . 7 5 
5 4 . 9 1 3 . 2 8 1 2 2 0 3 1 . 3 6 
5 5 . 9 3 1 . 9 7 1 2 3 0 3 1 . 4 3 
5 6 . 9 3 7 . 3 0 1 2 4 0 3 1 . 4 5 
5 7 . 9 4 1 . 2 8 1 2 5 . 0 4 1 . 3 1 
5 8 . 9 4 9 . 1 7 1 2 6 . 0 4 1 . 4 2 
5 9 . 9 5 2 . 0 6 1 2 6 . 9 9 7 . 8 6 
6 0 9 5 9 . 1 7 1 3 3 0 0 3 . 9 3 
6 4 . 9 6 3 , 3 9 1 3 4 0 1 1 1 8 0 
6 5 . 9 7 0 . 6 6 1 3 5 0 2 1 0 . 4 8 
6 6 9 8 1 . 3 1 1 3 6 0 3 2 7 . 3 5 
6 7 . 9 8 1 . 3 3 1 3 7 . 0 3 3 . 9 3 
5 8 . 9 7 3 . 9 3 1 3 8 . 0 4 2 6 4 
6 9 . 9 9 1 . 3 1 1 3 9 . 0 3 1 . 3 1 
7 1 . 0 0 1 . 3 1 1 4 5 0 0 1 . 9 7 
7 3 . 0 0 1 3 1 1 4 6 0 1 1 . 3 1 
7 5 0 1 3 9 3 1 4 7 0 2 1 . 4 6 
7 6 . 9 9 2 . 6 3 1 4 8 0 3 3 . 2 8 
8 0 0 2 1 1 9 1 4 9 0 2 5 . 4 3 
3 1 0 2 1 3 2 1 5 0 . 0 4 4 . 6 0 
8 2 0 2 1 3 1 1 5 1 . 0 1 3 . 9 3 
8 3 0 2 1 3 1 1 5 2 . 0 3 6 . 0 0 
8 4 0 3 1 3 1 1 5 3 . 0 0 3 . 2 8 
8 5 0 3 1 3 1 1 5 4 . 0 3 2 . 0 7 
8 9 0 1 1 3 1 1 5 5 . 0 0 1 . 4 7 
9 1 0 1 3 9 3 1 5 7 0 0 1 . 3 1 
9 2 0 1 1 3 1 1 5 8 0 1 1 . 3 1 
9 3 0 3 7 9 0 1 5 9 0 2 1 . 5 1 
9 4 0 2 2 2 0 1 6 0 . 0 2 3 . 4 4 
9 5 0 1 1 9 7 1 6 1 . 0 2 2 . 6 2 
9 6 0 3 1 5 4 1 6 2 . 0 4 5 . 2 4 
9 7 0 3 1 3 1 1 6 3 . 0 3 2 . 7 5 
1 0 3 0 1 I 5 9 1 6 4 . 0 3 3 . 9 3 
1 0 7 0 1 1 3 8 1 6 5 . 0 3 5 . 9 3 
1 0 8 0 2 2 6 3 1 6 6 . 0 3 2 6 . 2 2 
1 0 9 0 2 4 6 1 1 6 7 . 0 3 3 . 0 2 
1 1 0 0 2 1 9 7 1 6 8 . 0 4 1 . 9 7 
1 1 1 . 0 4 2 . 2 1 1 6 8 . 9 8 1 3 . 1 1 
M a s s 
1 6 9 . 9 8 
1 7 0 . 9 8 
1 7 1 . 9 8 
1 7 2 . 9 9 
1 7 4 . 0 2 
1 7 5 . 0 3 
1 7 5 . 0 3 
1 7 7 . 0 2 
1 7 8 0 3 
1 7 9 0 3 
1 3 0 . 0 3 
1 8 0 . 9 9 
1 8 1 . 9 9 
1 8 2 . 9 9 
1 8 4 . 0 0 
1 8 5 . 0 2 
1 8 5 . 0 1 
1 8 7 . 0 2 
1 8 8 . 0 1 
1 9 6 . 0 1 
1 9 7 . 0 2 
1 9 8 . 0 1 
2 0 0 . 0 0 
2 1 0 . 0 3 
2 1 1 . 0 0 
2 1 2 . 0 2 
2 1 8 . 9 8 
2 2 0 9 9 
2 2 2 . 0 0 
2 2 6 . 0 3 
2 2 8 . 0 5 
2 6 9 . 0 4 
3 5 4 . 0 0 
3 5 4 . 9 9 
3 5 6 . 0 0 
3 5 7 . 0 1 
3 5 8 . 0 3 
3 7 0 . 0 2 
3 7 1 . 9 9 
3 7 4 . 0 1 
3 8 4 9 9 
5BB 
7. B a s e 
1 0 0 . 0 0 
1 3 . 1 1 
3 4 . 1 7 
6 . 5 6 
3 . 2 8 
1 . 9 7 
2 . 6 2 
1 . 9 7 
3 . 9 3 
1 . 5 0 
1 . 3 7 
1 . 3 1 
3 . 2 8 
2 . 0 9 
2 . 6 2 
1 . 5 5 
1 . 4 1 
I . 3 1 
1 . 3 1 
1 . 9 7 
0 . 6 7 
1 . 4 0 
1 . 3 1 ' 
1 . 3 1 
1 . 3 1 
1 . 3 1 
1 . 3 1 
1 1 . 1 7 
1 . 4 1 
1 . 9 7 
2 . 6 2 
1 . 9 7 
1 . 3 1 
1 . 3 1 
5 . 3 5 
1 . 9 0 
1 . 3 1 
1 . 3 1 
1 . 3 1 
1 . 3 1 
1 . 3 1 
33BGG838 
178 
GB8 788 
M a s s Z B a s e 
3 8 5 . 9 8 6 . 5 6 
3 8 6 . 9 8 1 . 7 2 
3 8 7 . 9 7 2 . 1 3 
3 8 8 . 9 2 1 . 5 2 
3 8 9 . 9 2 1 2 . 8 4 
3 9 0 . 9 4 3 . 9 3 
3 9 1 . 9 3 5 . 2 4 
3 9 2 . 9 4 1 . 3 1 
3 9 3 . 9 6 0 . 6 6 
S p e c t r u m No.38 (FAB+) 
301 
NCPPEPI9 . x l B9d=G 5 - n R Y - 3 2 1 1 : 5 6 - 8 : 8 1 : 2 8 78E E B -
Bnn=8 l=7Bin. H«=87? 110=4644666 B e n t : S y s : E R 6 HJK: 
NIGEL PRRKINSON " = 8 ° C a t : P E ™ "RSS: 
168, 153 
512888 
153 
117 
1,1,11 
391 
217 
l l l . l l II I 
268 366 568 
N C P P E P I l l . x l 6gd=l 5 - B R Y - 9 2 1 1 : 5 6 . 6 : 8 1 : 4 2 78E 
Bpl1=6 1=5.8^1 H«=835 T ! C = 2 3 9 2 8 3 B 8 8 Rent : 
N I G E L 
, 155 
S y s : E f l B HNR: 37896886 
P T = 6 ° Ca t :PE i ;5Bf lY URSS: 155 
9! I j l 
263 357 
266 366 588 
M a s s y. B a s e M a s s 
y. B a s e 
5 0 8 8 2 7 0 
1 4 0 9 4 1 3 5 
3 1 
5 2 
8 9 
9 0 
1 3 5 1 4 2 9 3 1 3 5 
1 3 5 1 4 3 9 4 0 6 8 
5 3 9 1 1 3 5 
1 4 4 . 9 4 1 3 6 
5 4 9 1 2 2 6 
1 4 5 . 9 5 1 3 5 
3 8 
1 4 6 . 9 6 2 0 5 
5 6 . 9 2 3 1 4 7 . 9 6 1 3 5 
5 8 . 9 2 4 0 5 1 4 8 . 9 4 1. 5 1 
6 0 9 3 2 8 2 1 4 9 . 9 5 1 . 3 5 
6 3 . 9 3 1 4 7 1 5 0 . 9 6 2 . 2 0 
6 4 . 9 4 2 7 0 1 3 2 . 9 4 2 . 0 1 
6 6 . 9 6 1. 3 5 1 5 3 . 9 1 1 . 4 9 
6 7 . 9 6 1. 3 5 1 5 4 . 9 1 1 0 0 . 0 0 
6 8 . 9 5 7 . 5 2 1 5 5 . 9 1 1 0 . 1 3 
6 9 . 9 7 1 . 3 5 1 5 6 . 9 0 3 1 . 8 7 
7 0 . 9 7 2 0 3 1 5 7 . 9 1 3 3 8 
7 4 . 9 8 2 0 5 1 5 8 . 9 4 1 9 8 
7 6 . 9 6 3 5 1 1 5 9 . 9 5 1 3 5 
8 4 . 9 9 1 3 5 1 6 0 . 9 4 1 . 3 5 
9 0 . 9 8 1 2 . 9 2 1 6 2 . 9 4 2 . 0 3 
9 1 . 9 8 1. 5 4 1 6 6 . 9 1 1 . 3 5 
9 2 . 9 9 4 . 0 5 1 6 7 . 9 1 1. 4 5 
9 3 . 9 8 2 . 0 3 1 6 8 . 9 1 1. 3 9 
9 4 . 9 6 2 . 0 6 1 6 9 . 9 1 1. 3 5 
1 0 8 . 9 6 2 . 2 4 1 7 0 . 9 2 1. 3 5 
1 1 2 9 5 3 0 1 1 7 2 . 9 3 1. 
3 6 
1 1 4 9 6 6 0 6 1 7 4 . 9 3 1 . 3 5 
1 1 6 9 5 1 3 5 1 8 0 . 9 0 2 . 8 0 
1 1 7 9 6 1 3 5 1 8 4 9 2 1 3 9 
1 1 8 9 5 6 7 6 1 9 2 9 1 1 3 5 
1 1 9 9 6 4 9 2 1 9 4 9 1 1 3 5 
1 2 0 9 7 1 4 3 5 2 0 0 9 0 1 5 8 
1 2 1 9 7 2 0 3 2 0 1 9 1 1 3 5 
1 2 2 9 7 1 3 5 2 0 2 9 1 2 0 4 6 
1 3 2 9 3 5 4 0 2 0 3 . 9 1 y 2 0 3 
1 3 3 9 6 2 0 3 2 1 0 9 2 1 3 5 
1 3 4 9 5 4 7 3 2 1 2 9 4 1 3 5 
1 3 5 9 6 2 11 2 2 0 8 9 1 3 5 
1 3 6 9 5 5 6 7 
8 9 . 3 8 2 3 8 3 
1 3 8 9 4 1 3 5 
2 3 9 9 0 1 . 3 5 
M a s s y. B a s e 
2 5 2 . 9 1 1 . 3 5 
2 7 2 . 8 4 2 . 0 7 
2 7 3 . 8 5 0 . 7 4 
2 7 4 . 8 5 1. 3 5 
3 2 0 8 3 1 . 3 5 
3 5 4 7 8 1 4 1 
3 5 5 7 6 0 6 8 
3 3 6 7 8 1 8 2 4 
3 5 7 7 8 4 7 3 
3 5 8 7 7 6 9 3 
3 5 9 . 7 8 1 6 4 
3 6 0 . 8 0 0 6 8 
302 
S p e c t r u m No.39(FAB+) 
rds0200001 Scan 8 RT=0:44 100%=134539 mv 7 Jul 93 15:00 
LRP +FAB NCP 79 718706 POS-FAB-MS GLY 
l o o -
s e -
|liiiii|liliiiiii|ili|kiii 
200 250 
llilill[llllilll|lilJllil|!iiliil,l;lllj 
300 350 
no numeric data 
•133 "59 
lUljll itillljiirlllll liilli|llllliil.jl!lliihl|illillitl|l.r. ..t'l I,';, i., iillrl|liill,l..jl ^ .. I, l l l j ju jp 
493 
.l.llulllitl 
4 0 0 450 
303 
S p e c t r u m No .40 (FAB- ) 
NCP344IB. x l Bgd^G 5-flRY-92 l f l : 5 4 - 8 : 
flp/l=8 l=4G.u H«=B93 IIC=887188fl 
NIGEL PflRUNSON 
188, 342 
151 
:21 7BE F 8 -
R c n t : S y s : F R B 
PI= 8° C a l : P f i ; 5 n R Y 
HflR: 
flRSS: 
385888 
3 4 ? 
132 
I 
453 478 513 542 57B 613 B51 s p g 785 742 8 1 3 . 85B 22S 272 
NCP344I11. x l Bgd=l 5-nflY-32 18 : 5 4-8 : 8 1 : 4 2 78E 
8pn=8 1=4. lu H«=B32 IIC=3GB1GBB16 R e n t : 
NIGEL PRRCINSflN 8 
188, 344 
F B -
Sys:Ffl8 
C a L : P r M Y 
182 
95 
5,163 I 136 
288 388 588 
M a s s 
6 5 . 9 7 
8 9 . 9 9 
1 1 2 . 9 8 
1 3 0 . 9 7 
1 3 1 . 9 7 
1 4 4 . 9 9 
1 5 0 . 9 8 
1 5 2 . 0 0 
1 5 9 . 9 9 
1 6 8 . 9 9 
1 6 9 . 9 9 
1 7 9 . 9 8 
3 3 9 . 0 0 
3 4 1 .01 
3 4 2 . 0 1 
•/. B a s e 
1 7 . 5 6 
2 0 . 1 2 
21 .00 
2 0 . 9 7 
2 4 . 8 9 
1 5 . 50 
31 .98 
1 8 . 7 8 • 
1 6 . 3 4 
1 9 . 7 9 
18 .94 
19 .71 
3 9 . 9 8 
19 .11 
1 0 0 . 0 0 
S p e c t r u m No .41 (FAB+) 
304 
.'iCP34 X 
3Dfl=178 1=5.9u 
NIGEL PBRKINSON 
138, 
8gd=5 5 -BRY-92 18 :28 -8 :82 -11 / B E 
K.= I827 nC=338884BB8 Rent : 
158 
? I = 8 ' 
•3ys-Ffl8 HflR: 
C i l :?F t :5 f lRY flflSS 
2573888 
158 
-a J 
53 J 
U J l , , k , i i , 
372 
221 
188 288 
M a s s /. B a s e M a s s V. B a s e 
4 7 8 6 1 3 1 1 5 4 . 0 3 3 . 2 8 
5 0 . 8 6 2 . 5 2 1 5 5 . 0 0 1 . 9 7 
5 1 8 8 1 3 1 1 5 7 . 0 0 2 . 6 2 
5 2 8 9 1 3 1 1 5 8 . 0 1 1 . 9 7 
5 3 9 0 I 9 7 1 5 9 . 0 2 3 . 9 3 
5 4 9 1 3 2 8 I S O . 0 2 1 . 5 0 
5 5 9 3 1 9 7 1 6 1 . 0 2 1 . 3 7 
5 6 9 3 7 3 0 1 6 2 . 0 4 1 . 3 1 
5 7 9 4 1 2 8 1 6 3 . 0 3 3 . 2 8 
5 8 9 4 9 1 7 1 6 4 . 0 3 2 . 0 9 
5 9 9 5 2 0 6 1 6 5 0 3 2 . 6 2 
5 0 9 5 q 1 7 1 6 6 . 0 3 1 . 5 5 
6 4 9 6 3 3 9 1 6 7 . 0 3 1 . 4 1 
5 5 9 7 0 6 6 1 5 8 . 0 4 1 . 3 1 
6 6 9 8 1 3 1 1 6 8 . 9 8 3 . 9 3 
5 7 . 9 8 1 3 3 1 6 9 . 9 8 2 . 5 4 
6 8 . 9 7 3 9 3 1 7 0 , 9 8 1 . 3 1 
6 9 . 9 9 I . 3 1 1 7 1 . 9 8 1 9 7 
7 1 . 0 0 1 . 3 1 • 7 2 , 9 9 1 . 3 1 
7 3 0 0 1 3 1 ! 7 4 0 2 1 . 4 6 
7 5 0 1 3 9 3 ; 7 5 0 3 3 . 2 8 
7 6 . 9 9 2 6 3 1 7 6 0 3 2 . 6 2 
3 0 0 2 1 1 9 1 7 7 0 2 1 . 9 7 
3 1 0 2 1 3 2 1 7 8 . 0 3 3 . 9 3 
3 2 . 0 2 1 3 1 1 7 9 . 0 3 1 . 5 0 
3 3 0 2 1 3 1 1 3 0 . 0 3 1 . 3 7 
3 4 . 0 3 1 3 1 1 8 0 9 9 1 . 3 1 
3 5 . 0 3 1 3 1 1 3 1 . 9 9 3 . 2 8 
3 9 0 1 I 3 1 1 3 2 . 9 9 2 . 0 9 
9 1 . 0 1 3 9 3 i 8 4 . 0 0 2 . 6 2 
9 2 . 0 1 1 . 3 1 1 8 5 . 0 2 1 . 5 6 
9 3 . 0 3 7 . 9 0 1 3 6 . 0 1 1 . 4 1 
9 4 0 2 -t 2 0 1 3 7 . 0 2 1 . 3 1 
9 5 . 0 1 1 9 7 ; 3 8 . 0 1 1 . 3 1 
9 6 . 0 3 1 . 5 4 1 9 6 . 0 1 1 . 9 7 
9 7 . 0 3 1 . 3 1 1 9 7 0 2 0 . 6 7 
1 0 3 . 0 1 1 . 5 9 1 9 8 . 0 1 1 . 4 0 
1 0 7 0 1 I 3 8 2 0 0 . 0 0 1 . 3 1 
; 0 8 . 0 2 2 . 5 3 2 1 0 0 3 1 . 3 1 
; 0 9 0 2 4 6 1 2 1 1 0 0 1 . 3 1 
; 1 0 0 2 9 7 2 1 2 . 0 2 1 . 3 1 
1 1 1 . 0 4 2 . 2 1 2 1 8 . 9 8 1 . 3 1 
1 1 9 . 0 0 2 0 7 2 2 0 . 9 9 1 1 . 1 7 
1 2 0 . 0 2 1 . 7 6 2 2 2 . 0 0 1 . 4 1 
1 2 1 . 0 2 2 . 7 5 2 2 6 . 0 3 1 . 9 7 
1 2 2 . 0 3 7 . 8 6 2 2 8 . 0 5 2 . 6 2 
1 2 3 . 0 3 3 . 9 3 2 6 9 . 0 4 1 . 9 7 
1 2 4 . 0 3 3 . 2 8 3 5 4 . 0 0 1 . 3 1 
1 2 5 . 0 4 2 0 7 3 3 4 9 9 1 . 3 1 
1 2 6 . 0 4 1 . 4 7 3 5 6 . 0 0 5 . 3 5 
1 2 6 . 9 9 1 3 1 3 3 7 . 0 1 1 . 9 0 
1 3 3 . 0 0 3 1 3 5 8 . 0 3 1 1 . 8 0 
1 3 4 . 0 1 1 5 1 3 7 0 0 2 1 0 . 4 8 
1 3 5 . 0 2 3 4 4 3 7 1 9 9 5 4 . 9 1 
1 3 6 . 0 3 2 5 2 3 7 3 0 1 2 7 . 3 5 
1 3 7 . 0 3 5 2 4 
9 . 1 7 
1 3 8 . 0 4 2 7 5 
3 7 9 0 3 
1 3 9 . 0 3 3 9 3 3 9 0 . 0 2 
1 0 . 4 8 
1 4 5 0 0 5 . 9 3 
3 8 4 . 9 9 1 3 . 1 1 
1 4 6 0 1 2 6 . 2 2 
1 4 7 . 0 2 3 . 0 2 
1 4 8 . 0 3 1 . 9 7 
1 4 9 . 0 2 1 3 . 1 1 
1 5 0 . 0 4 1 0 0 . 0 0 
1 5 1 . 0 1 . 1 3 . 1 1 
1 5 2 . 0 3 3 4 1 7 
1 5 3 . 0 0 5 . 5 6 
»88 788 
305 
S p e c t r u m No.42(FAB+) 
rds0220003 Scan 7 RT=0:39 100%=167789 mv 7 Jul 93 15:28 
L R P - K F A B N C P 83 718710 P O S - F A B - M S G L Y 
100—1 356 
50 • 
L n i l ^ Ll!lM^lf<l'!l|f¥jj^^ |^ i,(l||»,P.?P«,|l,,i<yllJ^4| A J l 
200 300 400 500 600 700 
no numeric data 
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S p e c t r u m No.43(FAB+) 
N C P 4 1 1 f l l l 2 » x l Bgd= 
Bpfl=B h l B v HB=B9 I 
NIGEL PRRKINSON 
- x i -0 
I m 
5 - f l R Y - 9 2 
r i C = 4 l 5 B B 6 B l G 
1 9 : 3 6 - 9 B l 49 7BE 
R e n t : 
EB-
P I = 9 ° 
S g s : E R B 
CaL :PEK5nRY 
HIIR: 
URSS: 
4352899 
243 
95 
9B 
B5 
BB 
75 
78 
G5 
B B J 
55 
58 
45 
4B 
35 
38 
25 
29 
15 
221 229 
277 
257 
337 
381 
323 
mm 
258 368 
IllililllllJlk 
359 
M a s s V. B a s e M a s s 7. B a s e 
5 4 . 9 0 1 . 9 8 1 3 4 . 9 9 1 . 5 6 
5 5 . 9 0 3 . 1 3 1 3 5 . 9 9 3 . 1 3 
5 6 . 9 2 2 9 . 3 0 1 3 6 . 9 8 8 . 1 6 
5 7 . 9 3 2 . 3 4 1 3 7 9 9 1 . 9 4 
5 8 . 9 3 1 . 2 1 1 4 8 9 8 4 1 7 
5 9 . 9 2 1 . 6 6 1 4 9 9 8 2 3 4 
6 0 4 9 0 . 3 9 1 5 0 9 8 5 1 5 6 
S O 9 2 S . 5 4 1 5 1 9 9 7 7 8 
6 8 9 6 1 . S O 1 5 2 . 9 9 2 . 7 4 
6 9 9 8 0 . 7 8 1 5 4 9 9 3 1 3 
7 0 9 8 1 . 1 7 1 6 5 9 9 2 0 3 
7 1 9 8 1 . 1 7 1 6 6 9 9 1 5 6 
7 2 9 7 2 . 7 9 1 6 9 9 4 1 5 6 
7 3 9 8 5 . 0 8 I S O 9 7 1 1 7 
7 4 9 9 3 9 . 4 7 1 3 5 . 0 1 5 4 . 0 1 
7 5 . 9 9 1 . 5 5 1 8 6 . 0 1 4 . 6 9 
8 3 0 1 1 . 1 2 1 8 5 . 9 5 1 . 5 7 
8 9 9 9 1 . 5 6 2 0 5 . 9 9 1 . 1 7 
9 0 9 9 1 . 1 7 2 1 2 . 9 9 1 5 5 
9 3 0 0 1 0 0 . 0 0 2 2 0 . 9 4 I 2 2 
9 4 0 0 5 . 4 0 2 2 8 . 9 8 1 . 3 0 
9 5 0 0 1 . 8 7 
2 4 0 . 9 9 1 . 5 6 
1 0 3 0 0 ! . 3 0 2 4 2 . 9 9 5 . 5 4 
1 0 4 2 0 - S . 2 5 2 4 3 . 9 9 1 . 2 3 
1 0 8 9 9 1 . 1 7 2 7 7 . 0 1 4 . 3 0 
1 1 0 0 0 3 . 9 1 2 7 9 . 0 1 1 . 1 7 
M I . 0 0 i 2 5 
1 1 4 . 
3 3 S . 9 0 1 1 7 
9 8 1 . 3 7 
1 1 5 . 9 9 1 . 7 1 
1 1 8 . 9 9 1 . 1 7 
1 1 9 . 9 8 1 . 1 5 
1 2 0 . 9 9 1 . 5 5 
1 2 2 . 9 9 1 . 5 6 
1 3 0 . 9 8 1 . 2 4 
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Spectrum No.44 (FAB+) 
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38 
Mass 
8 48 
•/. Base 
182 98 1 1 4 
184 96 61 54 
185 97 3 94 
186 91 3 85 
197 96 1 23 
201 98 12 35 
203 01 1 14 
227 96 1 13 
276 94 5 02 
287 89 1 . 49 
293 96 3 85 
321 84 15 43 
322 85 4 39 
323 84 7 69 
324 84 1 58 
325 91 0 8 1 
353 85 3 86 
354. 85 0 95 
355. 86 1 54 
365. 3 1 0 96 
3SB. 94 1 52 
383. 83 4. 18 
384. 85 1 . 38 
385. 88 3. 85 
4 1 1 . 83 1. 14 
412. 82 0. 60 
413. 82 1 1 . 54 
414. 85 3. 85 
415. 83 5. 17 
416. 82 0. 83 
414 
M a s s 
54. 90 
55. 90 
56. 92 
57. 93 
58. 93 
59. 92 
60. 93 
6 1 . 93 
68. 94 
72. 97 
73. 98 
74. 98 
75. 99 
39. 98 
90. 99 
92. 99 
94. 00 
94. 99 
102. 97 
108. 98 
1 10. 00 
U 1 . 00 
1 16. 98 
1 17. 99 
118 .97 
120. 98 
122. 00 
122. 97 
134 .97 
135 ,97 
136. 98 
137 .65 
137 .99 
148. 97 
149. 97 
150. 96 
161 .97 
164. 96 
165. 98 
166.96 
167. 98 
1 77. 96 
Base 
3. 85 
3. 85 
23. 08 
23 
83 
72 
12, 00 
1 , 08 
1,41 
3, 85 
3. 85 
30. 77 
1 , 13 
1 , 25 
0. 96 
100 .00 
01 
55 
16 
64 
48 
85 
38 
57 
08 
52 
53 
17 
50 
15, 38 
3, 85 
0, 54 
1 , 23 
2, 90 
1. 29 
1. 91 
58 
91 
85 
1 , 07 
59 
23 
;8B 
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Spectrum No.45(FAB + ) 
N C P L I Q I I U x l =3 3 B - S E P - 9 2 14 51*9 8 ^ 8 ? ? 8 [ f 9 -
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NIGCL PflRKlNSOH 
•XI -0 
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Hii=3593 I I C = I 8 7 B 8 2 8 B 8 flcnt; S y s FRBHI 
C a l P T O S S E P S 
Mass Mass y. Base Mass 
40. 99 74. 94 l i s SS 75. 93 4. 08 42. 97 3 e . 57 76. 94 24. G7 1 18 87 43. 01 
5. GS 1 19. 87 43. 98 78. 95 12. 80 120 90 44. 98 39 21 
45. 99 80. 88 13 89 124 87 46. 96 16 . 50 80. 97 126 .SS 47. 92 
81. 90 14 04 48. 95 127 90 82. 90 
49. 96 128. 89 83. 92 
50. 97 15. 92 129.89 84. 93 
51. 98 130.89 85. 93 
52. 98 86. 92 
53. 99 132 86 87. 95 
54. 98 134.89 88. 93 12. 90 
135.89 55. 99 89. 91 
90. 93 136 . 87 12. 25 56. 99 22. 25 
91. 92 137.88 57. 98 
92. 91 138.87 58. 98 100.00 
93. 91 139 81 59. 96 
140. 87 60. 96 94. 91 14. 02 
144 86 95. 91 61. 06 2. 28 
146.87 96. 91 
148.84 100.88 62. 96 9. 7C 
154.85 102. 93 17. 40 63. 95 
156 84 103. 92 64. 91 34. 22 
160 84 104.92 64. 97 16. 34 
106.91 164. 87 65. 97 
172, 80 107.92 G6. 96 6. 32 
18. 59 179. 89 108.91 20 33 68. 94 
180.81 109. 91 69. 94 
190 78 110. 90 70. 95 20 94 
192. 78 
112. 90 202 .73 12. 52 
114. 89 73. 93 203.81 14 0<J 
2B9 
,ui Urn II 
25B 3BB 
Base Mass '/. Base 
3 . 29 212 76 4 14 
2 . 37 220 79 4 63 
2 . 86 222 87 3 59 
3 41 236 71 3 07 
5 82 240 75 4 13 
3 05 244 75 3 07 
3 49 247 79 4 44 
11 43 257 75 2 75 
6 86 267 73 2 72 
18. 54 268 75 37 09 
5. 88 269 77 4 62 
17. 05 286. 73 2 1 7 
8. 85 291. 58 2. 35 
8. 20 323. 64 1. 55 
1 7. 54 324 73 1 . 45 
2. 40 336. 68 1 . 55 
2. 92 349. 66 1. 82 
6. 43 350. 77 0. 73 
5. 22 356. 68 1. 90 
2. 01 
4. 55 
3. 21 
4. 90 
10 46 
9. 61 
3. 48 
3. 67 
3. 59 
3. 81 
9. 70 
3. 38 
5. 07 
6. 78 
26. 39 
2. 69 
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Appendix Four 
The Board of Studies in Chemistry requires that each postgraduate research thesis 
contains an appendix listing ;-
(i) all research colloquia, seminars and lectiires arranged by the Department of 
Qiemistry during the period of the author's residence as a postgraduate student; 
(ii) lectures organised by Durham University Chemical Society; 
(iii) all research conferences attended and papers presented by the author during the 
period when research for the thesis was carried out; 
(iv) details of the postgraduate induction course. 
ColloQuia. Lectures and Seminars Given hv Invited Sneakers 
October 1989 - September 1992 
(Those attended are marked *) 
10.10.89 Prof. J.I.G Cadogan (B.P.) 
From Pure Science to Profit 
17.10.89 Dr. F. Palmer (Nottingham University) 
* Thunder and Lightning 
25.10.89 Prof. C. Floriani (Lausanne University, Switzerland) 
Molecular Aggregates - A Bridge Between Homogeneous and 
Heterogenous Systems 
01.11.89 Dr. J.P.S. Badyal (Durham University) 
Breakthroughs in Heterogeneous Catalysis 
09.11.89 Prof. N.N. Greenwood (Leeds University) 
Novel Cluster Geometries in Metalloborane Chemistry 
10.11.89 Prof. J.E. Bercaw (California InstittJte of Technology) 
Synthetic and Mechanistic Approaches to Ziegler-Natta Polymerisation 
of Olefins 
13.11.89 Dr. J. Becher (Odense University) 
* Synthesis of New Macrocyclic Systems using Heterocyclic Building 
Blocks 
16.11.89 Dr. D. Parker (Durham University) 
* Macrocycles, Drugs and Rock 'n' Roll 
* 
* 
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29.11.89 Prof. D J . Cole-Hamilton (St. Andrews University) 
New Polymers from Homogeneous Catalysis 
30.11.89 Dr. M.N. Hughes (King's CoUege, London) 
* A Bug's Eye View of the Periodic Table 
04.12.89 Dr. D. Graham (B.P. Research Centre) 
How Proteins Absorb on Interfaces 
06.12.89 Dr. R.L. Powel (ICI) 
* The Development of CFC Replacemerus 
07.12.89 Dr. A. Butler (St. Andrews University) 
* The Discovery of Penicillin: Facts and Fancies 
13.12.89 Dr. J. Klinowski (Cambridge University) 
Solid State NMR Studies of Zeolite Cages 
15.12.89 Prof. R. Huisgen (Universitai Miinchen) 
Recent Mechanistic Studies of [2+2J Additions 
24.01.90 Dr. R.N. Perutz (York University) 
Plotting the Course ofC-H Activations with Organometallics 
31.01.90 Dr. U. Dyer (Glaxo) 
Synthesis and Conformation of C-Glycosides 
01.02.90 Prof. J.H. Holloway (Leicester University) 
* Noble Gas Chemistry 
07.02.90 Dr. D.P. Thompson (Newcasde University) 
The Rdle of Nitrogen in Extending Silicate Crystal Chemistry 
08.02.90 Rev. R. Lancaster (Kimbolton Fireworks) 
* Fireworks - Principles and Practice 
12.02.90 Prof. L . Lunazzi (University of Bologna) 
Application of Dynamic NMR to the Study of Conformational Isomerism 
14.02.90 Prof. D. Sutton (Simon Eraser University, Vancouver B.C.) 
Synthesis and Applications of Dinitrogen and Diazo Compounds of 
Rhenium arui Iridium 
15.02.90 Prof. L. Crombie (Nottingham University) 
The Chemistry of Cannabis and Khat 
21.02.90 Dr. C. Bleasdale (Newcasde University) 
* The Mode of Action of some Anti-tumour Agents 
22.02.90 Prof. D.T. Clark (ICI WUton) 
Spatially Resolved Chemistry usin Nature's Paradigm in the Advanced 
Materials area 
28.02.90 Dr. R.K. Thomas (Oxford University) 
Neutron Reflectometry from Surfaces 
01.03.90 Dr. J.F. Stoddart (Sheffield University) 
Molecular Lego • 
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08.03.90 Dr. A .K. Cheetham (Oxford University) 
Chemistry of Zeolite Cages 
21.03.90 Dr. L Powis (Nottingham University) 
Spinning Off in a Huff: Photodissociation of Methyl Iodide 
23.03.90 Prof. J .M. Bowman (Emory University) 
Fitting Experiment with theory Ar-OH 
29.05.90 Prof. N . Bartlett (University of California) 
* Silver Trifluoride 
09.07.90 Prof L.S. German (USSR Academy of Sciences - Moscow) 
* New Syntheses in Fluoroaliphatic Chemistry: Recent Advances in the 
Chemistry of Fluorinated Oxiranes 
09.07.90 Prof V.E. Platonov (USSR Academy of Sciences - Novosibirsk) 
* Polyfluoroindanes: Synthesi and Transformation 
09.07.90 Prof I .N. Rozhkov (USSR Academy of Sciences - Moscow) 
* Reactivity of Perfluoroalkyl Bromides 
11.10.90 Dr. W.A. MacDonald (ICI Wilton) 
* Materials for the Space Age 
24.10.90 Dr. M . Bochmann (U.E.A) 
Synthesis, Reactions and Catalytic Activity ofCationic Titanium Alkyls 
26.10.90 Prof. R. Soulen (Soudi Western University, Texas) 
* Chemistry of some Fluorinated Cyclobutenes 
31.10.90 Dr. R. Jackson (Newcastle University) 
* New Synthetic Methods: a-Aminoacids and Small Rings 
01.11.90 Dr. N. Logan (Nottingham University) 
Rocket Prope Hants 
06.11.90 Dr. P. Kocovsky (Uppsala University) 
* Stereo-controlled Reactions Mediated by Transition and Non-Transition 
Metals 
07.11.90 Dr. D. Gerrard (B.P.) 
Raman Spectroscopy for Industrial Analysis 
07.11.90 Dr. W. Dolbier (Gainsville, Florida) 
* Rearrangements of bis CF3 Vinyl Aromatics: a route to IJ^-
Hexatrienes 
08.11.90 Dr. S. K. Scott (Leeds University) 
Clocks, Oscillations and Chaos 
14.11.90 Prof. T. Bell (SUNY, Stony Brook, U.S.A.) 
* Functional Molecular Architecture and Molecular Recognition 
21.11.90 Prof. J. Pritchard (Queen Mary and Westfield College, London) 
Copper Surfaces and Catalysis 
28.11.90 Dr. B.J. Whitaker (Leeds University) 
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Products 
29.11.90 
05.12.90 
13.12.90 
15.01.91 
17.01.91 
23.01.91 
24.01.91 
30.01.91 
active 
31.01.91 
06.02.91 
14.02.91 
20.02.91 
28.02.91 
* 
06.03.91 
07.03.91 
16.04.91 
Heterocycles 
24.04.91 
25.04.91 
Two-dimensiuonal Velocity Imaging of State-Selected Reaction 
Prof D. Crout (Warwick University) 
Enzymes in Organic Chemistry 
Dr. P.G. Pringle (Bristol University) 
Metal Complexes with Functionalised Phosphines 
Prof. A.H. Cowley (University of Texas) 
New Organometallic Routes to Electronic Materials 
Dr. B.J. Alder (Lawrence Livermore Labs., California) 
Hydrogen in all its Glory 
Dr. P. Sarre (Nottingham University) 
Comet Chemistry 
Prof. J.S. Higgins (imperial College, London) 
Rheology and Molecular Structure oflonomer Solutions 
Dr. PJ . Sadler (Birbeck College, London) 
Design of Inorganic Drugs: Precious Metals, Hypertension and HIV 
Prof. E. Sinn (Hull University) 
Coupling of Little Electrons in Big Molecules. Implications for the 
Site of Macromolecules 
Dr. D. Lacey (Hull University) 
Liquid Crystals 
Dr. R. Bushby (Leeds University) 
Biradicals and Organic Magnets 
Dr. M.C. Petty (Durham University) 
Molecular Electronics 
Prof. B.L. Shaw (Leeds University) 
Synthesis with Coordinated, Unsaturated Phosphine Ligands 
Dr. J. Brown (Oxford University) 
Can Chemistry Provide Catalysts Superior to Enzymes? 
Dr. C M . Dobson (Oxford University) 
NMR Studies of Dynamics in Molecular Crystals 
Dr. J. Markam (ICI Pharmaceuticals) 
DNA Fingerprinting 
Dr. J. Murphy (Nottingham University) 
The Rdle of Radicals in the Construction and Destruction of 
Prof. R.R. Schrock (MTT) 
Metal-Ligand Multiple Bonds and Metathesis Initiators 
Prof. T. Hudlicky (Virginia Polytechnic Institute) 
Biocatalysis and Symmetry Based Approaches to the Efficient Synthesis 
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of Complex Natural Products 
20.06.91 Prof. M.S. Brookhart (University of North Carolina) 
Olefin Polymeristaions, Oligomerisations and Dimerisations Using 
Electrophilic Late Transition Metal Catalysts 
29.07.91 Dr. M.A. Brimble (Massey University, New Zealand) 
Synthetic Studies Towards the Antibiotic Griseusin-A 
17.10.91 Dr. J.A. Salthouse (Manchester University) 
* Son et Lumiere 
31.10.91 Dr. R. Keeley (Meo-opolitan Police) 
Modern Forensic Science 
06.11.91 Dr. B.F.G. Johnson (Edinburgh University) 
Cluster-Surface Analogies 
07.11.91 Dr. A.R. Butler (St. Andrews University) 
* Traditional Chinese Herbal Drugs 
13.11.91 Prof. D. Gani (St. Adrews University) 
* The Chemistry ofPLP Dependant Enzymes 
20.11.91 Dr. R. More O'Ferrall (University CoUege, Dublin) 
* Some Acid-Catalysed Rearrangements in Organic Chemistry 
28.11.91 Prof. I . M . Ward (Leeds University) 
The Science & Technology of Orientated Polymers 
04.12.91 Prof. R. Grigg (Leeds University) 
* Palladium Catalysed Cyclisation and Ion Capture Processes 
05.12.91 Prof. A .L . Smith (ex Unilever) 
Soap Detergents and Black Puddings 
11.12.91 Dr. W.D. Cooper (SheU Research) 
Colloid Science, Theory, and Practice 
09.01.92 Mr . C.E. Snyder (U.S. Air Force, Ohio) 
* Perfluoropoly ethers 
16.01.92 Dr. N.J. Long (Exeter University) 
* Metallocenophanes-Chemical Sugar-tongs 
22.01.92 Dr. K.D.M. Harris (St Andrews University) 
Understanding the Properties of Solid Inclusion Compounds 
29.01.92 Dr. A. Holmes (Cambridge University) 
* Cycloaddition Reactions in the Service of the Synthesis of Piperidine 
and Indolizidine Natural Products 
30.01.92 Dr. M . Anderson (SheU Research, Sittingboume) 
* Recent Advances in the Safe and Selective Chemical Control of Insect 
Pests 
* 
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12.02.92 Dr. D.E. Fenton (Sheffield University) 
polynuclear Complexes of Molecular Clefts as Models for Copper 
Biosites 
13.02.92 Dr. J. Saunders (Glaxo Research) 
Molecular Modelling in Drug Discovery 
19.02.92 Prof. E J . Thomas (Manchester University) 
* Application of Organo-Stannanes to Organic Synthesis 
20.02.92 Prof. E. Vogel (University of Cologne) 
Porphyrins: Molecules of Interdisciplinary Interest 
25.02.92 Prof. J.F. Nixon (University of Sussex) 
Phosphaalkynes, New Building Blocks in Inorganic and Organometallic 
Chemistry 
26.02.92 Prof. M . L . Hitchman (Strathclyde University) 
Chemical Vapour Deposition 
05.03.92 Dr. N.C. Billingham (University of Sussex) 
Degradable Plastics-iVfyr/i or Magic? 
10.03.92 Dr. H.C. Fielding aCI, Chemicals & Polymers) 
* Fluoropolymer Membranes 
11.03.92 Dr. S.E. Thomas (Imperial CoUege, London) 
Recent Advances in Organoiron Chemistry 
12.03.92 Dr. R.A. Hann QCl Imagedata) 
Electronic Photography- An Inage of the Future 
18.03.92 Dr. H . Maskill (Newcastle University) 
Mechanistic Studies of Organic Group Transfer Reactions 
07.04.92 Prof. D.M. Knight (Durham University) 
Interpreting Experiments: The Beginning of Electrochemistry 
30.04.92 Dr. A. Marhold (Bayer Co., Leverkusen) 
* Fluorine Chemistry in the Bayer Company 
13.05.92 Dr. J-C. Gehert (Ciba Geigy, Basel) 
Some Aspects of Industrial Agrochemical Research 
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Research Conferences Attended 
15.12.89 Royal Society of Chemistry Perkin Division, One Day Meeting, 
E>urham University. 
07.03.90 Sa Graduate Symposium, York University. 
02.04.90 North East Graduate Symposium, Newcastle University. 
19.12.90 "Modem Aspects of Stereochemistry', One Day Meeting, Sheffield 
University 
Sept 91 13th International Symposium on Fluorine Chemistry, Ruhr Universitat, 
Bochum, Germany. 
05.09.92 Royal Society of Chemistry Perkin Division, Ehirham University. 
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First Ygar Induction Course 
This course consists of a series of one hour lectures on the services available in the 
department, as well as an examined six week taught course on modem nmr techniques. 
Safety Matters - Dr. M.R. Compton 
Electrical Appliances - Mr. B.T. Barker 
Chromatography and Microanalysis - Mr. T.F. Holmes 
Atomic Absorptiometry and Inorgaiuc Analysis - Mr. R. Coult 
Library Facilities - Ms M . Bird 
Mass Spectroscopy - Dr. M Jones 
Nuclear Magnetic Resonance Spectroscopy - E>r. R.S. Matthews 
Glass-blowing Techniques - Mr. R. Hart and Mr. G. Haswell 
Modem Nuclear Magnetic Resonance Techniques - Prof R.K. Harris 
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